
<html lang="en"     class="pb-page"  data-request-id="f457c8b2-c665-4a2d-9321-32dbc1fe8d12"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm500115w;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2014.57.issue-10"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of N-((4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A Highly Potent, Selective, and Orally Bioavailable Inhibitor of TGF-β Type I Receptor Kinase as Cancer Immunotherapeutic/Antifibrotic Agent" /></meta><meta name="dc.Creator" content="Cheng Hua  Jin" /></meta><meta name="dc.Creator" content="Maddeboina  Krishnaiah" /></meta><meta name="dc.Creator" content="Domalapally  Sreenu" /></meta><meta name="dc.Creator" content="Vura B.  Subrahmanyam" /></meta><meta name="dc.Creator" content="Kota S.  Rao" /></meta><meta name="dc.Creator" content="Hwa Jeong  Lee" /></meta><meta name="dc.Creator" content="So-Jung  Park" /></meta><meta name="dc.Creator" content="Hyun-Ju  Park" /></meta><meta name="dc.Creator" content="Kiho  Lee" /></meta><meta name="dc.Creator" content="Yhun Yhong  Sheen" /></meta><meta name="dc.Creator" content="Dae-Kee  Kim" /></meta><meta name="dc.Description" content="A series of 2-substituted-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)imidazoles was synthesized and evaluated to optimize a prototype inhibitor of TGF-β type I receptor kinase (..." /></meta><meta name="Description" content="A series of 2-substituted-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)imidazoles was synthesized and evaluated to optimize a prototype inhibitor of TGF-β type I receptor kinase (..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 13, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm500115w" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm500115w" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm500115w" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm500115w" /></link>
        
    
    

<title>Discovery of N-((4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A Highly Potent, Selective, and Orally Bioavailable Inhibitor of TGF-β Type I Receptor Kinase as Cancer Immunotherapeutic/Antifibrotic Agent | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm500115w" /></meta><meta property="og:title" content="Discovery of N-((4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A Highly Potent, Selective, and Orally Bioavailable Inhibitor of TGF-β Type I Receptor Kinase as Cancer Immunotherapeutic/Antifibrotic Agent" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0012.jpeg" /></meta><meta property="og:description" content="A series of 2-substituted-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)imidazoles was synthesized and evaluated to optimize a prototype inhibitor of TGF-β type I receptor kinase (ALK5), 6. Combination of replacement of a quinoxalin-6-yl moiety of 6 with a [1,2,4]triazolo[1,5-a]pyridin-6-yl moiety, insertion of a methyleneamino linker, and a o-F substituent in the phenyl ring markedly increased ALK5 inhibitory activity, kinase selectivity, and oral bioavailability. The 12b (EW-7197) inhibited ALK5 with IC50 value of 0.013 μM in a kinase assay and with IC50 values of 0.0165 and 0.0121 μM in HaCaT (3TP-luc) stable cells and 4T1 (3TP-luc) stable cells, respectively, in a luciferase assay. Selectivity profiling of 12b using a panel of 320 protein kinases revealed that it is a highly selective ALK5/ALK4 inhibitor. Pharmacokinetic study with 12b·HCl in rats showed an oral bioavailability of 51% with high systemic exposure (AUC) of 1426 ng × h/mL and maximum plasma concentration (Cmax) of 1620 ng/mL. Rational optimization of 6 has led to the identification of a highly potent, selective, and orally bioavailable ALK5 inhibitor 12b." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm500115w"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm500115w">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm500115w&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm500115w&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm500115w&amp;href=/doi/10.1021/jm500115w" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 10</span><span class="cit-fg-pageRange">, 4213-4238</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/10" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm500073h" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm5001453" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A Highly Potent, Selective, and Orally Bioavailable Inhibitor of TGF-β Type I Receptor Kinase as Cancer Immunotherapeutic/Antifibrotic Agent</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cheng+Hua++Jin">Cheng Hua Jin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maddeboina++Krishnaiah">Maddeboina Krishnaiah</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Domalapally++Sreenu">Domalapally Sreenu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vura+B.++Subrahmanyam">Vura B. Subrahmanyam</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kota+S.++Rao">Kota S. Rao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hwa+Jeong++Lee">Hwa Jeong Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=So-Jung++Park">So-Jung Park</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hyun-Ju++Park">Hyun-Ju Park</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kiho++Lee">Kiho Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yhun+Yhong++Sheen">Yhun Yhong Sheen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dae-Kee++Kim">Dae-Kee Kim</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul 120-750, Korea</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Korea</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Bioevaluation Center, Korea Research Institute of Bioscience and Biotechnology, Cheongwon, Chungbuk 363-883, Korea</span></div><div class="corresp-info"><strong>*</strong>Phone: (82) 2-3277-3025. Fax: (82) 2 3277-2467. E-mail: <a href="/cdn-cgi/l/email-protection#eb8f80808286ab8e9c838ac58a88c58099"><span class="__cf_email__" data-cfemail="4d29262624200d283a252c632c2e63263f">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm500115w&amp;href=/doi/10.1021%2Fjm500115w" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 10</span><span class="cit-pageRange">, 4213–4238</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 2, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>22 January 2014</li><li><span class="item_label"><b>Published</b> online</span>13 May 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 May 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm500115w" title="DOI URL">https://doi.org/10.1021/jm500115w</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm500115w"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">6018</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">64</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm500115w" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of N-((4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A Highly Potent, Selective, and Orally Bioavailable Inhibitor of TGF-β Type I Receptor Kinase as Cancer Immunotherapeutic/Antifibrotic Agent&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Cheng&quot;,&quot;last_name&quot;:&quot;Hua Jin&quot;},{&quot;first_name&quot;:&quot;Maddeboina&quot;,&quot;last_name&quot;:&quot;Krishnaiah&quot;},{&quot;first_name&quot;:&quot;Domalapally&quot;,&quot;last_name&quot;:&quot;Sreenu&quot;},{&quot;first_name&quot;:&quot;Vura&quot;,&quot;last_name&quot;:&quot;B. Subrahmanyam&quot;},{&quot;first_name&quot;:&quot;Kota&quot;,&quot;last_name&quot;:&quot;S. Rao&quot;},{&quot;first_name&quot;:&quot;Hwa&quot;,&quot;last_name&quot;:&quot;Jeong Lee&quot;},{&quot;first_name&quot;:&quot;So-Jung&quot;,&quot;last_name&quot;:&quot;Park&quot;},{&quot;first_name&quot;:&quot;Hyun-Ju&quot;,&quot;last_name&quot;:&quot;Park&quot;},{&quot;first_name&quot;:&quot;Kiho&quot;,&quot;last_name&quot;:&quot;Lee&quot;},{&quot;first_name&quot;:&quot;Yhun&quot;,&quot;last_name&quot;:&quot;Yhong Sheen&quot;},{&quot;first_name&quot;:&quot;Dae-Kee&quot;,&quot;last_name&quot;:&quot;Kim&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;10&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;4213-4238&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm500115w&quot;},&quot;abstract&quot;:&quot;A series of 2-substituted-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)imidazoles was synthesized and evaluated to optimize a prototype inhibitor of TGF-β type I receptor kinase (ALK5), 6. Combination of replacement of a quinoxalin-6-yl moiety of 6 with a [1,2,4]triazolo[1,5-a]pyridin-6-yl moiety, insertion of a methyleneamino linker, and a o-F substituent in the phenyl ring markedly increased ALK5 inhibitory activity, kinase selectivity, and oral bioavailability. The 12b (EW-7197) inhibited ALK5 with IC50 value of 0.013 μM in a kinase assay and with IC50 values of 0.0165 and 0.0121 μM in HaCaT (3TP-luc) stable cells and 4T1 (3TP-luc) stable cells, respectively, in a luciferase assay. Selectivity profiling of 12b using a panel of 320 protein kinases revealed that it is a highly selective ALK5/ALK4 inhibitor. Pharmacokinetic study with 12b·HCl in rats showed an oral bioavailability of 51% with high systemic exposure (AUC) of 1426 ng × h/mL and maximum plasma concentration (Cmax) of 1620 ng/mL&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500115w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500115w" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500115w&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500115w" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm500115w&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500115w" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm500115w&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm500115w&amp;href=/doi/10.1021/jm500115w" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm500115w" /></input><a href="/doi/pdf/10.1021/jm500115w" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm500115w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm500115w%26sid%3Dliteratum%253Aachs%26pmid%3D24786585%26genre%3Darticle%26aulast%3DJin%26date%3D2014%26atitle%3DDiscovery%2Bof%2BN-%2528%25284-%2528%255B1%252C2%252C4%255DTriazolo%255B1%252C5-a%255Dpyridin-6-yl%2529-5-%25286-methylpyridin-2-yl%2529-1H-imidazol-2-yl%2529methyl%2529-2-fluoroaniline%2B%2528EW-7197%2529%253A%2BA%2BHighly%2BPotent%252C%2BSelective%252C%2Band%2BOrally%2BBioavailable%2BInhibitor%2Bof%2BTGF-%25CE%25B2%2BType%2BI%2BReceptor%2BKinase%2Bas%2BCancer%2BImmunotherapeutic%252FAntifibrotic%2BAgent%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D10%26spage%3D4213%26epage%3D4238%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/10" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jmcmar.2014.57.issue-10/production/jmcmar.2014.57.issue-10.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of 2-substituted-4-([1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)imidazoles was synthesized and evaluated to optimize a prototype inhibitor of TGF-β type I receptor kinase (ALK5), <b>6</b>. Combination of replacement of a quinoxalin-6-yl moiety of <b>6</b> with a [1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl moiety, insertion of a methyleneamino linker, and a <i>o</i>-F substituent in the phenyl ring markedly increased ALK5 inhibitory activity, kinase selectivity, and oral bioavailability. The <b>12b</b> (EW-7197) inhibited ALK5 with IC<sub>50</sub> value of 0.013 μM in a kinase assay and with IC<sub>50</sub> values of 0.0165 and 0.0121 μM in HaCaT (3TP-luc) stable cells and 4T1 (3TP-luc) stable cells, respectively, in a luciferase assay. Selectivity profiling of <b>12b</b> using a panel of 320 protein kinases revealed that it is a highly selective ALK5/ALK4 inhibitor. Pharmacokinetic study with <b>12b</b>·HCl in rats showed an oral bioavailability of 51% with high systemic exposure (AUC) of 1426 ng × h/mL and maximum plasma concentration (<i>C</i><sub>max</sub>) of 1620 ng/mL. Rational optimization of <b>6</b> has led to the identification of a highly potent, selective, and orally bioavailable ALK5 inhibitor <b>12b</b>.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63374" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63374" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Transforming growth factor-β (TGF-β) belongs to the TGF-β superfamily, which consists of TGF-β1, TGF-β2, TGF<i>-</i>β3, activins, inhibins, and bone morphogenetic proteins. TGF-β is involved in many cellular processes, including cell proliferation, cell migration, invasion, epithelial–mesenchymal transition (EMT), extracellular matrix production, and immune suppression. TGF-β and its receptors are often chronically overexpressed in various human diseases, including cancer, tissue fibrosis, inflammation, and autoimmunity. Therefore, blockade of TGF-β signaling pathway is an attractive target for drug development. TGF-β signals via two related transmembrane type I and type II serine/threonine kinase receptors. Following TGF-β binding to the constitutively active type II receptor, the type I receptor (activin receptor-like kinase 5 (ALK5)) is phosphorylated and creates a binding site for Smad2/Smad3 proteins, which are further phosphorylated. Phosphorylated Smad2/Smad3 proteins form a heteromeric complex with Smad4, which translocates into the nucleus, assembles with specific DNA-binding cofactors and comodulators, and binds to the promoters of TGF-β target genes involved in cell differentiation, proliferation, apoptosis, migration, and extracellular matrix production.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a></div><div class="NLM_p">Small molecule ATP-competitive ALK5 inhibitors such as <b>1</b> (SB-505124),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a><b>2</b> (SB-525334),<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a><b>3</b> (GW6604),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a><b>4</b> (SD-208),<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> and <b>5</b> (LY-2157299)<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) specifically inhibited the Smad pathway by occupying the ATP binding site of the ALK5 kinase domain, which is essential for the phosphorylation of its substrates, Smad2/Smad3 proteins. The ALK5 inhibitors <b>4</b> and <b>5</b> showed promise in blocking TGF-β-mediated tumor progression, metastasis, and suppression of antitumor immunity, and <b>2</b>, <b>3</b>, and <b>4</b> effectively retarded progressive tissue fibrosis in animal models. Among them, <b>5</b> has progressed to phase II trials for glioma, glioblastoma, hepatocellular carcinoma, and pancreatic cancer.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> We have previously reported an imidazole-based ALK5 inhibitor, IN-1130 (<b>6</b>) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The inhibitor <b>6</b> effectively prevented tumor progression and enhanced immune response in mice bearing prostate cancer.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> It showed its remarkable activity as a suppressor of fibrogenic process in models of unilateral ureteral obstruction (UUO) in adult mice<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and rats,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> ameliorated experimental autoimmune encephalomyelitis in mice,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and significantly reduced tunical fibrosis and corrected penile curvature in rats.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Although <b>6</b> demonstrated its pronounced efficacy in various animal models of cancer and fibrosis, there were two drawbacks to develop it as a clinical candidate: (1) pharmacokinetic studies with <b>6</b> showed good oral bioavailability in dog (85%) and monkey (34%) but much lower in mouse (9%) and rat (11%), and (2) the kinase selectivity index of <b>6</b> against p38α having one of the most homologous kinase domains to that of ALK5 is <35.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. ALK5 inhibitors under development.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Therefore, in this report, we attempted further structural optimization of <b>6</b> to get a clinical candidate possessing favorable pharmacologic, pharmacokinetic, and toxicologic profiles.</div><div class="NLM_p">Our strategy of structural optimization of <b>6</b> consists of replacement of a quinoxalin-6-yl moiety of <b>6</b> with a [1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl moiety,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> insertion of a suitable linker with a heteroatom between a central imidazole ring and a phenyl ring, and refinement of phenyl ring substituent with various functional groups.</div><div class="NLM_p">In pharmacokinetic studies with orally administered <b>6</b> in rodents, 3-((4-(2-hydroxyquinoxalin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)benzamide or 3-((4-(3-hydroxyquinoxalin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)benzamide (<b>7</b>) was isolated as a major metabolite in the systemic circulation of rat and mouse, showing that extensive oxidation occurred in the quinoxaline ring (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of a major metabolite of <b>6</b> in rat and mouse.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of this finding, we envisioned that replacement of a quinoxalin-6-yl moiety of <b>6</b> with a [1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl moiety could increase its oral bioavailability because metabolic oxidation of 2-position of the latter moiety is assumed to be difficult due to the presence of two adjacent nitrogen atoms.</div><div class="NLM_p last">We have also reported that insertion of a small linker such as methylene, ethylene, <i>n</i>-propylene, methyleneamino, aminomethylene, thioamido, methyleneamido, or methylenethioamido between two pharmacophores, the central five-membered heterocyclic ring and a phenyl ring significantly increased ALK5 inhibitory activity and selectivity.<a onclick="showRef(event, 'ref10 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref10 ref19 ref20 ref21">(10, 19-21)</a> Among them, the methyleneamino linker was the most beneficial in ALK5 inhibitory activity.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> To further optimize the linker, we compared the potential of methyleneoxy or methylenethio group with that of methyleneamino group. It was one of our concerns whether an incorporated heteroatom such as O, S, or N into those three linkers might form another binding interaction with ALK5.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13565" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13565" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As our starting point, we designed three target molecules, 6-(5-(6-methylpyridin-2-yl)-2-(phenoxymethyl)-1<i>H</i>-imidazol-4-yl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridine (<b>9a</b>), 6-(5-(6-methylpyridin-2-yl)-2-((phenylthio)methyl)-1<i>H</i>-imidazol-4-yl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridine (<b>9b</b>), and <i>N</i>-((4-([1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)aniline (<b>12a</b>), to examine the potential of the three different linker moieties, methyleneoxy, methylenethio, and methyleneamino in ALK5 inhibition and kinase selectivity against p38α.</div><div class="NLM_p">The <b>9a</b> and <b>9b</b> were prepared as shown in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The 1-([1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl)-2-(6-methylpyridin-2-yl)ethane-1,2-dione (<b>8</b>)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> was condensed with either 2-phenoxyacetaldehyde<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> or 2-(phenylthio)acetaldehyde<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and NH<sub>4</sub>OAc in a mixture of <i>t</i>-BuOMe and MeOH at room temperature to produce the 2-(phenoxymethyl)imidazole <b>9a</b> or the 2-((phenylthio)methyl)imidazole <b>9b</b> in 56% or 38% yield, respectively.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-phenoxyacetaldehyde (for <b>9a</b>) or 2-(phenylthio)acetaldehyde (for <b>9b</b>), NH<sub>4</sub>OAc, <i>t</i>-BuOMe/MeOH, rt, 70–180 min.</p></p></figure><div class="NLM_p">The <b>12a</b> was prepared as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Condensation of the diketone <b>8</b> with 2,2-dimethoxyacetaldehyde and NH<sub>4</sub>OAc in a mixture of <i>t</i>-BuOMe and MeOH afforded the 2-(dimethoxymethyl)imidazole <b>10</b> in 83% yield. The acetal protecting group of the <b>10</b> was removed in 1 N HCl solution to give the imidazole-2-carbaldehyde <b>11</b> in 96% yield. Coupling of the <b>11</b> with aniline in the presence of AcOH in 1,2-dichloroethane followed by reduction of the resulting imine with NaBH<sub>4</sub> gave the 2-((phenylamino)methyl)imidazole <b>12a</b> in 87% yield.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 60% 2,2-dimethoxyacetaldehyde in H<sub>2</sub>O, NH<sub>4</sub>OAc, <i>t</i>-BuOMe/MeOH, rt, 4 h; (b) 1 N HCl, 70 °C, 4 h; (c) AcOH, 1,2-dichloroethane, reflux (for <b>12a</b>–<b>h</b>, <b>12j</b>–<b>l</b>, <b>12n</b>–<b>an</b>, <b>12ap</b>, <b>12ar</b>–<b>az</b>, and <b>12bb</b>–<b>bh</b>), rt (for <b>12i</b>, <b>12ao</b>, and <b>12bi</b> (without AcOH)), or 120 °C (for <b>12ba</b>, in sealed tube), then (AcO)<sub>3</sub>BHNa (for <b>12c</b>, <b>12e</b>–<b>h</b>, <b>12j</b>, <b>12k</b>, <b>12q</b>, <b>12s</b>–<b>x</b>, <b>12ab</b>–<b>af</b>, <b>12ah</b>, <b>12aj</b>–<b>an</b>, <b>12ap</b>, <b>12ar</b>, <b>12as</b>, <b>12au</b>, <b>12ax</b>, <b>12az</b>, <b>12bd</b>, <b>12be</b>, and <b>12bg</b>–<b>bi</b>) or NaBH<sub>4</sub> (<b>12a</b>, <b>12b</b>, <b>12d</b>, <b>12i</b>, <b>12m</b>, <b>12n</b>–<b>p</b>, <b>12r</b>, <b>12y</b>, <b>12z</b>, <b>12aa</b>, <b>12ag</b>, <b>12ai</b>, <b>12ao</b>, <b>12at</b>, <b>12av</b>, <b>12aw</b>, <b>12ay</b>, <b>12ba</b>–<b>bc</b>, and <b>12bf</b>), THF, MeOH, rt; (d) 34.5% H<sub>2</sub>O<sub>2</sub>, 1 N NaOH, EtOH, rt, 2–3 h (for <b>12m</b> and <b>12aq</b>).</p></p></figure><div class="NLM_p">The ALK5 inhibitory activity of <b>9a</b> possessing a methyleneoxy linker (IC<sub>50</sub> = 0.013 μM) was comparable to that of <b>12a</b> possessing a methyleneamino linker (IC<sub>50</sub> = 0.013 μM), whereas that of <b>9b</b> possessing a methylenethio linker (IC<sub>50</sub> = 0.021 μM) was somewhat lower than that of <b>12a</b> in a kinase assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). As we hoped, introduction of a [1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl moiety significantly influenced selectivity against p38α. Regardless of the linker moiety, all the three compounds showed high selectivity against p38α, thus exhibiting selectivity indices with >176. Because <b>9a</b>, <b>9b</b>, and <b>12a</b> showed the similar level of potency in ALK5 inhibition in a kinase assay, a cell-based luciferase assay was performed using HaCaT cells permanently transfected with p3TP-luciferase reporter construct<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> at a lower concentration, 0.03 μM, to discriminate their ALK5 inhibitory activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Contrary to the kinase assay, <b>9a</b> (11% inhibition) and <b>9b</b> (8% inhibition) were much less inhibitory than <b>12a</b> (52% inhibition) in a cell-based luciferase assay, suggesting that a methyleneoxy or methylenethio linker contributes to the lower cellular permeability compared to a methyleneamino linker.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. ALK5 and p38α Inhibitory Activity of 2-(Phenoxymethyl)imidazole <b>9a</b>, 2-((Phenylthio)methyl)imidazole <b>9b</b>, and 2-((Phenylamino)methyl)imidazoles <b>12a</b>–<b>bi</b> in Kinase Assay</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0009.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center" char=".">ALK5<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">p38α<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">selectivity index<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.013</td><td class="colsep0 rowsep0" align="char" char=".">4.89</td><td class="colsep0 rowsep0" align="char" char=".">376</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.021</td><td class="colsep0 rowsep0" align="char" char=".">6.24</td><td class="colsep0 rowsep0" align="char" char=".">297</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char=".">0.013</td><td class="colsep0 rowsep0" align="char" char=".">2.29</td><td class="colsep0 rowsep0" align="char" char=".">176</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="char" char=".">1.72</td><td class="colsep0 rowsep0" align="char" char=".">246</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>1111</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2-Br</td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="char" char=".">1.98</td><td class="colsep0 rowsep0" align="char" char=".">283</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12e</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2-Me</td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char=".">1.94</td><td class="colsep0 rowsep0" align="char" char=".">139</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12f</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2-Et</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">1.53</td><td class="colsep0 rowsep0" align="char" char=".">139</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12g</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2-<i>i</i>-Pr</td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char=".">1.10</td><td class="colsep0 rowsep0" align="char" char=".">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12h</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2-OMe</td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char=".">3.68</td><td class="colsep0 rowsep0" align="char" char=".">263</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12i</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.012</td><td class="colsep0 rowsep0" align="char" char=".">2.56</td><td class="colsep0 rowsep0" align="char" char=".">213</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12j</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2-SMe</td><td class="colsep0 rowsep0" align="char" char=".">0.010</td><td class="colsep0 rowsep0" align="char" char=".">1.30</td><td class="colsep0 rowsep0" align="char" char=".">130</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12k</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2-CH═CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char=".">2.05</td><td class="colsep0 rowsep0" align="char" char=".">146</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12l</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2-CN</td><td class="colsep0 rowsep0" align="char" char=".">0.020</td><td class="colsep0 rowsep0" align="char" char=".">3.64</td><td class="colsep0 rowsep0" align="char" char=".">182</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12m</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2-CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.030</td><td class="colsep0 rowsep0" align="char" char=".">3.94</td><td class="colsep0 rowsep0" align="char" char=".">131</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12n</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2-NHSO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">1.63</td><td class="colsep0 rowsep0" align="char" char=".">109</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12o</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2-NHCOMe</td><td class="colsep0 rowsep0" align="char" char=".">0.040</td><td class="colsep0 rowsep0" align="char" char=".">2.83</td><td class="colsep0 rowsep0" align="char" char=".">71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12p</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-F</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">0.82</td><td class="colsep0 rowsep0" align="char" char=".">91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12q</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">0.73</td><td class="colsep0 rowsep0" align="char" char=".">122</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12r</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-Br</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">0.87</td><td class="colsep0 rowsep0" align="char" char=".">174</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12s</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-Me</td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">1.31</td><td class="colsep0 rowsep0" align="char" char=".">146</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12t</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-Et</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td><td class="colsep0 rowsep0" align="char" char=".">1.18</td><td class="colsep0 rowsep0" align="char" char=".">148</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12u</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-<i>i</i>-Pr</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td><td class="colsep0 rowsep0" align="char" char=".">1.21</td><td class="colsep0 rowsep0" align="char" char=".">76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12v</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-OMe</td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char=".">2.43</td><td class="colsep0 rowsep0" align="char" char=".">174</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12w</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.023</td><td class="colsep0 rowsep0" align="char" char=".">1.86</td><td class="colsep0 rowsep0" align="char" char=".">81</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12x</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-SMe</td><td class="colsep0 rowsep0" align="char" char=".">0.007</td><td class="colsep0 rowsep0" align="char" char=".">0.70</td><td class="colsep0 rowsep0" align="char" char=".">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12y</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-CH═CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.012</td><td class="colsep0 rowsep0" align="char" char=".">1.46</td><td class="colsep0 rowsep0" align="char" char=".">122</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12z</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-CN</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">1.50</td><td class="colsep0 rowsep0" align="char" char=".">300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12aa</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">1.54</td><td class="colsep0 rowsep0" align="char" char=".">171</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ab</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-CH<sub>2</sub>CN</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">1.41</td><td class="colsep0 rowsep0" align="char" char=".">128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ac</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-COMe</td><td class="colsep0 rowsep0" align="char" char=".">0.013</td><td class="colsep0 rowsep0" align="char" char=".">1.28</td><td class="colsep0 rowsep0" align="char" char=".">98</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ad</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-CO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="char" char=".">1.39</td><td class="colsep0 rowsep0" align="char" char=".">82</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ae</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-NHSO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">2.27</td><td class="colsep0 rowsep0" align="char" char=".">151</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12af</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-NHCOMe</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">3.98</td><td class="colsep0 rowsep0" align="char" char=".">265</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ag</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="char" char=".">3.93</td><td class="colsep0 rowsep0" align="char" char=".">231</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ah</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">9.30</td><td class="colsep0 rowsep0" align="char" char=".">845</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ai</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-Br</td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>588</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12aj</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-Me</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>625</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ak</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-<i>i</i>-Pr</td><td class="colsep0 rowsep0" align="char" char=".">0.046</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>217</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12al</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-OMe</td><td class="colsep0 rowsep0" align="char" char=".">0.048</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>208</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12am</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-OCF<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.060</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>166</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12an</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-SMe</td><td class="colsep0 rowsep0" align="char" char=".">0.040</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ao</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-CH═CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.030</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>333</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ap</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-CN</td><td class="colsep0 rowsep0" align="char" char=".">0.032</td><td class="colsep0 rowsep0" align="char" char=".">7.81</td><td class="colsep0 rowsep0" align="char" char=".">244</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12aq</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-CONH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.055</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>181</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ar</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-CH<sub>2</sub>CN</td><td class="colsep0 rowsep0" align="char" char=".">0.025</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12as</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-COMe</td><td class="colsep0 rowsep0" align="char" char=".">0.059</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>169</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12at</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-CO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char=".">0.078</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>128</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12au</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-NHSO<sub>2</sub>Me</td><td class="colsep0 rowsep0" align="char" char=".">0.047</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>212</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12av</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-NHCOMe</td><td class="colsep0 rowsep0" align="char" char=".">0.039</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>256</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12aw</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2,3-F<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.009</td><td class="colsep0 rowsep0" align="char" char=".">2.54</td><td class="colsep0 rowsep0" align="char" char=".">282</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ax</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2,3-Cl<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.012</td><td class="colsep0 rowsep0" align="char" char=".">8.64</td><td class="colsep0 rowsep0" align="char" char=".">720</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ay</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2,3-Me<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.018</td><td class="colsep0 rowsep0" align="char" char=".">3.49</td><td class="colsep0 rowsep0" align="char" char=".">194</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12az</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2,3-(OMe)<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.058</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>172</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ba</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">2,3-(CN)<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.021</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>476</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12bb</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3,4-F<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.010</td><td class="colsep0 rowsep0" align="char" char=".">1.25</td><td class="colsep0 rowsep0" align="char" char=".">125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12bc</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3,4-Cl<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.008</td><td class="colsep0 rowsep0" align="char" char=".">3.89</td><td class="colsep0 rowsep0" align="char" char=".">486</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12bd</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3,4-Me<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>588</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12be</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3,4-(OMe)<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.044</td><td class="colsep0 rowsep0" align="char" char=".">>10.00</td><td class="colsep0 rowsep0" align="char" char=".">>227</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12bf</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3,5-F<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.006</td><td class="colsep0 rowsep0" align="char" char=".">0.50</td><td class="colsep0 rowsep0" align="char" char=".">83</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12bg</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3,5-Cl<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">1.07</td><td class="colsep0 rowsep0" align="char" char=".">71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12bh</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3,5-Me<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char=".">3.00</td><td class="colsep0 rowsep0" align="char" char=".">214</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12bi</b></td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3,5-(OMe)<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.014</td><td class="colsep0 rowsep0" align="char" char=".">2.85</td><td class="colsep0 rowsep0" align="char" char=".">204</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.054</td><td class="colsep0 rowsep0" align="char" char=".">0.59</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="char" char=".">0.48</td><td class="colsep0 rowsep0" align="char" char=".">28</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">ALK5 was expressed in Sf9 insect cells as human recombinant GST-fusion protein by means of the vaculovirus expression system. A proprietary radioisotopic protein kinase assay (<sup>33</sup>PanQinase activity assay) was performed at ProQinase GmbH (Freiburg, Germany) using casein as a substrate.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">p38α MAP kinase was expressed as untagged human recombinant protein in <i>E. coli</i>. The enzyme was purified by Ni-NTH-agarose (Qiagen). A proprietary radioisotopic protein kinase assay (<sup>33</sup>PanQinase activity assay) was performed at ProQinase GmbH (Freiburg, Germany) using ATF2 as a substrate.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">IC<sub>50</sub> of p38α/IC<sub>50</sub> of ALK5.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. ALK5 Inhibitory Activity in Luciferase Assay and Solubility of <b>9a</b>, <b>9b</b>, and <b>12a</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center" char=".">luciferase activity<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> (% control)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">solubility in aqueous buffer (mg/mL)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">p3TP-luc<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">pH 1.2<a class="ref internalNav" href="#t2fn5" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">pH 6.8<a class="ref internalNav" href="#t2fn6" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mock</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TGF-β</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="char" char=".">89</td><td class="colsep0 rowsep0" align="char" char=".">9.6</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char=".">17.6</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">38.5</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Activity is given as the mean of three independent experiments run in triplicate relative to control incubations with DMSO vehicle.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Luciferase activity was determined at a concentration of 0.03 μM of inhibitor.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">HaCaT (3TP-luc) stable cells were used.</p></div><div class="footnote" id="t2fn5"><sup>d</sup><p class="last">The buffer solution was prepared by mixing of 50 mL of 0.2 M KCl and 85.0 mL of 0.2 M HCl.</p></div><div class="footnote" id="t2fn6"><sup>e</sup><p class="last">The buffer solution was prepared by mixing of 100 mL of 0.1 M KH<sub>2</sub>PO<sub>4</sub> and 44.8 mL of 0.1 M NaOH.</p></div></div></div><div class="NLM_p">We next determined the solubility of <b>9a</b>, <b>9b</b>, and <b>12a</b> in pH 1.2 and 6.8 aqueous buffers (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Indeed, although <b>9a</b>, <b>9b</b>, and <b>12a</b> were almost insoluble in pH 6.8 aqueous buffer (<0.001 mg), <b>12a</b> (38.5 mg/mL) was 4.0- and 2.2-fold more soluble in pH 1.2 aqueous buffer than <b>9a</b> (9.6 mg/mL) and <b>9b</b> (17.6 mg/mL), respectively.</div><div class="NLM_p">Because a methyleneamino linker was proved to be the most beneficial to the ALK5 inhibition in both assays, we next turned our attention to the refinement of phenyl ring substituent to examine whether the substituent could increase the ALK5 inhibitory activity and oral bioavailability of <b>12a</b>. Thus, a series of the 60 2-((phenylamino)methyl)imidazoles possessing various substituents such as F, Cl, Br, Me, Et, <i>i</i>-Pr, OMe, OCF<sub>3,</sub> SMe, CH═CH<sub>2</sub>, CN, CONH<sub>2</sub>, CH<sub>2</sub>CN, COMe, CO<sub>2</sub>Me, NHSO<sub>2</sub>Me, and NHCOMe in the phenyl ring, <b>12b</b>–<b>bi</b>, were prepared (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Most of the requisite anilines are commercially available, and the commercially unavailable anilines such as 2-(3-aminophenyl)acetonitrile,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a><i>N</i>-(2-aminophenyl)methanesulfonamide,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a><i>N</i>-(4-aminophenyl)methanesulfonamide,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> and 3-aminophthalonitrile<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> were prepared according to the known procedures in the literatures. Coupling of <b>11</b> with appropriately substituted anilines in the presence of AcOH in 1,2-dichloroethane followed by reduction of the resulting imines with either (AcO)<sub>3</sub>BHNa or NaBH<sub>4</sub> in a mixture of THF and MeOH gave the target compounds <b>12b</b>–<b>l</b>, <b>12n</b>–<b>ap</b>, and <b>12ar</b>–<b>bi</b> in various yields (14–92%). Transformation of the carbonitrile group of <b>12l</b> and <b>12ap</b> to the corresponding carboxamide group was accomplished by treatment with 34.5% H<sub>2</sub>O<sub>2</sub> and 1 N NaOH in EtOH at room temperature to provide the <b>12m</b> and <b>12aq</b> in 84% and 63% yields, respectively.</div><div class="NLM_p">The results indicated that introduction of a halogen atom such as F, Cl, or Br at <i>ortho</i>-position in the phenyl ring had impact on ALK5 inhibitory activity, thus, <b>12b</b> (R = 2-F, IC<sub>50</sub> = 0.007 μM), <b>12c</b> (R = 2-Cl, IC<sub>50</sub> = 0.009 μM), and <b>12d</b> (R = 2-Br, IC<sub>50</sub> = 0.007 μM) displayed higher ALK5 inhibitory activity than the unsubstituted <b>12a</b> (IC<sub>50</sub> = 0.013 μM) in a kinase assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). At <i>meta</i>-position, halogen atoms, small alkyl groups such as Me and Et, and small functional groups, SMe and CN, were beneficial to the ALK5 inhibitory activity. Hence, <b>12p</b> (R = 3-F, IC<sub>50</sub> = 0.009 μM), <b>12q</b> (R = 3-Cl, IC<sub>50</sub> = 0.006 μM), <b>12r</b> (R = 3-Br, IC<sub>50</sub> = 0.005 μM), <b>12s</b> (R = 3-Me, IC<sub>50</sub> = 0.009 μM), <b>12t</b> (R = 3-Et, IC<sub>50</sub> = 0.008 μM), <b>12x</b> (R = 3-SMe, IC<sub>50</sub> = 0.007 μM), and <b>12z</b> (R = 3-CN, IC<sub>50</sub> = 0.005 μM) were more inhibitory than <b>12a</b>. In contrast with the <i>ortho</i>- and <i>meta</i>-substituted compounds, 15 out of 16 <i>para</i>-substituted compounds displayed lower ALK5 inhibitory activity than <b>12a</b>, suggesting that a <i>para</i>-substituent in the phenyl ring seemed to be not accommodated favorably into the ATP binding pocket of ALK5. In the 13 disubstituted compounds, di-F substituted compounds <b>12aw</b> (R = 2,3-F<sub>2</sub>, IC<sub>50</sub> = 0.009 μM), <b>12bb</b> (R = 3,4-F<sub>2</sub>, IC<sub>50</sub> = 0.010 μM), and <b>12bf</b> (R = 3,5-F<sub>2</sub>, IC<sub>50</sub> = 0.006 μM) and di-Cl substituted compounds <b>12ax</b> (R = 2,3-Cl<sub>2</sub>, IC<sub>50</sub> = 0.012 μM) and <b>12bc</b> (R = 3,4-Cl<sub>2</sub>, IC<sub>50</sub> = 0.008 μM) were more inhibitory than <b>12a</b>.</div><div class="NLM_p">Considering the IC<sub>50</sub> of ALK5 inhibition and selectivity index against p38α, the <b>12b</b>–<b>d</b>, <b>12p</b>–<b>s</b>, <b>12x</b>, <b>12z</b>, <b>12aa</b>, <b>12ai</b>, <b>12aj</b>, <b>12aw</b>, and <b>12bf</b> were chosen and their ALK5 inhibitory activity was compared at a concentration of 0.03 μM in a luciferase assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. ALK5 Inhibitory Activity of <b>12b</b>–<b>d</b>, <b>12p</b>–<b>s</b>, <b>12x</b>, <b>12z</b>, <b>12aa</b>, <b>12ai</b>, <b>12aj</b>, <b>12aw</b>, and <b>12bf</b> in Luciferase Assay and Solubility of <b>12b</b>–<b>d</b>, <b>12p</b>–<b>s</b>, <b>12x</b>, <b>12z</b>, <b>12ai</b>, <b>12aj</b>, <b>12aw</b>, and <b>12bf</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" align="center" char=".">luciferase activity<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> (% control)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">solubility in aqueous buffer (mg/mL)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">p3TP-luc<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">pH 1.2<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">pH 6.8<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mock</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TGF-β</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="char" char=".">31.4</td><td class="colsep0 rowsep0" align="char" char=".">0.042</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12c</b></td><td class="colsep0 rowsep0" align="char" char=".">54</td><td class="colsep0 rowsep0" align="char" char=".">38.0</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12d</b></td><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="char" char=".">36.9</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12p</b></td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="char" char=".">44.6</td><td class="colsep0 rowsep0" align="char" char=".">0.029</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12q</b></td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">21.0</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12r</b></td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">16.8</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12s</b></td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="char" char=".">54.1</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12x</b></td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">33.2</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12z</b></td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">29.5</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12aa</b></td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12ai</b></td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">12.6</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12aj</b></td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">25.6</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12aw</b></td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="char" char=".">18.6</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12bf</b></td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">9.7</td><td class="colsep0 rowsep0" align="char" char="."><0.001</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Activity is given as the mean of three independent experiments run in triplicate relative to control incubations with DMSO vehicle.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Luciferase activity was determined at a concentration of 0.03 μM of inhibitor.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">HaCaT (3TP-luc) stable cells were used.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">The buffer solution was prepared by mixing of 50 mL of 0.2 M KCl and 85.0 mL of 0.2 M HCl.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">The buffer solution was prepared by mixing of 100 mL of 0.1 M KH<sub>2</sub>PO<sub>4</sub> and 44.8 mL of 0.1 M NaOH.</p></div></div></div><div class="NLM_p">All the tested compounds except <b>12aa</b> (2% inhibition) showed higher inhibitory activity (37–71% inhibition) than the competitor <b>1</b> (26% inhibition) in this luciferase assay. In the <i>ortho</i>-substituted compounds, the 2-F substituted <b>12b</b> (59% inhibition) was slightly more inhibitory than the 2-Cl substituted <b>12c</b> (46% inhibition) and 2-Br substituted <b>12d</b> (53% inhibition). Among the <i>meta</i>-substituted compounds, 3-Br substituted <b>12r</b> (71% inhibition) and 3-Cl substituted <b>12q</b> (66% inhibition) were the most inhibitory, and the rest of compounds showed the similar level of inhibition (52–62% inhibition). The 3,5-F<sub>2</sub> substituted <b>12bf</b> (64% inhibition) displayed much higher inhibition than the 2,3-F<sub>2</sub> substituted <b>12aw</b> (42% inhibition).</div><div class="NLM_p">Like the unsubstituted <b>12a</b>, all the compounds were sufficiently soluble in pH 1.2 aqueous buffer (9.7–54.1 mg/mL) but much less soluble in pH 6.8 aqueous buffer (<0.001–0.042 mg/mL) (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Nevertheless, it should be pointed out that introduction of a F atom at <i>ortho</i>- or <i>meta</i>-position in the phenyl ring fairly increased solubility in pH 6.8 aqueous buffer, thus <b>12b</b> (0.042 mg/mL) and <b>12p</b> (0.029 mg/mL) were at least 42- and 29-fold more soluble than the other compounds (<0.001 mg/mL). Interestingly, the di-F substituted <b>12aw</b> and <b>12bf</b> (<0.001 mg/mL) were less soluble than <b>12b</b> and <b>12p</b>.</div><div class="NLM_p">At this stage, we speculated that introduction of an additional <i>tert</i>-amino group such as dimethylamino, (dimethylamino)methyl, pyrrolidin-1-ylmethyl, or morpholinomethyl in the phenyl ring might increase the compound’s oral bioavailability by either increasing its aqueous solubility or allowing it to form a water-soluble acid salt with an acid. Thus, for this purpose, <b>12b</b> was selected as one of candidates in the 3 <i>ortho</i>-substituted compounds because it showed slightly higher ALK5 inhibitory activity in luciferase assay and much higher solubility in pH 6.8 aqueous buffer than the others. The <b>12z</b> was chosen as another candidate due to its the highest ALK5 inhibitory activity (IC<sub>50</sub> = 0.005 μM) in a kinase assay and selectivity index against p38α (300) among the seven <i>meta</i>-substituted compounds. The di-F substituted <b>12aw</b> and <b>12bf</b> were not considered as a candidate because they did not show any advantages over <b>12b</b>.</div><div class="NLM_p">In the cellular assays, <b>12a</b>, <b>12b</b>, and <b>12z</b> efficiently inhibited TGF-β1-induced Smad signaling, cell migration, invasion, and epithelial–mesenchymal transition (EMT) in mammary epithelial cells, MCF10A, NMuMG, and 4T1 cells.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30-32)</a></div><div class="NLM_p">On the basis of our finding that a <i>para</i>-substituent in the phenyl ring mostly decreased ALK5 inhibitory activity, a <i>tert</i>-amino group was preferentially introduced at the <i>ortho</i>- or <i>meta</i>-position rather than the <i>para</i>-position.</div><div class="NLM_p">Among the required anilines for the synthesis of the target compounds <b>14a</b>–<b>p</b>, the known 4-fluoro-<i>N</i><sup>1</sup>,<i>N</i><sup>1</sup>-dimethylbenzene-1,3-diamine (<b>13a</b>)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> was prepared according to the reported procedure, and the novel fluoroanilines or cyanoanilines possessing a (dimethylamino)methyl, pyrrolidin-1-ylmethyl, or morpholinomethyl group, <b>13b</b>–<b>p</b>, were prepared by new synthetic routes developed by us (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><div class="NLM_p">With these anilines in hand, another series of 2-substituted-4-([1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)imidazoles <b>14a</b>–<b>p</b> possessing a <i>tert</i>-amino group in the phenyl ring were prepared as shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Coupling of <b>11</b> with <b>13a</b>–<b>p</b> in the presence of AcOH in 1,2-dichloroethane followed by reduction of the resulting imines with either (AcO)<sub>3</sub>BHNa or NaBH<sub>4</sub> in a mixture of MeOH and THF gave <b>14a</b>–<b>p</b> in 42–79% yields.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) AcOH, 1,2-dichloroethane, reflux, then (AcO)<sub>3</sub>BHNa (for <b>14a</b>–<b>e</b> and <b>14j</b>–<b>l</b>) or NaBH<sub>4</sub> (for <b>14f</b>–<b>i</b> and <b>14m</b>–<b>p</b>), THF, MeOH, rt.</p></p></figure><div class="NLM_p">The ALK5 and p38α inhibitory activity of <b>14a</b>–<b>p</b> in a kinase assay is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Introduction of a dimethylamino group in <b>12b</b> (IC<sub>50</sub> = 0.0008 μM) led to 3.6-fold decrease in potency (<b>14a</b>, IC<sub>50</sub> = 0.0029 μM), and the bulkier analogues <b>14b</b>–<b>e</b> were 8.5–27.6-fold less potent than <b>12b</b>. Similarly, although a dimethylamino analogue of <b>12z</b>, <b>14m</b> (IC<sub>50</sub> = 0.0013 μM) showed comparable level of inhibition to that of <b>12z</b> (IC<sub>50</sub> = 0.0008 μM), the rest of analogues <b>14f</b>–<b>l</b> and <b>14n</b>–<b>p</b> were 3.0–22.2-fold less potent than <b>12z</b>. It is worth noting that introduction of a <i>tert</i>-amino group in <b>12b</b> and <b>12z</b> significantly affected the potency, but not the selectivity index, showing the variation less than 2-fold compared with that of <b>12b</b> and <b>12z</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibitory Activity of 2-Substituted-4-([1,2,4]triazolo[1,5-<i>a</i>]pyridine-6-yl)-5-(6-methylpyridin-2-yl)imidazoles <b>14a</b>–<b>p</b> on ALK5</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0010.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0011.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">ALK5 was expressed in Sf9 insect cells as human recombinant GST-fusion protein by means of the vaculovirus expression system. A proprietary radioisotopic protein kinase assay (<sup>33</sup>PanQinase activity assay) was performed at ProQinase GmbH (Freiburg, Germany) using casein as a substrate.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">p38α MAP kinase was expressed as untagged human recombinant protein in <i>E. coli</i>. The enzyme was purified by Ni-NTH-agarose (Qiagen). A Proprietary radioisotopic protein kinase assay (<sup>33</sup>PanQinase activity assay) was performed at ProQinase GmbH (Freiburg, Germany) using ATF2 as a substrate.</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">IC<sub>50</sub> of p38α/IC<sub>50</sub> of ALK5.</p></div></div><div></div></div><div class="NLM_p">To investigate whether these analogues could increase their oral bioavailability, the most potent two analogues of <b>12z</b>, <b>14m</b> and <b>14f</b> (IC<sub>50</sub> = 0.0024 μM), were chosen, and their pharmacokinetic profile was evaluated and compared with that of <b>12z</b> along with <b>12b</b>. Pharmacokinetic studies with their hydrochloride salts of the four compounds were carried out in Sprague–Dawley rats at an intravenous dose of 2 mg/kg (as a free base) and oral dose of 10 mg/kg (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). As we anticipated, a dimethylamino analogue <b>14m</b> (27%) and a (dimethylamino)methyl analogue <b>14f</b> (24%) were 3.0-fold and 2.7-fold more bioavailable than <b>12z</b> (9%), respectively. Gratifyingly, after oral administration, <b>12b</b> showed a superior pharmacokinetic profile over <b>12z</b>, <b>14m</b>, and <b>14f</b>, with higher systemic exposure (AUC) of 1426 ng × h/mL and maximum plasma concentration (<i>C</i><sub>max</sub>) of 1620 ng/mL, which lead to an oral bioavailability of 51%.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Rat PK Data of Selected Compounds<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="​" /></col><col align="char" char="." /></col><col align="center" /></col><col align="char" char="​" /></col><col align="char" char="​" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">intravenous dose, 2 mg/kg<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">oral dose, 10 mg/kg<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a>,<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">CL<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a> (L/h/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub><a class="ref internalNav" href="#t5fn5" aria-label="e">e</a> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="​">AUC<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a> (ng × h/mL)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub><a class="ref internalNav" href="#t5fn8" aria-label="h">h</a> (ng/mL)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub><a class="ref internalNav" href="#t5fn9" aria-label="i">i</a> (h)</th><th class="colsep0 rowsep0" align="center" char="​">AUC (ng × h/mL)</th><th class="colsep0 rowsep0" align="center" char="​"><i>F</i><a class="ref internalNav" href="#t5fn10" aria-label="j">j</a> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b·</b>HCl</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char="​">558</td><td class="colsep0 rowsep0" align="char" char=".">1620</td><td class="colsep0 rowsep0" align="center">2.5</td><td class="colsep0 rowsep0" align="char" char="​">1426</td><td class="colsep0 rowsep0" align="char" char="​">51</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12z</b>·HCl</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char="​">368</td><td class="colsep0 rowsep0" align="char" char=".">139</td><td class="colsep0 rowsep0" align="center">2.3</td><td class="colsep0 rowsep0" align="char" char="​">168</td><td class="colsep0 rowsep0" align="char" char="​">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14f</b>·HCl</td><td class="colsep0 rowsep0" align="char" char=".">7.0</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char="​">293</td><td class="colsep0 rowsep0" align="char" char=".">510</td><td class="colsep0 rowsep0" align="center">0.4</td><td class="colsep0 rowsep0" align="char" char="​">353</td><td class="colsep0 rowsep0" align="char" char="​">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14m</b>·HCl</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char="​">562<a class="ref internalNav" href="#t5fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="char" char=".">880</td><td class="colsep0 rowsep0" align="center">nd<a class="ref internalNav" href="#t5fn11" aria-label="k">k</a></td><td class="colsep0 rowsep0" align="char" char="​">768<a class="ref internalNav" href="#t5fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="char" char="​">27<a class="ref internalNav" href="#t5fn12" aria-label="l">l</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Pharmacokinetic parameters were estimated by a noncompartmental analysis of the mean plasma concentration (<i>n</i> = >3) versus time profile after oral and intravenous administration.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">The amount of dose is as a free base.</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Dosed as a solution in 0.9% saline solution.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Clearance.</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">Volume of distribution at steady state.</p></div><div class="footnote" id="t5fn6"><sup>f</sup><p class="last">AUC (area under the curve) was extrapolated to infinity.</p></div><div class="footnote" id="t5fn7"><sup>g</sup><p class="last">AUC<sub>last</sub> (AUC from zero hour to last quantifiable time point).</p></div><div class="footnote" id="t5fn8"><sup>h</sup><p class="last">Maximum concentration observed.</p></div><div class="footnote" id="t5fn9"><sup>i</sup><p class="last">Half-life.</p></div><div class="footnote" id="t5fn10"><sup>j</sup><p class="last">Oral bioavailability.</p></div><div class="footnote" id="t5fn11"><sup>k</sup><p class="last">Not determined. Terminal phase could not be defined. As a result, <i>t</i><sub>1/2</sub> could not be determined.</p></div><div class="footnote" id="t5fn12"><sup>l</sup><p class="last">Oral bioavailability was estimated using AUC<sub>last</sub>.</p></div></div></div><div class="NLM_p">With <b>12b</b> showing a favorable pharmacokinetic profile, we evaluated the selectivity of this compound on ALK family kinases, ALK1, ALK2, ALK3, ALK4, ALK5, and ALK6. The IC<sub>50</sub> values of <b>12b</b> along with staurosporine and dorsomorphine as positive controls are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. The <b>12b</b> selectively inhibited ALK5 and ALK4 with IC<sub>50</sub> values of 0.011 and 0.013 μM, respectively, but did not inhibit ALK1, ALK2, ALK3, and ALK6 (IC<sub>50</sub> >10 μM). Although ALK7 was not included in this assay, we expect that <b>12b</b> would inhibit this family member, also, which is very highly related to ALK5 in its kinase domain.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. ALK Family Kinase Profiling of <b>12b</b><a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center" char=".">IC<sub>50</sub><a class="ref internalNav" href="#t6fn2" aria-label="b">b</a> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">ALK1</th><th class="colsep0 rowsep0" align="center" char=".">ALK2</th><th class="colsep0 rowsep0" align="center" char=".">ALK3</th><th class="colsep0 rowsep0" align="center" char=".">ALK4</th><th class="colsep0 rowsep0" align="center" char=".">ALK5</th><th class="colsep0 rowsep0" align="center" char=".">ALK6</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b><a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">0.013</td><td class="colsep0 rowsep0" align="char" char=".">0.011</td><td class="colsep0 rowsep0" align="char" char=".">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">staurosporine<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">0.850</td><td class="colsep0 rowsep0" align="char" char=".">10.005</td><td class="colsep0 rowsep0" align="char" char=".">4.288</td><td class="colsep0 rowsep0" align="char" char=".">9.118</td><td class="colsep0 rowsep0" align="char" char=".">>18.500</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dorsomorphine<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">0.467</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">A radioisotopic protein kinase assay (HotSpot assay) was performed at Reaction Biology Corporation (Malvern, PA).</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Mean of four independent assays.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">Compound was tested in 10-dose IC<sub>50</sub> mode with 3-fold serial dilution starting at 10 μM.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">Control compound was tested in 10-dose IC<sub>50</sub> mode with 3-fold serial dilution starting at 20 μM.</p></div></div></div><div class="NLM_p">After confirming the selectivity profile of <b>12b</b> on ALK family kinases, we expanded the selectivity profiling of this compound using a panel of 320 protein kinases. The residual activity of each kinase was measured at four different concentrations of 0.01, 0.1, 1, and 10 μM. The <b>12b</b> reduced the residual activity of 45 protein kinases to ≤50% and 11 protein kinases to ≤10% of control at a concentration of 10 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). The residual activity of these 11 protein kinases were ≤50% of control at 1 μM. Of these, at a lower concentration of 0.1 μM, ALK5, ALK4, RIPK2, and VEGF-R2 were significantly inhibited by <b>12b</b>, thus showing the residual activity of 4, 7, 31, and 52% of control, respectively. At the lowest concentration of 0.01 μM, the residual activity of ALK5 and ALK4 only were ≤50%. Overall, it was found that <b>12b</b> is a highly selective ALK5/ALK4 inhibitor in this selectivity profiling assay.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Selectivity Profiling of <b>12b</b> Using Selected Protein Kinases<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">residual activity<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a> (%)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">protein kinase</th><th class="colsep0 rowsep0" align="center" char=".">0.01 μM</th><th class="colsep0 rowsep0" align="center" char=".">0.1 μM</th><th class="colsep0 rowsep0" align="center" char=".">1 μM</th><th class="colsep0 rowsep0" align="center" char=".">10 μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ALK5</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ALK4</td><td class="colsep0 rowsep0" align="char" char=".">39</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MAP4K4</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char=".">83</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MINK1</td><td class="colsep0 rowsep0" align="char" char=".">104</td><td class="colsep0 rowsep0" align="char" char=".">76</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDGFR-α V561D</td><td class="colsep0 rowsep0" align="char" char=".">90</td><td class="colsep0 rowsep0" align="char" char=".">74</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="char" char=".">–7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDGFR-α wt</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="char" char=".">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RIPK2</td><td class="colsep0 rowsep0" align="char" char=".">81</td><td class="colsep0 rowsep0" align="char" char=".">31</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TGFβR2</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VEGF-R1</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="char" char=".">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VEGF-R2</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VEGF-R3</td><td class="colsep0 rowsep0" align="char" char=".">98</td><td class="colsep0 rowsep0" align="char" char=".">75</td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">A proprietary radioisotopic protein kinase assay (<sup>33</sup>PanQinase activity assay) was performed at ProQinase GmbH (Freiburg, Germany).</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">The residual activity was measured at four concentrations in singlicate using 320 protein kinases.</p></div></div></div><div class="NLM_p">Activin signaling and overexpression of activin are associated with pathological disorders that involve extracellular matrix accumulation and fibrosis. Ichida and his colleagues reported that activin A, the ligand of ALK4, was overexpressed in rat cirrhotic and fibrotic livers, and activin A and TGF-β could act synergistically to induce extracellular matrix production.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Matsuse et al. observed the abundant expression of activin A in bleomycin-treated murine lungs compared with in normal lungs, suggesting that activin A may play a role in the pathogenesis of pulmonary fibrosis.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> It was also reported that intimal activin A expression was markedly upregulated in balloon-injured rat carotid arteries, implying that it may play an important role in the response to vascular injury and accompanying neointimal formation.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> Werner and his colleagues demonstrated a strong induction of activin in granulation tissue after skin injury in mice<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> and a marked increase in the amount of granulation tissue in the wounds of the transgenic mice<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> overexpressing the activin βA chain in the epidermis after skin injury. They also observed a severe delay in wound healing and a significantly reduced granulation tissue formation in the transgenic mice overexpressing the activin antagonist follistatin in the epidermis after skin injury, eventually leading to smaller scar area than in control animals after healing.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> These reports strongly support that dual inhibition of ALK5/ALK4 with <b>12b</b> may further potentiate its therapeutic effects on a number of fibrotic diseases.</div><div class="NLM_p">We next compared the inhibitory pattern of <b>12b</b> with those of potential competitors <b>1</b>, <b>5</b>, and <b>6</b> using the most sensitive kinases to <b>12b</b>, ALK5, ALK4, RIPK2, and VEGF-R2. The IC<sub>50</sub> values and selectivity indices of the compounds for these kinases are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>. <b>1</b>, <b>5</b>, and <b>6</b> strongly inhibited ALK5, ALK4, and RIPK2. This profile of potent and nonselective inhibition is similar to that of <b>12b</b>. A differential inhibitory pattern was observed on VEGF-R2 that was strongly inhibited by <b>12b</b> only.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Selectivity Profiling of <b>12b</b>, <b>1</b>, <b>5</b>, and <b>6</b> Using Four Protein Kinases<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">ALK5</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">ALK4</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">RIPK2</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">VEGF-R2</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub><a class="ref internalNav" href="#t8fn2" aria-label="b">b</a> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">selectivity index<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">selectivity index</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">selectivity index</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">selectivity index</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.013</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">0.054</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">0.097</td><td class="colsep0 rowsep0" align="char" char=".">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">0.047</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0.070</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">0.685</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char=".">>213</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">0.086</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0.199</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">0.044</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">2.440</td><td class="colsep0 rowsep0" align="char" char=".">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">0.013</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0.023</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">0.111</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">0.442</td><td class="colsep0 rowsep0" align="char" char=".">34</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">A proprietary radioisotopic protein kinase assay (<sup>33</sup>PanQinase activity assay) was performed at ProQinase GmbH (Freiburg, Germany).</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Mean of duplicate.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">IC<sub>50</sub> of each kinase/IC<sub>50</sub> of ALK5.</p></div></div></div><div class="NLM_p">In this kinase assay, <b>12b</b> and <b>6</b> (IC<sub>50</sub> = 0.013 μM) showed the same level of potency on ALK5 and were 3.6-fold and 6.6-fold more potent than <b>1</b> (IC<sub>50</sub> = 0.047 μM) and <b>5</b> (IC<sub>50</sub> = 0.086 μM), respectively.</div><div class="NLM_p">The potency of the four compounds was also compared in a luciferase assay using HaCaT (3TP-luc) and 4T1 (3TP-luc) stable cells. Luciferase activity of HaCaT (3TP-luc) stable cells and 4T1 (3TP-luc) stable cells was increased by 65-fold and 46-fold after treatment of TGF-β1 (2 ng/mL), respectively, and <b>12b</b> displayed the most potent inhibition on the TGF-β1-induced luciferase reporter activity with IC<sub>50</sub> values of 0.0165 and 0.0121 μM in HaCaT (3TP-luc) stable cells and 4T1 (3TP-luc) stable cells, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>).</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. ALK5 Inhibitory Activity of <b>12b</b>, <b>1</b>, <b>5</b>, and <b>6</b> in Luciferase Assay</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">IC<sub>50</sub><a class="ref internalNav" href="#t9fn1" aria-label="a">a</a> for p3TP-luc (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">HaCaT<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">4T1<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0165</td><td class="colsep0 rowsep0" align="char" char=".">0.0121</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0438</td><td class="colsep0 rowsep0" align="char" char=".">0.0766</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">>0.1</td><td class="colsep0 rowsep0" align="char" char=".">>0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">0.0196</td><td class="colsep0 rowsep0" align="char" char=".">0.0442</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">Mean of triplicates.</p></div><div class="footnote" id="t9fn2"><sup>b</sup><p class="last">HaCaT (3TP-luc) stable cells were used.</p></div><div class="footnote" id="t9fn3"><sup>c</sup><p class="last">4T1 (3TP-luc) stable cells were used.</p></div></div></div><div class="NLM_p">To determine whether <b>12b</b> is competitive with respect to ATP against ALK5 and to obtain a <i>K</i><sub>i</sub> value of <b>12b</b>, kinase ATP competition study was performed (Reaction Biology Corporation, Malvern, PA). The progress curves for ALK5 reactions were not linear with time in the absence and presence of <b>12b</b> for 120 min (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>A). Because progress curves were nonlinear, the slopes obtained from the linear portion of the progress curves (15–60 min) were plotted against ATP concentrations for Michaelis–Menten plot (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B) and double-reciprocal plot (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C) for <b>12b</b> at concentrations of 41.2, 123, and 370 nM against ALK5. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>B and Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a>, the apparent <i>K</i><sub>m</sub> values for ATP are increased when <b>12b</b> concentration is increased in Michaelis–Menten plot and all lines are converged on the <i>Y</i>-axis in the double-reciprocal plot (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>C), suggesting that <b>12b</b> is competitive with respect to ATP against ALK5. Although the <i>K</i><sub>i</sub> value can be obtained by traditional graphical method, global fit is more accurate, therefore, we performed global fit using GraFit software. The global fit of Michaelis–Menten plot is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>D, and its results are listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl11" href="#tbl11">11</a>. If the compound is purely noncompetitive, the <i>K</i><sub>i</sub> (inhibitor affinity for enzyme) and <i>K</i><sub>i</sub>′ (inhibitor affinity for enzyme/ATP complex) values become the same. The very high <i>K</i><sub>i</sub>′ value (almost infinity) means the compound is competitive with respect with ATP. Therefore, it should be concluded that <b>12b</b> is purely competitive with respect to ATP with the <i>K</i><sub>i</sub> value of 20.59 nM.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. <i>V</i><sub>max</sub> and <i>K</i><sub>m</sub> Values on Different Concentrations of <b>12b</b><a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="×" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">concentration (nM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">0<a class="ref internalNav" href="#t10fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">41.2</th><th class="colsep0 rowsep0" align="center" char=".">123</th><th class="colsep0 rowsep0" align="center" char="×">370</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>max</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.2226</td><td class="colsep0 rowsep0" align="char" char=".">0.2643</td><td class="colsep0 rowsep0" align="char" char=".">0.5844</td><td class="colsep0 rowsep0" align="char" char="×">1.067 × 10<sup>11</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>m</sub></td><td class="colsep0 rowsep0" align="char" char=".">71.99</td><td class="colsep0 rowsep0" align="char" char=".">341.3</td><td class="colsep0 rowsep0" align="char" char=".">1648</td><td class="colsep0 rowsep0" align="char" char="×">8.673 × 10<sup>14</sup></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup>a</sup><p class="last">A radioisotopic protein kinase assay (HotSpot assay) was performed at Reaction Biology Corporation (Malvern, PA).</p></div><div class="footnote" id="t10fn2"><sup>b</sup><p class="last">DMSO 0.1% as vehicle control.</p></div></div></div><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Kinetic Parameters of <b>12b</b> Obtained from Global Fit of Michaelis–Menten Plot</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinetic parameter</th><th class="colsep0 rowsep0" align="center">value</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>max</sub> (μM/min)</td><td class="colsep0 rowsep0" align="left">0.2278</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>m</sub> (μM)</td><td class="colsep0 rowsep0" align="left">78.1764</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub>i</sub> (nM)</td><td class="colsep0 rowsep0" align="left">20.5937</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>K</i><sub class="stack">i</sub><sup class="stack">′</sup> (nM)</td><td class="colsep0 rowsep0" align="left">6.29600 × 10<sup>23</sup></td></tr></tbody></table></div></div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Progress curves for ALK5. (B) Michaelis–Menten plot for ALK5/<b>12b</b>. (C) Lineweaver–Burk plot for ALK5/<b>12b</b>. (D) Global fit of Michaelis–Menten plot by GraFit software for ALK5/<b>12b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Melanoma is a prototypical immunogenic tumor expressing a number of cell surface antigens and melanosomal antigens, which are targeted by cytotoxic T-lymphocytes (CTLs).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> CTLs lyse the target tumor cells with the cytolytic molecules such as perforin, granzymes A and B, and FasL.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Intensive efforts have been made to develop immunotherapies and tumor vaccines that activate antimelanoma T-cell responses.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> However, resistance of melanoma cells to the antiproliferative activity of TGF-β limits the success of immunotherapies and tumor vaccines by rendering the host immune response tolerant to tumor-associated antigens.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> TGF-β is one of the most potent immunosuppressive cytokines, therefore, it was of our particular interest whether <b>12b</b> could enhance antimelanoma CTL responses in a melanoma-bearing animal model. We have recently reported the therapeutic efficacy and the cellular and molecular mechanisms of <b>12b</b> in B16 melanoma-bearing mice.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><div class="NLM_p">Oral administration of <b>12b</b> (2.5 mg/kg, daily) for 18 days not only blocked Smad2/Smad3 phosphorylation but also induced ubiquitin-mediated degradation of Smad4 mainly in CD8<sup>+</sup> T cells in melanoma-bearing mice.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Treatment with <b>12b</b> significantly increased the proportions and numbers of CD8<sup>+</sup> T cells in the draining lymph nodes and the protein expression of perforin and granzyme B in the draining lymph node CD8<sup>+</sup> T cells, thus enhancing CTL activity. The T cell-specific deficiency of Smad4 suppressed the progression of primary melanomas and lymph node metastasis by derepressing eomesodermin, a T-box transcription factor regulating CTL function. Notably, a daily dose of 2.5 mg/kg (QD) of <b>12b</b> was more efficacious than a daily dose of 150 mg/kg (75 mg/kg, BID) of <b>5</b> in suppressing the growth of primary tumors (tumor weight, 76% inhibition for <b>12b</b>, 61% inhibition for <b>5</b>; tumor volume, 97% inhibition for <b>12b</b>, 81% inhibition for <b>5</b>) and lymph node metastasis (green fluorescent protein (GFP)-positive B16 cells in the draining lymph nodes: 78% inhibition for <b>12b</b>, 64% inhibition for <b>5</b>) compared with the vehicle control.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a></div><div class="NLM_p">The antifibrotic effect of <b>12b</b> was investigated in the CCl<sub>4</sub>-induced liver fibrosis model which is the best characterized toxin-based experimental model for the induction of fibrosis.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> After intraperitoneal injection of CCl<sub>4</sub> (1 mL/kg) to mice twice a week for 4 weeks, the protein levels of α-smooth muscle actin and collagen type 1, common hallmarks of fibrotic diseases, in CCl<sub>4</sub>-induced mice liver were elevated by 2.3-fold and 4.1-fold, respectively, compared to those in control mice liver. Oral administration of <b>12b</b> (0.625, 1.25, 2.5, or 5 mg/kg, daily) 5 times a week for 4 weeks reduced significantly the elevated level of α-smooth muscle actin at doses of 1.25, 2.5, and 5 mg/kg and of collagen type 1 at all dose levels tested.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> A significant increase (2.1-fold) in serum level of AST was observed in CCl<sub>4</sub>-induced mice compared to that in control mice. The <b>12b</b> decreased significantly the elevated serum level of AST at all dose levels, reflecting improvement of liver function.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><div class="NLM_p">The <b>12b</b> was crystallized from MeOH, and a single crystal was obtained as a <b>12b</b>·MeOH solvate. A single-crystal X-ray analysis was conducted on <b>12b</b>·MeOH to determine its solid-state conformation.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The X-ray crystallographic structure and crystal data of <b>12b</b>·MeOH are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl12" href="#tbl12">12</a>, respectively. Because the crystal structure of <b>12b</b> bound to ALK5 is not available to us, we carried out a docking study to examine docking poses of <b>12b</b> along with <b>12a</b>, <b>9a</b>, and <b>9b</b> in the active site of ALK5 using flexible molecular docking program Surflex-Dock. After docking, we compared the docking pose of <b>12b</b> with those of <b>12a</b>, <b>9a</b>, and <b>9b</b>. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>, all ligands docked into the acive site cavity of ALK5 well with similar docking pose. The [1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl moiety occupies the pocket for adenine ring of ATP and commonly forms a hydrogen bonding with NH of His283 in the backbone of hinge region of ALK5. Similar to LY580276 having 6-methylpyridine in the X-ray structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RW8">1RW8</a>),<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> the methyl group of 6-methylpyridine forms hydrophobic interaction with the aromatic ring of Tyr249 and the nitrogen atom forms a water-mediated hydrogen bond network with the side chain of Tyr249 and Glu245 and the backbone of Asp351. Additionally, the imidazole ring NH of our compounds is also involved in this hydrogen bond network, which may contribute to tighter fit into the active site. The amino group linked to the imidazole 2-position in <b>12b</b> forms hydrogen bonds with both backbone Lys337 and side chain Asn338, while that in <b>12a</b> forms a hydrogen bond with side chain Asn338. The 2-fluorophenyl ring of <b>12b</b> is stretched to the backside hydrophobic pocket consisting of Ile339 and Leu340 (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>E). The oxygen atom in <b>9a</b> and the sulfur atom in <b>9b</b> did not interact with ALK5. Our docking results demonstrate that the most active compound <b>12b</b> forms the most favorable intermolecular interactions in the ATP-binding pocket of ALK5.</div><div class="NLM_table-wrap" id="tbl12"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 12. Crystal Data of <b>12b</b>·MeOH</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">empirical formula</td><td class="colsep0 rowsep0" align="left">C<sub>22</sub>H<sub>18</sub>FN<sub>7</sub>·CH<sub>3</sub>OH</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">formula weight</td><td class="colsep0 rowsep0" align="left">431.46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">crystal system</td><td class="colsep0 rowsep0" align="left">monoclinic</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">space group</td><td class="colsep0 rowsep0" align="left"><i>P</i>2(1)/<i>n</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>a</i>, <i>b</i>, <i>c</i> (Å)</td><td class="colsep0 rowsep0" align="left">7.9179(2), 10.3592(3), 25.6193(6)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">α, β, γ (deg)</td><td class="colsep0 rowsep0" align="left">90.00, 91.643(10), 90.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">volume (Å<sup>3</sup>)</td><td class="colsep0 rowsep0" align="left">2100.51(9)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">temperature (K)</td><td class="colsep0 rowsep0" align="left">100(1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Z</i></td><td class="colsep0 rowsep0" align="left">4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">goodness-of-fit on <i>F</i><sup>2</sup></td><td class="colsep0 rowsep0" align="left">1.069</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">final <i>R</i> indices [5212 data; <i>I</i> > 2σ(<i>I</i>)]</td><td class="colsep0 rowsep0" align="left"><i>R</i><sub>1</sub> = 0.0465, <i>wR</i><sub>2</sub> = 0.1266</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i> indices [all data]</td><td class="colsep0 rowsep0" align="left"><i>R</i><sub>1</sub> = 0.0490, <i>wR</i><sub>2</sub> = 0.1288</td></tr></tbody></table></div></div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystallographic structure of <b>12b</b>·MeOH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking pose of candidate compounds in the active site of ALK5 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RW8">1RW8</a>). (A) Docking pose of <b>12b</b> (magenta capped sticks). (B) <b>12a</b> (cyan capped sticks). (C) <b>9a</b> (yellow capped sticks). (D) <b>9b</b> (green capped sticks). Gray capped sticks represent key amino acid residues within the binding site and ribbon is backbone of ALK5. Ball and stick is water molecule. Red dashed lines are hydrogen bonding interactions (<2.8 Å). (E) Docking pose of <b>12b</b> (magenta carbon). The active site is shown as MOLCAD lipophilic potential surface map. Lipophilicity increases from blue (hydrophilic) to brown (lipophilic).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">IC<sub>50</sub> values of <b>12b</b> against the five most common drug metabolizing CYP450 isoforms (CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4) in human liver microsomes were determined by N-in-1 approach<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> with specific CYP450 substrates. All IC<sub>50</sub> values of <b>12b</b> against the five CYP450 isoforms were >10 μM (Table <a class="ref showTableEvent internalNav" data-ID="tbl13" href="#tbl13">13</a>), indicating that <b>12b</b> has low potential for CYP-mediated drug/drug interactions.</div><div class="NLM_table-wrap" id="tbl13"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 13. CYP450 Inhibition of <b>12b</b> in Human Liver Microsomes</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">CYP450</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="±">% inhibition at 10 μM<a class="ref internalNav" href="#t13fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">1A2</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char="±">23.3 ± 3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2C9</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char="±">30.1 ± 3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2C19</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char="±">30.7 ± 4.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">2D6</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char="±">14.6 ± 1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">3A4</td><td class="colsep0 rowsep0" align="char" char=".">>10</td><td class="colsep0 rowsep0" align="char" char="±">44.8 ± 5.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t13fn1"><div class="footnote" id="t13fn1"><sup>a</sup><p class="last">Mean ± SD (<i>n</i> = 3).</p></div></div></div><div class="NLM_p">The safety pharmacology studies of <b>12b</b> were conducted to assess its effect on the cardiovascular system, central nervous system, and respiratory system.</div><div class="NLM_p">Inhibition of hERG channels is associated with potential risk of QT prolongation. The whole cell patch-clamp technique was used to record inward rectifying potassium currents (<i>I</i><sub>Kr</sub>) from single HEK293 cells stably expressing the potassium hERG channel (MPI Research, Inc. Mattawan, MI).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Superfusion of <b>12b</b> at concentrations of 1, 10, 30, and 100 μM produced mean concentration-dependent inhibition of 1.79%, 22.13%, 50.84%, and 76.60%, respectively, with an IC<sub>50</sub> value of 31.04 μM, indicating low cardiac toxicity risk (Table <a class="ref showTableEvent internalNav" data-ID="tbl14" href="#tbl14">14</a>).</div><div class="NLM_table-wrap" id="tbl14"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 14. Effect of <b>12b</b> on Cloned hERG Channels Expressed in Human Embryonic Kidney (HEK293) Cells<a class="ref internalNav" href="#t14fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">concentration (μM)</th><th class="colsep0 rowsep0" align="center" char="±">hERG current inhibition (%)</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vehicle<a class="ref internalNav" href="#t14fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char="±">1.18 ± 0.343<a class="ref internalNav" href="#t14fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char="±">1.79 ± 0.457</td><td class="colsep0 rowsep0" align="char" char=".">31.04</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char="±">22.13 ± 3.579</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char="±">50.84 ± 0.219</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char="±">76.60 ± 2.135</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cisapride<a class="ref internalNav" href="#t14fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char="±">83.60 ± 0.977</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t14fn1"><div class="footnote" id="t14fn1"><sup>a</sup><p class="last">Assay was performed at MPI Research, Inc. (Mattawan, MI).</p></div><div class="footnote" id="t14fn2"><sup>b</sup><p class="last">Physiological salt solution (PSS) with 0.1% DMSO.</p></div><div class="footnote" id="t14fn3"><sup>c</sup><p class="last">Mean ± SE (<i>n</i> = 3).</p></div><div class="footnote" id="t14fn4"><sup>d</sup><p class="last">Positive control compound.</p></div></div></div><div class="NLM_p">The potential cardiovascular effect of <b>12b</b> was evaluated in conscious freely moving beagle dogs instrumented with radiotelemetry transmitters measuring electrocardiogram (ECG), heart rate, and blood pressure (MPI Research, Inc. Mattawan, MI). Oral administration of <b>12b</b> at dose levels of 10, 30, and 100 mg/kg was without effect on clinical observations, body weight, body temperature, ECG, heart rate, and blood pressure, establishing a no-observed-effect level (NOEL) of at least 100 mg/kg.</div><div class="NLM_p">The potential acute neurobehavioral toxicity of <b>12b</b> and the potential effect of <b>12b</b> on respiratory function were evaluated in SD rats (MPI Research, Inc. Mattawan, MI). Acute oral administration of <b>12b</b> at 1000 mg/kg produced mortality (3 out of 10 animals) and was associated with various clinical signs and effects on measured functional observational battery (FOB) and respiratory parameters. Specifically, these animals experienced decreased activity, low carriage, partially or completely closed eyelids, salivation, difficulty breathing, and lacrimation between 1 and 6 h postdose. Various effects observed on FOB end points were consistent with the general toxicity and/or morbidity observed in animals at the same dose level. There were some slight decrease in respiratory rate and increase in tidal volume and minute volume. These changes in respiration are considered to be related to <b>12b</b> but are not considered to be adverse.</div><div class="NLM_p">Doses of 10 and 100 mg/kg did not produce mortality and were without effects on clinical observations and respiratory parameters. Potential FOB effects at doses of 10 and 100 mg/kg were limited to slight decrease in activity and arousal at 24 h postdose, establishing a no-observed-adverse-effect level (NOAEL) of at least 100 mg/kg.</div><div class="NLM_p">The genotoxic potential of <b>12b</b> was assessed using a bacterial reverse mutation assay, a mammalian chromosome aberration assay, and an in vivo rat bone marrow erythrocyte micronucleus test.</div><div class="NLM_p">The mutagenic potential of <b>12b</b> was evaluated by measuring its ability to induce reverse mutations at selected loci of <i>Salmonella typhimurium</i> strains TA98, TA100, TA1535, and TA1537, and <i>Escherichia coli</i> strain WP2 <i>uvr</i>A in the presence and absence of aroclor-induced rat liver S9 metabolic activation system (BioReliance, Rockville, MD). No positive mutagenic responses were observed with any of the strains in either the presence or absence of S9 activation at dose levels of 50, 150, 500, 1500, and 5000 μg per plate.</div><div class="NLM_p">To evaluate the clastogenic potential of <b>12b</b>, a chromosome aberration assay was performed using Chinese hamster ovary (CHO) cells in both the absence and presence of aroclor-induced rat liver S9 (BioReliance, Rockville, MD). No significant or dose-dependent increase in aberrant metaphases, polyploid, or endoreduplicated cells were observed in treatment groups with or without S9 at dose levels tested.</div><div class="NLM_p">The clastogenic effect and aneugenic effect of <b>12b</b> were evaluated by measuring its ability to induce micronucleated polychromatic erythrocytes in rat bone marrow (BioReliance, Rockville, MD). A single oral administration of <b>12b</b> at dose levels of 500, 1000, and 2000 mg/kg did not induce a significant increase in the incidence of micronucleated polychromatic erythrocytes in bone marrow of female SD rats. The results of these three studies indicate that <b>12b</b> is negative for the induction of genotoxicity.</div><div class="NLM_p">A 4-week toxicity study in rats with a 4-week recovery period was conducted to evaluate the potential subchronic toxicity and toxicokinetics after oral administration of <b>12b</b> at dose levels of 10, 20, and 50 mg/kg/day once daily for 4 weeks and to examine reversibility, progression, or delayed appearance of any observed changes following a 4-week post dose observation period (MPI Research, Inc. Mattawan, MI). The microscopic findings related to <b>12b</b> were present in the liver (panlobular hypertrophy), kidney (tubular hypertrophy), spleen (extramedullary hematopoiesis), femur, and sternum (subphyseal hyperostosis, growth plate thickening) in males and/or females and in ovaries (ovarian atrophy) in females at terminal necropsy. In general, females had higher incidence and/or severity of microscopic findings at a given dose level. There was a complete resolution of compound-related findings in all tissues in males and in the liver, kidney, spleen, and ovaries in females. There was a partial resolution of microscopic findings in the femur and sternum in females. For males, there were no adverse <b>12b</b>-related effects noted for any parameter evaluated. In females at 50 mg/kg/day, ovarian atrophy observed microscopically was considered an adverse <b>12b</b>-related effect. As a result, the NOAEL following once daily oral administration of <b>12b</b> for 4 weeks was 50 mg/kg/day for males and 20 mg/kg/day for females. Following 4 weeks of dosing, systemic exposure (AUC<sub>0–6 h</sub>) to <b>12b</b> in males at 50 mg/kg/day was 3500 ng × h/mL and <i>C</i><sub>max</sub> was 2240 ng/mL. Systemic exposure in females at 20 mg/kg/day was 5350 ng × h/mL and <i>C</i><sub>max</sub> was 3910 ng/mL.</div><div class="NLM_p">Frazier and his colleagues observed the three major toxicities, pulmonary hemorrhage, bone physeal abnormalities (hypertrophy of the physes or growth plates), and heart valve lesions, during an ALK5 program at GSK.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Heier et al. reported that small molecule ALK5 inhibitors induced histopathological heart valve lesions and physeal dysplasia characterized by increased growth plate thickness in the femoro-tibial joint in rats.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> In this study, we also observed physeal dysplasia characterized by subphyseal hyperostosis and growth plate thickening in femur, a finding consistent with that observed by Frazier’s group<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> and Heier’s group with ALK5 inhibitors. Frazier’s group hypothesized that physeal dysplasia observed in test animals might not be problematic because adults, the target population for ALK5 inhibitors, have already closed growth plates.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></div><div class="NLM_p">Heart valve lesions were observed at doses that also caused a physeal dysplasia in rats.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> The hemorrhagic, degenerative, and inflammatory lesions in heart valves can cause hemodynamic overload to the ventricles, which eventually leads to myocardial dysfunction and heart failure.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> However, clinical trials with <b>5</b> to date have not revealed medically significant cardiotoxicities or bone physeal abnormalities.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Nevertheless, considering the key role of heart valves in cardiac function, in this study, we performed an extended evaluation of the heart for the control and high dose groups at both terminal and recovery necropsies to capture/represent as many heart valves as possible in the plane of the section including the attachment of the aorta at the heart base. It should be noted that there was no evidence of inflammation or necrosis at the base of the aorta and/or within the heart valves in either sex at 50 mg/kg/day at terminal and recovery necropsies.</div><div class="NLM_p">A 4-week toxicity study in dogs with a 2-week recovery period was conducted to evaluate the potential subchronic toxicity and toxicokinetics after oral administration of <b>12b</b> at dose levels of 3, 10, and 30 mg/kg/day once daily for 4 weeks and to examine reversibility, progression, or delayed appearance of any observed changes following a 2-week post dose observation period (MPI Research, Inc. Mattawan, MI). The only detailed clinical observations that could be related to <b>12b</b> were soft and watery feces at 30 mg/kg/day in both sexes. There were no <b>12b</b>-related changes in ECG, hematology, or clinical chemistry and no <b>12b</b>-related macroscopic and microscopic findings at all dose levels. Consequently, the NOAEL was considered to be 30 mg/kg/day in both sexes. AUC<sub>0–6 h</sub> and <i>C</i><sub>max</sub> values on day 28 for 30 mg/kg/day, sexes combined, were 21500 ng × h/mL and 11400 ng/mL, respectively.</div><div class="NLM_p">The development of potent, selective, and orally bioavailable ALK5 inhibitors such as <b>12b</b> may offer many therapeutic opportunities. A clinically useful antibody drug, ipilimumab exerts its effect on melanoma by binding to cytotoxic T-lympocyte antigen 4 (CTLA-4), a negative regulator of T-cell activation, and blocking the interaction of CTLA-4 with ligand CD80/CD86, thus enhancing T-cell mediated antitumor immune responses. In a phase III clinical trial in 676 patients with previously treated, unresectable or metastatic melanoma, median overall survival in patients receiving ipilimumab plus a peptide vaccine, gp100, was 10.0 months, compared with 6.4 months in patients receiving gp100 alone.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> It also increased the rates of survival at 12 months (46% vs 25%) and 24 months (24% vs 14%) by a near doubling compared with the peptide vaccine. Although ipilimumab achieved a breakthrough in metastatic melanoma, long-time exposure of this antibody drug frequently caused severe and fatal immune-mediated adverse reactions such as enterocolitis, hepatitis, dermatitis, neuropathies, and endocrinopathies by T-cell activation and proliferation.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a></div><div class="NLM_p">Because <b>12b</b> has a short half-life and a different mechanism of action to activate CTLs from that of ipilimumab, it might have a high potential to be developed as another much safer cancer immunotherapeutic agent.</div><div class="NLM_p">The potential clinical applications of ALK5 inhibitors on various fibrotic diseases have recently been reviewed by Akhurst and Hata.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> They include radiation-induced fibrosis, idiopathic pulmonary fibrosis, renal fibrosis, cardiac fibrosis, scleroderma, restenosis following coronary artery bypass and angioplasty, Marfan syndrome, and postoperative scarring in ocular conditions. We have also demonstrated the therapeutic utility of ALK5 inhibitors with <b>6</b>,<a onclick="showRef(event, 'ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14 ref15">(12-15)</a> 3-((4-(6-methylpyridin-2-yl)-5-(quinolin-6-yl)-1<i>H</i>-imidazol-2-yl)methyl)benzamide (IN-1233),<a onclick="showRef(event, 'ref57 ref58 ref59 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref57 ref58 ref59 ref60 ref61">(57-61)</a> and <b>12b</b><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> in animal models of renal fibrosis, multiple sclerosis, penile fibrosis, airway fibrosis, stent-induced tissue hyperplasia, pulmonary arterial hypertension, and liver fibrosis.</div><div class="NLM_p last">On the basis of the proposed therapeutic applications of ALK5 inhibitors and favorable pharmacologic, pharmacokinetic, and toxicologic profiles of <b>12b</b> (EW-7197), a first-in-human phase I dose-escalation study of <b>12b</b> is scheduled to start soon in U.S. (IND 119528).</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48686" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48686" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We have synthesized a series of 2-substituted-4-([1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)imidazoles to optimize a prototype ALK5 inhibitor <b>6</b>. The structure–activity relationships in this series of compounds have been established and discussed. Combination of replacement of a quinoxalin-6-yl moiety of <b>6</b> with a [1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl moiety, insertion of a methyleneamino linker, and a <i>o-</i>F substituent in the phenyl ring markedly increased ALK5 inhibitory activity, kinase selectivity, and oral bioavailability. The <b>12b</b> inhibited ALK5 with IC<sub>50</sub> value of 0.013 μM in a kinase assay and with IC<sub>50</sub> values of 0.0165 μM and 0.0121 μM in HaCaT (3TP-luc) stable cells and 4T1 (3TP-luc) stable cells, respectively, in a luciferase assay. Selectivity profiling of <b>12b</b> using a panel of 320 protein kinases, including ALK family kinases ALK1, ALK2, ALK3, ALK4, ALK5, and ALK6, revealed that it is a highly selective ALK5/ALK4 inhibitor. Pharmacokinetic study with <b>12b</b>·HCl in rats showed an oral bioavailability of 51% with high systemic exposure (AUC) of 1426 ng × h/mL and maximum plasma concentration (<i>C</i><sub>max</sub>) of 1620 ng/mL. Kinase ATP competition study indicated that <b>12b</b> is purely competitive with respect to ATP with the <i>K</i><sub>i</sub> value of 20.59 nM. Docking pose of <b>12b</b> generated by flexible molecular docking program with ALK5:<b>12b</b> complex shows it fits well into the active site cavity of ALK5 by forming several hydrogen bond interactions. The <b>12b</b> inhibited the potassium hERG channel with IC<sub>50</sub> value of 31.04 μM, indicating low cardiac toxicity risk. In the safety pharmacology studies of <b>12b</b> in dogs and rats, it showed no adverse effect on the cardiovascular system, central nervous system, and respiratory system up to an oral dose of 100 mg/kg. The genotoxic potential of <b>12b</b> was found to be negative in a bacterial reverse mutation assay, a mammalian chromosome aberration assay, and an in vivo rat bone marrow erythrocyte micronucleus test. In a 4-week toxicity study in rats with a 4-week recovery period, the NOAEL following once daily oral administration of <b>12b</b> at dose levels of 10, 20, and 50 mg/kg/day was 50 mg/kg/day for males and 20 mg/kg/day for females. Unlike the earlier ALK5 inhibitors developed by GSK<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> and AstraZeneca,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> there was no evidence of <b>12b</b>-related inflammation or necrosis at the base of the aorta and/or within the heart valves in either sex at 50 mg/kg/day at terminal and recovery necropsies. In a 4-week toxicity study in dogs with a 2-week recovery period, the NOAEL following once daily oral administration of <b>12b</b> at dose levels of 3, 10, and 30 mg/kg/day was 30 mg/kg/day in both sexes. Taken together, <b>12b</b> holds great promise as an anticancer/antifibrotic agent.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34513" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34513" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> General Methods</h3><div class="NLM_p">All commercial chemicals and solvents are of reagent grade and were used without further purification unless otherwise stated. All reactions were monitored for completion by TLC using Merck silica gel 60 F<sub>254</sub> glass plates (20 cm × 20 cm). Spots were detected by viewing under UV light (254 and 365 nm) and colorizing with charring after dipping in either <i>p</i>-anislaldehyde solution with acetic acid, or ninhydrin solution with EtOH, or KMnO<sub>4</sub> solution with water. MPLC was performed on Merck silica gel 60 (230–400 mesh) with an YFLC-540 ceramic pump (Yamagen).</div><div class="NLM_p"><sup>1</sup>H NMR spectra were recorded on a Varian Unity-Inova 400 MHz instrument. The <sup>1</sup>H NMR data are reported as peak multiplicities: s for singlet, d for doublet, dd for double of doublets, t for triplet, q for quartet, br s for broad singlet, br d for broad double, br t for broad triplet, and m for multiplet. The chemical shifts are reported in parts per million (ppm), and coupling constants are reported in hertz (Hz). For <sup>1</sup>H NMR spectra, CDCl<sub>3</sub>, CD<sub>3</sub>OD, or DMSO-<i>d</i><sub>6</sub> was used as solvent, and it served as the internal standard at δ 7.26, 3.31, or 2.50. <sup>13</sup>C NMR spectra were recorded on a Varian Unity-Inova 100 or 125 MHz instrument. For <sup>13</sup>C NMR spectra, CDCl<sub>3</sub>, CDCl<sub>3</sub>/CD<sub>3</sub>OD, CD<sub>3</sub>OD, or DMSO-<i>d</i><sub>6</sub> was used as solvent, and it served as the internal standard at δ 77.23 (CDCl<sub>3</sub>, CDCl<sub>3</sub>/CD<sub>3</sub>OD), 49.05 (CD<sub>3</sub>OD), or 39.50 (DMSO-<i>d</i><sub>6</sub>). <sup>19</sup>F NMR spectra were recorded on Varian Unity-Inova 376 MHz instrument.</div><div class="NLM_p">High resolution mass spectra electrospray ionization (HRMS-ESI) was obtained on an Agilent Technologies 6220 TOF LC/MS spectrometer. Infrared spectra were recorded on a FT-infrared spectrometer (FTS-135, Bio-Rad) using KBr discs with absorption in cm<sup>–1</sup>. All melting points were taken in Pyrex capillaries using an electrothermal digital melting apparatus (B-540, Büchi) and are not corrected.</div><div class="NLM_p last">The purity of compounds was confirmed by following method. The HPLC analyses were accomplished with an Agilent 1100 series HPLC system (Agilent Technologies, Waldbronn, Germany) consisting of a solvent degasser (G1379A degasser), a quaternary pump (G1311A liquid chromatography), and an auto sampler injector (G1329A). Separations were carried out using a reversed-phase C<sub>18</sub> analytical column (Capcell-pak C<sub>18</sub> MG 5 μm, 3.0 mm × 250 mm) (Shiseido, Tokyo, Japan) with a solvent system consisting of an isocratic solvent. The solvent contained 15–35% acetonitrile in distilled water containing 0.1% trifluoroacetic acid and was delivered at 0.5 mL/min over 25 min. The column was maintained at room temperature with a column oven (G1316A). All compounds were dissolved in MeOH or MeOH and CH<sub>2</sub>Cl<sub>2</sub> cosolvent and detected at 230 nm with a G1314A variable wavelength detector (VWD). The HPLC system was controlled by a ChemStation Software (Agilent). The purity of the each compound was calculated from a surface integral of detected peaks and is described as percent (%). All compounds were found to be ≥95% pure. Retention times are given in minutes (min).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Procedure for the Preparation of the 6-(5-(6-Methylpyridin-2-yl)-2-(phenoxymethyl)- or -2-((phenylthio)methyl)-1<i>H</i>-imidazol-4-yl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridine (<b>9a</b> and <b>9b</b>)</h3><div class="NLM_p">To a stirred solution of 1-([1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl)-2-(6-methylpyridin-2-yl)ethane-1,2-dione (<b>8</b>) (1.50 mmol) in a mixture of <i>tert</i>-butyl methyl ether (4 mL) and MeOH (4 mL) were added 2-phenoxyacetaldehyde (1.80 mmol) or 2-(phenylthio)acetaldehyde (2.25 mmol) and NH<sub>4</sub>OAc (4.51 mmol), and the mixture was stirred at room temperature for 70–180 min under nitrogen atmosphere. The pH of the reaction mixture was adjusted to 8 with saturated aqueous NaHCO<sub>3</sub> solution. After removal of solvent, the mixture was extracted with EtOAc (2 × 50 mL), and the combined EtOAc solution was washed with water (20 mL) and brine (20 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and then evaporated to dryness under reduced pressure. The residue was purified by MPLC on silica gel to afford the titled compounds as a solid.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 6-(5-(6-Methylpyridin-2-yl)-2-(phenoxymethyl)-1<i>H</i>-imidazol-4-yl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridine (<b>9a</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CHCl<sub>3</sub>/MeOH (97:3) as eluent to give the titled compound as a yellow solid. Yield 56%; mp 203.2–205.2 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.94 (s, 1 H), 8.37 (s, 1 H), 7.77–7.72 (m, 2 H), 7.51 (t, 1 H, <i>J</i> = 7.6 Hz), 7.32–7.25 (m, 3 H), 7.06 (d, 1 H, <i>J</i> = 7.6 Hz), 7.00 (t, 1 H, overlapped, <i>J</i> = 7.6 Hz), 6.97 (d, 2 H, overlapped, <i>J</i> = 8.0 Hz), 5.22 (s, 2 H), 2.54 (s, 3 H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.10, 157.16, 154.32, 149.81, 149.06, 144.29, 137.52, 131.81, 129.61 (2 C), 129.39, 128.01, 121.79, 121.14, 120.65, 118.56, 115.25, 114.88, 114.76 (2 C), 62.62, 23.73. IR (KBr) 3071, 2930, 1588, 1496, 1237 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>19</sub>N<sub>6</sub>O 383.1615, found 383.1631. HPLC purity: 98.08%.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 6-(5-(6-Methylpyridin-2-yl)-2-((phenylthio)methyl)-1<i>H</i>-imidazol-4-yl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridine (<b>9b</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (40:1) as eluent to give the titled compound as a white solid. Yield 38%; mp 168.0–170.0 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.89 (t, 1 H, <i>J</i> = 1.4 Hz), 8.35 (s, 1 H), 7.76–7.19 (m, 2 H), 7.45 (t, 1 H, <i>J</i> = 7.8 Hz), 7.39–7.36 (m, 2 H), 7.30–7.26 (m, 2 H), 7.23–7.19 (m, 2 H), 7.01 (d, 1 H, <i>J</i> = 7.6 Hz), 4.26 (s, 2 H), 2.49 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.41, 154.60, 150.08, 147.16, 146.31, 138.17, 134.78, 131.50, 130.21 (2C), 129.50 (2C), 128.16, 127.36, 122.36, 117.81, 116.55, 31.68, 24.04 (3 peaks were not observed). IR (KBr) 3068, 2927, 1577, 1466, 1316 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>19</sub>N<sub>6</sub>S 399.1386, found 399.1402. HPLC purity: 97.61%.</div></div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Synthesis of 6-(2-(Dimethoxymethyl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-4-yl)-[1,2,4]triazolo[1,5-<i>a</i>]pyridine (<b>10</b>)</h3><div class="NLM_p last">To a stirred solution of <b>8</b> (13.50 g, 50.70 mmol) in a mixture of <i>tert</i>-butyl methyl ether (80 mL) and MeOH (40 mL) were added 60% 2,2-dimethoxyacetaldehyde in H<sub>2</sub>O (17.7 mL, 101.40 mmol) and NH<sub>4</sub>OAc (9.77 g, 126.75 mmol). The mixture was stirred at room temperature for 4 h, and the solvent was removed under reduced pressure. The pH of the reaction mixture was adjusted to 8 with saturated aqueous NaHCO<sub>3</sub> solution and extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 50 mL). The combined CH<sub>2</sub>Cl<sub>2</sub> solution was washed with brine (30 mL), dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to dryness under reduced pressure. The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a white solid. Yield 83%; mp 149.1–151.1 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.54 (s, 1 H), 8.96 (s, 1 H), 8.36 (s, 1 H), 7.82 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.77 (d, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.47 (t, 1 H, <i>J</i> = 7.8 Hz), 7.23 (d, 1 H, <i>J</i> = 7.6 Hz), 7.04 (d, 1 H, <i>J</i> = 8.0 Hz), 5.57 (s, 1 H), 3.48 (s, 6 H), 2.58 (s, 3 H). IR (KBr) 3079, 2960, 1576, 1502, 1191, 1115, 1067 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>19</sub>N<sub>6</sub>O<sub>2</sub> 351.1564, found 351.1573.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Synthesis of 4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazole-2-carbaldehyde (<b>11</b>)</h3><div class="NLM_p last">Compound <b>10</b> (12.30 g, 35.11 mmol) was dissolved in 1 N HCl (105 mL), and the mixture was heated at 70 °C for 4 h. The reaction mixture was allowed to cool to 0 °C, and then it was neutralized with saturated aqueous NaHCO<sub>3</sub> solution. The light-yellow precipitates were collected through a glass filtered funnel, and the filtered cake was washed with water (100 mL) and ether (200 mL). The solid was dried in a vacuum oven over P<sub>2</sub>O<sub>5</sub> at 60 °C for 12 h to give the titled compound as a light-yellow solid. Yield 96%; mp 193.8–196.2 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.03 (dd, 1 H, <i>J</i> = 1.6, 0.8 Hz), 9.56 (s, 1 H), 8.42 (s, 1 H), 8.27 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.82 (br d, 1 H, <i>J</i> = 0.8 Hz), 7.72 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.65 (t, 1 H, <i>J</i> = 7.8 Hz), 7.05 (d, 1 H, <i>J</i> = 7.6 Hz), 2.46 (s, 3 H). IR (KBr) 1691, 1438 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>13</sub>N<sub>6</sub>O 305.1145, found 305.1158.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> General Procedure for the Preparation of the 2-Substituted-4-([1,2,4]triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)imidazoles <b>12a</b>–<b>l</b>, <b>12n</b>–<b>ap</b>, <b>12ar</b>–<b>bi</b>, and <b>14a</b>–<b>p</b></h3><div class="NLM_p">To a stirred solution of <b>11</b> (13.14 mmol) in 1,2-dichloroethane (240 mL) were added appropriate substituted anilines (19.71 mmol) and AcOH (13.14 mmol), and the mixture was heated to reflux for 2 h under nitrogen atmosphere. The reaction mixture was cooled to 0 °C, and MeOH (60 mL) and THF (20 mL) were added. To it, (AcO)<sub>3</sub>BHNa (26.20 mmol) or NaBH<sub>4</sub> (52.56 mmol) was added portionwise, and then the reaction mixture was allowed to warm to room temperature and stirred for an additional 3 h. The pH of the reaction mixture was adjusted to 7–8 at 0 °C with 1 N HCl, and then the organic layer was separated. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (2 × 300 mL). The combined organic layers was washed with brine (300 mL) and dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to dryness under reduced pressure. The residue was purified by MPLC on silica gel to afford the titled compounds as a solid.</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)aniline (<b>12a</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (24:1) as eluent to give the titled compound as a yellow solid. Yield 87%; mp 162.1–164.3 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.43 (br s, 1 H), 8.96 (s, 1 H), 8.37 (s, 1 H), 7.82 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.77 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.45 (t, 1 H, <i>J</i> = 7.6 Hz), 7.25–7.19 (m, 3 H), 7.01 (d, 1 H, <i>J</i> = 7.6 Hz), 6.80 (tt, 1 H, <i>J</i> = 8.0, 1.2 Hz), 6.74–6.72 (m, 2 H), 4.55 (s, 2 H), 2.53 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.72, 154.49, 149.94, 147.91, 147.84, 147.51, 137.51, 133.54, 131.45, 129.61 (2C), 128.41, 127.96, 122.24, 122.20, 118.97, 117.99, 116.31, 113.50 (2C), 42.67, 24.28. IR (KBr) 3399, 2924, 1602, 1503, 1316 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>20</sub>N<sub>7</sub> 382.1775, found 382.1786. HPLC purity: 100%.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2-fluoroaniline (<b>12b</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a pale-yellow solid. Yield 92%; mp 129.5–131.5 °C. <sup>1</sup>H NMR(400 MHz, CD<sub>3</sub>OD) δ 9.13 (s, 1 H), 8.41 (s, 1 H), 7.84 (d, 1 H, <i>J</i> = 8.8 Hz), 7.74 (d, 1 H, <i>J</i> = 8.8 Hz), 7.65 (t, 1 H, <i>J</i> = 7.6 Hz), 7.36 (br s, 1 H), 7.17 (d, 1 H, <i>J</i> = 7.6 Hz), 6.99–6.93 (m, 2 H), 6.84–6.79 (m, 1 H), 6.66–6.60 (m, 1 H), 4.55 (s, 2 H), 2.49 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.68, 154.40, 151.80 (d, <i>J</i> = 237.6 Hz), 149.87, 148.10, 147.56, 137.44, 135.88 (d, <i>J</i> = 11.6 Hz), 133.71, 131.38, 128.58, 127.75, 124.92 (d, <i>J</i> = 3.9 Hz), 122.34, 122.19, 118.32, 118.26, 116.18, 114.76 (d, <i>J</i> = 17.8 Hz), 112.71 (d, <i>J</i> = 3.1 Hz), 42.26, 23.91. <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) −135.50. IR (KBr) 3070, 2962, 1518, 749 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>19</sub>FN<sub>7</sub> 400.1680, found 400.1689. HPLC purity: 100%.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2-chloroaniline (<b>12c</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 67%; mp 181.4–183.4 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.97 (br s, 1 H), 8.37 (s, 1 H), 7.82 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.77 (dd, 1 H, <i>J</i> = 9.2, 1.0 Hz), 7.46 (t, 1 H, <i>J</i> = 7.6 Hz), 7.29 (dd, 1 H, <i>J</i> = 7.6, 1.6 Hz), 7.23 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.14 (td, 1 H, <i>J</i> = 8.4, 1.6 Hz), 7.01 (dd, 1 H, <i>J</i> = 7.6, 0.4 Hz), 6.75 (dd, 1 H, <i>J</i> = 8.8, 1.4 Hz), 6.71 (td, 1 H, <i>J</i> = 8.4, 1.6 Hz), 5.01 (br s, 1 H), 4.60 (br s, 2 H), 2.50 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.68, 154.48, 149.95, 147.86, 147.34, 143.47, 137.63, 133.78, 131.45, 129.48, 128.48, 128.26, 127.93, 122.32, 122.21, 119.92, 118.95, 118.16, 116.31, 112.03, 42.47, 24.15. IR (KBr) 3413, 3083, 2927, 1597, 1507, 795 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>19</sub>ClN<sub>7</sub> 416.1385, found 416.1398. HPLC purity: 100%.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2-bromoaniline (<b>12d</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 78%; mp 188.3–190.3 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.94 (br s, 1 H), 8.97 (br s, 1 H), 8.36 (s, 1 H), 7.82 (d, 1 H, <i>J</i> = 9.2 Hz), 7.75 (d, 1 H, <i>J</i> = 9.2 Hz), 7.45 (t, 1 H, overlapped, <i>J</i> = 7.8 Hz), 7.43 (dd, 1 H, <i>J</i> = 8.0, 1.6 Hz), 7.21 (d, 1 H, <i>J</i> = 8.0 Hz), 7.16 (td, 1 H, <i>J</i> = 8.4, 1.2 Hz), 6.99 (d, 1 H, <i>J</i> = 7.6 Hz), 6.71 (dd, 1 H, <i>J</i> = 8.4, 1.2 Hz), 6.63 (td, 1 H, <i>J</i> = 8.0, 1.6 Hz), 4.99 (t, 1 H, <i>J</i> = 5.6 Hz), 4.57 (d, 2 H, <i>J</i> = 5.6 Hz), 2.44 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.64, 154.49, 149.96, 147.81, 147.31, 144.46, 137.70, 133.83, 132.76, 131.44, 128.95, 128.42, 127.96, 122.34, 122.19, 119.50, 118.16, 116.34, 112.14, 110.38, 42.67, 24.15. IR (KBr) 3393, 3072, 3003, 1593, 1505, 1460, 1315 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>19</sub>BrN<sub>7</sub> 460.0880, found 460.0896. HPLC purity: 100%.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2-methylaniline (<b>12e</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 53%; mp 164.6–166.6 °C. <sup>1</sup>H NMR(400 MHz, CDCl<sub>3</sub>) δ 8.97 (s, 1 H), 8.37 (s, 1 H), 7.83 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.78 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.46 (t, 1 H, <i>J</i> = 7.8 Hz), 7.23 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.14 (t, 1 H, overlapped, <i>J</i> = 8.0 Hz), 7.12 (d, 1 H, overlapped, <i>J</i> = 7.6 Hz), 7.01 (d, 1 H, <i>J</i> = 8.0 Hz), 6.76 (td, 1 H, <i>J</i> = 7.6, 0.8 Hz), 6.69 (d, 1 H, <i>J</i> = 7.6 Hz), 4.61 (s, 2 H), 2.54 (s, 3 H), 2.26 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.70, 154.46, 149.95, 147.94, 145.58, 137.54, 133.78, 131.52, 130.55, 128.30, 127.95, 127.51, 123.02, 122.38, 122.22, 118.62, 118.01, 116.31, 110.53, 42.70, 24.30, 17.71. IR (KBr) 3416, 3011, 1511, 750 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>7</sub> 396.1931, found 396.1938. HPLC purity: 100%.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2-ethylaniline (<b>12f</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 65%; mp 169.0–171.0 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.97 (br s, 1 H), 8.37 (s, 1 H), 7.83 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.78 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.46 (t, 1 H, <i>J</i> = 7.8 Hz), 7.23 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.16–7.11 (m, 2 H), 7.01 (d, 1 H, <i>J</i> = 7.6 Hz), 6.80 (td, 1 H, <i>J</i> = 7.6, 1.2 Hz), 6.71 (dd, 1 H, <i>J</i> = 8.4, 1.2 Hz), 4.60 (s, 2 H), 2.60 (q, 2 H, <i>J</i> = 7.6 Hz), 2.52 (s, 3 H), 1.32 (t, 3 H, <i>J</i> = 7.6 Hz). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.56, 153.81, 149.49, 148.34, 148.26, 144.85, 137.41, 132.31, 132.00, 129.11, 128.03, 127.81, 127.05, 122.30, 122.12, 118.59, 118.41, 115.69, 110.60, 41.92, 24.05, 23.62, 12.93 (1 peak was not observed). IR (KBr) 3421, 3071, 1510, 753 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>24</sub>N<sub>7</sub> 410.2088, found 410.2092. HPLC purity: 100%.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2-isopropylaniline (<b>12g</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (24:1) as eluent to give the titled compound as a yellow solid. Yield 67%; mp 155.5–157.5 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.97 (br s, 1 H), 8.37 (s, 1 H), 7.82 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.76 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.45 (t, 1 H, <i>J</i> = 7.8 Hz), 7.23 (br d, 1 H, overlapped, <i>J</i> = 8.0 Hz), 7.21 (dd, 1 H, overlapped, <i>J</i> = 7.6, 1.6 Hz), 7.12 (td, 1 H, <i>J</i> = 7.6, 1.6 Hz), 7.00 (d, 1 H, <i>J</i> = 7.6 Hz), 6.83 (td, 1 H, <i>J</i> = 7.6, 1.2 Hz), 6.71 (dd, 1 H, <i>J</i> = 8.0, 1.2 Hz), 4.58 (s, 2 H), 3.00 (heptet, 1 H, <i>J</i> = 6.8 Hz), 2.50 (s, 3 H), 1.31 (d, 6 H, <i>J</i> = 6.8 Hz). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.70, 154.46, 149.95, 147.92, 144.26, 137.50, 133.80, 133.38, 131.52, 128.25, 127.92, 127.10, 125.45, 122.47, 122.15, 119.05, 117.87, 116.29, 111.38, 42.95, 27.40, 24.32, 22.67 (2 C) (1 peak was not observed). IR (KBr) 3402, 3072, 2962, 1579, 1508, 1453, 1313 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>26</sub>N<sub>7</sub> 424.2244, found 424.2254. HPLC purity: 99.53%.</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2-methoxyaniline (<b>12h</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (24:1) as eluent to give the titled compound as a yellow solid. Yield 51%; mp 77.1–79.1 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.98 (br s, 1 H), 8.37 (s, 1 H), 7.83 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.78 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.45 (t, 1 H, <i>J</i> = 7.6 Hz), 7.22 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.00 (d, 1 H, <i>J</i> = 7.6 Hz), 6.87 (td, 1 H, <i>J</i> = 7.6, 1.6 Hz), 6.84 (dd, 1 H, <i>J</i> = 8.0, 1.6 Hz), 6.77 (td, 1 H, <i>J</i> = 7.8, 1.6 Hz), 6.69 (dd, 1 H, <i>J</i> = 7.8, 1.6 Hz), 4.58 (s, 2 H), 3.91 (s, 3 H), 2.53 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.74, 154.42, 149.92, 148.16, 148.13, 147.29, 137.51, 137.33, 133.68, 131.57, 128.41, 127.84, 122.52, 122.04, 121.59, 118.34, 117.98, 116.22, 110.93, 109.79, 55.65, 42.78, 24.22. IR (KBr) 3414, 1514, 1252, 1030, 746 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>7</sub>O 412.1880, found 412.1888. HPLC purity: 100%.</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2-(trifluoromethoxy)aniline (<b>12i</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CHCl<sub>3</sub>/MeOH (24:1) as eluent to give the titled compound as a white solid. Yield 21%; mp 162.9–164.9 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.42 (br s, 1 H), 8.96 (br s, 1 H), 8.37 (s, 1 H), 7.82 (d, 1 H, <i>J</i> = 9.2 Hz), 7.78 (d, 1 H, <i>J</i> = 9.2 Hz), 7.45 (t, 1 H, <i>J</i> = 7.8 Hz), 7.25–7.18 (m, 2 H), 7.15 (td, 1 H, <i>J</i> = 7.8, 1.2 Hz), 7.01 (d, 1 H, <i>J</i> = 7.6 Hz), 6.81 (dd, 1 H, <i>J</i> = 8.0, 1.2 Hz), 6.77 (td, 1 H, <i>J</i> = 7.8, 1.6 Hz), 4.85 (t, 1 H, <i>J</i> = 5.6 Hz), 4.61 (d, 2 H, <i>J</i> = 5.6 Hz), 2.52 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 157.11, 154.94, 154.71, 150.27, 149.26, 145.44, 140.75, 139.53, 136.89, 133.17, 131.06, 129.45, 128.83, 128.06, 123.36, 121.12, 121.07 (q, <i>J</i> = 257.0 Hz), 119.19, 118.24, 117.00, 112.85, 41.12, 22.47. IR (KBr) 3424, 3073, 1612, 1517, 1319, 1252, 1218, 1171, 750 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>19</sub>F<sub>3</sub>N<sub>7</sub>O 466.1598, found 466.1617. HPLC purity: 100%.</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2-(methylthio)aniline (<b>12j</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (24:1) as eluent to give the titled compound as a yellow solid. Yield 67%; mp 122.3–124.3 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.34 (br s, 1 H), 8.99 (s, 1 H), 8.34 (s, 1 H), 7.83 (br d, 1 H, <i>J</i> = 9.2 Hz), 7.72 (br d, 1 H, <i>J</i> = 9.2 Hz), 7.43 (t, 1 H, <i>J</i> = 7.8 Hz), 7.35 (dd, 1 H, <i>J</i> = 7.6, 1.6 Hz), 7.21 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.12 (td, 1 H, <i>J</i> = 7.8, 1.6 Hz), 6.95 (d, 1 H, <i>J</i> = 8.0 Hz), 6.70 (td, 1 H, <i>J</i> = 7.6, 1.2 Hz), 6.65 (dd, 1 H, <i>J</i> = 8.0, 1.2 Hz), 5.49 (br t, 1 H, <i>J</i> = 4.8 Hz), 4.55 (d, 2 H, <i>J</i> = 4.8 Hz), 2.33 (s, 3 H), 2.32 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.59, 154.46, 149.94, 147.89, 147.84, 147.38, 137.66, 133.74, 133.60, 131.48, 129.50, 128.26, 127.94, 122.27, 122.17, 121.21, 118.81, 118.17, 116.28, 110.93, 42.65, 24.04, 18.51. IR (KBr) 3370, 3071, 2924, 1585, 1502, 1314 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>7</sub>S 428.1652, found 428.1643. HPLC purity: 96.15%.</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2-vinylaniline (<b>12k</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 62%; mp 171.7–173.7 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.96 (br s, 1 H), 8.35 (s, 1 H), 7.80 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.73 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.44 (t, 1 H, <i>J</i> = 7.8 Hz), 7.28 (dd, 1 H, <i>J</i> = 7.6, 1.2 Hz), 7.22 (br d, 1 H, <i>J</i> = 8.0 Hz), 7.15 (td, 1 H, <i>J</i> = 7.8, 1.2 Hz), 6.99 (d, 1 H, <i>J</i> = 7.6 Hz), 6.79 (dd, 1H, overlapped, <i>J</i> = 17.2, 11.2 Hz), 6.78 (td, 1 H, overlapped, <i>J</i> = 7.6, 0.8 Hz), 6.68 (dd, 1 H, <i>J</i> = 8.2, 1.0 Hz), 5.62 (dd, 1 H, <i>J</i> = 17.2, 1.4 Hz), 5.34 (dd, 1 H, <i>J</i> = 11.2, 1.4 Hz), 4.53 (s, 2 H), 2.45 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.57, 154.56, 150.01, 147.95, 147.57, 144.46, 137.86, 133.64, 132.69, 131.43, 129.35, 128.11, 127.69, 127.34, 125.33, 122.41, 121.87, 119.02, 117.14, 116.39, 111.52, 42.61, 24.14. IR (KBr) 3421, 3079, 1507, 751 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>22</sub>N<sub>7</sub> 408.1931, found 408.1940. HPLC purity: 95.01%.</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)benzonitrile (<b>12l</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 51%; mp 260.9–262.9 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.98 (br s, 1 H), 8.36 (s, 1 H), 7.83 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.76 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.47 (t, 1 H, <i>J</i> = 7.8 Hz), 7.40 (br d, 1 H, overlapped, <i>J</i> = 7.6 Hz), 7.38 (t, 1 H, <i>J</i> = 7.8 Hz), 7.25 (br d, 1 H, <i>J</i> = 8.0 Hz), 7.00 (d, 1 H, <i>J</i> = 7.6), 6.80 (d, 1 H, <i>J</i> = 8.4 Hz), 6.75 (td, 1 H, <i>J</i> = 8.0, 0.8 Hz), 5.32 (br t, 1 H, <i>J</i> = 5.6 Hz), 4.62 (d, 2 H, <i>J</i> = 5.6 Hz), 2.41 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.53, 153.82, 149.70, 149.46, 148.43, 146.82, 137.44, 134.64, 132.96, 132.29, 131.93, 129.74, 127.79, 122.33, 122.03, 118.67, 117.89, 117.65, 115.65, 111.34, 96.22, 40.98, 24.00. IR (KBr) 3376, 3083, 2931, 2215, 1578, 1514, 1315 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>19</sub>N<sub>8</sub> 407.1727, found 407.1751. HPLC purity: 100%.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> <i>N</i>-(2-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)phenyl)methanesulfonamide (<b>12n</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CHCl<sub>3</sub>/MeOH (12:1) as eluent to give the titled compound as a yellow solid. Yield 21%; mp 195.2–197.2 °C. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.18 (dd, 1 H, <i>J</i> = 1.6, 0.8 Hz), 8.41 (s, 1 H), 7.87 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.75 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.66 (t, 1 H, <i>J</i> = 7.8 Hz), 7.38 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.20 (dd, 1 H, <i>J</i> = 7.8, 1.4 Hz), 7.16 (d, 1 H, overlapped, <i>J</i> = 7.6 Hz), 7.15 (td, 1 H, overlapped, <i>J</i> = 8.0, 1.6 Hz), 6.82 (dd, 1 H, <i>J</i> = 8.0, 1.2 Hz), 6.71 (td, 1 H, <i>J</i> = 8.0, 1.4 Hz), 4.59 (s, 2 H), 3.05 (s, 3 H), 2.48 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.46, 153.91, 149.52, 148.60, 147.93, 144.74, 137.46, 131.96, 131.26, 130.12, 129.70, 128.30, 128.00, 122.34, 121.45, 121.42, 118.61, 118.12, 115.56, 112.23, 40.99, 39.01, 24.08. IR (KBr) 3417, 3305, 3094, 1600, 1515, 1457, 1318, 1147 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>23</sub>N<sub>8</sub>O<sub>2</sub>S 475.1659, found 475.1668. HPLC purity: 100%.</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-(2-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)phenyl)acetamide (<b>12o</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CHCl<sub>3</sub>/MeOH (12:1) as eluent to give the titled compound as a yellow solid. Yield 63%; mp 183.2–185.2 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.56 (br s, 1 H), 9.58 (s, 1 H), 9.36 (s, 1 H), 8.50 (s, 1 H), 8.00 (br d, 1 H, <i>J</i> = 9.2 Hz), 7.82 (d, 1 H, <i>J</i> = 9.2 Hz), 7.71 (t, 1 H, <i>J</i> = 7.8 Hz), 7.44 (br s, 1 H), 7.16 (d, 1 H, overlapped, <i>J</i> = 8.0 Hz), 7.15 (d, 1 H, overlapped, <i>J</i> = 7.6 Hz), 7.03 (td, 1 H, <i>J</i> = 7.6, 1.2 Hz), 6.81 (d, 1 H, <i>J</i> = 7.6 Hz), 6.61 (td, 1 H, <i>J</i> = 7.6, 1.2 Hz), 5.65 (t, 1 H, <i>J</i> = 6.0 Hz), 4.45 (d, 2 H, <i>J</i> = 6.0 Hz), 2.47 (br s, 3 H), 2.09 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 171.09, 158.43, 153.94, 149.52, 148.98, 148.10, 141.96, 137.42, 131.96, 128.17, 128.02, 126.83, 126.78, 123.53, 123.42, 122.32, 121.27, 118.83, 118.42, 115.43, 112.34, 41.30, 24.14, 23.31. IR (KBr) 3206, 1663, 1601, 1515, 1453, 1315, 750 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>23</sub>N<sub>8</sub>O 439.1989, found 439.2003. HPLC purity: 100%.</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3-fluoroaniline (<b>12p</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a white pink solid. Yield 33%; mp 161.6–163.6 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.94 (t, 1 H, <i>J</i> = 1.4 Hz), 8.36 (s, 1 H), 7.79 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.75 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.46 (t, 1 H, <i>J</i> = 7.8 Hz), 7.23 (d, 1 H, <i>J</i> = 8.0 Hz), 7.13–7.07 (m, 1 H), 7.01 (d, 1 H, <i>J</i> = 7.6 Hz), 6.47–6.41 (m, 2 H), 6.37 (dt, 1 H, <i>J</i> = 8.8, 2.4 Hz), 4.49 (s, 2 H), 2.49 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 164.14 (d, <i>J</i> = 242.2 Hz), 158.67, 154.52, 149.97, 149.27 (d, <i>J</i> = 10.1 Hz), 147.73, 147.27, 137.73, 133.47, 131.40, 130.73 (d, <i>J</i> = 10.1 Hz), 128.47, 128.03, 122.41, 121.92, 118.14, 116.37, 109.20 (d, <i>J</i> = 2.3 Hz), 105.32 (d, <i>J</i> = 21.7 Hz), 100.34 (d, <i>J</i> = 25.5 Hz), 42.31, 24.18. <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) −112.19. IR (KBr) 3277, 3076, 1619, 1592, 1502, 1460 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>19</sub>FN<sub>7</sub> 400.1680, found 400.1689. HPLC purity: 100%.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3-chloroaniline (<b>12q</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 52%; mp 180.8–182.8 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.95 (t, 1 H, <i>J</i> = 1.6 Hz), 8.37 (s, 1 H), 7.81 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.77 (dd, 1 H, <i>J</i> = 9.2, 1.2 Hz), 7.47 (t, 1 H, <i>J</i> = 7.8 Hz), 7.24 (d, 1 H, <i>J</i> = 8.0 Hz), 7.10 (t, 1 H, <i>J</i> = 8.0 Hz), 7.02 (d, 1 H, <i>J</i> = 7.6 Hz), 6.75 (ddd, 1 H, <i>J</i> = 8.0, 2.0, 0.8 Hz), 6.69 (t, 1 H, <i>J</i> = 2.0 Hz), 6.57 (ddd, 1 H, <i>J</i> = 8.0, 2.4, 0.8 Hz), 4.51 (s, 2 H), 2.52 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.57, 153.99, 149.60, 148.73, 148.15, 147.66, 137.61, 135.08, 132.21, 131.87, 130.42, 129.16, 127.93, 122.48, 121.73, 118.69, 118.23, 115.90, 112.99, 111.48, 41.45, 24.07. IR (KBr) 3261, 2927, 1599, 1577 1503, 1468 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>19</sub>ClN<sub>7</sub> 416.1385, found 416.1398. HPLC purity: 100%.</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3-bromoaniline (<b>12r</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a white yellow solid. Yield 83%; mp 208.9–210.9 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 8.89 (br s, 1 H), 8.30 (s, 1 H), 7.75 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.69 (d, 1 H, <i>J</i> = 9.2 Hz), 7.44 (br t, 1 H, <i>J</i> = 7.6 Hz), 7.12 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.00 (d, 1 H, <i>J</i> = 8.0 Hz), 6.97 (t, 1 H, overlapped, <i>J</i> = 8.0 Hz), 6.82–6.77 (m, 2 H), 6.58 (ddd, 1 H, <i>J</i> = 8.2, 2.4, 0.8 Hz), 4.41 (s, 2 H), 2.49 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.55, 153.88, 149.53, 148.91, 148.27, 147.63, 137.54, 132.13, 131.92, 130.66, 129.30, 127.85, 123.24, 122.43, 121.84, 121.04, 118.70, 115.87, 115.78, 111.80, 41.38, 24.02. IR (KBr) 3268, 3074, 1595, 1501, 1317, 1252 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>19</sub>BrN<sub>7</sub> 460.0880, found 460.0890. HPLC purity: 99.54%.</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3-methylaniline (<b>12s</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a white solid. Yield 74%; mp 111.7–113.7 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.96 (dd, 1 H, <i>J</i> = 1.6, 1.2 Hz), 8.37 (s, 1 H), 7.82 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.78 (dd, 1 H, <i>J</i> = 9.2, 1.2 Hz), 7.46 (t, 1 H, <i>J</i> = 7.8 Hz), 7.22 (br d, 1 H, <i>J</i> = 8.0 Hz), 7.11 (t, 1 H, <i>J</i> = 7.8 Hz), 7.01 (d, 1 H, <i>J</i> = 7.6 Hz), 6.63 (dt, 1 H, <i>J</i> = 7.6, 0.8 Hz), 6.57–6.53 (m, 2 H), 4.55 (s, 2 H), 2.54 (s, 3 H), 2.29 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.74, 154.44, 149.91, 148.07, 147.89, 147.59, 139.46, 137.39, 133.65, 131.49, 129.48, 128.44, 127.87, 122.44, 122.13, 119.91, 117.93, 116.25, 114.39, 110.50, 42.78, 24.32, 21.75. IR (KBr) 3487, 3278, 1601, 754 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>7</sub> 396.1931, found 396.1941. HPLC purity: 97.84%.</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3-ethylaniline (<b>12t</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a white solid. Yield 84%; mp 89.7–91.7 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.96 (d, 1 H, <i>J</i> = 1.2 Hz), 8.37 (s, 1 H), 7.82 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.77 (dd, 1 H, <i>J</i> = 9.2, 1.2 Hz), 7.45 (t, 1 H, <i>J</i> = 7.8 Hz), 7.22 (br d, 1 H, <i>J</i> = 8.0 Hz), 7.14 (t, 1 H, <i>J</i> = 7.8 Hz), 7.01 (d, 1 H, <i>J</i> = 7.6 Hz), 6.66 (dd, 1 H, <i>J</i> = 7.6, 0.8 Hz), 6.58 (d, 1 H, <i>J</i> = 2.0 Hz), 6.55 (dd, 1 H, <i>J</i> = 7.6, 2.0 Hz), 4.55 (s, 2 H), 2.58 (q, 2 H, <i>J</i> = 7.6 Hz), 2.53 (s, 3 H), 1.21 (t, 3 H, <i>J</i> = 7.6 Hz). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.73, 154.43, 149.91, 148.01, 147.92, 147.63, 145.88, 137.41, 133.57, 131.51, 129.57, 128.44, 127.90, 122.39, 122.14, 118.71, 117.92, 116.25, 113.35, 110.70, 42.79, 29.09, 24.32, 15.64. IR (KBr) 3248, 3045, 1602, 1499, 1317, 754 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>24</sub>N<sub>7</sub> 410.2088, found 410.2096. HPLC purity: 99.42%.</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3-isopropylaniline (<b>12u</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (24:1) as eluent to give the titled compound as a yellow solid. Yield 78%; mp 158.8–160.8 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.96 (dd, 1 H, <i>J</i> = 1.4, 0.8 Hz), 8.35 (s, 1 H), 7.79 (dd, 1 H, <i>J</i> = 9.2, 1.4 Hz), 7.73 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.44 (t, 1 H, <i>J</i> = 7.8 Hz), 7.21 (d, 1 H, <i>J</i> = 7.6 Hz), 7.11 (t, 1 H, <i>J</i> = 7.8 Hz), 6.99 (dd, 1 H, <i>J</i> = 7.8, 0.4 Hz), 6.67 (d, 1 H, <i>J</i> = 7.6 Hz), 6.57 (t, 1 H, <i>J</i> = 2.4 Hz), 6.50 (ddd, 1 H, <i>J</i> = 8.0, 2.4, 0.8 Hz), 4.51 (s, 2 H), 2.80 (heptet, 1 H, <i>J</i> = 6.8 Hz), 2.47 (s, 3 H), 1.20 (d, 6 H, <i>J</i> = 6.8 Hz). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.74, 154.42, 150.55, 149.91, 148.00, 147.93, 147.61, 137.40, 133.56, 131.53, 129.59, 128.44, 127.91, 122.42, 122.14, 117.89, 117.26, 116.25, 112.14, 110.77, 42.83, 34.32, 24.35, 24.08 (2 C). IR (KBr) 3418, 3314, 2962, 1599, 1499, 1317 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>26</sub>N<sub>7</sub> 424.2244, found 424.2257. HPLC purity: 100%.</div></div><div id="sec4_3_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3-methoxyaniline (<b>12v</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (40:1) as eluent to give the titled compound as a yellow solid. Yield 62%; mp 196.2–198.2 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.95 (br s, 1 H), 8.37 (s, 1 H), 7.81 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.76 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.45 (t, 1 H, <i>J</i> = 7.6 Hz), 7.22 (d, 1 H, <i>J</i> = 7.6 Hz), 7.11 (t, 1 H, <i>J</i> = 8.0 Hz), 7.01 (d, 1 H, <i>J</i> = 7.6 Hz), 6.36–6.30 (m, 2 H), 6.27 (t, 1 H, <i>J</i> = 2.4 Hz), 4.52 (s, 2 H), 3.75 (s, 3 H), 2.51 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.02, 158.74, 154.47, 149.94, 148.96, 148.01, 147.65, 137.45, 133.67, 131.49, 130.41, 128.45, 127.90, 122.41, 122.17, 117.94, 116.29, 106.39, 103.95, 99.78, 55.30, 42.68, 24.32. IR (KBr) 3286, 1600, 1502, 1210, 1165 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>7</sub>O 412.1880, found 412.1891. HPLC purity: 100%.</div></div><div id="sec4_3_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3-(trifluoromethoxy)aniline (<b>12w</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a white solid. Yield 35%; mp 170.7–172.7 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.94 (br s, 1 H), 8.37 (s, 1 H), 7.80 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.77 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.46 (t, 1 H, <i>J</i> = 7.8 Hz), 7.23 (br d, 1 H, <i>J</i> = 8.0 Hz), 7.19 (t, 1 H, <i>J</i> = 8.2 Hz), 7.02 (d, 1 H, <i>J</i> = 7.6 Hz), 6.64–6.60 (m, 2 H), 6.55 (br s, 1 H), 4.62 (br s, 1 H), 4.52 (s, 2 H), 2.52 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.74, 154.48, 150.55, 149.94, 148.92, 147.88, 146.89, 137.62, 133.76, 131.38, 130.60, 128.57, 127.90, 122.34, 122.28, 120.60 (q, <i>J</i> = 255.4 Hz), 118.06, 116.34, 111.54, 110.53, 105.76, 42.34, 24.19. IR (KBr) 3396, 3074, 1616, 1500, 1318, 1257, 1220, 1160 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>19</sub>F<sub>3</sub>N<sub>7</sub>O 466.1598, found 466.1624. HPLC purity: 100%.</div></div><div id="sec4_3_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3-(methylthio)aniline (<b>12x</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (24:1) as eluent to give the titled compound as a white solid. Yield 82%; mp 145.8–147.8 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.06 (br s, 1 H), 8.94 (s, 1 H), 8.35 (s, 1 H), 7.78 (dd, 1 H, <i>J</i> = 9.2, 1.2 Hz), 7.74 (d, 1 H, <i>J</i> = 9.2 Hz), 7.45 (t, 1 H, <i>J</i> = 7.8 Hz), 7.21 (br d, 1 H, <i>J</i> = 8.0 Hz), 7.07 (t, 1 H, <i>J</i> = 7.8 Hz), 6.99 (d, 1 H, <i>J</i> = 7.6 Hz), 6.64 (dd, 1 H, <i>J</i> = 7.6, 2.0 Hz), 6.54 (t, 1 H, <i>J</i> = 1.6 Hz), 6.42 (dd, 1 H, <i>J</i> = 8.0, 1.6 Hz), 4.47 (s, 2 H) 4.42 (br s, 1 H), 2.45 (s, 3 H), 2.40 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.67, 154.41, 149.87, 147.97, 147.88, 147.58, 139.81, 137.51, 133.35, 131.43, 129.89, 128.62, 127.89, 122.27, 122.12, 118.13, 116.68, 116.24, 111.25, 110.21, 42.38, 24.21, 15.71. IR (KBr) 3402, 3074, 2927, 1589, 1503, 1317 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>7</sub>S 428.1652, found 428.1664. HPLC purity: 99.10%.</div></div><div id="sec4_3_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3-vinylaniline (<b>12y</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 75%; mp 165.3 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.59 (br s, 1 H), 8.94 (s, 1 H), 8.37 (s, 1 H), 7.81 (d, 1 H, <i>J</i> = 9.2 Hz), 7.77 (d, 1 H, <i>J</i> = 9.2 Hz), 7.45 (t, 1 H, <i>J</i> = 7.8 Hz), 7.20 (br d, 1 H, overlapped, <i>J</i> = 7.6 Hz), 7.15 (t, 1 H, overlapped, <i>J</i> = 7.8 Hz), 7.00 (d, 1 H, <i>J</i> = 8.0 Hz), 6.86 (d, 1 H, <i>J</i> = 7.6 Hz), 6.75 (t, 1 H, <i>J</i> = 2.0 Hz), 6.63 (dd, 1 H, overlapped, <i>J</i> = 17.6, 10.8 Hz), 6.61 (dd, 1 H, overlapped, <i>J</i> = 8.0, 2.0 Hz), 5.69 (dd, 1 H, <i>J</i> = 17.6, 0.8 Hz), 5.21 (dd, 1 H, <i>J</i> = 10.8, 0.8 Hz), 4.55 (s, 2 H), 4.39 (br s, 1 H), 2.51 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.58, 154.56, 150.01, 147.95, 147.59, 144.47, 137.85, 132.70, 131.45, 132.70, 131.45, 129.35, 128.09, 127.70, 125.33, 122.40, 121.93, 119.03, 118.14, 117.17, 116.40, 111.52, 42.63, 24.15. IR (KBr) 3272, 3078, 1584, 1501, 754 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>22</sub>N<sub>7</sub> 408.1931, found 408.1944. HPLC purity: 98.39%.</div></div><div id="sec4_3_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)benzonitrile (<b>12z</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 91%; mp 238.3–240.3 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.94 (t, 1 H, <i>J</i> = 1.2 Hz), 8.38 (s, 1 H), 7.80 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.77 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.55 (t, 1 H, <i>J</i> = 8.0 Hz), 7.31 (d, 1 H, <i>J</i> = 8.0 Hz), 7.25 (t, 1 H, <i>J</i> = 8.0 Hz), 7.08 (d, 1 H, <i>J</i> = 8.0 Hz), 7.02 (dt, 1 H, <i>J</i> = 7.6, 1.2 Hz), 6.96–6.92 (m, 2 H), 4.56 (s, 2 H), 2.62 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.55, 153.89, 149.52, 148.32, 148.02, 147.16, 137.58, 132.24, 131.89, 130.10, 129.46, 127.82, 122.46, 121.85, 121.46, 119.43, 118.74, 117.70, 115.79, 115.79, 115.36, 112.69, 41.07, 24.01. IR (KBr) 3280, 2925, 2229, 1598, 1507, 1445, 1321, 1258, 1178 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>19</sub>N<sub>8</sub> 407.1727, found 407.1732. HPLC purity: 100%.</div></div><div id="sec4_3_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)benzamide (<b>12aa</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CHCl<sub>3</sub>/MeOH (16:1) as eluent to give the titled compound as a yellow solid. Yield 54%; mp 184.4–186.4 °C. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.06 (br s, 1 H), 8.34 (s, 1 H), 7.83 (br d, 1 H, <i>J</i> = 9.2 Hz), 7.71 (d, 1 H, <i>J</i> = 9.2 Hz), 7.59–7.55 (m, 2 H), 7.22–7.17 (m, 2 H), 7.15 (dt, 1 H, <i>J</i> = 7.6, 2.0 Hz), 7.10 (dd, 1 H, <i>J</i> = 8.4, 0.8 Hz), 6.86 (ddd, 1 H, <i>J</i> = 7.6, 2.0, 0.8 Hz), 4.51 (s, 2 H), 2.50 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 171.10, 158.53, 153.81, 149.44, 148.53, 147.85, 147.71, 137.41, 134.05, 131.93, 131.65, 129.78, 129.49, 127.82, 122.36, 121.76, 118.74, 117.12, 117.04, 115.60, 111.58, 41.11, 24.01. IR (KBr) 3337, 3183, 1664, 1581 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>21</sub>N<sub>8</sub>O 425.1833, found 425.1837. HPLC purity: 99.37%.</div></div><div id="sec4_3_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 2-(3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)phenyl)acetonitrile (<b>12ab</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 30%; mp 260.1–262.1 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.76 (br s, 1 H), 8.94 (br s, 1 H), 8.37 (s, 1 H), 7.81 (br d, 1 H, <i>J</i> = 9.2 Hz), 7.76 (br d, 1 H, <i>J</i> = 9.2 Hz), 7.46 (t, 1 H, <i>J</i> = 7.6 Hz), 7.21 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.20–7.15 (m, 1 H), 7.01 (d, 1 H, <i>J</i> = 7.6 Hz), 6.69 (dd, 1 H, <i>J</i> = 7.6, 0.8 Hz), 6.64–6.62 (m, 2 H), 4.53 (br s, 1 H, overlapped), 4.52 (br s, 2 H, overlapped), 3.65 (s, 2 H), 2.50 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.51, 153.81, 149.46, 148.33, 148.21, 147.83, 137.50, 131.96, 131.04, 130.11, 129.38, 127.84, 122.38, 121.85, 118.68, 118.30, 117.56, 115.67, 112.65, 112.39, 41.38, 23.98, 23.48 (1 peak was not observed). IR (KBr) 3077, 2933, 2247, 1601, 1500, 1316 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>21</sub>N<sub>8</sub> 421.1884, found 421.1876. HPLC purity: 97.46%.</div></div><div id="sec4_3_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 1-(3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)phenyl)ethanone (<b>12ac</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CHCl<sub>3</sub>/MeOH (10:1) as eluent to give the titled compound as a yellow solid. Yield 33%; mp 154.3–156.3 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.09 (br s, 1 H), 8.92 (s, 1 H), 8.35 (s, 1 H), 7.79 (d, 1 H, <i>J</i> = 9.2 Hz), 7.74 (d, 1 H, <i>J</i> = 9.2 Hz), 7.44 (t, 1 H, <i>J</i> = 7.8 Hz), 7.30 (d, 1 H, <i>J</i> = 7.6 Hz), 7.26–7.24 (m, 1 H), 7.23 (t, 1 H, overlapped, <i>J</i> = 7.8 Hz), 7.19 (br d, 1 H, <i>J</i> = 8.0 Hz), 7.00 (d, 1 H, <i>J</i> = 8.0 Hz), 6.86 (dd, 1 H, <i>J</i> = 8.0, 1.8 Hz), 4.68 (br s, 1 H), 4.52 (d, 2 H, <i>J</i> = 5.2 Hz), 2.53 (s, 3 H), 2.47 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 199.91, 158.63, 154.07, 149.66, 148.09, 147.81, 147.67, 137.99, 137.61, 131.83, 129.70, 129.30, 128.08, 122.55, 121.35, 119.09, 118.78, 118.68, 115.93, 111.41, 41.18, 26.78, 24.12 (1 peak was not observed). IR (KBr) 3362, 1676, 1600, 1318, cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>22</sub>N<sub>7</sub>O 424.1880, found 424.1876. HPLC purity: 95.06%.</div></div><div id="sec4_3_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> Methyl 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)benzoate (<b>12ad</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (10:1) as eluent to give the titled compound as a yellow solid. Yield 34%; mp 271.2–273.2 °C. <sup>1</sup>H NMR(400 MHz, CDCl<sub>3</sub>) δ 8.94 (br s, 1 H), 8.34 (s, 1 H), 7.77 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.72 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.44 (t, 1 H, <i>J</i> = 7.8 Hz), 7.39 (dt, 1 H, <i>J</i> = 7.6, 1.2 Hz), 7.32 (dd, 1 H, <i>J</i> = 2.4, 1.6 Hz), 7.22 (d, 1 H, overlapped, <i>J</i> = 8.0 Hz), 7.19 (t, 1 H, overlapped, <i>J</i> = 8.0 Hz), 6.98 (d, 1 H, <i>J</i> = 7.6 Hz), 6.81 (ddd, 1 H, <i>J</i> = 8.0, 2.4, 0.8 Hz), 4.49 (s, 2 H), 3.84 (s, 3 H), 2.43 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 167.98, 158.58, 153.95, 149.57, 148.30, 147.65, 147.64, 137.50, 132.07, 131.91, 130.94, 129.48, 129.34, 127.94, 122.40, 121.78, 119.46, 118.62, 118.03, 115.79, 113.62, 52.24, 41.44, 24.10. IR (KBr) 3291, 1715, 1600, 1287 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>22</sub>N<sub>7</sub>O<sub>2</sub> 440.1829, found 440.1812. HPLC purity: 97.89%.</div></div><div id="sec4_3_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-(3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)phenyl)methanesulfonamide (<b>12ae</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CHCl<sub>3</sub>/MeOH (93:7) as eluent to give the titled compound as a light-brown solid. Yield 14%; mp 11.7–113.7 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.92 (br s, 1 H), 8.35 (s, 1 H), 7.78 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.73 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.46 (t, 1 H, <i>J</i> = 7.6 Hz), 7.21 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.11 (t, 1 H, overlapped, <i>J</i> = 8.2 Hz), 7.10 (br s, 1 H, overlapped), 7.01 (d, 1 H, <i>J</i> = 7.6 Hz), 6.58 (t, 1 H, <i>J</i> = 2.0 Hz), 6.54 (ddd, 1 H, <i>J</i> = 8.2, 2.0, 0.8 Hz), 6.49 (ddd, 1 H, <i>J</i> = 8.2, 2.0, 0.8 Hz), 4.50 (s, 2 H), 2.94 (s, 3 H), 2.51 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.56, 154.02, 149.60, 148.56, 148.15, 147.95, 138.63, 137.68, 131.83, 131.76, 130.43, 129.35, 127.99, 122.57, 121.42, 118.78, 115.90, 110.14, 109.87, 104.73, 41.27, 38.91, 24.04. IR (KBr) 3411, 3271, 3089, 1607, 1509, 1462, 1321, 1148 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>23</sub>N<sub>8</sub>O<sub>2</sub>S 475.1659, found 475.1673. HPLC purity: 95.10%.</div></div><div id="sec4_3_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-(3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)phenyl)acetamide (<b>12af</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 31%; mp 118.8–120.8 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.97 (br s, 1 H), 8.35 (s, 1 H), 7.79 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.73 (d, 1 H, <i>J</i> = 9.2 Hz), 7.46 (t, 1 H, <i>J</i> = 7.8 Hz), 7.38 (br s, 1 H), 7.24 (d, 1 H, <i>J</i> = 8.0 Hz), 7.15 (br s, 1 H), 7.09 (t, 1 H, <i>J</i> = 8.0 Hz), 7.01 (d, 1 H, <i>J</i> = 7.6 Hz), 6.69 (br d, 1 H, <i>J</i> = 8.0 Hz), 6.41 (dd, 1 H, <i>J</i> = 8.0, 1.6 Hz), 4.50 (s, 2 H), 2.51 (s, 3 H), 2.13 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 169.82, 158.55, 153.91, 149.52, 148.50, 148.15, 147.96, 139.25, 137.47, 131.95, 129.75, 127.92, 122.39, 121.65, 118.75, 115.67, 110.15, 110.05, 109.56, 104.74, 104.64, 41.44, 24.07 (2 C). IR (KBr) 3272, 3085, 1669, 1611, 1551, 1317, 1258 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>23</sub>N<sub>8</sub>O 439.1989, found 439.2004. HPLC purity: 98.90%.</div></div><div id="sec4_3_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-4-fluoroaniline (<b>12ag</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 85%; mp 156.4–158.4 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.95 (dd, 1 H, <i>J</i> = 1.6, 1.2 Hz), 8.37 (s, 1 H), 7.80 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.76 (dd, 1 H, <i>J</i> = 9.2, 1.2 Hz), 7.46 (t, 1 H, <i>J</i> = 7.6 Hz), 7.23 (d, 1 H, <i>J</i> = 7.6 Hz), 7.01 (d, 1 H, <i>J</i> = 7.6 Hz), 6.92–6.87 (m, 2 H), 6.65–6.62 (m, 2 H), 4.49 (s, 2 H), 2.51 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.75, 156.61 (d, <i>J</i> = 235.3 Hz), 154.44, 149.89, 148.04, 147.55, 143.82 (d, <i>J</i> = 2.3 Hz), 137.47, 133.63, 131.42, 128.57, 127.85, 122.36, 122.22, 118.02, 116.20 (d, 2 C, <i>J</i> = 13.2 Hz), 115.90, 114.38 (d, 2 C, <i>J</i> = 7.0 Hz), 43.22, 24.27. <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) −126.29. IR (KBr) 3275, 3070, 1575, 1512, 1465, 1315, 1253 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>19</sub>FN<sub>7</sub> 400.1680, found 400.1686. HPLC purity: 100%.</div></div><div id="sec4_3_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-4-chloroaniline (<b>12ah</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 57%; mp 154.3–156.3 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.95 (t, 1 H, <i>J</i> = 1.4 Hz), 8.38 (s, 1 H), 7.81 (dd, 1 H, overlapped, <i>J</i> = 9.2, 1.4 Hz), 7.78 (dd, 1 H, overlapped, <i>J</i> = 9.2, 1.2 Hz), 7.47 (t, 1 H, <i>J</i> = 7.6 Hz), 7.23 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.16 (m, 2 H), 7.02 (br d, 1 H, <i>J</i> = 7.6 Hz), 6.65 (m, 2 H), 4.51 (s, 2 H), 2.54 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.60, 154.58, 150.01, 147.58, 147.49, 146.02, 137.90, 133.68, 131.37, 129.44 (2 C), 128.22, 128.07, 123.61, 122.46, 121.89, 118.10, 116.46, 114.61 (2 C), 42.55, 24.16. IR (KBr) 3286, 2928, 1597, 1502, 1315, 1253 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>19</sub>ClN<sub>7</sub> 416.1385, found 416.1397. HPLC purity: 100%.</div></div><div id="sec4_3_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-4-bromoaniline (<b>12ai</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a white solid. Yield 59%; mp 118.1–120.1 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.94 (br s, 1 H), 8.38 (s, 1 H), 7.82–7.77 (m, 2 H), 7.46 (t, 1 H, <i>J</i> = 7.6 Hz), 7.29 (m, 2 H), 7.21 (d, 1 H, <i>J</i> = 7.6 Hz), 7.02 (d, 1 H, <i>J</i> = 7.6 Hz), 6.61 (m, 2 H), 4.51 (s, 2 H), 4.44 (br s, 1 H), 2.54 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.67, 154.47, 149.90, 147.87, 147.28, 146.48, 137.64, 133.51, 132.26 (2 C), 131.29, 128.57, 127.92, 122.36, 122.09, 118.13, 116.32, 114.98 (2 C), 110.57, 42.46, 24.22. IR (KBr) 3276, 3084, 3013, 1594, 1500, 1465, 1315, 1254 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>19</sub>BrN<sub>7</sub> 460.0880, found 460.0886. HPLC purity: 100%.</div></div><div id="sec4_3_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-4-methylaniline (<b>12aj</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 65%; mp 122.4–124.4 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.96 (t, 1 H, <i>J</i> = 1.2 Hz), 8.37 (s, 1 H), 7.82 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.77 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.45 (t, 1 H, <i>J</i> = 7.8 Hz), 7.22 (br d, 1 H, <i>J</i> = 8.0 Hz), 7.03 (m, 2 H), 7.02 (d, 1 H, overlapped, <i>J</i> = 7.6 Hz), 6.65 (m, 2 H), 4.53 (s, 2 H), 2.53 (s, 3 H), 2.25 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.76, 154.44, 149.93, 148.09, 147.96, 145.25, 137.37, 133.71, 131.54, 130.08 (2 C), 128.43, 128.30, 127.89, 122.53, 122.10, 117.88, 116.26, 113.69 (2 C), 43.15, 24.37, 20.56. IR (KBr) 3314, 3010, 1521, 754 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>7</sub> 396.1931, found 396.1931. HPLC purity: 99.58%.</div></div><div id="sec4_3_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-4-isopropylaniline (<b>12ak</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (24:1) as eluent to give the titled compound as an off-white solid. Yield 68%; mp 151.1–153.1 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.96 (t, 1 H, <i>J</i> = 1.2 Hz), 8.36 (s, 1 H), 7.81 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.75 (d, 1 H, <i>J</i> = 9.2 Hz), 7.44 (t, 1 H, <i>J</i> = 7.8 Hz), 7.21 (d, 1 H, <i>J</i> = 8.0 Hz), 7.06 (m, 2 H), 6.99 (d, 1 H, <i>J</i> = 7.6 Hz), 6.64 (m, 2 H), 4.50 (s, 2 H), 2.80 (heptet, 1 H, <i>J</i> = 6.8 Hz), 2.48 (s, 3 H), 1.19 (d, 6 H, <i>J</i> = 6.8 Hz). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.58, 153.85, 149.50, 148.38, 148.34, 145.40, 139.29, 137.41, 132.19, 132.00, 129.13, 127.84, 127.27 (2 C), 122.29, 122.06, 118.53, 115.71, 113.51 (2 C), 42.27, 33.20, 24.14 (2 C), 24.08. IR (KBr) 3364, 2959, 1614, 1519, 1462, 1315 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>26</sub>N<sub>7</sub> 424.2244, found 424.2256. HPLC purity: 98.98%.</div></div><div id="sec4_3_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-4-methoxyaniline (<b>12al</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CHCl<sub>3</sub>/MeOH (39:1) as eluent to give the titled compound as a pale-yellow solid. Yield 84%; mp 197.8–199.8 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.96 (br s, 1 H), 8.37 (s, 1 H), 7.82 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.77 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.45 (t, 1 H, <i>J</i> = 7.8 Hz), 7.22 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.01 (br d, 1 H, <i>J</i> = 8.0 Hz), 6.80 (m, 2 H), 6.70 (m, 2 H), 4.50 (s, 2 H), 3.74 (s, 3 H), 2.53 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.60, 154.05, 153.91, 153.00, 149.56, 148.41, 148.18, 141.45, 137.40, 131.97, 127.82, 122.64, 122.25, 118.46, 115.79, 115.04 (2 C), 114.99 (2 C), 114.84, 55.81, 43.04, 24.15. IR (KBr) 3376, 1514, 1242, 1036 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>7</sub>O 412.1880, found 412.1894. HPLC purity: 100%.</div></div><div id="sec4_3_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-4-(trifluoromethoxy)aniline (<b>12am</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a white solid. Yield 34%; mp 125.3–127.3 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.95 (s, 1 H), 8.38 (s, 1 H), 7.81 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.78 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.46 (t, 1 H, <i>J</i> = 7.8 Hz), 7.23 (d, 1 H, <i>J</i> = 8.0 Hz), 7.08 (m, 2 H), 7.02 (d, 1 H, <i>J</i> = 7.6 Hz), 6.70 (m, 2 H), 4.53 (s, 2 H), 2.54 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.57, 153.85, 149.49, 148.38, 147.78, 146.40, 141.09 (d, 2 C, <i>J</i> = 1.6 Hz), 137.48, 132.31, 131.93, 129.31, 127.79, 122.44 (2 C), 122.37, 122.05, 120.69 (q, <i>J</i> = 253.8 Hz), 118.66, 115.74, 113.54, 41.83, 24.02. IR (KBr) 3294, 3075, 1515, 1317, 1255, 1206, 1161 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>19</sub>F<sub>3</sub>N<sub>7</sub>O 466.1598, found 466.1625. HPLC purity: 100%.</div></div><div id="sec4_3_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-4-(methylthio)aniline (<b>12an</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CHCl<sub>3</sub>/MeOH (24:1) as eluent to give the titled compound as a yellow solid. Yield 74%; mp 106.0–108.0 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.08 (br s, 1 H), 8.94 (s, 1 H), 8.35 (s, 1 H), 7.78 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.73 (d, 1 H, <i>J</i> = 9.2 Hz), 7.45 (t, 1 H, <i>J</i> = 7.8 Hz), 7.21 (br d, 1 H, <i>J</i> = 8.0 Hz), 7.17 (m, 2 H), 6.99 (d, 1 H, <i>J</i> = 7.6 Hz), 6.60 (m, 2 H), 4.46 (s, 2 H), 2.45 (s, 3 H), 2.37 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.69, 154.46, 149.90, 147.92, 147.61, 146.10, 137.57, 133.27, 131.46, 131.01 (2 C), 128.64, 127.99, 126.33, 122.32, 122.00, 118.12, 116.27, 114.12 (2 C), 42.51, 24.27, 18.66. IR (KBr) 3392, 3083, 2924, 1597, 1504, 1314 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>22</sub>N<sub>7</sub>S 428.1652, found 428.1656. HPLC purity: 100%.</div></div><div id="sec4_3_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-4-vinylaniline (<b>12ao</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a white solid. Yield 67%; mp 121.2–123.2 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.39 (br s, 1 H), 8.96 (s, 1 H), 8.37 (s, 1 H), 7.82 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.78 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.45 (t, 1 H, <i>J</i> = 7.6 Hz), 7.28 (m, 2 H), 7.22 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.01 (d, 1 H, <i>J</i> = 7.6 Hz), 6.69 (m, 2 H), 6.61 (dd, 1 H, <i>J</i> = 17.6, 10.8 Hz), 5.55 (dd, 1 H, <i>J</i> = 17.6, 0.8 Hz), 5.05 (dd, 1 H, <i>J</i> = 10.8, 0.8 Hz), 4.56, (s, 2 H), 2.53 (s, 3 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.78, 154.39, 149.89, 148.21, 147.48, 147.25, 137.31, 136.49, 131.53, 128.91, 128.64, 127.83, 127.59 (2 C), 122.66, 122.11, 117.95, 116.22, 113.65, 113.35 (2 C), 110.49, 42.65, 24.36. IR (KBr) 3275, 3079, 1610, 1520, 754 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>22</sub>N<sub>7</sub> 408.1931, found 408.1943. HPLC purity: 95.14%.</div></div><div id="sec4_3_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 4-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)benzonitrile (<b>12ap</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 75%; mp 179.1–181.1 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.93 (t, 1 H, <i>J</i> = 1.2 Hz), 8.37 (s, 1 H), 7.79 (dd, 1 H, overlapped, <i>J</i> = 9.2, 1.6 Hz), 7.76 (dd, 1 H, overlapped, <i>J</i> = 9.2, 0.8 Hz), 7.48 (t, 1 H, <i>J</i> = 7.8 Hz), 7.43 (m, 2 H), 7.24 (d, 1H, <i>J</i> = 8.0 Hz), 7.03 (d, 1 H, <i>J</i> = 7.6 Hz), 6.68 (m, 2 H), 5.12 (br s, 1 H), 4.54 (d, 2 H, <i>J</i> = 4.0 Hz), 2.51 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.53, 153.89, 151.10, 149.50, 148.28, 146.86, 137.63, 133.77 (2 C), 132.23, 131.83, 129.49, 127.80, 122.50, 121.80, 120.35, 118.78, 115.80, 112.67 (2 C), 99.09, 40.63, 23.98. IR (KBr) 3363, 3075, 2926, 2215, 1607, 1526, 1319 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>19</sub>N<sub>8</sub> 407.1727, found 407.1726. HPLC purity: 100%.</div></div><div id="sec4_3_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 2-(4-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)phenyl)acetonitrile (<b>12ar</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 37%; mp 192.7–194.7 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.78 (br s, 1 H), 8.94 (br s, 1 H), 8.36 (s, 1 H), 7.80 (dd, 1 H, <i>J</i> = 9.2, 1.2 Hz), 7.76 (d, 1 H, <i>J</i> = 9.2 Hz), 7.46 (t, 1 H, <i>J</i> = 7.8 Hz), 7.22 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.11 (d, 2 H, <i>J</i> = 8.4 Hz), 7.01 (d, 1 H, <i>J</i> = 8.0 Hz), 6.67 (d, 2 H, <i>J</i> = 8.4 Hz), 4.50 (br s, 3 H), 3.61 (s, 2 H), 2.49 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.56, 153.92, 149.55, 148.19, 147.91, 147.29, 137.57, 132.06, 131.89, 129.21, 129.03 (2 C), 127.90, 122.45, 121.73, 119.09, 118.68, 115.81, 113.65 (2 C), 41.54, 24.04, 22.69 (1 peak was not observed). IR (KBr) 3089, 2926, 2257, 1624, 1530, 1318 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>21</sub>N<sub>8</sub> 421.1884, found 421.1886. HPLC purity: 96.86%.</div></div><div id="sec4_3_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 1-(4-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)phenyl)ethanone (<b>12as</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 39%; mp 165.3–167.3 °C. <sup>1</sup>H NMR(400 MHz, CDCl<sub>3</sub>) δ 8.96 (t, 1 H, <i>J</i> = 1.4 Hz), 8.37 (s, 1 H), 7.81 (d, 2 H, <i>J</i> = 8.8 Hz), 7.79–7.77 (m, 2 H), 7.54 (t, 1 H, <i>J</i> = 7.8 Hz), 7.30 (d, 1 H, <i>J</i> = 8.0 Hz), 7.07 (d, 1 H, <i>J</i> = 7.6 Hz), 6.70 (d, 2 H, <i>J</i> = 8.8 Hz), 4.63 (s, 2 H), 2.59 (s, 3 H), 2.48 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 197.53, 158.54, 154.16, 151.79, 149.72, 147.79, 147.31, 137.95, 131.85, 131.72, 131.00 (2 C), 129.13, 128.14, 127.31, 122.78, 121.05, 118.87, 116.10, 112.01 (2 C), 40.65, 26.04, 23.97. IR (KBr) 3274, 1652, 1596, 1279 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>22</sub>N<sub>7</sub>O 424.1880, found 424.1890. HPLC purity: 96.91%.</div></div><div id="sec4_3_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Methyl 4-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)benzoate (<b>12at</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 41%; mp 150.4–152.4 °C. <sup>1</sup>H NMR(400 MHz, CDCl<sub>3</sub>) δ 10.52 (br s, 1 H), 8.94 (s, 1 H), 8.37 (s, 1 H), 7.89 (m, 2 H), 7.81 (br d, 1 H, <i>J</i> = 9.6 Hz), 7.78 (br d, 1 H, <i>J</i> = 9.6 Hz), 7.46 (t, 1 H, <i>J</i> = 8.0 Hz), 7.21 (d, 1 H, <i>J</i> = 8.0 Hz), 7.02 (d, 1 H, <i>J</i> = 8.0 Hz), 6.68 (m, 2 H), 4.90 (t, 1 H, <i>J</i> = 5.6 Hz), 4.58 (d, 2 H, <i>J</i> = 5.6 Hz), 3.85 (s, 3 H), 2.51 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 167.72, 158.56, 154.00, 151.54, 149.60, 148.18, 147.30, 137.64, 132.25, 131.84, 131.63 (2 C), 129.28, 127.92, 122.51, 121.71, 119.07, 118.74, 115.91, 112.01 (2 C), 51.73, 40.94, 24.04. IR (KBr) 3273, 1698, 1605, 1281 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>22</sub>N<sub>7</sub>O<sub>2</sub> 440.1829, found 440.1825. HPLC purity: 100%.</div></div><div id="sec4_3_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> <i>N</i>-(4-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)phenyl)methanesulfonamide (<b>12au</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CHCl<sub>3</sub>/MeOH (12:1) as eluent to give the titled compound as a yellow solid. Yield 69%; mp 121.4–123.4 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.93 (br s, 1 H), 8.38 (s, 1 H), 7.80 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.76 (d, 1 H, <i>J</i> = 9.2 Hz), 7.46 (t, 1 H, <i>J</i> = 7.8 Hz), 7.22 (br d, 1 H, <i>J</i> = 8.0 Hz), 7.09 (d, 2 H, <i>J</i> = 8.8 Hz), 7.02 (d, 1 H, <i>J</i> = 7.6 Hz), 6.67 (d, 2 H, <i>J</i> = 8.8 Hz), 6.34 (br s, 1 H), 4.52 (br s, 3 H), 2.93 (s, 3 H), 2.54 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.57, 154.08, 149.64, 148.14, 147.89, 146.11, 137.69, 132.18, 131.77, 129.22, 127.99, 127.20, 125.55, 122.53, 121.57, 118.70, 115.97 (2 C), 113.82 (2 C), 41.84, 38.73, 24.11. IR (KBr) 3406, 3260, 3023, 1608, 1574, 1517, 1320, 1149, 974 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>23</sub>N<sub>8</sub>O<sub>2</sub>S 475.1659, found 475.1673. HPLC purity: 100%.</div></div><div id="sec4_3_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> <i>N</i>-(4-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)phenyl)acetamide (<b>12av</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CHCl<sub>3</sub>/MeOH (12:1) as eluent to give the titled compound as a yellow solid. Yield 55%; mp 236.0–238.0 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.96 (br s, 1 H), 8.37 (s, 1 H), 7.81 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.76 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.46 (t, 1 H, <i>J</i> = 7.8 Hz), 7.27 (m, 2 H), 7.23 (d, 1 H, <i>J</i> = 8.0 Hz), 7.10 (br s, 1 H), 7.01 (d, 1 H, <i>J</i> = 7.6 Hz), 6.66 (m, 2 H), 4.50 (s, 2 H), 2.53 (s, 3 H), 2.13 (s, 3 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.37, 157.18, 154.27, 148.99, 147.62, 144.44, 137.28, 131.80, 129.41, 127.82, 121.77, 121.53, 120.78 (2 C), 119.76, 118.39, 114.82, 112.58 (2 C), 41.20, 23.84, 23.71 (2 peaks were not observed). IR (KBr) 3283, 1677, 1548, 1517, 1464, 1307, 1239, 747 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>23</sub>N<sub>8</sub>O 439.1989, found 439.2004. HPLC purity: 100%.</div></div><div id="sec4_3_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2,3-difluoroaniline (<b>12aw</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a white solid. Yield 46%; mp 176.0–178.0 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.96 (br s, 1 H), 8.38 (s, 1 H), 7.82 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.78 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.47 (t, 1 H, <i>J</i> = 7.6 Hz), 7.24 (d, 1 H, <i>J</i> = 7.6 Hz), 7.02 (dd, 1 H, <i>J</i> = 7.6, 0.4 Hz), 6.94–6.88 (m, 1 H), 6.60–6.51 (m, 2 H), 4.71 (br s, 1 H), 4.58 (d, 2 H, <i>J</i> = 3.6 Hz), 2.51 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.69, 154.48, 150.83 (dd, <i>J</i> = 244.2, 14.4 Hz), 149.94, 147.91, 147.06, 140.06 (dd, <i>J</i> = 238.9, 14.4 Hz), 137.73 (d, <i>J</i> = 3.0 Hz), 137.65, 133.82, 131.31, 128.57, 127.85, 124.43 (dd, <i>J</i> = 9.1, 4.5 Hz), 122.34, 122.21, 118.25, 116.31, 107.83, 106.41 (d, <i>J</i> = 17.4 Hz), 42.30, 23.97. <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>) −139.18, −160.99. IR (KBr) 3079, 3005, 1635, 1576, 1534, 1489, 1465 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>18</sub>F<sub>2</sub>N<sub>7</sub> 418.1586, found 418.1598. HPLC purity: 100%.</div></div><div id="sec4_3_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2,3-dichloroaniline (<b>12ax</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a white solid. Yield 46%; mp 89.1–91.1 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.02 (br s, 1 H), 8.97 (s, 1 H), 8.36 (s, 1 H), 7.81 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.75 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.46 (t, 1 H, <i>J</i> = 8.0 Hz), 7.24 (d, 1 H, <i>J</i> = 8.0 Hz), 7.03 (t, 1 H, overlapped, <i>J</i> = 8.0 Hz), 7.00 (d, 1 H, overlapped, <i>J</i> = 8.0 Hz), 6.85 (dd, 1 H, <i>J</i> = 8.0, 1.6 Hz), 6.63 (dd, 1 H, <i>J</i> = 8.0, 1.6 Hz), 5.15 (t, 1 H, <i>J</i> = 5.6 Hz), 4.57 (d, 2 H, <i>J</i> = 5.6 Hz), 2.43 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.57, 154.53, 149.97, 147.71, 146.95, 144.95, 137.86, 133.86, 133.28, 131.35, 128.47, 128.17, 127.96, 122.45, 122.03, 119.57, 118.29, 118.03, 116.39, 109.80, 42.46, 24.04. IR (KBr) 3411, 3077, 1586, 1501, 1315 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>7</sub> 450.0995, found 450.1006. HPLC purity: 100%.</div></div><div id="sec4_3_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2,3-dimethylaniline (<b>12ay</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as an off-white solid. Yield 36%; mp 114.9–116.9 °C. <sup>1</sup>H NMR(400 MHz, CDCl<sub>3</sub>) δ 8.97 (s, 1 H), 8.37 (s, 1 H), 7.83 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.78 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.45 (t, 1 H, <i>J</i> = 7.8 Hz), 7.22 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.03 (t, 1 H, overlapped, <i>J</i> = 7.8 Hz), 7.02 (d, 1 H, overlapped, <i>J</i> = 8.0 Hz), 6.69 (d, 1 H, <i>J</i> = 7.6 Hz), 6.58 (d, 1 H, <i>J</i> = 8.0 Hz), 4.59 (s, 2 H), 2.54 (s, 3 H), 2.31 (s, 3 H), 2.17 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.73, 154.43, 149.94, 148.06, 148.03, 145.56, 137.44, 137.13, 133.76, 131.53, 128.33, 127.89, 126.57, 122.48, 122.14, 121.42, 120.94, 117.98, 116.26, 108.82, 43.04, 24.32, 20.83, 12.82. IR (KBr): 3421, 2927, 1589, 754 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>24</sub>N<sub>7</sub> 410.2088, found 410.2092. HPLC purity: 99.28%.</div></div><div id="sec4_3_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2,3-dimethoxyaniline (<b>12az</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (30:1) as eluent to give the titled compound as a yellow solid. Yield 40%; mp 186.7–188.7 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.96 (br s, 1 H), 8.34 (s, 1 H), 7.80 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.72 (d, 1 H, <i>J</i> = 9.2 Hz), 7.42 (t, 1 H, <i>J</i> = 7.6 Hz), 7.20 (br d, 1 H, <i>J</i> = 7.6 Hz), 6.96 (d, 1 H, <i>J</i> = 7.6 Hz), 6.88 (td, 1 H, <i>J</i> = 8.2, 0.4 Hz), 6.36 (d, 1 H, overlapped, <i>J</i> = 8.0 Hz), 6.34 (d, 1 H, overlapped, <i>J</i> = 8.2 Hz), 4.52 (s, 2 H), 3.84 (s, 3 H), 3.81 (s, 3 H), 2.43 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.64, 154.48, 152.68, 149.97, 148.10, 147.88, 141.74, 137.48, 135.90, 133.67, 131.52, 128.24, 127.98, 124.75, 122.30, 122.13, 117.89, 116.27, 104.92, 102.87, 60.37, 55.91, 42.67, 24.25. IR (KBr) 3400, 1601, 1480, 1134 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>24</sub>N<sub>7</sub>O<sub>2</sub> 442.1986, found 442.2000. HPLC purity: 98.39%.</div></div><div id="sec4_3_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)phthalonitrile (<b>12ba</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CHCl<sub>3</sub>/MeOH (19:1) as eluent to give the titled compound as a yellow solid. Yield 26%; mp 241.1–243.1 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.99 (br s, 1 H), 8.35 (s, 1 H), 7.84 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.74 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.50 (t, 1 H, <i>J</i> = 7.8 Hz), 7.37 (t, 1 H, <i>J</i> = 8.2 Hz), 7.27 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.05 (d, 1 H, <i>J</i> = 8.8 Hz), 7.01 (d, 1 H, overlapped, <i>J</i> = 8.0 Hz), 6.98 (d, 1 H, overlapped, <i>J</i> = 7.6 Hz), 5.94 (br t, 1 H, <i>J</i> = 5.6 Hz), 4.66 (d, 2 H, <i>J</i> = 5.6 Hz), 2.30 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.53, 153.91, 150.66, 149.53, 148.23, 145.93, 137.75, 134.49, 132.14, 131.83, 129.93, 127.85, 122.59, 122.06, 121.70, 118.83, 116.15, 115.98, 115.80 (2 C), 114.79, 97.65, 40.56, 23.95. IR (KBr) 3367, 3082, 2928, 2224, 1592, 1315 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>18</sub>N<sub>9</sub> 432.1680, found 432.1683. HPLC purity: 100%.</div></div><div id="sec4_3_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3,4-difluoroaniline (<b>12bb</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a white solid. Yield 31%; mp 188.9–190.9 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.94 (t, 1 H, <i>J</i> = 1.4 Hz), 8.38 (s, 1 H), 7.81 (dd, 1 H, overlapped, <i>J</i> = 9.2, 1.6 Hz), 7.78 (dd, 1 H, overlapped, <i>J</i> = 9.2, 1.2 Hz), 7.47 (t, 1 H, <i>J</i> = 7.8 Hz), 7.24 (d, 1 H, <i>J</i> = 8.0 Hz), 7.03 (d, 1 H, <i>J</i> = 7.6 Hz), 7.04–6.95 (m, 1 H), 6.52 (ddd, 1 H, <i>J</i> = 12.4, 6.8, 2.8 Hz), 6.42–6.37 (m, 1 H), 4.48 (s, 2 H), 2.55 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.56, 153.82, 150.84 (dd, <i>J</i> = 243.8, 13.1 Hz), 149.47, 148.37, 147.60, 144.59, 143.47 (dd, <i>J</i> = 238.3, 13.1 Hz), 137.50, 132.16, 131.94, 129.40, 127.79, 122.39, 121.97, 118.68, 117.53 (dd, <i>J</i> = 17.8, 1.5 Hz), 115.70, 108.36 (dd, <i>J</i> = 5.4, 3.1 Hz), 101.95 (d, <i>J</i> = 20.9 Hz), 41.89, 24.01. <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) −137.48, −152.61. IR (KBr) 3271, 3074, 1635, 1601, 1574, 1523, 1464 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>18</sub>F<sub>2</sub>N<sub>7</sub> 418.1586, found 418.1599. HPLC purity: 100%.</div></div><div id="sec4_3_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3,4-dichloroaniline (<b>12bc</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 53%; mp 194.3–196.3 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.94 (t, 1 H, <i>J</i> = 1.2 Hz), 8.37 (s, 1 H), 7.80 (dd, 1 H, overlapped, <i>J</i> = 9.2, 1.6 Hz), 7.77 (dd, 1 H, overlapped, <i>J</i> = 9.2, 1.2 Hz), 7.47 (t, 1 H, <i>J</i> = 8.0 Hz), 7.24 (br d, 1 H, <i>J</i> = 8.0 Hz), 7.20 (d, 1 H, <i>J</i> = 8.8 Hz), 7.03 (d, 1 H, <i>J</i> = 8.0 Hz), 6.77 (d, 1 H, <i>J</i> = 2.8 Hz), 6.53 (dd, 1 H, <i>J</i> = 8.8, 2.8 Hz), 4.47 (s, 2 H), 2.51 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.69, 153.94, 149.62, 148.45, 147.64, 147.37, 137.79, 132.92, 132.13, 131.81, 130.83, 129.80, 128.05, 122.70, 121.76, 120.66, 119.00, 115.82, 114.43, 112.98, 41.34, 24.04. IR (KBr) 3400, 3288, 2927, 1597, 1500, 1317 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>7</sub> 450.0995, found 450.1008. HPLC purity: 100%.</div></div><div id="sec4_3_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3,4-dimethylaniline (<b>12bd</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as an off-white solid. Yield 68%; mp 167.7–169.7 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.96 (d, 1 H, <i>J</i> = 1.2 Hz), 8.37 (s, 1 H), 7.82 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.77 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.45 (t, 1 H, <i>J</i> = 7.6 Hz), 7.22 (br d, 1 H, <i>J</i> = 8.0 Hz), 7.00 (d, 1 H, <i>J</i> = 7.6 Hz), 6.98 (d, 1 H, <i>J</i> = 8.0 Hz), 6.57 (d, 1 H, <i>J</i> = 2.4 Hz), 6.50 (dd, 1 H, <i>J</i> = 8.0, 2.4 Hz), 4.53 (s, 2 H), 2.54 (s, 3 H), 2.20 (s, 3 H), 2.16 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.74, 154.42, 149.91, 148.14, 148.07, 145.65, 137.76, 137.33, 133.67, 131.53, 130.59, 128.43, 127.86, 127.13, 122.55, 122.06, 117.89, 116.22, 115.50, 110.86, 43.16, 24.35, 20.17, 18.87. IR (KBr) 3280, 3074, 1508 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>24</sub>N<sub>7</sub> 410.2088, found 410.2093. HPLC purity: 98.94%.</div></div><div id="sec4_3_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3,4-dimethoxyaniline (<b>12be</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (30:1) as eluent to give the titled compound as a yellow solid. Yield 33%; mp 135.5–137.5 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.94 (dd, 1 H, <i>J</i> = 1.6, 0.8 Hz), 8.34 (s, 1 H), 7.78 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.72 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.44 (t, 1 H, <i>J</i> = 8.0 Hz), 7.21 (br d, 1 H, <i>J</i> = 8.0 Hz), 6.99 (d, 1 H, <i>J</i> = 8.0 Hz), 6.71 (d, 1 H, <i>J</i> = 8.4 Hz), 6.30 (d, 1 H, <i>J</i> = 2.4 Hz), 6.19 (dd, 1 H, <i>J</i> = 8.4, 2.4 Hz), 4.46 (s, 2 H), 3.78 (s, 3 H), 3.76 (s, 3 H), 2.47 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.71, 154.46, 150.21, 149.91, 147.95, 147.88, 142.68, 142.14, 137.44, 133.39, 131.45, 128.53, 127.94, 122.24, 122.19, 117.90, 116.27, 113.20, 104.16, 99.85, 56.73, 55.98, 43.39, 24.35. IR (KBr) 3367, 1515, 1233, 1027 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>24</sub>N<sub>7</sub>O<sub>2</sub> 442.1986, found 442.1999. HPLC purity: 100%.</div></div><div id="sec4_3_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3,5-difluoroaniline (<b>12bf</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a pale-yellow solid. Yield 47%; mp 199.5–201.5 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.94 (t, 1 H, <i>J</i> = 1.2 Hz), 8.38 (s, 1 H), 7.81 (dd, 1 H, overlapped, <i>J</i> = 9.2, 1.6 Hz), 7.79 (dd, 1 H, overlapped, <i>J</i> = 9.2, 1.2 Hz), 7.47 (t, 1 H, <i>J</i> = 7.8 Hz), 7.24 (d, 1 H, <i>J</i> = 8.0 Hz), 7.03 (d, 1 H, <i>J</i> = 7.6 Hz), 6.24–6.19 (m, 3 H), 4.71 (br s, 1 H), 4.50 (s, 2 H), 2.55 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 164.19 (dd, 2 C, <i>J</i> = 243.0, 15.5 Hz), 158.57, 153.98, 149.99 (t, <i>J</i> = 13.2 Hz), 149.60, 148.19, 147.28, 137.67, 132.13, 131.88, 129.33, 127.93, 122.55, 121.66, 118.78, 115.89, 95.90 (dd, 2 C, <i>J</i> = 20.1, 8.5 Hz), 93.1 (t, <i>J</i> = 25.9 Hz), 41.22, 24.02. <sup>19</sup>F NMR (376 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) −110.32. IR (KBr) 3268, 3086, 1634, 1596, 1524, 1494, 1318 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>18</sub>F<sub>2</sub>N<sub>7</sub> 418.1586, found 418.1599. HPLC purity: 99.11%.</div></div><div id="sec4_3_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3,5-dichloroaniline (<b>12bg</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a pale-yellow solid. Yield 39%; mp 240.5–242.5 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 8.90 (s, 1 H), 8.24 (s, 1 H), 7.71 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.64 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.45 (t, 1 H, <i>J</i> = 7.6 Hz), 7.16 (d, 1 H, <i>J</i> = 7.6 Hz), 6.99 (d, 1 H, <i>J</i> = 7.6 Hz), 6.57 (t, 1 H, <i>J</i> = 1.6 Hz), 6.51 (d, 2 H, <i>J</i> = 1.6 Hz), 4.36 (s, 2 H), 2.45 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.95, 154.12, 150.07, 149.87, 148.98, 147.90, 138.23, 135.91 (2 C), 132.58, 132.12, 130.31, 128.36, 123.07, 122.03, 119.50, 117.82, 115.92, 111.62 (2 C), 41.30, 24.11. IR (KBr) 3422, 3115, 1600, 1500 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>7</sub> 450.0995, found 450.1002. HPLC purity: 100%.</div></div><div id="sec4_3_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3,5-dimethylaniline (<b>12bh</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 69%; mp 185.3–187.3 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.95 (d, 1 H, <i>J</i> = 1.2 Hz), 8.36 (s, 1 H), 7.79 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.74 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.45 (t, 1 H, <i>J</i> = 7.8 Hz), 7.22 (d, 1 H, <i>J</i> = 8.0 Hz), 6.99 (d, 1 H, <i>J</i> = 7.6 Hz), 6.44 (br s, 1 H), 6.31 (s, 2 H), 4.49 (s, 2 H), 2.48 (s, 3 H), 2.21 (s, 6 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.73, 154.42, 149.90, 148.11, 147.98, 147.66, 139.34 (2 C), 137.34, 133.64, 131.50, 128.44, 127.85, 122.51, 122.08, 120.97, 117.90, 116.21 111.44 (2 C), 42.83, 24.33, 21.62 (2 C). IR (KBr) 3279, 3009, 1601, 1504, 1467, 1319 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>24</sub>N<sub>7</sub> 410.2088, found 410.2097. HPLC purity: 100%.</div></div><div id="sec4_3_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3,5-dimethoxyaniline (<b>12bi</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (19:1) as eluent to give the titled compound as a yellow solid. Yield 74%; mp 188.6–190.6 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.43 (br s, 1 H), 8.94 (s, 1 H), 8.37 (s, 1 H), 7.81 (d, 1 H, <i>J</i> = 9.2 Hz), 7.77 (d, 1 H, <i>J</i> = 9.2 Hz), 7.45 (t, 1 H, <i>J</i> = 7.6 Hz), 7.20 (d, 1 H, <i>J</i> = 7.6 Hz), 7.01 (d, 1 H, <i>J</i> = 7.6 Hz), 5.96 (t, 1 H, <i>J</i> = 2.0 Hz), 5.92 (d, 2 H, <i>J</i> = 2.0 Hz), 4.52 (d, 2 H, <i>J</i> = 2.8 Hz), 4.41 (br s, 1 H), 3.75 (s, 6 H), 2.54 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.92 (2 C), 158.67, 154.42, 149.89, 149.49, 147.99, 147.61, 137.46, 133.28, 131.45, 128.60, 127.91, 122.21, 122.13, 118.06, 116.20, 92.40 (2 C), 90.84, 55.34, 42.43, 24.25. IR (KBr) 3310, 1605, 1204, 1154, 754 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>24</sub>N<sub>7</sub>O<sub>2</sub> 442.1986, found 442.2005. HPLC purity: 100%.</div></div><div id="sec4_3_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> <i>N</i><sup>3</sup>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-4-fluoro-<i>N</i><sup>1</sup>,<i>N</i><sup>1</sup>-dimethylbenzene-1,3-diamine (<b>14a</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (10:1) as eluent to give the titled compound as a yellow solid. Yield 42%; mp 198.8–200.8 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.95 (t, 1 H, <i>J</i> = 1.2 Hz), 8.35 (s, 1 H), 7.78 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.70 (dd, 1 H, <i>J</i> = 9.2, 1.2 Hz), 7.43 (t, 1 H, <i>J</i> = 7.8 Hz), 7.21 (d, 1 H, <i>J</i> = 8.0 Hz), 6.94 (d, 1 H, <i>J</i> = 7.6 Hz), 6.80–6.73 (m, 1 H), 6.14 (br d, 1 H, <i>J</i> = 7.6 Hz), 6.00–5.95 (m, 1 H), 4.49 (s, 2 H), 2.79 (s, 6 H), 2.31 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.59, 153.92, 149.56, 148.50, 147.99, 147.87, 145.59 (d, <i>J</i> = 229.1 Hz), 137.33, 136.00 (d, <i>J</i> = 12.3 Hz), 132.84, 131.96, 127.72, 122.54, 122.17, 118.40, 115.80, 114.76 (d, <i>J</i> = 19.3 Hz), 114.66 (d, <i>J</i> = 18.6 Hz), 102.41 (d, <i>J</i> = 7.0 Hz), 99.07 (d, <i>J</i> = 1.6 Hz), 41.78, 41.71 (2 C), 24.15. IR (KBr) 3425, 3090, 2955, 1615, 1528, 1257, 1200 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>24</sub>FN<sub>8</sub> 443.2102, found 443.2130. HPLC purity: 100%.</div></div><div id="sec4_3_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-5-((dimethylamino)methyl)-2-fluoroaniline (<b>14b</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (17:3) as eluent to give the titled compound as a brown solid. Yield 72%; mp 134.1–136.1 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.06 (s, 1 H), 8.34 (s, 1 H), 7.84 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.72 (d, 1 H, <i>J</i> = 9.2 Hz), 7.48 (t, 1 H, <i>J</i> = 7.6 Hz), 7.32 (br s, 1 H), 7.18 (br s, 1 H), 7.00 (d, 1 H, <i>J</i> = 7.6 Hz), 6.90 (dd, 1 H, <i>J</i> = 11.2, 8.0 Hz), 6.55–6.51 (m, 1 H), 4.78 (br s, 1 H), 4.59 (d, 2 H, <i>J</i> = 6.4 Hz), 3.54 (s, 2 H), 2.50 (s, 3 H), 2.34 (s, 6 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.47, 154.31, 151.66 (d, <i>J</i> = 239.4 Hz), 149.83, 149.56, 149.02, 147.15, 146.73, 137.22, 136.34 (d, <i>J</i> = 12.3 Hz), 131.78, 127.96, 122.29, 121.93, 118.82 (d, <i>J</i> = 6.9 Hz), 118.32, 115.82, 115.27, 114.66 (d, <i>J</i> = 18.6 Hz), 113.41 (d, <i>J</i> = 3.3 Hz), 63.39, 44.30 (2 C), 41.19, 24.44. IR (KBr) 3413, 3082, 2950, 1619, 1527, 1454 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>26</sub>FN<sub>8</sub> 457.2259, found 457.2292. HPLC purity: 100%.</div></div><div id="sec4_3_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-3-((dimethylamino)methyl)-2-fluoroaniline (<b>14c</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (17:3) as eluent to give the titled compound as a brown solid. Yield 56%; mp 51.8–53.8 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.99 (br s, 1 H), 8.36 (s, 1 H), 7.83 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.76 (d, 1 H, <i>J</i> = 9.2 Hz), 7.46 (t, 1 H, <i>J</i> = 7.8 Hz), 7.24 (br s, 1 H), 6.99 (d, 1 H, overlapped, <i>J</i> = 8.0 Hz), 6.96 (t, 1 H, overlapped, <i>J</i> = 8.0 Hz), 6.76–6.70 (m, 2 H), 4.73 (br s, 1 H), 4.56 (d, 2 H, <i>J</i> = 5.6 Hz), 3.60 (s, 2 H), 2.50 (s, 3 H), 2.36 (s, 6 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.80, 154.43, 150.60 (d, <i>J</i> = 239.2 Hz), 149.94, 148.28, 147.20, 137.27, 136.12 (d, <i>J</i> = 11.6 Hz), 131.62, 127.88, 124.57 (d, <i>J</i> = 4.6 Hz), 123.40 (d, <i>J</i> = 11.6 Hz), 122.65, 122.07, 120.59 (d, <i>J</i> = 3.1 Hz), 117.92, 116.21, 112.52, 44.96 (2 C), 42.48, 24.45. IR (KBr) 3425, 3075, 2951, 2827, 1628, 1512, 1454, 1318 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>26</sub>FN<sub>8</sub> 457.2259, found 457.2288. HPLC purity: 100%.</div></div><div id="sec4_3_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2-fluoro-3-(pyrrolidin-1-ylmethyl)aniline (<b>14d</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (22:3) as eluent to give the titled compound as a brown solid. Yield 70%; mp 54.6–56.6 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.11 (br s, 1 H), 8.98 (s, 1 H), 8.35 (s, 1 H), 7.81 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.73 (d, 1 H, <i>J</i> = 9.2 Hz), 7.44 (t, 1 H, <i>J</i> = 7.8 Hz), 7.23 (br s, 1 H), 6.97 (d, 1 H, <i>J</i> = 8.0 Hz), 6.91 (t, 1 H, <i>J</i> = 8.0 Hz), 6.75 (td, 1 H, <i>J</i> = 8.0, 1.2 Hz), 6.65 (td, 1 H, <i>J</i> = 8.0, 1.2 Hz), 4.66 (br s, 1 H), 4.51 (d, 2 H, <i>J</i> = 5.6 Hz), 3.66 (s, 2 H), 2.59 (br s, 4 H), 2.42 (s, 3 H), 1.81–1.75 (m, 4 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.53, 153.84, 150.62 (d, <i>J</i> = 238.9 Hz), 149.49, 148.05, 147.72, 137.27, 136.01, 135.92, 135.91 (d, <i>J</i> = 12.1 Hz), 132.01, 127.73, 124.31 (d, <i>J</i> = 4.1 Hz), 123.61 (d, <i>J</i> = 12.8 Hz), 122.12, 120.10, 120.07, 118.55, 115.61, 112.29, 53.88 (2 C), 52.77 (d, <i>J</i> = 2.1 Hz), 41.68, 24.13, 23.20 (2 C). IR (KBr) 3430, 3067, 2964, 2802, 1626, 1511, 1319 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>27</sub>H<sub>28</sub>FN<sub>8</sub> 483.2415, found 483.2449. HPLC purity: 98.71%.</div></div><div id="sec4_3_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2-fluoro-3-(morpholinomethyl)aniline (<b>14e</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (22:3) as eluent to give the titled compound as a brown solid. Yield 64%; mp 61.8–63.8 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.97 (s, 1 H), 8.36 (s, 1 H), 7.82 (dd, 1 H, <i>J</i> = 9.2, 2.0 Hz), 7.76 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.46 (t, 1 H, <i>J</i> = 7.6 Hz), 7.23 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.00 (d, 1 H, <i>J</i> = 7.6 Hz), 6.95 (t, 1 H, <i>J</i> = 8.0 Hz), 6.76 (t, 1 H, <i>J</i> = 7.6 Hz), 6.70 (td, 1 H, <i>J</i> = 8.0, 1.6 Hz), 4.67 (br s, 1 H), 4.54 (d, 2 H, <i>J</i> = 4.8 Hz), 3.73 (m, 4 H), 3.59 (s, 2 H), 2.53 (br s, 4 H), 2.47 (s, 3 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.78, 154.39, 150.56 (d, <i>J</i> = 238.8 Hz), 149.89, 148.22, 147.29, 137.31, 136.03 (d, <i>J</i> = 12.3 Hz), 133.95, 131.55, 128.58, 127.81, 124.37 (d, <i>J</i> = 4.3 Hz), 123.60 (d, <i>J</i> = 12.3 Hz), 122.67, 122.11, 120.43 (d, <i>J</i> = 3.1 Hz), 118.01, 116.21, 111.97 (d, <i>J</i> = 2.8 Hz), 66.96 (2 C), 55.92 (d, <i>J</i> = 2.1 Hz), 53.49 (2 C), 42.52, 24.32. IR (KBr) 3425, 3071, 2960, 2858, 1627, 1511, 1452, 1318, 1116, 755 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>27</sub>H<sub>28</sub>FN<sub>8</sub>O 499.2365, found 499.2402. HPLC purity: 99.37%.</div></div><div id="sec4_3_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)-2-((dimethylamino)methyl)benzonitrile (<b>14f</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 72%; mp 172.4–174.3 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.70 (br s, 1 H), 9.54 (s, 1 H), 8.50 (s, 1 H), 7.99 (dd, 1 H, <i>J</i> = 9.2, 2.0 Hz), 7.83 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.72 (t, 1 H, <i>J</i> = 7.8 Hz), 7.52 (br s, 1 H), 7.32 (t, 1 H, <i>J</i> = 7.6 Hz), 7.17–7.13 (m, 2 H), 7.07 (d, 1 H, <i>J</i> = 8.0 Hz), 7.02 (dd, 1 H, <i>J</i> = 7.6, 0.8 Hz), 4.48 (d, 2 H, <i>J</i> = 5.6 Hz), 3.68 (s, 2 H), 2.47 (s, 3 H), 2.23 (s, 6 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.58, 153.92, 153.76, 149.41, 147.87, 147.49, 137.20, 134.03, 131.76, 129.25, 127.77, 127.55, 125.33, 122.88, 122.09, 121.39, 118.30, 115.73, 114.77, 113.22, 59.66, 44.73 (2 C), 41.40, 24.09 (1 peak was not observed). IR (KBr) 3202, 3089, 2954, 2826, 2225, 1586, 1506, 1465, 1316 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>26</sub>N<sub>9</sub> 464.2306, found 464.2343. HPLC purity: 98.88%.</div></div><div id="sec4_3_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)-2-(pyrrolidin-1-ylmethyl)benzonitrile (<b>14g</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a brown solid. Yield 62%; mp 206.7–208.5 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.71 (br s, 1 H), 9.52 (s, 1 H), 8.50 (s, 1 H), 7.98 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.83 (d, 1 H, <i>J</i> = 9.2 Hz), 7.71 (t, 1 H, <i>J</i> = 7.8 Hz), 7.51 (br s, 1 H), 7.37 (t, 1 H, <i>J</i> = 5.2 Hz), 7.31 (t, 1 H, <i>J</i> = 8.0 Hz), 7.16 (d, 1 H, <i>J</i> = 7.6 Hz), 7.05 (d, 1 H, <i>J</i> = 8.0 Hz), 7.00 (dd, 1 H, <i>J</i> = 8.0, 1.2 Hz), 4.47 (d, 2 H, <i>J</i> = 5.2 Hz), 3.87 (s, 2 H), 2.51 (br s, 4 H), 2.47 (s, 3 H), 1.74 (br s, 4 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.62, 153.82, 149.48, 147.97, 147.58, 137.34, 134.12, 131.98, 129.10, 127.89, 127.68, 126.35, 123.03, 122.21, 121.41, 118.57, 118.43, 115.73, 114.60, 112.60, 56.11, 53.62 (2 C), 41.42, 24.15, 23.64 (2 C) (1 peak was not observed). IR (KBr) 3432, 3180, 3089, 2964, 2225, 1585, 1507, 1465, 1317 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>28</sub>H<sub>28</sub>N<sub>9</sub> 490.2462, found 490.2441. HPLC purity: 99.24%.</div></div><div id="sec4_3_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)-2-(morpholinomethyl)benzonitrile (<b>14h</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 48%; mp 241.5–243.6 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.70 (br s, 1 H), 9.48 (br s, 1 H), 8.50 (s, 1 H), 7.95 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.84 (d, 1 H, <i>J</i> = 9.2 Hz), 7.71 (t, 1 H, <i>J</i> = 7.6 Hz), 7.44 (br s, 1 H), 7.34 (t, 1 H, <i>J</i> = 8.0 Hz), 7.28 (t, 1 H, <i>J</i> = 5.6 Hz), 7.16 (d, 1 H, <i>J</i> = 7.6 Hz), 7.07 (d, 1 H, <i>J</i> = 8.4 Hz), 7.03 (dd, 1 H, <i>J</i> = 7.6, 1.2 Hz), 4.49 (d, 2 H, <i>J</i> = 5.6 Hz), 3.76 (s, 2 H), 3.58 (m, 4 H), 2.48 (s, 3 H), 2.41 (br s, 4 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.61, 153.87, 149.52, 148.19, 147.16, 137.48, 132.00, 129.93, 127.74, 122.34, 121.63, 118.58, 118.35, 115.77, 115.19, 113.98, 66.50 (2 C), 60.68, 52.80 (2 C), 41.16, 24.14 (5 peaks were not observed). IR (KBr) 3221, 3090, 2962, 2225, 1585, 1507, 1464, 1317 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>28</sub>H<sub>28</sub>N<sub>9</sub>O 506.2411, found 506.2412. HPLC purity: 98.89%.</div></div><div id="sec4_3_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)-5-(dimethylamino)benzonitrile (<b>14i</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a white solid. Yield 79%; mp 203.2–205.2 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.94 (t, 1 H, <i>J</i> = 1.2 Hz), 8.38 (s, 1 H), 7.80 (dd, 1 H, overlapped, <i>J</i> = 9.2, 1.6 Hz), 7.78 (dd, 1 H, overlapped, <i>J</i> = 9.2, 1.2 Hz), 7.49 (t, 1 H, <i>J</i> = 7.6 Hz), 7.25 (d, 1 H, <i>J</i> = 7.6 Hz), 7.04 (d, 1 H, <i>J</i> = 7.6 Hz), 6.38 (dd, 1 H, <i>J</i> = 2.4, 1.2 Hz), 6.30 (t, 1 H, <i>J</i> = 1.6 Hz), 6.18 (t, 1 H, <i>J</i> = 2.2 Hz), 4.53 (s, 2 H), 2.92 (s, 6 H), 2.56 (s, 3 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.56, 153.91, 151.50, 149.53, 148.89, 148.41, 147.47, 137.43, 132.44, 131.86, 129.34, 127.76, 122.30, 122.15, 120.24, 118.54, 115.78, 112.97, 106.30, 104.49, 100.86, 41.48, 40.20 (2 C), 24.11. IR (KBr) 3391, 3085, 2928, 2228, 1593 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>24</sub>N<sub>9</sub> 450.2149, found 450.2169. HPLC purity: 100%.</div></div><div id="sec4_3_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)-5-((dimethylamino)methyl)benzonitrile (<b>14j</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (10:1) as eluent to give the titled compound as a light-brown solid. Yield 65%; mp 124.1–127.1 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.01 (s, 1 H), 8.36 (s, 1 H), 7.83 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.76 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.49 (t, 1 H, <i>J</i> = 7.6 Hz), 7.28 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.15 (br s, 1 H), 7.03 (d, 1 H, <i>J</i> = 7.6 Hz), 6.94 (s, 1 H), 6.82 (dd, 1 H, <i>J</i> = 2.0, 1.2 Hz), 4.86 (br s, 1 H), 4.55 (d, 2 H, <i>J</i> = 5.6 Hz), 3.48 (s, 2 H), 2.54 (s, 3 H), 2.32 (s, 6 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.55, 153.87, 149.50, 148.38, 148.34, 146.99, 140.28, 137.27, 131.93, 127.72, 122.17, 122.00, 119.26, 118.54, 117.56, 115.63, 115.29, 112.76, 63.64, 45.11 (2 C), 40.92, 24.20 (3 peaks were not observed). IR (KBr) 3267, 3073, 2949, 2229, 1601, 1457 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>26</sub>N<sub>9</sub> 464.2306, found 464.2341. HPLC purity: 100%.</div></div><div id="sec4_3_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)-5-(pyrrolidin-1-ylmethyl)benzonitrile (<b>14k</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (10:1) as eluent to give the titled compound as a yellow solid. Yield 46%; mp 165.0–167.0 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.99 (s, 1 H), 8.36 (s, 1 H), 7.82 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.77 (d, 1 H, <i>J</i> = 9.2 Hz), 7.48 (t, 1 H, <i>J</i> = 7.6 Hz), 7.27 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.13 (br s, 1 H), 7.03 (d, 1 H, <i>J</i> = 7.6 Hz), 6.97 (br s, 1 H), 6.81 (dd, 1 H, <i>J</i> = 2.4, 1.2 Hz), 4.81 (br s, 1 H), 4.54 (d, 2 H, <i>J</i> = 5.6 Hz), 3.62 (s, 2 H), 2.57 (br s, 4 H), 2.54 (s, 3 H), 1.79 (br s, 4 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.69, 154.26, 149.74, 147.74, 147.60, 146.06, 142.18, 137.19, 134.30, 131.26, 128.00, 127.62, 122.63, 122.22, 122.03, 119.27, 117.81, 117.68, 116.15, 114.14, 112.79, 59.94, 54.12 (2 C), 41.86, 24.25, 23.44 (2 C). IR (KBr) 3396, 3287, 3079, 2963, 2229, 1600, 1458 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>28</sub>H<sub>28</sub>N<sub>9</sub> 490.2462, found 490.2456. HPLC purity: 100%.</div></div><div id="sec4_3_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)-5-(morpholinomethyl)benzonitrile (<b>14l</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a light-yellow solid. Yield 69%; mp 122.2–124.7 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.97 (s, 1 H), 8.38 (s, 1 H), 7.82 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.78 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.48 (t, 1 H, <i>J</i> = 7.6 Hz), 7.28 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.06 (br s, 1 H, overlapped), 7.04 (d, 1 H, <i>J</i> = 7.6 Hz), 7.01 (s, 1 H), 6.84 (dd, 1 H, <i>J</i> = 2.0, 1.2 Hz), 4.79 (br s, 1 H), 4.54 (d, 2 H, <i>J</i> = 7.6 Hz), 3.70 (m, 4 H), 3.48 (s, 2 H), 2.55 (s, 3 H), 2.47 (br s, 4 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.63, 153.90, 149.52, 148.25, 148.21, 146.90, 139.97, 137.37, 134.16, 131.85, 127.68, 122.27, 122.13, 119.37, 118.53, 118.11, 115.79, 114.63, 112.75, 66.72 (2 C), 62.76, 53.51 (2 C), 41.16, 24.18 (2 peaks were not observed). IR (KBr) 3269, 3079, 2958, 2229, 1600, 1457 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>28</sub>H<sub>28</sub>N<sub>9</sub>O 506.2411, found 506.2407. HPLC purity: 100%.</div></div><div id="sec4_3_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)-4-(dimethylamino)benzonitrile (<b>14m</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a white solid. Yield 76%; mp 200.5–202.6 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.96 (t, 1 H, <i>J</i> = 1.6 Hz), 8.38 (s, 1 H), 7.82 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.79 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.53 (t, 1 H, <i>J</i> = 7.8 Hz), 7.31 (d, 1 H, <i>J</i> = 8.0 Hz), 7.08–7.03 (m, 3 H), 6.87 (d, 1 H, <i>J</i> = 1.6 Hz), 5.44 (br s, 1 H), 4.55 (s, 2 H), 2.74 (s, 6 H), 2.58 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 158.53, 153.93, 149.58, 148.35, 147.01, 145.20, 142.47, 137.53, 133.00, 131.93, 129.11, 127.82, 122.73, 122.33, 122.27, 120.03, 119.38, 118.64, 115.84, 112.83, 106.94, 43.17 (2 C), 41.71, 24.13. IR (KBr) 3356, 3081, 2949, 2837, 2224, 1572, 1515 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>24</sub>N<sub>9</sub> 450.2149, found 450.2170. HPLC purity: 100%.</div></div><div id="sec4_3_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)-4-((dimethylamino)methyl)benzonitrile (<b>14n</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (10:1) as eluent to give the titled compound as a white solid. Yield 79%; mp 188.5–190.7 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.99 (s, 1 H), 8.36 (s, 1 H), 7.86 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.78 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.47 (t, 1 H, <i>J</i> = 7.6 Hz), 7.27 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.09 (d, 1 H, <i>J</i> = 7.6 Hz), 7.01 (d, 1 H, <i>J</i> = 7.6 Hz), 6.98 (dd, 1 H, <i>J</i> = 7.6, 1.6 Hz), 6.93 (br s, 1 H), 4.59 (s, 2 H), 3.63 (s, 2 H), 2.53 (s, 3 H), 2.33 (s, 6 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.71, 154.39, 149.93, 148.16, 146.86, 137.30, 131.58, 128.13, 122.75, 122.06, 121.40, 119.59, 117.80, 116.26, 113.06, 112.54, 63.45, 45.06 (2 C), 41.80, 24.54. IR (KBr) 3212, 3080, 2951, 2229, 1576, 1525 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>26</sub>N<sub>9</sub> 464.2306, found 464.2341. HPLC purity: 99.47%.</div></div><div id="sec4_3_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)-4-(pyrrolidin-1-ylmethyl)benzonitrile (<b>14o</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 60%; mp 143.9–145.8 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.40 (br s, 1 H), 8.96 (s, 1 H), 8.36 (s, 1 H), 7.84 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.77 (d, 1 H, <i>J</i> = 9.2 Hz), 7.46 (t, 1 H, <i>J</i> = 7.6 Hz), 7.24 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.09 (d, 1 H, <i>J</i> = 7.6 Hz), 7.00 (d, 1 H, <i>J</i> = 7.6 Hz), 6.96 (dd, 1 H, <i>J</i> = 7.6, 1.6 Hz), 6.86 (br s, 1 H), 4.55 (s, 2 H), 3.74 (s, 2 H), 2.54 (br s, 4 H), 2.51 (s, 3 H), 1.81 (br s, 4 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.83, 154.43, 149.97, 148.15, 147.80, 146.75, 137.28, 134.59, 131.57, 129.96, 129.08, 127.92, 122.78, 123.00, 122.05, 121.36, 119.71, 117.59, 116.32, 112.68, 112.20, 59.74, 53.82 (2 C), 41.75, 24.54, 23.87 (2 C). IR (KBr) 3218, 3078, 2963, 2228, 1576, 1445 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>28</sub>H<sub>28</sub>N<sub>9</sub> 490.2462, found 490.2443. HPLC purity: 99.53%.</div></div><div id="sec4_3_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)-4-(morpholinomethyl)benzonitrile (<b>14p</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CH<sub>2</sub>Cl<sub>2</sub>/MeOH (20:1) as eluent to give the titled compound as a yellow solid. Yield 68%; mp 191.0–192.8 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.97 (s, 1 H), 8.37 (s, 1 H), 7.84 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.79 (dd, 1 H, <i>J</i> = 9.2, 1.2 Hz), 7.49 (t, 1 H, <i>J</i> = 7.8 Hz), 7.29 (br d, 1 H, <i>J</i> = 8.0 Hz), 7.12 (d, 1 H, <i>J</i> = 7.6 Hz), 7.03 (d, 1 H, <i>J</i> = 7.6 Hz), 6.99 (dd, 1 H, <i>J</i> = 7.6, 1.6 Hz), 6.93 (br s, 1 H), 4.57 (s, 2 H), 3.75 (br s, 4 H, overlapped), 3.72 (s, 2 H, overlapped), 2.55 (br s, 7 H). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 158.87, 154.46, 149.97, 148.14, 147.69, 146.19, 137.37, 134.57, 131.48, 130.97, 128.07, 127.79, 126.92, 122.94, 122.15, 121.29, 119.58, 117.56, 116.38, 112.82, 112.59, 67.03 (2 C), 62.56, 53.21 (2 C), 41.62, 24.58. IR (KBr) 3220, 3079, 2962, 2228, 1574, 1453 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>28</sub>H<sub>28</sub>N<sub>9</sub>O 506.2411, found 506.2401. HPLC purity: 100%.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> General Procedure for the Preparation of the 2- or 4-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)benzamide (<b>12m</b> and <b>12aq</b>)</h3><div class="NLM_p">To a stirred solution of <b>12l</b> (0.52 mmol) or <b>12ap</b> (0.52 mmol) in EtOH (2 mL) were added 34.5% H<sub>2</sub>O<sub>2</sub> (1.82 mmol) and 1 N NaOH (1.55 mmol) at room temperature. The mixture was stirred at room temperature for 2–3 h, cooled to 0 °C, and then neutralized with 1 N HCl to pH 8. After removal of the solvent, the residue was extracted with 20% MeOH in CHCl<sub>3</sub> (3 × 100 mL). The combined organic layers was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and then evaporated to dryness under reduced pressure. The residue was purified by MPLC on silica gel to afford the titled compounds as a solid.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> 2-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)benzamide (<b>12m</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CHCl<sub>3</sub>/MeOH (23:2) as eluent to give the titled compound as a yellow solid. Yield 84%; mp 121.8–123.8 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.04 (dd, 1 H, <i>J</i> = 1.6, 0.8 Hz), 8.48 (br s, 1 H), 8.33 (s, 1 H), 7.84 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.72 (d, 1 H, <i>J</i> = 9.2 Hz), 7.41 (t, 1 H, <i>J</i> = 7.8 Hz), 7.37 (dd, 1 H, <i>J</i> = 7.6, 1.2 Hz), 7.29 (td, 1 H, <i>J</i> = 8.4, 1.2 Hz), 7.21 (br d, 1 H, <i>J</i> = 8.0 Hz), 6.92 (d, 1 H, <i>J</i> = 7.6 Hz), 6.83 (d, 1 H, <i>J</i> = 8.4 Hz), 6.62 (td, 1 H, <i>J</i> = 8.0, 1.0 Hz), 6.25 (br s, 2 H), 4.59 (d, 2 H, <i>J</i> = 5.2 Hz), 2.32 (s, 3 H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 172.65, 158.52, 154.21, 149.72, 149.68, 148.64, 148.26, 137.27, 133.87, 132.78, 131.61, 129.37, 128.61, 127.91, 122.10, 122.03, 118.64, 116.13, 115.88, 114.20, 112.52, 41.58, 23.94. IR (KBr) 3336, 3185, 1654, 1514, 1315 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + Na]<sup>+</sup> calcd for C<sub>23</sub>H<sub>20</sub>N<sub>8</sub>NaO 447.1652, found 447.1680. HPLC purity: 99.52%.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> 4-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)benzamide (<b>12aq</b>)</h4><div class="NLM_p last">The residue was purified by MPLC on silica gel using CHCl<sub>3</sub>/MeOH (23:2) as eluent to give the titled compound as a yellow solid. Yield 63%; mp 255.7–257.7 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>/CD<sub>3</sub>OD) δ 9.03 (br s, 1 H), 8.32 (s, 1 H), 7.81 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.70 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.67 (m, 2 H), 7.55 (t, 1 H, <i>J</i> = 7.6 Hz), 7.26 (br d, 1 H, <i>J</i> = 7.6 Hz), 7.09 (d, 1 H, <i>J</i> = 7.6 Hz), 6.71 (m, 2 H), 4.52 (s, 2 H), 2.51 (s, 3 H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.93, 157.18, 154.28, 150.80, 148.99, 146.98, 137.34, 131.73, 129.01 (2 C), 127.84, 121.80, 121.60, 118.41, 114.86, 111.28 (2 C), 48.60, 23.79 (2 peaks were not observed). IR (KBr) 3325, 2925, 1650, 1604, 1528, 1389 cm<sup>–1</sup>. HRMS-ESI <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>21</sub>N<sub>8</sub>O 425.1833, found 425.1835. HPLC purity: 100%.</div></div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> Synthesis of <i>N</i>-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methyl)-2-fluoroaniline Hydrochloride (<b>12b</b>·HCl)</h3><div class="NLM_p last">To a stirred solution of <b>12b</b> in CH<sub>2</sub>Cl<sub>2</sub> (1 mL) cooled 0 °C, was added 1.0 M HCl in Et<sub>2</sub>O (1.9 mL, 1.88 mmol) under nitrogen atmosphere. The mixture was stirred at room temperature for 5 min and evaporated to dryness under reduced pressure. The solid was dried using a rotary evaporator in vacuo at 40 °C for 16 h to afford the titled compound as a yellow solid. Yield 97%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.44 (d, 1 H, <i>J</i> = 0.8 Hz), 8.62 (s, 1 H), 7.96 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.83 (t, 1 H, <i>J</i> = 8.0 Hz), 7.80 (dd, 1 H, <i>J</i> = 9.2, 1.6 Hz), 7.53 (d, 1 H, <i>J</i> = 8.0 Hz), 7.38 (d, 1 H, <i>J</i> = 7.6 Hz), 7.10 (ddd, 1 H, <i>J</i> = 12.0, 8.0, 1.2 Hz), 7.01 (td, 1 H, <i>J</i> = 7.6, 1.2 Hz), 6.88 (br t, 1 H, <i>J</i> = 8.6 Hz), 6.70–6.64 (m, 1 H), 4.75 (s, 2 H), 2.54 (s, 3 H).</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> Synthesis of 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)benzonitrile Hydrochloride (<b>12z</b>·HCl)</h3><div class="NLM_p last">To a stirred suspension of <b>12z</b> (4.60 g, 11.32 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (500 mL) under nitrogen atmosphere, <i>i</i>-PrOH (50 mL) was added to give a clear solution. To it, 5.0 M HCl in <i>i</i>-PrOH (4.53 mL, 22.64 mmol) was added dropwise, and the mixture was stirred at room temperature for 1 h. The yellow suspension was diluted with <i>tert</i>-butyl methyl ether (1000 mL) and stirred for an additional 3 h. The mixture was filtered under nitrogen atmosphere and washed with <i>tert</i>-butyl methyl ether (2 × 100 mL). The filtered solid was again suspended in <i>tert</i>-butyl methyl ether (400 mL) for 1 h, filtered under nitrogen atmosphere, and washed with <i>tert</i>-butyl methyl ether (2 × 100 mL). The solid was thoroughly dried in a vacuum oven over P<sub>2</sub>O<sub>5</sub> at 50 °C for 12 h. To remove a trace amount of residual solvent, the dried solid was again suspended in <i>n</i>-heptane (400 mL) for 1.5 h, filtered, and dried in a vacuum oven over P<sub>2</sub>O<sub>5</sub> at 40 °C for 4 h to afford the titled compound as a yellow solid. Yield 98%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.47 (d, 1 H, <i>J</i> = 0.8 Hz), 8.66 (s, 1 H), 7.97 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.87 (t, 1 H, overlapped, <i>J</i> = 7.8 Hz), 7.85 (dd, 1 H, overlapped, <i>J</i> = 9.2, 1.6 Hz), 7.63 (d, 1 H, <i>J</i> = 7.6 Hz), 7.40 (d, 1 H, <i>J</i> = 8.0 Hz), 7.33 (t, 1 H, <i>J</i> = 7.8 Hz), 7.16 (t, 1 H, <i>J</i> = 1.6 Hz), 7.11 (dd, 1 H, <i>J</i> = 8.4, 1.6 Hz), 7.06 (br d, 1 H, <i>J</i> = 7.6 Hz), 4.79 (s, 2 H), 2.53 (s, 3 H).</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> Synthesis of 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)-2-((dimethylamino)methyl)benzonitrile Hydrochloride (<b>14f</b>·HCl)</h3><div class="NLM_p last">A stirred suspension of <b>14f</b> (0.05 g, 0.11 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) was heated at 50 °C to give a clear solution under nitrogen atmosphere. The CH<sub>2</sub>Cl<sub>2</sub> solution was cooled to 0 °C, and to it was added 1.0 M HCl in Et<sub>2</sub>O (0.32 mL, 0.32 mmol). The mixture was stirred at room temperature for 15 min, and solvent was evaporated by nitrogen gas bubbling into the solution. The solid was dried using a rotary evaporator in vacuo at 40 °C for 16 h to afford the titled compound as an off-white solid. Yield 90%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.48 (t, 1 H, <i>J</i> = 1.2 Hz), 8.60 (s, 1 H), 7.92 (dd, 1 H, <i>J</i> = 9.2, 1.2 Hz), 7.86 (dd, 1 H, overlapped, <i>J</i> = 9.2, 1.6 Hz), 7.85 (t, 1 H, overlapped, <i>J</i> = 8.0 Hz), 7.64 (d, 1 H, <i>J</i> = 8.0 Hz), 7.49 (t, 1 H, <i>J</i> = 7.8 Hz), 7.37 (d, 1 H, <i>J</i> = 8.0 Hz), 7.24 (dd, 1 H, <i>J</i> = 7.6, 0.8 Hz), 7.10 (dd, 1 H, <i>J</i> = 8.0, 0.8 Hz), 4.81 (s, 2 H), 4.61 (s, 2 H), 2.89 (s, 6 H), 2.52 (s, 3 H).</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> Synthesis of 3-((4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1<i>H</i>-imidazol-2-yl)methylamino)-4-(dimethylamino)benzonitrile Hydrochloride (<b>14m</b>·HCl)</h3><div class="NLM_p last">A stirred suspension of <b>14m</b> (0.05 g, 0.11 mmol) in a mixture of CH<sub>2</sub>Cl<sub>2</sub> (3 mL) and CHCl<sub>3</sub> (0.5 mL) was heated at 50 °C to give a clear solution under nitrogen atmosphere. The solution was cooled to 0 °C, and to it was added 1.0 M HCl in Et<sub>2</sub>O (0.33 mL, 0.33 mmol). The mixture was stirred at room temperature for 15 min, and solvent was evaporated by nitrogen gas bubbling into the solution. The solid was dried using a rotary evaporator in vacuo at 40 °C for 16 h to afford the titled compound as an off-white solid. Yield 100%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.44 (dd, 1 H, <i>J</i> = 1.6, 0.8 Hz), 8.64 (s, 1 H), 7.99 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.84 (t, 1 H, overlapped, <i>J</i> = 7.8 Hz), 7.82 (dd, 1 H, <i>J</i> = 9.2, 0.8 Hz), 7.51 (d, 1 H, <i>J</i> = 8.0 Hz), 7.39 (d, 1 H, <i>J</i> = 7.6 Hz), 7.15 (dd, 2 H, overlapped, <i>J</i> = 7.6, 0.8 Hz), 7.14 (d, 1 H, overlapped, <i>J</i> = 1.2 Hz), 4.79 (s, 2 H), 2.71 (s, 6 H), 2.56 (s, 3 H).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> Luciferase Assay</h3><div class="NLM_p last">To establish HaCaT (3TP-luc) and 4T1 (3TP-luc) stable cells, cells were seeded on six-well plates. Cells were allowed to adhere overnight and then transfected with the p3TP-luc (neo) expression plasmid using PEI reagent (Sigma-Aldrich). Transfected cells were cultured for 4 weeks in the presence of G418 (500 μg/mL). Several single clones were isolated and measured luciferase activity. The clone showing response to TGF-β1 treatment was used for reporter assay. HaCaT (3TP-luc) stable cells or 4T1 (3TP-luc) stable cells were seeded at 2.5 × 10<sup>4</sup> cells/well or 5 × 10<sup>5</sup> cells/well in 96-well plate, respectively, and were allowed to adhere overnight. Cells were concomitantly treated with TGF-β1 (2 ng/mL) and indicated concentrations of ALK5 inhibitors in 0.2% FBS medium and incubated for 24 h at 37 °C in 5% CO<sub>2</sub>. Cell lysates were prepared using Luciferase Assay System (Promega) according to the manufacturer’s instruction, and luminescence was measured by a luminometer, Micro Lumat Plus (Berthold, Germany).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> Aqueous Solubility Determination</h3><div class="NLM_p last">A standard solution was prepared by dissolving 1 mg of sample in 10 mL of pH 1.2 or pH 6.8 buffer solution at 25 °C. The standard solution was diluted with pH 1.2 or 6.8 buffer solution as necessary, and the diluted standard solutions were scanned by UV (U-3010, Hitachi, Japan) at 225.00–326.00 nm to obtain a standard curve. A saturated solution was prepared by vortex mixing in pH 1.2 or pH 6.8 buffer solution for 10 min, then standing for 24 h, and then vortex mixing for an additional 10 min in the presence of excess compound. The saturated solution was filtered to remove excess compound using 0.45 μm Millex filters, diluted to at least 4 mL, and then scanned by UV at 225.00–326.00 nm. Total solubility was then determined by the comparison of the absorbance of the saturated solution with that of the standard curve.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> Pharmacokinetic Study in Rats</h3><div class="NLM_p last">Four groups of healthy male Sprague–Dawley rats (7 weeks and 190–210 g) were received <b>12b</b>·HCl, <b>12z</b>·HCl, <b>14f</b>·HCl, and <b>14m</b>·HCl intravenously at a dose of 2 mg/kg, respectively. Another four groups of rats were orally administered with these four compounds at a dose of 10 mg/kg, respectively. About 0.2 mL of blood samples were collected from the common carotid artery at 0, 0.08, 0.16, 0.25, 0.5, 0.75, 1, 2, and 4 h after intravenous or oral administration. Blood samples were centrifuged at 12000 rpm for 15 min immediately after sampling, and about 100 μL of plasma samples were stored at −70 °C until LC/MS/MS analysis. All animal procedures were approved by the Institutional Animal Ethics Committee of Ewha Womans University, Korea. Protein precipitation was conducted on 100 μL of plasma samples with 3 volumes of CH<sub>3</sub>CN containing <b>12a</b> as analytical internal standard. After centrifugation, supernatant was analyzed by API2000 LC-ESI/MS/MS system in a positive MRM mode. Analytical data were processed using Analyst TM1.4.2. (Applied Biosystems, Concord, Canada.) Pharmacokinetic parameters were obtained by noncompartmental analysis of the plasma concentration–time profiles using Kinetica 4.4.1 (Thermo Fisher Scientific, Inc., Woburn, MA, USA).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> Docking Study</h3><div class="NLM_p last">All computational works were performed on the Tripos Sybyl-X 2.0 (Tripos Inc., St Louis, MO) molecular modeling package with CentOS Linux 5.4. operating system.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Except the compound <b>12b</b>, all ligands were prepared with using sketch modules and saved as MOL2 format. The X-ray coordinates <b>12b</b> was used for docking calculation. After sketching all ligands, Gasteiger–Hückel charges were assigned to all atoms in ligand. Energy minimization was carried out with the standard tripos force field with convergence to maximum derivatives of 0.001 kcal mol<sup>–1</sup> Å<sup>–1</sup>. The X-ray structure of ALK5 complexed with 5,6-dihydro-4<i>H</i>-pyrrolo[1,2-<i>b</i>]pyrazole inhibitor was used as a receptor for docking performance (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RW8">1RW8</a>). Native ligand was extracted, and all water molecules except key water molecules for water-mediated hydrogen bond network were deleted from the complex structure. To understand binding poses of candidate compounds which showed good inhibitory activity against ALK5, docking study was conducted using Surflex-Dock<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> embedded in Tripos Sybyl X 2.0 software package. The active site was generated by constructing protomol based on the native ligand. Docking was performed using default parameters, and maximum number of poses per ligand was 20 conformers. Binding affinity of each docking pose of ligand was calculated by Surflex-Dock score and consensus scoring function (CScore<sup>1</sup>).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> CYP Inhibition Assay</h3><div class="NLM_p last">The incubation mixtures (final volume, 200 μL) contained 1 mg/mL microsomal protein, 0.1 M potassium phosphate buffer (pH 7.4), 1 mM NADPH, and various P450 enzyme-specific substrate cocktail (CYP1A2:50 μM phenacetin, CYP2C9:100 μM tolbutamide, CYP2C19:100 μM S-mephenytoin, CYP2D6:5 μM dextromethorphan, CYP3A4:5 μM midazolam). The substrate cocktail was used at concentrations approximately equal to their respective <i>K</i><sub>m</sub> values. The <b>12b</b> was used at concentrations from 0.5 nM to 10 μM. After a 5 min preincubation at 37 °C, the reactions were initiated by the addition of 1 mM NADPH. The incubations were performed at 37 °C in water bath for 10 min. The reactions were terminated by placing the tubes on ice, adding 200 μL of cold CH<sub>3</sub>CN and agitating with a vortex mixer before centrifugation. The samples for each enzyme assay were centrifuged at 3000<i>g</i> for 20 min at 4 °C, and the supernatants of the individual reaction samples were analyzed by 3200 QTRAP LC/MS/MS system in a positive MRM mode. Sample analysis was performed by 3200 QTRAP LC/MS/MS system (Applied Biosystems, Concord, Canada) in a positive MRM mode. The LC/MS/MS system consisted of an Agilent 1100 series HPLC system (Agilent Technologies) equipped with autosampler, binary pump, degasser, and thermostated column compartment and an 3200 QTRP triple quadrupole mass spectrometer with a Turbo V Ion spray source (Applied Biosystems). Analytical data were processed using Analyst 1.4.2. (Applied Biosystems). IC<sub>50</sub> values were calculated using GraphPad Prism 4.0.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> hERG Assay</h3><div class="NLM_p last">The hERG assay was performed at MPI Research, Inc. in Mattawan, MI. HEK293 cells stably expressing the hERG potassium channel were plated onto sterile glass coverslips up to 2 days prior to electrophysiological evaluation. Following whole-cell patch clamp and demonstration of stable hERG current for at least 2 min, baseline testing was conducted, and the test and control articles were applied in physiological salt solution (PSS) via superfusion at 35.2 to 35.7 °C for 3.0 to 5.7 min. The superfusion flow rate was 3.3 to 3.8 mL per min. The concentration levels for <b>12b</b> were 1, 10, 30, and 100 μM. PSS containing 0.1% DMSO and cisapride (0.1 μM) were used as the vehicle and positive control, respectively. Currents were recorded from HEK293 cells stably expressing hERG using whole-cell patch clamp technique with a Multiclamp 700A amplifier and pClamp software. Signals were acquired at 2000 μs/point and filtered at 100 Hz. Patch pipettes were pulled from borosilicate capillary glass tubing (Sutter Instuments) using a Sutter-Flaming/Brown type, model P-97 micropipet puller. Internal pipet solution contained (in mM): K-methanesulfonate 115, KCl 10, MgCl<sub>2</sub> 1, EGTA 5, HEPES 10, ATP-Mg 3, GTP-Na 0.3, phosphocreatine 4 (pH was adjusted to 7.21 with 0.1 M KOH). The pipet solutions were stored in aliquots at −10 to −30 °C. The resistance of the patch pipettes, when filled with internal solution, ranged between 1.5 and 2.0 MΩ. Once stably patch clamped in whole-cell mode, HEK293 cells expressing hERG were held at a potential of −80 mV. hERG mediated currents were evoked by application of a depolarizing voltage command step to +40 mV for 2 s, followed by a repolarizing command step to −50 mV for 1.5 s. This voltage command protocol was repeated once every 10 s. Analysis of current amplitudes was performed with pClamp software. Peak tail currents from the last 30 s of the baseline period were averaged and compared to 30 s of data recorded in the presence of the test solutions. Current inhibition is reported in percent according to Inhibition (%) = 100 × (1 – (<i>I</i><sub>test</sub>/<i>I</i><sub>baseline</sub>)) where <i>I</i><sub>test</sub> was the peak tail current measured in the presence of the test solution, and <i>I</i><sub>baseline</sub> was the peak tail current measured prior to exposure to the test solution; each cell served as its own control. Peak tail current readings were adjusted for cell rundown by a linear model derived from available baseline data for each cell. Aberrant waveforms with a holding current more negative than −250 pA were excluded from analysis.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i114"><a href="/doi/suppl/10.1021/jm500115w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43375" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43375" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures for compounds <b>13b</b>–<b>p</b> and detailed HPLC conditions for confirming purity of target compounds.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500115w/suppl_file/jm500115w_si_001.pdf">jm500115w_si_001.pdf (288.13 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm500115w" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50566" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50566" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dae-Kee Kim</span> - <span class="hlFld-Affiliation affiliation">Graduate School of Pharmaceutical Sciences, College of
Pharmacy, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul 120-750, Korea</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#04606f6f6d694461736c652a65672a6f76"><span class="__cf_email__" data-cfemail="80e4ebebe9edc0e5f7e8e1aee1e3aeebf2">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cheng Hua Jin</span> - <span class="hlFld-Affiliation affiliation">Graduate School of Pharmaceutical Sciences, College of
Pharmacy, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul 120-750, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maddeboina Krishnaiah</span> - <span class="hlFld-Affiliation affiliation">Graduate School of Pharmaceutical Sciences, College of
Pharmacy, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul 120-750, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Domalapally Sreenu</span> - <span class="hlFld-Affiliation affiliation">Graduate School of Pharmaceutical Sciences, College of
Pharmacy, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul 120-750, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vura B. Subrahmanyam</span> - <span class="hlFld-Affiliation affiliation">Graduate School of Pharmaceutical Sciences, College of
Pharmacy, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul 120-750, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kota S. Rao</span> - <span class="hlFld-Affiliation affiliation">Graduate School of Pharmaceutical Sciences, College of
Pharmacy, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul 120-750, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hwa Jeong Lee</span> - <span class="hlFld-Affiliation affiliation">Graduate School of Pharmaceutical Sciences, College of
Pharmacy, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul 120-750, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">So-Jung Park</span> - <span class="hlFld-Affiliation affiliation">School of Pharmacy, Sungkyunkwan
University, Suwon 440-746, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hyun-Ju Park</span> - <span class="hlFld-Affiliation affiliation">School of Pharmacy, Sungkyunkwan
University, Suwon 440-746, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kiho Lee</span> - <span class="hlFld-Affiliation affiliation">Bioevaluation Center, Korea Research Institute of Bioscience and Biotechnology, Cheongwon, Chungbuk 363-883, Korea</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yhun Yhong Sheen</span> - <span class="hlFld-Affiliation affiliation">Graduate School of Pharmaceutical Sciences, College of
Pharmacy, Ewha Womans University, 11-1 Daehyun-dong, Seodaemun-gu, Seoul 120-750, Korea</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d2601e12912-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i119">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18553" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18553" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by a grant from Ministry of Education, Science and Technology, Korea (20082005585) and a RP-Grant 2012 of Ewha Womans University.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i120" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i120"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i121" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i121"> Abbreviations Used</h2><tr><td class="NLM_term">(AcO)<sub>3</sub>BHNa</td><td class="NLM_def"><p class="first last">sodium triacetoxyborohydride</p></td></tr><tr><td class="NLM_term">AcOH</td><td class="NLM_def"><p class="first last">acetic acid</p></td></tr><tr><td class="NLM_term">ALK5</td><td class="NLM_def"><p class="first last">activin receptor-like kinase 5</p></td></tr><tr><td class="NLM_term">AST</td><td class="NLM_def"><p class="first last">aspartate aminotransferase</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under curve</p></td></tr><tr><td class="NLM_term">BID</td><td class="NLM_def"><p class="first last">twice daily</p></td></tr><tr><td class="NLM_term"><i>t</i>-BuOMe</td><td class="NLM_def"><p class="first last"><i>tert</i>-buty methyl ether</p></td></tr><tr><td class="NLM_term">CCl<sub>4</sub></td><td class="NLM_def"><p class="first last">carbon tetrachloride</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum concentration</p></td></tr><tr><td class="NLM_term">CTL</td><td class="NLM_def"><p class="first last">cytotoxic T-lymphocyte</p></td></tr><tr><td class="NLM_term">CuCN</td><td class="NLM_def"><p class="first last">cuprous cyanide</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i><i>N</i>,<i>N</i></i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">ECG</td><td class="NLM_def"><p class="first last">electrocardiogram</p></td></tr><tr><td class="NLM_term">EMT</td><td class="NLM_def"><p class="first last">epithelial–mesenchymal transition</p></td></tr><tr><td class="NLM_term">Et<sub>2</sub>O</td><td class="NLM_def"><p class="first last">diethyl ether</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">FasL</td><td class="NLM_def"><p class="first last">fas ligand</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">food and drug administration</p></td></tr><tr><td class="NLM_term">FOB</td><td class="NLM_def"><p class="first last">functional observational battery</p></td></tr><tr><td class="NLM_term">GFP</td><td class="NLM_def"><p class="first last">green fluorescent protein</p></td></tr><tr><td class="NLM_term">HEK</td><td class="NLM_def"><p class="first last">human embryonic kidney</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human <i>Ether</i>-<i>à</i>-<i>go</i>-<i>go</i>-related gene</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">IND</td><td class="NLM_def"><p class="first last">investigational new drug</p></td></tr><tr><td class="NLM_term">MeI</td><td class="NLM_def"><p class="first last">iodomethane</p></td></tr><tr><td class="NLM_term">Me<sub>2</sub>NH·HCl</td><td class="NLM_def"><p class="first last">dimethylamine hydrochloride</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">MOLCAD</td><td class="NLM_def"><p class="first last">molecular computer-aided design</p></td></tr><tr><td class="NLM_term">mp</td><td class="NLM_def"><p class="first last">melting point</p></td></tr><tr><td class="NLM_term">MPLC</td><td class="NLM_def"><p class="first last">medium pressure liquid chromatography</p></td></tr><tr><td class="NLM_term">NaBH<sub>4</sub></td><td class="NLM_def"><p class="first last">sodium borohydride</p></td></tr><tr><td class="NLM_term">NaH</td><td class="NLM_def"><p class="first last">sodium hydride</p></td></tr><tr><td class="NLM_term">NaOH</td><td class="NLM_def"><p class="first last">sodium hydroxide</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">NH<sub>4</sub>OAc</td><td class="NLM_def"><p class="first last">ammonium acetate</p></td></tr><tr><td class="NLM_term">NOAEL</td><td class="NLM_def"><p class="first last">no-observed-adverse-effect level</p></td></tr><tr><td class="NLM_term">NOEL</td><td class="NLM_def"><p class="first last">no-observed-effect level</p></td></tr><tr><td class="NLM_term">PBr<sub>3</sub></td><td class="NLM_def"><p class="first last">phosphorus tribromide</p></td></tr><tr><td class="NLM_term">Pd/C</td><td class="NLM_def"><p class="first last">palladium/charcoal</p></td></tr><tr><td class="NLM_term">PSS</td><td class="NLM_def"><p class="first last">physiological salt solution</p></td></tr><tr><td class="NLM_term">QD</td><td class="NLM_def"><p class="first last">once daily</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">RIPK2</td><td class="NLM_def"><p class="first last">receptor-interacting protein kinase 2</p></td></tr><tr><td class="NLM_term">SnCl<sub>2</sub></td><td class="NLM_def"><p class="first last">stannous chloride</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">TGF-β</td><td class="NLM_def"><p class="first last">transforming growth factor-β</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">UUO</td><td class="NLM_def"><p class="first last">unilateral ureteral obstruction</p></td></tr><tr><td class="NLM_term">VEGF-R2</td><td class="NLM_def"><p class="first last">vascular endothelial growth factor receptor 2</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i122">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 63 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Massague, J.</span><span> </span><span class="NLM_article-title">How cells read TGF-β signals</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1038%2F35043051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=11252892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVGjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=169-178&author=J.+Massague&title=How+cells+read+TGF-%CE%B2+signals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">How cells read TGF-β signals</span></div><div class="casAuthors">Massague, Joan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-178</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with 109 refs.  Cell proliferation, differentiation and death are controlled by a multitude of cell-cell signals, and loss of this control has devastating consequences.  Prominent among these regulatory signals is the transforming growth factor-β (TGF-β) family of cytokines, which can trigger a bewildering diversity of responses, depending on the genetic makeup and environment of the target cell.  The networks of cell-specific mols. that mold the TGF-β response to each cell's needs are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhcrvp8y40VLVg90H21EOLACvtfcHk0ljOQKPOB3ne2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVGjsro%253D&md5=1959515f609d76d5c6de2fe95fb78d49</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F35043051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35043051%26sid%3Dliteratum%253Aachs%26aulast%3DMassague%26aufirst%3DJ.%26atitle%3DHow%2520cells%2520read%2520TGF-%25CE%25B2%2520signals%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2000%26volume%3D1%26spage%3D169%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Derynck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. E.</span><span> </span><span class="NLM_article-title">Smad-dependent and Smad-independent pathways in TGF-β family signalling</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">584</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=577-584&author=R.+Derynckauthor=Y.+E.+Zhang&title=Smad-dependent+and+Smad-independent+pathways+in+TGF-%CE%B2+family+signalling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDerynck%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%2BE.%26atitle%3DSmad-dependent%2520and%2520Smad-independent%2520pathways%2520in%2520TGF-%25CE%25B2%2520family%2520signalling%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D577%26epage%3D584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Akhurst, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hata, A.</span><span> </span><span class="NLM_article-title">Targeting the TGFβ signalling pathway in disease</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">790</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=790-811&author=R.+J.+Akhurstauthor=A.+Hata&title=Targeting+the+TGF%CE%B2+signalling+pathway+in+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkhurst%26aufirst%3DR.%2BJ.%26aulast%3DHata%26aufirst%3DA.%26atitle%3DTargeting%2520the%2520TGF%25CE%25B2%2520signalling%2520pathway%2520in%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D790%26epage%3D811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Byfield, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laping, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. B.</span><span> </span><span class="NLM_article-title">SB-505124 is a selective inhibitor of transforming growth factor-β type I receptors ALK4, ALK5, and ALK7</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">744</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=744-752&author=S.+D.+Byfieldauthor=C.+Majorauthor=N.+J.+Lapingauthor=A.+B.+Roberts&title=SB-505124+is+a+selective+inhibitor+of+transforming+growth+factor-%CE%B2+type+I+receptors+ALK4%2C+ALK5%2C+and+ALK7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DByfield%26aufirst%3DS.%2BD.%26aulast%3DMajor%26aufirst%3DC.%26aulast%3DLaping%26aufirst%3DN.%2BJ.%26aulast%3DRoberts%26aufirst%3DA.%2BB.%26atitle%3DSB-505124%2520is%2520a%2520selective%2520inhibitor%2520of%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%2520I%2520receptors%2520ALK4%252C%2520ALK5%252C%2520and%2520ALK7%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D65%26spage%3D744%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Grygielko, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweed, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laping, N. J.</span><span> </span><span class="NLM_article-title">Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-β type I receptor kinase in puromycin-induced nephritis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">943</span><span class="NLM_x">–</span> <span class="NLM_lpage">951</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1124%2Fjpet.104.082099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=15769863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslektrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=943-951&author=E.+T.+Grygielkoauthor=W.+M.+Martinauthor=C.+Tweedauthor=P.+Thorntonauthor=J.+Harlingauthor=D.+P.+Brooksauthor=N.+J.+Laping&title=Inhibition+of+gene+markers+of+fibrosis+with+a+novel+inhibitor+of+transforming+growth+factor-%CE%B2+type+I+receptor+kinase+in+puromycin-induced+nephritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-β type I receptor kinase in puromycin-induced nephritis</span></div><div class="casAuthors">Grygielko, Eugene T.; Martin, William M.; Tweed, Christopher; Thornton, Peter; Harling, John; Brooks, David P.; Laping, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">943-951</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">SB-525334 (6-[2-tert-butyl-5-(6-methyl-pyridin-2-yl)-1H-imidazol-4-yl]-quinoxaline) has been characterized as a potent and selective inhibitor of the transforming growth factor-β1 (TGF-β1) receptor, activin receptor-like kinase (ALK5).  The compd. inhibited ALK5 kinase activity with an IC50 of 14.3 nM and was ∼4-fold less potent as an inhibitor of ALK4 (IC50 = 58.5 nM).  SB-525334 was inactive as an inhibitor of ALK2, ALK3, and ALK6 (IC50 > 10,000 nM).  In cell-based assays, SB-525334 (1 μM) blocked TGF-β1-induced phosphorylation and nuclear translocation of Smad2/3 in renal proximal tubule cells and inhibited TGF-β1-induced increases in plasminogen activator inhibitor-1 (PAI-1) and procollagen α1(I) mRNA expression in A498 renal epithelial carcinoma cells.  In view of this profile, SB-525334 was used to investigate the role of TGF-β1 in the acute puromycin aminonucleoside (PAN) rat model of renal disease, a model of nephritis-induced renal fibrosis.  Orally administered doses of 1, 3, or 10 mg/kg/day SB-525334 for 11 days produced statistically significant redns. in renal PAI-1 mRNA.  Also, the compd. produced dose-dependent decreases in renal procollagen α1(I) and procollagen α1(III) mRNA, which reached statistical significance at the 10-mg/kg/day dose when compared with vehicle-treated PAN controls.  Furthermore, PAN-induced proteinuria was significantly inhibited at the 10-mg/kg/day dose level.  These results provide further evidence for the involvement of TGF-β1 in the profibrotic changes that occur in the PAN model and for the first time, demonstrate the ability of a small mol. inhibitor of ALK5 to block several of the markers that are predictive of fibrosis and renal injury in this model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquItdIyglCEbVg90H21EOLACvtfcHk0ljOQKPOB3ne2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslektrw%253D&md5=405654b7353c72eb3f3ad8b51c8b4a62</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.082099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.082099%26sid%3Dliteratum%253Aachs%26aulast%3DGrygielko%26aufirst%3DE.%2BT.%26aulast%3DMartin%26aufirst%3DW.%2BM.%26aulast%3DTweed%26aufirst%3DC.%26aulast%3DThornton%26aufirst%3DP.%26aulast%3DHarling%26aufirst%3DJ.%26aulast%3DBrooks%26aufirst%3DD.%2BP.%26aulast%3DLaping%26aufirst%3DN.%2BJ.%26atitle%3DInhibition%2520of%2520gene%2520markers%2520of%2520fibrosis%2520with%2520a%2520novel%2520inhibitor%2520of%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%2520I%2520receptor%2520kinase%2520in%2520puromycin-induced%2520nephritis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D943%26epage%3D951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">De Gouville, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boullay, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krysa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriolle, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papworth, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laroze, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huet, S.</span><span> </span><span class="NLM_article-title">Inhibition of TGF-β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1038%2Fsj.bjp.0706172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=15723089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1ShtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2005&pages=166-177&author=A.+C.+De+Gouvilleauthor=V.+Boullayauthor=G.+Krysaauthor=J.+Pilotauthor=J.+M.+Brusqauthor=F.+Loriolleauthor=J.+M.+Gauthierauthor=S.+A.+Papworthauthor=A.+Larozeauthor=F.+Gellibertauthor=S.+Huet&title=Inhibition+of+TGF-%CE%B2+signaling+by+an+ALK5+inhibitor+protects+rats+from+dimethylnitrosamine-induced+liver+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of TGF-β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis</span></div><div class="casAuthors">de Gouville, Anne-Charlotte; Boullay, Valerie; Krysa, Gael; Pilot, Julia; Brusq, Jean-Marie; Loriolle, Florence; Gauthier, Jean-Michel; Papworth, Stephen A.; Laroze, Alain; Gellibert, Francoise; Huet, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">166-177</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chronic liver disease is characterized by an exacerbated accumulation of matrix, causing progressive fibrosis, which may lead to cirrhosis.  Transforming growth factor beta (TGF-β), a well-known profibrotic cytokine, transduces its signal through the ALK5 ser/thr kinase receptor, and increases transcription of different genes including PAI-1 and collagens.  The identification of GW6604 (2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine), an ALK5 inhibitor, allowed us to evaluate the therapeutic potential of inhibiting TGF-β pathway in different models of liver disease.  A cellular assay was used to identify GW6604 as a TGF-β signaling pathway inhibitor.  This ALK5 inhibitor was then tested in a model of liver hepatectomy in TGF-β-overexpressing transgenic mice, in an acute model of liver disease and in a chronic model of dimethylnitrosamine (DMN)-induced liver fibrosis.  In vitro, GW6604 inhibited autophosphorylation of ALK5 with an IC50 of 140 nM and in a cellular assay inhibited TGF-β-induced transcription of PAI-1 (IC50: 500 nM).  In vivo, GW6604 (40 mg kg-1 p.o.) increased liver regeneration in TGF-β-overexpressing mice, which had undergone partial hepatectomy.  In an acute model of liver disease, GW6604 reduced by 80% the expression of collagen IA1.  In a chronic model of DMN-induced fibrosis where DMN was administered for 6 wk and GW6604 dosed for the last 3 wk (80 mg kg-1 p.o., b.i.d.), mortality was prevented and DMN-induced elevations of mRNA encoding for collagen IA1, IA2, III, TIMP-1 and TGF-β were reduced by 50-75%.  Inhibition of matrix genes overexpression was accompanied by reduced matrix deposition and redn. in liver function deterioration, as assessed by bilirubin and liver enzyme levels.  Our results suggest that inhibition of ALK5 could be an attractive new approach to treatment of liver fibrotic diseases by both preventing matrix deposition and promoting hepatocyte regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3D2GxxCUg5bVg90H21EOLACvtfcHk0ljieRGXeo6p_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1ShtbY%253D&md5=f499fcf77d4b4d58bbf9b52ecf0131df</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706172%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGouville%26aufirst%3DA.%2BC.%26aulast%3DBoullay%26aufirst%3DV.%26aulast%3DKrysa%26aufirst%3DG.%26aulast%3DPilot%26aufirst%3DJ.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DLoriolle%26aufirst%3DF.%26aulast%3DGauthier%26aufirst%3DJ.%2BM.%26aulast%3DPapworth%26aufirst%3DS.%2BA.%26aulast%3DLaroze%26aufirst%3DA.%26aulast%3DGellibert%26aufirst%3DF.%26aulast%3DHuet%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520TGF-%25CE%25B2%2520signaling%2520by%2520an%2520ALK5%2520inhibitor%2520protects%2520rats%2520from%2520dimethylnitrosamine-induced%2520liver%2520fibrosis%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D145%26spage%3D166%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Ge, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajeev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattime, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medicherla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnard, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, M.</span><span> </span><span class="NLM_article-title">Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-β type I receptor kinase in vivo</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4315</span><span class="NLM_x">–</span> <span class="NLM_lpage">4330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1158%2F1078-0432.CCR-06-0162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=16857807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFSmsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4315-4330&author=R.+Geauthor=V.+Rajeevauthor=P.+Rayauthor=E.+Lattimeauthor=S.+Rittlingauthor=S.+Medicherlaauthor=A.+Protterauthor=A.+Murphyauthor=J.+Chakravartyauthor=S.+Dugarauthor=G.+Schreinerauthor=N.+Barnardauthor=M.+Reiss&title=Inhibition+of+growth+and+metastasis+of+mouse+mammary+carcinoma+by+selective+inhibitor+of+transforming+growth+factor-%CE%B2+type+I+receptor+kinase+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-β type I receptor kinase in vivo</span></div><div class="casAuthors">Ge, Rongrong; Rajeev, Vaishali; Ray, Partha; Lattime, Edmund; Rittling, Susan; Medicherla, Satya; Protter, Andy; Murphy, Alison; Chakravarty, Jit; Dugar, Sundeep; Schreiner, George; Barnard, Nicola; Reiss, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">14, Pt. 1</span>),
    <span class="NLM_cas:pages">4315-4330</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Transforming growth factor-β (TGF-β) suppresses tumor development by inhibiting cellular proliferation, inducing differentiation and apoptosis, and maintaining genomic integrity.  However, once tumor cells escape from the tumor-suppressive effects of TGF-β, they often constitutively overexpress and activate TGF-β, which may promote tumor progression by enhancing invasion, metastasis, and angiogenesis and by suppressing antitumor immunity.  The purpose of this study was to test this hypothesis using TGF-β pathway antagonists.  We examd. the effects of selective TGF-β type I receptor kinase inhibitors, SD-093 and SD-208, on two murine mammary carcinoma cell lines (R3T and 4T1) in vitro and in vivo.  Both agents blocked TGF-β-induced phosphorylation of the receptor-assocd. Smads, Smad2 and Smad3, in a dose-dependent manner, with IC50 between 20 and 80 nmol/L.  TGF-β failed to inhibit growth of these cell lines but stimulated epithelial-to-mesenchymal trans-differentiation, migration, and invasiveness into Matrigel in vitro.  These effects were inhibited by SD-093, indicating that these processes are partly driven by TGF-β.  Treatment of syngeneic R3T or 4T1 tumor-bearing mice with orally given SD-208 inhibited primary tumor growth as well as the no. and size of metastases.  In contrast, SD-208 failed to inhibit R3T tumor growth or metastasis in athymic nude mice.  Moreover, in vitro anti-4T1 cell cytotoxic T-cell responses of splenocytes from drug-treated animals were enhanced compared with cells from control animals.  In addn., SD-208 treatment resulted in a decrease in tumor angiogenesis.  CONCLUSION: TGF-β type I receptor kinase inhibitors hold promise as novel therapeutic agents for metastatic breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqDEiIuRyLeLVg90H21EOLACvtfcHk0ljieRGXeo6p_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFSmsb8%253D&md5=610a8880817eae037d36b257fa066d64</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-0162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-0162%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DR.%26aulast%3DRajeev%26aufirst%3DV.%26aulast%3DRay%26aufirst%3DP.%26aulast%3DLattime%26aufirst%3DE.%26aulast%3DRittling%26aufirst%3DS.%26aulast%3DMedicherla%26aufirst%3DS.%26aulast%3DProtter%26aufirst%3DA.%26aulast%3DMurphy%26aufirst%3DA.%26aulast%3DChakravarty%26aufirst%3DJ.%26aulast%3DDugar%26aufirst%3DS.%26aulast%3DSchreiner%26aufirst%3DG.%26aulast%3DBarnard%26aufirst%3DN.%26aulast%3DReiss%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520growth%2520and%2520metastasis%2520of%2520mouse%2520mammary%2520carcinoma%2520by%2520selective%2520inhibitor%2520of%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%2520I%2520receptor%2520kinase%2520in%2520vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D4315%26epage%3D4330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Kapoun, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damm, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Young, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protter, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, F.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennard, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, L. S.</span><span> </span><span class="NLM_article-title">Transforming growth factor-β receptor type 1 (TGFβRI) kinase activity but not p38 activation is required for TGFβRI-induced myofibroblast differentiation and profibrotic gene expression</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=518-531&author=A.+M.+Kapounauthor=N.+J.+Gasparauthor=Y.+Wangauthor=D.+Dammauthor=Y.-W.+Liuauthor=G.+O%E2%80%99Youngauthor=D.+Quonauthor=A.+Lamauthor=K.+Munsonauthor=T.-T.+Tranauthor=J.+Y.+Maauthor=A.+Murphyauthor=S.+Dugarauthor=S.+Chakravartyauthor=A.+A.+Protterauthor=F.-Q.+Wenauthor=X.+Liuauthor=S.+I.+Rennardauthor=L.+S.+Higgins&title=Transforming+growth+factor-%CE%B2+receptor+type+1+%28TGF%CE%B2RI%29+kinase+activity+but+not+p38+activation+is+required+for+TGF%CE%B2RI-induced+myofibroblast+differentiation+and+profibrotic+gene+expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKapoun%26aufirst%3DA.%2BM.%26aulast%3DGaspar%26aufirst%3DN.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDamm%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.-W.%26aulast%3DO%25E2%2580%2599Young%26aufirst%3DG.%26aulast%3DQuon%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DA.%26aulast%3DMunson%26aufirst%3DK.%26aulast%3DTran%26aufirst%3DT.-T.%26aulast%3DMa%26aufirst%3DJ.%2BY.%26aulast%3DMurphy%26aufirst%3DA.%26aulast%3DDugar%26aufirst%3DS.%26aulast%3DChakravarty%26aufirst%3DS.%26aulast%3DProtter%26aufirst%3DA.%2BA.%26aulast%3DWen%26aufirst%3DF.-Q.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DRennard%26aufirst%3DS.%2BI.%26aulast%3DHiggins%26aufirst%3DL.%2BS.%26atitle%3DTransforming%2520growth%2520factor-%25CE%25B2%2520receptor%2520type%25201%2520%2528TGF%25CE%25B2RI%2529%2520kinase%2520activity%2520but%2520not%2520p38%2520activation%2520is%2520required%2520for%2520TGF%25CE%25B2RI-induced%2520myofibroblast%2520differentiation%2520and%2520profibrotic%2520gene%2520expression%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D518%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Bueno, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Alwis, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yingling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glatt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trocóniz, I. F.</span><span> </span><span class="NLM_article-title">Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-β kinase antagonist, in mice</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">142</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2008&pages=142-150&author=L.+Buenoauthor=D.+P.+de+Alwisauthor=C.+Pitouauthor=J.+Yinglingauthor=M.+Lahnauthor=S.+Glattauthor=I.+F.+Troc%C3%B3niz&title=Semi-mechanistic+modelling+of+the+tumour+growth+inhibitory+effects+of+LY2157299%2C+a+new+type+I+receptor+TGF-%CE%B2+kinase+antagonist%2C+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBueno%26aufirst%3DL.%26aulast%3Dde%2BAlwis%26aufirst%3DD.%2BP.%26aulast%3DPitou%26aufirst%3DC.%26aulast%3DYingling%26aufirst%3DJ.%26aulast%3DLahn%26aufirst%3DM.%26aulast%3DGlatt%26aufirst%3DS.%26aulast%3DTroc%25C3%25B3niz%26aufirst%3DI.%2BF.%26atitle%3DSemi-mechanistic%2520modelling%2520of%2520the%2520tumour%2520growth%2520inhibitory%2520effects%2520of%2520LY2157299%252C%2520a%2520new%2520type%2520I%2520receptor%2520TGF-%25CE%25B2%2520kinase%2520antagonist%252C%2520in%2520mice%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2008%26volume%3D44%26spage%3D142%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Kim, D.-K.; Bang, Y.-J.; Kim, H.-T.; Cho, I.-S.; Park, M.-S.; An, Y. J.; Choi, J. H.</span><span> </span><span class="NLM_article-title">2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors</span>. US 7,407,958 B2,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=D.-K.+Kim&author=Y.-J.+Bang&author=H.-T.+Kim&author=I.-S.+Cho&author=M.-S.+Park&author=Y.+J.+An&author=J.+H.+Choi&title=2-Pyridyl+substituted+imidazoles+as+ALK5+and%2For+ALK4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.-K.%26atitle%3D2-Pyridyl%2520substituted%2520imidazoles%2520as%2520ALK5%2520and%252For%2520ALK4%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Lee, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, I. Y.</span><span> </span><span class="NLM_article-title">Effect of IN-1130, a small molecule inhibitor of transforming growth factor-β type I receptor/activin receptor-like kinase-5, on prostate cancer cells</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">2660</span><span class="NLM_x">–</span> <span class="NLM_lpage">2667</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1016%2Fj.juro.2008.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=18951571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFant7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=2660-2667&author=G.+T.+Leeauthor=J.+H.+Hongauthor=T.+J.+Muellerauthor=J.+A.+Watsonauthor=C.+Kwakauthor=Y.+Y.+Sheenauthor=D.-K.+Kimauthor=S.+J.+Kimauthor=I.+Y.+Kim&title=Effect+of+IN-1130%2C+a+small+molecule+inhibitor+of+transforming+growth+factor-%CE%B2+type+I+receptor%2Factivin+receptor-like+kinase-5%2C+on+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of IN-1130, a small molecule inhibitor of transforming growth factor-β type I receptor/activin receptor-like kinase-5, on prostate cancer cells</span></div><div class="casAuthors">Lee, Geun Taek; Hong, Jun Hyuk; Mueller, Thomas J.; Watson, John A.; Kwak, Cheol; Sheen, Youn Young; Kim, Dae-Kee; Kim, Seong Jin; Kim, Isaac Yi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2660-2667</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Purpose: Transforming growth factor-β is a potent immune suppressor that is over expressed by most malignant cells to evade the host immune response.  Thus, a potential anticancer therapeutic strategy is the inhibition of transforming growth factor-β signaling.  Materials and Methods: We investigated the specificity and the antitumor effect of IN-1130, a novel small mol. inhibitor of the transforming growth factor-β type I receptor ALK-5.  Results: IN-1130 inhibited transforming growth factor-β induced cell death and gene transcriptional activity in a concn. dependent manner in the human hepatoma cell line HepG2.  Simultaneously immunoblot anal. demonstrated that IN-1130 inhibited the Smad2 phosphorylation induced by transforming growth factor-β.  To det. the specificity of IN-1130 for transforming growth factor-β signaling the effect on active and bone morphogenic protein signaling was subsequently investigated.  Results demonstrated that IN-1130 did not inhibit bone morphogenic protein signaling.  However, active signaling was blocked by IN-1130 in a concn. dependent manner.  Furthermore, immunoblot anal. for phospho-Smad2 following transfection with constitutively active ALK-1 to 7 demonstrated that IN-1130 inhibited ALK-4 (active receptor type IB), 5 (TβRI) and 7 (nodal type I receptor).  To investigate the antitumor effect of IN-1130 WT mice were injected s.c. with the murine prostate cancer cell line Tramp C2.  Seven days later IN-1130 was administered i.p. daily for 30 days.  Results demonstrated a dramatic decrease in tumor vol. in assocn. with an enhanced immune response in the treatment group.  Conclusions: Taken together these results demonstrate that IN-1130 is a relatively nontoxic inhibitor of ALK-4/5/7 that may potentially treat prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiaK-TKcMdlLVg90H21EOLACvtfcHk0lhFZMjggrTydA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFant7vL&md5=76ec24260fef96d45b275d5b22d8109f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2008.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2008.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DG.%2BT.%26aulast%3DHong%26aufirst%3DJ.%2BH.%26aulast%3DMueller%26aufirst%3DT.%2BJ.%26aulast%3DWatson%26aufirst%3DJ.%2BA.%26aulast%3DKwak%26aufirst%3DC.%26aulast%3DSheen%26aufirst%3DY.%2BY.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DI.%2BY.%26atitle%3DEffect%2520of%2520IN-1130%252C%2520a%2520small%2520molecule%2520inhibitor%2520of%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%2520I%2520receptor%252Factivin%2520receptor-like%2520kinase-5%252C%2520on%2520prostate%2520cancer%2520cells%26jtitle%3DJ.%2520Urol.%26date%3D2008%26volume%3D180%26spage%3D2660%26epage%3D2667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Galarreta, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornhill, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpkins, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevalier, R. L.</span><span> </span><span class="NLM_article-title">Transforming growth factor-β1 receptor inhibition preserves glomerulotubular integrity during ureteral obstruction in adults but worsens injury in neonatal mice</span> <span class="citation_source-journal">J. Physiol. Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">F481</span><span class="NLM_x">–</span> <span class="NLM_lpage">F490</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2013&pages=F481-F490&author=C.+I.+Galarretaauthor=B.+A.+Thornhillauthor=M.+S.+Forbesauthor=L.+N.+Simpkinsauthor=D.-K.+Kimauthor=R.+L.+Chevalier&title=Transforming+growth+factor-%CE%B21+receptor+inhibition+preserves+glomerulotubular+integrity+during+ureteral+obstruction+in+adults+but+worsens+injury+in+neonatal+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalarreta%26aufirst%3DC.%2BI.%26aulast%3DThornhill%26aufirst%3DB.%2BA.%26aulast%3DForbes%26aufirst%3DM.%2BS.%26aulast%3DSimpkins%26aufirst%3DL.%2BN.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DChevalier%26aufirst%3DR.%2BL.%26atitle%3DTransforming%2520growth%2520factor-%25CE%25B21%2520receptor%2520inhibition%2520preserves%2520glomerulotubular%2520integrity%2520during%2520ureteral%2520obstruction%2520in%2520adults%2520but%2520worsens%2520injury%2520in%2520neonatal%2520mice%26jtitle%3DJ.%2520Physiol.%2520Renal%2520Physiol.%26date%3D2013%26volume%3D304%26spage%3DF481%26epage%3DF490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Moon, J.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, I.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span> </span><span class="NLM_article-title">IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy</span> <span class="citation_source-journal">Kidney Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1234</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1038%2Fsj.ki.5001775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=16929250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpsl2qtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1234-1243&author=J.-A.+Moonauthor=H.-T.+Kimauthor=I.-S.+Choauthor=Y.+Y.+Sheenauthor=D.-K.+Kim&title=IN-1130%2C+a+novel+transforming+growth+factor-%CE%B2+type+I+receptor+kinase+%28ALK5%29+inhibitor%2C+suppresses+renal+fibrosis+in+obstructive+nephropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy</span></div><div class="casAuthors">Moon, J.-A.; Kim, H.-T.; Cho, I.-S.; Sheen, Y. Y.; Kim, D.-K.</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1234-1243</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The transforming growth factor-β (TGF-β) plays a central role in the progression of renal fibrosis.  TGF-β transduces its signal through the activin receptor-like kinase (ALK)5.  IN-1130, a novel small mol. ALK5 inhibitor, inhibited the purified kinase domain of ALK5-mediated Smad3 phosphorylation with an IC50 value of 5.3 nM.  IN-1130 proved to be highly selective in a panel of 27 serine/threonine and tyrosine kinases including p38α mitogen-activated protein kinase.  We evaluated the efficacy of IN-1130 to block renal fibrogenesis induced by unilateral ureteral obstruction (UUO) in rats.  Either vehicle (saline) or IN-1130 (10 and 20 mg/kg/day) was i.p. administered to UUO rats for 7 and 14 days.  Phosphorylated Smad2 (pSmad2) and markers of fibrosis were analyzed in kidney tissues.  In UUO control kidneys, interstitial fibrosis including tubular atrophy, loss and dilation, inflammatory cell infiltration, and fibroblast cell proliferation was prominent.  These morphol. changes were notably reduced by IN-1130 treatment.  IN-1130 decreased levels of TGF-β1 mRNA (mRNA), type I collagen mRNA, and pSmad2, compared to UUO control rats.  As detd. by measuring the hydroxyproline content, total kidney collagen amt. was increased in UUO control kidneys, but significantly reduced by IN-1130 treatment, which was comparable to results of histochem. staining for collagen.  IN-1130 also suppressed the expression of α-smooth muscle actin (α-SMA) and fibronectin in UUO kidneys.  Our results show that IN-1130 suppressed the fibrogenic process of UUO, further underscoring the potential clin. benefits of IN-1130 in the treatment of renal fibrosis.Kidney International (2006) 70, 1234-1243.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraDwwUCC-olrVg90H21EOLACvtfcHk0ljEY7Tz_Aid_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpsl2qtr0%253D&md5=1f0a083a00e7d2fc967ada1cca7bcb6c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fsj.ki.5001775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ki.5001775%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DJ.-A.%26aulast%3DKim%26aufirst%3DH.-T.%26aulast%3DCho%26aufirst%3DI.-S.%26aulast%3DSheen%26aufirst%3DY.%2BY.%26aulast%3DKim%26aufirst%3DD.-K.%26atitle%3DIN-1130%252C%2520a%2520novel%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%2520I%2520receptor%2520kinase%2520%2528ALK5%2529%2520inhibitor%252C%2520suppresses%2520renal%2520fibrosis%2520in%2520obstructive%2520nephropathy%26jtitle%3DKidney%2520Int.%26date%3D2006%26volume%3D70%26spage%3D1234%26epage%3D1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckwalter, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marion, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambhir, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss-Coray, T.</span><span> </span><span class="NLM_article-title">Glia-dependent TGF-β signaling, acting independently of the TH 17 pathway, is critical for initiation of murine autoimmune encephalomyelitis</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">3306</span><span class="NLM_x">–</span> <span class="NLM_lpage">3315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=3306-3315&author=J.+Luoauthor=P.+P.+Hoauthor=M.+S.+Buckwalterauthor=S.+Marionauthor=T.+Hsuauthor=L.+Y.+Leeauthor=H.+Zhangauthor=D.-K.+Kimauthor=S.-J.+Kimauthor=S.+S.+Gambhirauthor=L.+Steinmanauthor=T.+Wyss-Coray&title=Glia-dependent+TGF-%CE%B2+signaling%2C+acting+independently+of+the+TH+17+pathway%2C+is+critical+for+initiation+of+murine+autoimmune+encephalomyelitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DHo%26aufirst%3DP.%2BP.%26aulast%3DBuckwalter%26aufirst%3DM.%2BS.%26aulast%3DMarion%26aufirst%3DS.%26aulast%3DHsu%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DL.%2BY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DKim%26aufirst%3DS.-J.%26aulast%3DGambhir%26aufirst%3DS.%2BS.%26aulast%3DSteinman%26aufirst%3DL.%26aulast%3DWyss-Coray%26aufirst%3DT.%26atitle%3DGlia-dependent%2520TGF-%25CE%25B2%2520signaling%252C%2520acting%2520independently%2520of%2520the%2520TH%252017%2520pathway%252C%2520is%2520critical%2520for%2520initiation%2520of%2520murine%2520autoimmune%2520encephalomyelitis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D3306%26epage%3D3315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ryu, J.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, I.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, J.-K.</span><span> </span><span class="NLM_article-title">IN-1130, a novel transforming growth factor-β type 1 receptor kinase (activin receptor-like kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie’s disease</span> <span class="citation_source-journal">J. Sex. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1284</span><span class="NLM_x">–</span> <span class="NLM_lpage">1296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1111%2Fj.1743-6109.2009.01216.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=19473283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtFaitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=1284-1296&author=J.-K.+Ryuauthor=S.+Piaoauthor=H.-Y.+Shinauthor=M.+J.+Choiauthor=L.+W.+Zhangauthor=H.-R.+Jinauthor=W.+J.+Kimauthor=J.-Y.+Hanauthor=S.+S.+Hongauthor=S.+H.+Parkauthor=S.-J.+Leeauthor=I.-H.+Kimauthor=C.+R.+Leeauthor=D.-K.+Kimauthor=M.+Mamuraauthor=S.-J.+Kimauthor=J.-K.+Suh&title=IN-1130%2C+a+novel+transforming+growth+factor-%CE%B2+type+1+receptor+kinase+%28activin+receptor-like+kinase+5%29+inhibitor%2C+promotes+regression+of+fibrotic+plaque+and+corrects+penile+curvature+in+a+rat+model+of+Peyronie%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">IN-1130, a novel transforming growth factor-β type I receptor kinase (activin receptor-like kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie's disease</span></div><div class="casAuthors">Ryu, Ji-Kan; Piao, Shuguang; Shin, Hwa-Yean; Choi, Min Ji; Zhang, Lu Wei; Jin, Hai-Rong; Kim, Woo Jean; Han, Jee-Young; Hong, Soon Sun; Park, Seok Hee; Lee, Sang-Jin; Kim, In-Hoo; Lee, Chung Ryul; Kim, Dae-Kee; Mamura, Mizuko; Kim, Seong-Jin; Suh, Jun-Kyu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Sexual Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1284-1296</span>CODEN:
                <span class="NLM_cas:coden">JSMOAN</span>;
        ISSN:<span class="NLM_cas:issn">1743-6095</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Introduction: Transforming growth factor-β1 (TGF-β1) has been known to play a crucial role in the pathogenesis of Peyronie's disease (PD).  Aim: The aim of this paper was to investigate the therapeutic effect of IN-1130, a novel small mol. inhibitor of activin receptor-like kinase (ALK)5, a type I receptor of TGF-β, in an animal model of PD.  Methods: PD was induced in rats through repeated injections of adenovirus expressing TGF-β1 (days 0, 3, and 6; 1 × 1010 particles/0.1 mL, resp.) into the tunica albuginea.  The rats were divided into five groups (N = 10 per group): group 1, age-matched controls without treatment; group 2, age-matched controls receiving repeated injections of IN-1130 (days 30 and 37; 5 mg/kg in 0.1 mL saline, resp.); group 3, PD rats without treatment; group 4, PD rats receiving repeated injections of saline (days 30 and 37; 0.1 mL, resp.); group 5, PD rats receiving repeated injections of IN-1130 (days 30 and 37; 5 mg/kg in 0.1 mL saline, resp.) into the lesion.  Main Outcome Measures: Penile curvature was evaluated by use of an artificial erection test at day 45, and the penis was then harvested for histol. examn.  Collagen in the plaque was quant. assessed by hydroxyproline detn.  Results: IN-1130 induced significant regression of fibrotic plaque through reduced infiltration of inflammatory cells, reduced transnuclear expression of phospho-Smad2/phospho-Smad3, reduced hydroxyproline content, and reduced cartilage content and restoration of elastin fibers in the fibrotic plaque of PD rats, which was accompanied by the correction of penile curvature.  Conclusion: Antagonizing TGF-β signaling through the use of ALK5 inhibitors may represent an exciting new therapeutic strategy for the future treatment of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6d3E4YdiRcbVg90H21EOLACvtfcHk0ljEY7Tz_Aid_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtFaitLw%253D&md5=069c9c8ec5f81feacf2d21d5bc9e81c7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1743-6109.2009.01216.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1743-6109.2009.01216.x%26sid%3Dliteratum%253Aachs%26aulast%3DRyu%26aufirst%3DJ.-K.%26aulast%3DPiao%26aufirst%3DS.%26aulast%3DShin%26aufirst%3DH.-Y.%26aulast%3DChoi%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%2BW.%26aulast%3DJin%26aufirst%3DH.-R.%26aulast%3DKim%26aufirst%3DW.%2BJ.%26aulast%3DHan%26aufirst%3DJ.-Y.%26aulast%3DHong%26aufirst%3DS.%2BS.%26aulast%3DPark%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DS.-J.%26aulast%3DKim%26aufirst%3DI.-H.%26aulast%3DLee%26aufirst%3DC.%2BR.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DMamura%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.-J.%26aulast%3DSuh%26aufirst%3DJ.-K.%26atitle%3DIN-1130%252C%2520a%2520novel%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%25201%2520receptor%2520kinase%2520%2528activin%2520receptor-like%2520kinase%25205%2529%2520inhibitor%252C%2520promotes%2520regression%2520of%2520fibrotic%2520plaque%2520and%2520corrects%2520penile%2520curvature%2520in%2520a%2520rat%2520model%2520of%2520Peyronie%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Sex.%2520Med.%26date%3D2009%26volume%3D6%26spage%3D1284%26epage%3D1296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Jin, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaiah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreenu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subrahmanyam, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span> </span><span class="NLM_article-title">4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazole and -pyrazole derivatives as potent and selective inhibitors of transforming growth factor-β type 1 receptor kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2724</span><span class="NLM_x">–</span> <span class="NLM_lpage">2732</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=2724-2732&author=C.+H.+Jinauthor=M.+Krishnaiahauthor=D.+Sreenuauthor=V.+B.+Subrahmanyamauthor=H.-J.+Parkauthor=S.-J.+Parkauthor=Y.+Y.+Sheenauthor=D.-K.+Kim&title=4-%28%5B1%2C2%2C4%5DTriazolo%5B1%2C5-a%5Dpyridin-6-yl%29-5%283%29-%286-methylpyridin-2-yl%29imidazole+and+-pyrazole+derivatives+as+potent+and+selective+inhibitors+of+transforming+growth+factor-%CE%B2+type+1+receptor+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DC.%2BH.%26aulast%3DKrishnaiah%26aufirst%3DM.%26aulast%3DSreenu%26aufirst%3DD.%26aulast%3DSubrahmanyam%26aufirst%3DV.%2BB.%26aulast%3DPark%26aufirst%3DH.-J.%26aulast%3DPark%26aufirst%3DS.-J.%26aulast%3DSheen%26aufirst%3DY.%2BY.%26aulast%3DKim%26aufirst%3DD.-K.%26atitle%3D4-%2528%255B1%252C2%252C4%255DTriazolo%255B1%252C5-a%255Dpyridin-6-yl%2529-5%25283%2529-%25286-methylpyridin-2-yl%2529imidazole%2520and%2520-pyrazole%2520derivatives%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%25201%2520receptor%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D2724%26epage%3D2732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Kim, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, Y. Y.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and tissue distribution of 3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1<i>H</i>-imidazol-2-yl)methyl)benzamide; a novel ALK5 inhibitor and a potential anti-fibrosis drug</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=325-339&author=Y.+W.+Kimauthor=Y.+K.+Kimauthor=J.+Y.+Leeauthor=K.+T.+Changauthor=H.+J.+Leeauthor=D.-K.+Kimauthor=Y.+Y.+Sheen&title=Pharmacokinetics+and+tissue+distribution+of+3-%28%285-%286-methylpyridin-2-yl%29-4-%28quinoxalin-6-yl%29-1H-imidazol-2-yl%29methyl%29benzamide%3B+a+novel+ALK5+inhibitor+and+a+potential+anti-fibrosis+drug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BW.%26aulast%3DKim%26aufirst%3DY.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DChang%26aufirst%3DK.%2BT.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DSheen%26aufirst%3DY.%2BY.%26atitle%3DPharmacokinetics%2520and%2520tissue%2520distribution%2520of%25203-%2528%25285-%25286-methylpyridin-2-yl%2529-4-%2528quinoxalin-6-yl%2529-1H-imidazol-2-yl%2529methyl%2529benzamide%253B%2520a%2520novel%2520ALK5%2520inhibitor%2520and%2520a%2520potential%2520anti-fibrosis%2520drug%26jtitle%3DXenobiotica%26date%3D2008%26volume%3D38%26spage%3D325%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Kim, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, Y. Y.</span><span> </span><span class="NLM_article-title">Identification of human cytochrome P450 enzymes involved in the metabolism of IN-1130, a novel activin receptor-like kinase-5 (ALK5) inhibitor</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=451-464&author=Y.+W.+Kimauthor=Y.+K.+Kimauthor=D.-K.+Kimauthor=Y.+Y.+Sheen&title=Identification+of+human+cytochrome+P450+enzymes+involved+in+the+metabolism+of+IN-1130%2C+a+novel+activin+receptor-like+kinase-5+%28ALK5%29+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BW.%26aulast%3DKim%26aufirst%3DY.%2BK.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DSheen%26aufirst%3DY.%2BY.%26atitle%3DIdentification%2520of%2520human%2520cytochrome%2520P450%2520enzymes%2520involved%2520in%2520the%2520metabolism%2520of%2520IN-1130%252C%2520a%2520novel%2520activin%2520receptor-like%2520kinase-5%2520%2528ALK5%2529%2520inhibitor%26jtitle%3DXenobiotica%26date%3D2008%26volume%3D38%26spage%3D451%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, J.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 4(5)-(6-alkylpyridin-2-yl)imidazoles as transforming growth factor-β type 1 receptor kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3143</span><span class="NLM_x">–</span> <span class="NLM_lpage">3147</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070129k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3143-3147&author=D.-K.+Kimauthor=Y.+Jangauthor=H.+S.+Leeauthor=H.-J.+Parkauthor=J.+Yoo&title=Synthesis+and+biological+evaluation+of+4%285%29-%286-alkylpyridin-2-yl%29imidazoles+as+transforming+growth+factor-%CE%B2+type+1+receptor+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm070129k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070129k%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DJang%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DH.%2BS.%26aulast%3DPark%26aufirst%3DH.-J.%26aulast%3DYoo%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25204%25285%2529-%25286-alkylpyridin-2-yl%2529imidazoles%2520as%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%25201%2520receptor%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3143%26epage%3D3147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Dewang, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 2-pyridyl-substituted pyrazoles and imidazoles as transforming growth factor-β type 1 receptor kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4228</span><span class="NLM_x">–</span> <span class="NLM_lpage">4232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4228-4232&author=P.+M.+Dewangauthor=D.-K.+Kim&title=Synthesis+and+biological+evaluation+of+2-pyridyl-substituted+pyrazoles+and+imidazoles+as+transforming+growth+factor-%CE%B2+type+1+receptor+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDewang%26aufirst%3DP.%2BM.%26aulast%3DKim%26aufirst%3DD.-K.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25202-pyridyl-substituted%2520pyrazoles%2520and%2520imidazoles%2520as%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%25201%2520receptor%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4228%26epage%3D4232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Jin, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaiah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreenu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subrahmanyam, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin-2-yl)-4-(quinolin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2633</span><span class="NLM_x">–</span> <span class="NLM_lpage">2640</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2633-2640&author=C.+H.+Jinauthor=M.+Krishnaiahauthor=D.+Sreenuauthor=K.+S.+Raoauthor=V.+B.+Subrahmanyamauthor=C.-Y.+Parkauthor=J.-Y.+Sonauthor=Y.+Y.+Sheenauthor=D.-K.+Kim&title=Synthesis+and+biological+evaluation+of+1-substituted-3%285%29-%286-methylpyridin-2-yl%29-4-%28quinolin-6-yl%29pyrazoles+as+transforming+growth+factor-%CE%B2+type+1+receptor+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DC.%2BH.%26aulast%3DKrishnaiah%26aufirst%3DM.%26aulast%3DSreenu%26aufirst%3DD.%26aulast%3DRao%26aufirst%3DK.%2BS.%26aulast%3DSubrahmanyam%26aufirst%3DV.%2BB.%26aulast%3DPark%26aufirst%3DC.-Y.%26aulast%3DSon%26aufirst%3DJ.-Y.%26aulast%3DSheen%26aufirst%3DY.%2BY.%26aulast%3DKim%26aufirst%3DD.-K.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25201-substituted-3%25285%2529-%25286-methylpyridin-2-yl%2529-4-%2528quinolin-6-yl%2529pyrazoles%2520as%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%25201%2520receptor%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2633%26epage%3D2640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Gaster, L. M.; Hadley, M. S.; Harling, J. D.; Harrington, F. P.; Heer, J. P.; Heightman, T. D.</span><span> </span><span class="NLM_article-title">Pyridinylimidazoles</span>. WO 01/62756 A1,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=L.+M.+Gaster&author=M.+S.+Hadley&author=J.+D.+Harling&author=F.+P.+Harrington&author=J.+P.+Heer&author=T.+D.+Heightman&title=Pyridinylimidazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGaster%26aufirst%3DL.%2BM.%26atitle%3DPyridinylimidazoles%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Brussee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loos, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Der Gen, A.</span><span> </span><span class="NLM_article-title">Synthesis of optically active silyl protected cyanohydrins</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1990&pages=979-986&author=J.+Brusseeauthor=W.+T.+Loosauthor=C.+G.+Kruseauthor=A.+Van+Der+Gen&title=Synthesis+of+optically+active+silyl+protected+cyanohydrins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DLoos%26aufirst%3DW.%2BT.%26aulast%3DKruse%26aufirst%3DC.%2BG.%26aulast%3DVan%2BDer%2BGen%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520optically%2520active%2520silyl%2520protected%2520cyanohydrins%26jtitle%3DTetrahedron%26date%3D1990%26volume%3D46%26spage%3D979%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Ishibashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kameoka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iriyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span> </span><span class="NLM_article-title">Sulfur-directed regioselective radical cyclization leading to β-lactams: formal synthesis of (±)-PS-5 and (+)-thienamycin</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1276</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00110a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=1276-1284&author=H.+Ishibashiauthor=C.+Kameokaauthor=H.+Iriyamaauthor=K.+Kodamaauthor=T.+Satoauthor=M.+Ikeda&title=Sulfur-directed+regioselective+radical+cyclization+leading+to+%CE%B2-lactams%3A+formal+synthesis+of+%28%C2%B1%29-PS-5+and+%28%2B%29-thienamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo00110a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00110a035%26sid%3Dliteratum%253Aachs%26aulast%3DIshibashi%26aufirst%3DH.%26aulast%3DKameoka%26aufirst%3DC.%26aulast%3DIriyama%26aufirst%3DH.%26aulast%3DKodama%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DIkeda%26aufirst%3DM.%26atitle%3DSulfur-directed%2520regioselective%2520radical%2520cyclization%2520leading%2520to%2520%25CE%25B2-lactams%253A%2520formal%2520synthesis%2520of%2520%2528%25C2%25B1%2529-PS-5%2520and%2520%2528%252B%2529-thienamycin%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D1276%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Wrana, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attisano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carcamo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zentella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laiho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massague, J.</span><span> </span><span class="NLM_article-title">TGFβ signals through a heteromeric protein kinase receptor complex</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1003</span><span class="NLM_x">–</span> <span class="NLM_lpage">1014</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1992&pages=1003-1014&author=J.+L.+Wranaauthor=L.+Attisanoauthor=J.+Carcamoauthor=A.+Zentellaauthor=J.+Doodyauthor=M.+Laihoauthor=X.+F.+Wangauthor=J.+Massague&title=TGF%CE%B2+signals+through+a+heteromeric+protein+kinase+receptor+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWrana%26aufirst%3DJ.%2BL.%26aulast%3DAttisano%26aufirst%3DL.%26aulast%3DCarcamo%26aufirst%3DJ.%26aulast%3DZentella%26aufirst%3DA.%26aulast%3DDoody%26aufirst%3DJ.%26aulast%3DLaiho%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%2BF.%26aulast%3DMassague%26aufirst%3DJ.%26atitle%3DTGF%25CE%25B2%2520signals%2520through%2520a%2520heteromeric%2520protein%2520kinase%2520receptor%2520complex%26jtitle%3DCell%26date%3D1992%26volume%3D71%26spage%3D1003%26epage%3D1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Gerlach, K.; Priepke, H.; Wienen, W.; Schuler-Metz, A.; Nar, H.</span><span> </span><span class="NLM_article-title">Preparation of <i>N</i>-heteroaryl azetidinedicarboxamides as factor Xa inhibitors</span>. WO 2008/135525 A2,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=K.+Gerlach&author=H.+Priepke&author=W.+Wienen&author=A.+Schuler-Metz&author=H.+Nar&title=Preparation+of+N-heteroaryl+azetidinedicarboxamides+as+factor+Xa+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGerlach%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520N-heteroaryl%2520azetidinedicarboxamides%2520as%2520factor%2520Xa%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Taveras, A.; Zheng, J.; Biju, P. J.; Yu, Y.; Chao, J.; Fine, J.; Lundell, D.; Priestley, T.; Reggiani, A.; Merritt, J. R.; Baldwin, J. J.; Lai, G.; Wu, M.</span><span> </span><span class="NLM_article-title">Preparation of isothiazole dioxides as CXC- and CC-chemokine receptor ligands</span>. WO 2005/068460 A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=A.+Taveras&author=J.+Zheng&author=P.+J.+Biju&author=Y.+Yu&author=J.+Chao&author=J.+Fine&author=D.+Lundell&author=T.+Priestley&author=A.+Reggiani&author=J.+R.+Merritt&author=J.+J.+Baldwin&author=G.+Lai&author=M.+Wu&title=Preparation+of+isothiazole+dioxides+as+CXC-+and+CC-chemokine+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTaveras%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520isothiazole%2520dioxides%2520as%2520CXC-%2520and%2520CC-chemokine%2520receptor%2520ligands%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Dragovich, P.; Zhou, Y.; Webber, S. E.</span><span> </span><span class="NLM_article-title">Pyridazinone derivatives as NS5B polymerase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of hepatitis C infection</span>. US 2008/0188466 A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+Dragovich&author=Y.+Zhou&author=S.+E.+Webber&title=Pyridazinone+derivatives+as+NS5B+polymerase+inhibitors+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+hepatitis+C+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDragovich%26aufirst%3DP.%26atitle%3DPyridazinone%2520derivatives%2520as%2520NS5B%2520polymerase%2520inhibitors%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520hepatitis%2520C%2520infection%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Leznoff, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terekhov, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Multisubstituted phthalonitriles, naphthalenedicarbonitriles, and phenanthrenetetracarbonitriles as precursors for phthalocyanine syntheses</span> <span class="citation_source-journal">Can. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1995&pages=435-443&author=C.+C.+Leznoffauthor=D.+S.+Terekhovauthor=C.+R.+McArthurauthor=S.+Vighauthor=J.+Li&title=Multisubstituted+phthalonitriles%2C+naphthalenedicarbonitriles%2C+and+phenanthrenetetracarbonitriles+as+precursors+for+phthalocyanine+syntheses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeznoff%26aufirst%3DC.%2BC.%26aulast%3DTerekhov%26aufirst%3DD.%2BS.%26aulast%3DMcArthur%26aufirst%3DC.%2BR.%26aulast%3DVigh%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DMultisubstituted%2520phthalonitriles%252C%2520naphthalenedicarbonitriles%252C%2520and%2520phenanthrenetetracarbonitriles%2520as%2520precursors%2520for%2520phthalocyanine%2520syntheses%26jtitle%3DCan.%2520J.%2520Chem.%26date%3D1995%26volume%3D73%26spage%3D435%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Park, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, Y. Y.</span><span> </span><span class="NLM_article-title">EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type 1 receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1889</span><span class="NLM_x">–</span> <span class="NLM_lpage">1896</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1111%2Fj.1349-7006.2011.02014.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=21707864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSis7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2011&pages=1889-1896&author=C.-Y.+Parkauthor=D.-K.+Kimauthor=Y.+Y.+Sheen&title=EW-7203%2C+a+novel+small+molecule+inhibitor+of+transforming+growth+factor-%CE%B2+%28TGF-%CE%B2%29+type+1+receptor%2Factivin+receptor-like+kinase-5%2C+blocks+TGF-%CE%B21-mediated+epithelial-to-mesenchymal+transition+in+mammary+epithelial+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells</span></div><div class="casAuthors">Park, Chul-Yong; Kim, Dae-Kee; Sheen, Yhun Yhong</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1889-1896</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Recently, small mol. inhibitors of transforming growth factor-β (TGF-β) type I receptor kinase/activin receptor-like kinase-5 (ALK5) were developed to target TGF-β signaling as a therapeutic strategy for combating cancer.  In the present study, the authors examd. a novel small mol. inhibitor of ALK5, 3-((5-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(6-methylpyridin-2-yl)thiazol-2-ylamino)methyl)benzonitrile (EW-7203) in breast cancer cells to det. if it has potential for cancer treatment.  The inhibitory effects of EW-7203 on TGF-β-induced Smad signaling and epithelial-to-mesenchymal transition (EMT) were investigated in mammary epithelial cells using luciferase reporter assays, immunoblotting, confocal microscopy, and wound healing assays.  In addn., the suppressive effects of EW-7203 on mammary cancer metastasis to the lung were examd. using a Balb/c xenograft model system.  The novel ALK5 inhibitor, EW-7203, inhibited the TGF-β1-stimulated transcriptional activation of p3TP-Lux and pCAGA12-Luc.  In addn., EW-7203 decreased phosphorylated Smad2 levels and the nuclear translocation of Smad2 was increased by TGF-β1.  In addn., EW-7203 inhibited TGF-β1-induced EMT and wound healing of NMuMG cells.  Furthermore, in xenografted Balb/c mice, EW-7203 inhibited metastasis to the lung from breast tumors.  The novel ALK5 inhibitor, EW-7203, efficiently inhibited TGF-β1-induced Smad signaling, EMT, and breast tumor metastasis to the lung in vivo, demonstrating that EW-7203 has therapeutic potential for breast cancer metastasis to the lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBvoWNUurGorVg90H21EOLACvtfcHk0lj-raoZ44MZbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSis7%252FP&md5=99bb811045f057424651b0e127ff9d16</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2011.02014.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2011.02014.x%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.-Y.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DSheen%26aufirst%3DY.%2BY.%26atitle%3DEW-7203%252C%2520a%2520novel%2520small%2520molecule%2520inhibitor%2520of%2520transforming%2520growth%2520factor-%25CE%25B2%2520%2528TGF-%25CE%25B2%2529%2520type%25201%2520receptor%252Factivin%2520receptor-like%2520kinase-5%252C%2520blocks%2520TGF-%25CE%25B21-mediated%2520epithelial-to-mesenchymal%2520transition%2520in%2520mammary%2520epithelial%2520cells%26jtitle%3DCancer%2520Sci.%26date%3D2011%26volume%3D102%26spage%3D1889%26epage%3D1896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Son, J. Y.; Kim, S.-J.; Lee, S. J.; Park, S.-Y.; Park, S.-A.; Kim, M.-J.; Kim, S. W.; Kim, D.-K.; Nam, J.-S.; Sheen, Y. Y.</span><span> </span><span class="NLM_article-title">EW-7197, a novel ALK-5 kinase inhibitor, potently inhibits breast to lung metastasis</span>.  <span class="citation_source-journal">Mol. Cancer Ther.</span> In press. DOI:<span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0903</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1158%2F1535-7163.MCT-13-0903" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Son%2C+J.+Y.%3B+Kim%2C+S.-J.%3B+Lee%2C+S.+J.%3B+Park%2C+S.-Y.%3B+Park%2C+S.-A.%3B+Kim%2C+M.-J.%3B+Kim%2C+S.+W.%3B+Kim%2C+D.-K.%3B+Nam%2C+J.-S.%3B+Sheen%2C+Y.+Y.+EW-7197%2C+a+novel+ALK-5+kinase+inhibitor%2C+potently+inhibits+breast+to+lung+metastasis.+Mol.+Cancer+Ther.+In+press.+DOI%3A+10.1158%2F1535-7163.MCT-13-0903."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0903%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DJ.%2BY.%26atitle%3DEW-7197%252C%2520a%2520novel%2520ALK-5%2520kinase%2520inhibitor%252C%2520potently%2520inhibits%2520breast%2520to%2520lung%2520metastasis%26jtitle%3DMol.%2520Cancer%2520Ther.%26doi%3D10.1158%2F1535-7163.MCT-13-0903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Park, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, Y. Y.</span><span> </span><span class="NLM_article-title">EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2642</span><span class="NLM_x">–</span> <span class="NLM_lpage">2653</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=2642-2653&author=C.-Y.+Parkauthor=J.-Y.+Sonauthor=C.+H.+Jinauthor=J.-S.+Namauthor=D.-K.+Kimauthor=Y.+Y.+Sheen&title=EW-7195%2C+a+novel+inhibitor+of+ALK5+kinase+inhibits+EMT+and+breast+cancer+metastasis+to+lung"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.-Y.%26aulast%3DSon%26aufirst%3DJ.-Y.%26aulast%3DJin%26aufirst%3DC.%2BH.%26aulast%3DNam%26aufirst%3DJ.-S.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DSheen%26aufirst%3DY.%2BY.%26atitle%3DEW-7195%252C%2520a%2520novel%2520inhibitor%2520of%2520ALK5%2520kinase%2520inhibits%2520EMT%2520and%2520breast%2520cancer%2520metastasis%2520to%2520lung%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2011%26volume%3D47%26spage%3D2642%26epage%3D2653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Aissaoui, H.; Boss, C.; Gude, M.; Koberstein, R.; Sifferlen, T.; Zumbrunn, A. C.</span><span> </span><span class="NLM_article-title">Benzenesulfonamide compounds as orexin receptor antagonists, their preparation, pharmaceutical compositions, and use in therapy</span>. WO 2007/116374 A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=H.+Aissaoui&author=C.+Boss&author=M.+Gude&author=R.+Koberstein&author=T.+Sifferlen&author=A.+C.+Zumbrunn&title=Benzenesulfonamide+compounds+as+orexin+receptor+antagonists%2C+their+preparation%2C+pharmaceutical+compositions%2C+and+use+in+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAissaoui%26aufirst%3DH.%26atitle%3DBenzenesulfonamide%2520compounds%2520as%2520orexin%2520receptor%2520antagonists%252C%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%252C%2520and%2520use%2520in%2520therapy%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Sugiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakura, H.</span><span> </span><span class="NLM_article-title">Expression of activin A is increased in cirrhotic and fibrotic rat livers</span> <span class="citation_source-journal">Gastroentenology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">550</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1016%2FS0016-5085%2898%2970539-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=9496947" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1998&pages=550-558&author=M.+Sugiyamaauthor=T.+Ichidaauthor=T.+Satoauthor=T.+Ishikawaauthor=Y.+Matsudaauthor=H.+Asakura&title=Expression+of+activin+A+is+increased+in+cirrhotic+and+fibrotic+rat+livers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0016-5085%2898%2970539-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0016-5085%252898%252970539-6%26sid%3Dliteratum%253Aachs%26aulast%3DSugiyama%26aufirst%3DM.%26aulast%3DIchida%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DMatsuda%26aufirst%3DY.%26aulast%3DAsakura%26aufirst%3DH.%26atitle%3DExpression%2520of%2520activin%2520A%2520is%2520increased%2520in%2520cirrhotic%2520and%2520fibrotic%2520rat%2520livers%26jtitle%3DGastroentenology%26date%3D1998%26volume%3D114%26spage%3D550%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Matsuse, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matusi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagase, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orimo, H.</span><span> </span><span class="NLM_article-title">Expression of immunoreactive and bioactive activin A protein in adult murine lung after bleomycin treatment</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1165%2Fajrcmb.13.1.7541220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=7541220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADyaK2MXmvFWntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1995&pages=17-24&author=T.+Matsuseauthor=Y.+Fukuchiauthor=Y.+Etoauthor=H.+Matusiauthor=T.+Hosoiauthor=T.+Okaauthor=E.+Ohgaauthor=T.+Nagaseauthor=H.+Orimo&title=Expression+of+immunoreactive+and+bioactive+activin+A+protein+in+adult+murine+lung+after+bleomycin+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of immunoreactive and bioactive activin A protein in adult murine lung after bleomycin treatment</span></div><div class="casAuthors">Matsuse, Takeshi; Fukuchi, Yoshinosuke; Eto, Yuzuru; Matsui, Hirotoshi; Hosoi, Takayuki; Oka, Teruaki; Ohga, Eijiro; Nagase, Takahide; Orimo, Hajime</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-24</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Lung Association</span>)
        </div><div class="casAbstract">Activin A is a homodimeric protein structurally and functionally related to transforming growth factor β (TGF-β), and the expression of activin A is modulated by TGF-β.  Here, we demonstrate the expression of activin A in normal and bleomycin (BLM)-treated murine lungs.  ICR mice were treated with BLM i.p. for 10 days, where saline vehicle was injected into control mice.  Intra-alveolar fibrotic changes were obsd. in the lung tissue obtained from the mice at day 14 after the final BLM administration.  Immunohistochem. studies using a polyclonal antibody to activin A revealed the presence of activin A in the bronchiolar epithelium and smooth muscle cells of veins in both control and BLM-treated mice.  In the BLM-treated mice at days 7 and 14, the marked infiltration of immunoreactive alveolar macrophages was obsd. in the area of fibrotic changes.  Bioactivity of activin A measured by erythroid differentiation factor assay in the conditioned medium of alveolar macrophages obtained from BLM-treated mice at day 14 was significantly increased.  These findings indicate that alveolar macrophages are a potent source of activin A after BLM treatment.  The present study demonstrates for the first time the abundant expression of activin A in murine lung tissues after BlM administration, suggesting that activin A may play a role in the pathogenesis of BLM-induced pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Fj3s3opZ4rVg90H21EOLACvtfcHk0liDB3Ucz4QnYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvFWntro%253D&md5=d6248478e7288ab0665e40f705507a4a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1165%2Fajrcmb.13.1.7541220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Fajrcmb.13.1.7541220%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuse%26aufirst%3DT.%26aulast%3DFukuchi%26aufirst%3DY.%26aulast%3DEto%26aufirst%3DY.%26aulast%3DMatusi%26aufirst%3DH.%26aulast%3DHosoi%26aufirst%3DT.%26aulast%3DOka%26aufirst%3DT.%26aulast%3DOhga%26aufirst%3DE.%26aulast%3DNagase%26aufirst%3DT.%26aulast%3DOrimo%26aufirst%3DH.%26atitle%3DExpression%2520of%2520immunoreactive%2520and%2520bioactive%2520activin%2520A%2520protein%2520in%2520adult%2520murine%2520lung%2520after%2520bleomycin%2520treatment%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D1995%26volume%3D13%26spage%3D17%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Pawlowski, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hail, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowala, M. C.</span><span> </span><span class="NLM_article-title">Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">639</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1997&pages=639-648&author=J.+E.+Pawlowskiauthor=D.+S.+Taylorauthor=M.+Valentineauthor=M.+E.+Hailauthor=P.+Ferrerauthor=M.+C.+Kowala&title=Stimulation+of+activin+A+expression+in+rat+aortic+smooth+muscle+cells+by+thrombin+and+angiotensin+II+correlates+with+neointimal+formation+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPawlowski%26aufirst%3DJ.%2BE.%26aulast%3DTaylor%26aufirst%3DD.%2BS.%26aulast%3DValentine%26aufirst%3DM.%26aulast%3DHail%26aufirst%3DM.%2BE.%26aulast%3DFerrer%26aufirst%3DP.%26aulast%3DKowala%26aufirst%3DM.%2BC.%26atitle%3DStimulation%2520of%2520activin%2520A%2520expression%2520in%2520rat%2520aortic%2520smooth%2520muscle%2520cells%2520by%2520thrombin%2520and%2520angiotensin%2520II%2520correlates%2520with%2520neointimal%2520formation%2520in%2520vivo%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1997%26volume%3D100%26spage%3D639%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Hübner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smola, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, S.</span><span> </span><span class="NLM_article-title">Strong induction of activin expression after injury suggests an important role of activin in wound repair</span> <span class="citation_source-journal">Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=1996&pages=490-498&author=G.+H%C3%BCbnerauthor=Q.+Huauthor=H.+Smolaauthor=S.+Werner&title=Strong+induction+of+activin+expression+after+injury+suggests+an+important+role+of+activin+in+wound+repair"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCbner%26aufirst%3DG.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DSmola%26aufirst%3DH.%26aulast%3DWerner%26aufirst%3DS.%26atitle%3DStrong%2520induction%2520of%2520activin%2520expression%2520after%2520injury%2520suggests%2520an%2520important%2520role%2520of%2520activin%2520in%2520wound%2520repair%26jtitle%3DDev.%2520Biol.%26date%3D1996%26volume%3D173%26spage%3D490%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Munz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smola, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelhardt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleuel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauchle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huylebroeck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, S.</span><span> </span><span class="NLM_article-title">Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5205</span><span class="NLM_x">–</span> <span class="NLM_lpage">5215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=5205-5215&author=B.+Munzauthor=H.+Smolaauthor=F.+Engelhardtauthor=K.+Bleuelauthor=M.+Brauchleauthor=I.+Letinauthor=L.+W.+Evansauthor=D.+Huylebroeckauthor=R.+Ballingauthor=S.+Werner&title=Overexpression+of+activin+A+in+the+skin+of+transgenic+mice+reveals+new+activities+of+activin+in+epidermal+morphogenesis%2C+dermal+fibrosis+and+wound+repair"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMunz%26aufirst%3DB.%26aulast%3DSmola%26aufirst%3DH.%26aulast%3DEngelhardt%26aufirst%3DF.%26aulast%3DBleuel%26aufirst%3DK.%26aulast%3DBrauchle%26aufirst%3DM.%26aulast%3DLetin%26aufirst%3DI.%26aulast%3DEvans%26aufirst%3DL.%2BW.%26aulast%3DHuylebroeck%26aufirst%3DD.%26aulast%3DBalling%26aufirst%3DR.%26aulast%3DWerner%26aufirst%3DS.%26atitle%3DOverexpression%2520of%2520activin%2520A%2520in%2520the%2520skin%2520of%2520transgenic%2520mice%2520reveals%2520new%2520activities%2520of%2520activin%2520in%2520epidermal%2520morphogenesis%252C%2520dermal%2520fibrosis%2520and%2520wound%2520repair%26jtitle%3DEMBO%2520J.%26date%3D1999%26volume%3D18%26spage%3D5205%26epage%3D5215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Wankell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hans, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goppelt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, S.</span><span> </span><span class="NLM_article-title">Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5361</span><span class="NLM_x">–</span> <span class="NLM_lpage">5372</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=5361-5372&author=M.+Wankellauthor=B.+Munzauthor=G.+H%C3%BCbnerauthor=W.+Hansauthor=E.+Wolfauthor=A.+Goppeltauthor=S.+Werner&title=Impaired+wound+healing+in+transgenic+mice+overexpressing+the+activin+antagonist+follistatin+in+the+epidermis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWankell%26aufirst%3DM.%26aulast%3DMunz%26aufirst%3DB.%26aulast%3DH%25C3%25BCbner%26aufirst%3DG.%26aulast%3DHans%26aufirst%3DW.%26aulast%3DWolf%26aufirst%3DE.%26aulast%3DGoppelt%26aufirst%3DA.%26aulast%3DWerner%26aufirst%3DS.%26atitle%3DImpaired%2520wound%2520healing%2520in%2520transgenic%2520mice%2520overexpressing%2520the%2520activin%2520antagonist%2520follistatin%2520in%2520the%2520epidermis%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26spage%3D5361%26epage%3D5372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Thomson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Real, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordon-Cardo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, A. N.</span><span> </span><span class="NLM_article-title">Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1988&pages=459-466&author=T.+M.+Thomsonauthor=F.+X.+Realauthor=S.+Murakamiauthor=C.+Cordon-Cardoauthor=L.+J.+Oldauthor=A.+N.+Houghton&title=Differentiation+antigens+of+melanocytes+and+melanoma%3A+analysis+of+melanosome+and+cell+surface+markers+of+human+pigmented+cells+with+monoclonal+antibodies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomson%26aufirst%3DT.%2BM.%26aulast%3DReal%26aufirst%3DF.%2BX.%26aulast%3DMurakami%26aufirst%3DS.%26aulast%3DCordon-Cardo%26aufirst%3DC.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DHoughton%26aufirst%3DA.%2BN.%26atitle%3DDifferentiation%2520antigens%2520of%2520melanocytes%2520and%2520melanoma%253A%2520analysis%2520of%2520melanosome%2520and%2520cell%2520surface%2520markers%2520of%2520human%2520pigmented%2520cells%2520with%2520monoclonal%2520antibodies%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D1988%26volume%3D90%26spage%3D459%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Russell, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, T. J.</span><span> </span><span class="NLM_article-title">Lymphocyte-mediated cytotoxicity</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1146%2Fannurev.immunol.20.100201.131730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=11861606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlWgtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=323-370&author=J.+H.+Russellauthor=T.+J.+Ley&title=Lymphocyte-mediated+cytotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Lymphocyte-mediated cytotoxicity</span></div><div class="casAuthors">Russell, John H.; Ley, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">323-370</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Virtually all of the measurable cell-mediated cytotoxicity delivered by cytotoxic T lymphocytes and natural killer cells comes from either the granule exocytosis pathway or the Fas pathway.  The granule exocytosis pathway utilizes perforin to traffic the granzymes to appropriate locations in target cells, where they cleave crit. substrates that initiate DNA fragmentation and apoptosis; granzymes A and B induce death via alternate, non-overlapping pathways.  The Fas/FasL system is responsible for activation-induced cell death but also plays an important role in lymphocyte-mediated killing under certain circumstances.  The interplay between these two cytotoxic systems provides opportunities for therapeutic interventions to control autoimmune diseases and graft vs. host disease, but over-suppression of these pathways may also lead to increased viral susceptibility and/or decreased tumor cell killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokipSkNOcfwrVg90H21EOLACvtfcHk0ljwM3eDAhV35A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlWgtLw%253D&md5=21fcde7e7b936ff95c7dbdfd2f77b643</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.20.100201.131730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.20.100201.131730%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DJ.%2BH.%26aulast%3DLey%26aufirst%3DT.%2BJ.%26atitle%3DLymphocyte-mediated%2520cytotoxicity%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2002%26volume%3D20%26spage%3D323%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Kirkwood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarhini, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panelli, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschos, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarour, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butterfield, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogas, H. J.</span><span> </span><span class="NLM_article-title">Next generation of immunotherapy for melanoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">3445</span><span class="NLM_x">–</span> <span class="NLM_lpage">3455</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1200%2FJCO.2007.14.6423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=18612161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvVWitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=3445-3455&author=J.+M.+Kirkwoodauthor=A.+A.+Tarhiniauthor=M.+C.+Panelliauthor=S.+J.+Moschosauthor=H.+M.+Zarourauthor=L.+H.+Butterfieldauthor=H.+J.+Gogas&title=Next+generation+of+immunotherapy+for+melanoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Next generation of immunotherapy for melanoma</span></div><div class="casAuthors">Kirkwood, John M.; Tarhini, Ahmad A.; Panelli, Monica C.; Moschos, Stergios J.; Zarour, Hassane M.; Butterfield, Lisa H.; Gogas, Helen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3445-3455</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  Purpose Immunotherapy has a long history with striking but limited success in patients with melanoma.  To date, interleukin-2 and interferon-alfa2b are the only approved immunotherapeutic agents for melanoma in the United States.  Design Tumor evasion of host immune responses, and strategies for overcoming tumor-induced immunosuppression are reviewed.  Several novel immunotherapies currently in worldwide phase III clin. testing for melanoma are discussed.  Results The limitations of immunotherapy for melanoma stem from tumor-induced mechanisms of immune evasion that render the host tolerant of tumor antigens.  For example, melanoma inhibits the maturation of antigen-presenting cells, preventing full T-cell activation and downregulating the effector antitumor immune response.  New immunotherapies targeting crit. regulatory elements of the immune system may overcome tolerance and promote a more effective antitumor immune response.  These include monoclonal antibodies that block the cytotoxic T lymphocyte-assocd. antigen 4 (CTLA4) and toll-like receptor 9 (TLR9) agonists.  Blockade of CTLA4 prevents inhibitory signals that downregulate T-cell activation.  TLR9 agonists stimulate dendritic cell maturation and ultimately induce a more effective immune response.  These approaches have been shown to stimulate acute immune activation with concomitant appearance of transient adverse events mediated by the immune system.  The pattern and duration of immune responses assocd. with these new modalities differ from those assocd. with cytokines and cytotoxic agents.  In addn., vaccines are being developed that may ultimately target melanoma either alone or in combination with these immunomodulatory therapies.  Conclusion The successes of cytokine and interferon therapy of melanoma, coupled with an array of new approaches, are generating new enthusiasm for the immunotherapy of melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyeng-cXpDZLVg90H21EOLACvtfcHk0ljwM3eDAhV35A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvVWitrY%253D&md5=bc7e4b7b8d72758e8ca3762b3079880c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1200%2FJCO.2007.14.6423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2007.14.6423%26sid%3Dliteratum%253Aachs%26aulast%3DKirkwood%26aufirst%3DJ.%2BM.%26aulast%3DTarhini%26aufirst%3DA.%2BA.%26aulast%3DPanelli%26aufirst%3DM.%2BC.%26aulast%3DMoschos%26aufirst%3DS.%2BJ.%26aulast%3DZarour%26aufirst%3DH.%2BM.%26aulast%3DButterfield%26aufirst%3DL.%2BH.%26aulast%3DGogas%26aufirst%3DH.%2BJ.%26atitle%3DNext%2520generation%2520of%2520immunotherapy%2520for%2520melanoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2008%26volume%3D26%26spage%3D3445%26epage%3D3455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Javelaud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexaki, V.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauviel, A.</span><span> </span><span class="NLM_article-title">Transforming growth factor-β in cutaneous melanoma</span> <span class="citation_source-journal">Pigm. Cell Melanoma Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1111%2Fj.1755-148X.2008.00450.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=18426405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvVSnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=123-132&author=D.+Javelaudauthor=V.-I.+Alexakiauthor=A.+Mauviel&title=Transforming+growth+factor-%CE%B2+in+cutaneous+melanoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Transforming growth factor-β in cutaneous melanoma</span></div><div class="casAuthors">Javelaud, Delphine; Alexaki, Vasileia-Ismini; Mauviel, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Pigment Cell & Melanoma Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-132</span>CODEN:
                <span class="NLM_cas:coden">PCMRCM</span>;
        ISSN:<span class="NLM_cas:issn">1755-1471</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Transforming growth factor-β (TGF-β) plays a complex role during carcinogenesis.  It may either act as a tumor suppressor through its broad antiproliferative potential or as a tumor promoter either via direct effects on tumor cell aggressiveness or indirectly by modulating stromal responses, angiogenesis and immune surveillance.  Increased prodn. of TGF-β by cancer cells is often assocd. with tumor grade.  Melanoma cells largely escape cell cycle arrest normally induced by TGF-β in normal melanocytes, yet produce active TGF-β and are capable of efficient transcriptional responses to the growth factor.  In this review, we summarize the current knowledge about the role played by TGF-β in melanoma progression and hypothesize about the appropriateness of targeting TGF-β signaling for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3uy1imhjr0LVg90H21EOLACvtfcHk0ljwM3eDAhV35A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvVSnsLg%253D&md5=89e8ceac1c0ce86a1a26da497fa70413</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-148X.2008.00450.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-148X.2008.00450.x%26sid%3Dliteratum%253Aachs%26aulast%3DJavelaud%26aufirst%3DD.%26aulast%3DAlexaki%26aufirst%3DV.-I.%26aulast%3DMauviel%26aufirst%3DA.%26atitle%3DTransforming%2520growth%2520factor-%25CE%25B2%2520in%2520cutaneous%2520melanoma%26jtitle%3DPigm.%2520Cell%2520Melanoma%2520Res.%26date%3D2008%26volume%3D21%26spage%3D123%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Yoon, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, I.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakae, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, O.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ju, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamura, M.</span><span> </span><span class="NLM_article-title">Activin receptor-like kinase 5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1720</span><span class="NLM_x">–</span> <span class="NLM_lpage">1739</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1002%2Femmm.201302524" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=24127404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWms73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1720-1739&author=J.-H.+Yoonauthor=S.+M.+Jungauthor=S.+H.+Parkauthor=M.+Katoauthor=T.+Yamashitaauthor=I.-K.+Leeauthor=K.+Sudoauthor=S.+Nakaeauthor=J.+S.+Hanauthor=O.-H.+Kimauthor=B.-C.+Ohauthor=T.+Sumidaauthor=M.+Kurodaauthor=J.-H.+Juauthor=K.+C.+Jungauthor=S.+H.+Parkauthor=D.-K.+Kimauthor=M.+Mamura&title=Activin+receptor-like+kinase+5+inhibition+suppresses+mouse+melanoma+by+ubiquitin+degradation+of+Smad4%2C+thereby+derepressing+eomesodermin+in+cytotoxic+T+lymphocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes</span></div><div class="casAuthors">Yoon, Jeong-Hwan; Jung, Su Myung; Park, Seok Hee; Kato, Mitsuyasu; Yamashita, Tadashi; Lee, In-Kyu; Sudo, Katsuko; Nakae, Susumu; Han, Jin Soo; Kim, Ok-Hee; Oh, Byung-Chul; Sumida, Takayuki; Kuroda, Masahiko; Ju, Ji-Hyeon; Jung, Kyeong Cheon; Park, Seong Hoe; Kim, Dae-Kee; Mamura, Mizuko</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1720-1739</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Varieties of transforming growth factor-β (TGF-β) antagonists have been developed to intervene with excessive TGF-β signalling activity in cancer.  Activin receptor-like kinase5 (ALK5) inhibitors antagonize TGF-β signalling by blocking TGF-β receptor-activated Smad (R-Smad) phosphorylation.  Here we report the novel mechanisms how ALK5 inhibitors exert a therapeutic effect on a mouse B16 melanoma model.  Oral treatment with a novel ALK5 inhibitor, EW-7197 (2.5 mg/kg daily) or a representative ALK5 inhibitor, LY-2157299 (75 mg/kg bid) suppressed the progression of melanoma with enhanced cytotoxic T-lymphocyte (CTL) responses.  Notably, ALK5 inhibitors not only blocked R-Smad phosphorylation, but also induced ubiquitin-mediated degrdn. of the common Smad, Smad4 mainly in CD8+ T cells in melanoma-bearing mice.  Accordingly, T-cell-specific deletion of Smad4 was sufficient to suppress the progression of melanoma.  We further identified eomesodermin (Eomes), the T-box transcription factor regulating CTL functions, as a specific target repressed by TGF-β via Smad4 and Smad3 in CD8+ T cells.  Thus, ALK5 inhibition enhances anti-melanoma CTL responses through ubiquitin-mediated degrdn. of Smad4 in addn. to the direct inhibitory effect on R-Smad phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBWYUCVgPm97Vg90H21EOLACvtfcHk0ljWvBJnlfb5xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWms73I&md5=f647384d8ad977a4ee446fb2de7623e6</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Femmm.201302524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201302524%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DJ.-H.%26aulast%3DJung%26aufirst%3DS.%2BM.%26aulast%3DPark%26aufirst%3DS.%2BH.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DI.-K.%26aulast%3DSudo%26aufirst%3DK.%26aulast%3DNakae%26aufirst%3DS.%26aulast%3DHan%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DO.-H.%26aulast%3DOh%26aufirst%3DB.-C.%26aulast%3DSumida%26aufirst%3DT.%26aulast%3DKuroda%26aufirst%3DM.%26aulast%3DJu%26aufirst%3DJ.-H.%26aulast%3DJung%26aufirst%3DK.%2BC.%26aulast%3DPark%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DMamura%26aufirst%3DM.%26atitle%3DActivin%2520receptor-like%2520kinase%25205%2520inhibition%2520suppresses%2520mouse%2520melanoma%2520by%2520ubiquitin%2520degradation%2520of%2520Smad4%252C%2520thereby%2520derepressing%2520eomesodermin%2520in%2520cytotoxic%2520T%2520lymphocytes%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D1720%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Constandinou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iredale, J. P.</span><span> </span><span class="NLM_article-title">Modeling liver fibrosis in rodents</span> <span class="citation_source-journal">Methods Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=16118456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A280%3ADC%252BD2MvltFCqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2005&pages=237-250&author=C.+Constandinouauthor=N.+Hendersonauthor=J.+P.+Iredale&title=Modeling+liver+fibrosis+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling liver fibrosis in rodents</span></div><div class="casAuthors">Constandinou Christothea; Henderson Neil; Iredale John P</div><div class="citationInfo"><span class="NLM_cas:title">Methods in molecular medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">237-50</span>
        ISSN:<span class="NLM_cas:issn">1543-1894</span>.
    </div><div class="casAbstract">Animal models of hepatic fibrosis provide a means to study the cell and molecular mediators of fibrosis in a serial manner during both progression and recovery.  Several approaches to induction of fibrosis have been described.  Of these, CCl(4) intoxication in rats and mice is probably the most widely studied.  In addition, the CCl(4) model is the best characterized with respect to histological, biochemical, cell, and molecular changes associated with the development of fibrosis.  CCl(4) can be given intraperitoneally or by oral gavage; it induces zone III necrosis and hepatocyte apoptosis with associated hepatic stellate cell activation and tissue fibrosis.  With repetitive dosing CCl(4) can be used to induce bridging hepatic fibrosis (4 wk of twice-weekly dosing), cirrhosis (8 wk of twice-weekly dosing) and advanced micronodular cirrhosis (12 wk of twice-weekly dosing).  In addition, for each of these models spontaneous recovery from fibrosis can be studied after cessation of dosing.  Mechanistic studies using gene knockout and transgenic animals can also be established using CCl(4).  Together these models have provided unparalleled insights into the mechanisms underlying hepatic fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSzYI3kOuuGXZPq5LRczm8ffW6udTcc2eY6TnArMOlaPbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MvltFCqsw%253D%253D&md5=1076cb561bd7ec945c2e3364dc778d39</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConstandinou%26aufirst%3DC.%26aulast%3DHenderson%26aufirst%3DN.%26aulast%3DIredale%26aufirst%3DJ.%2BP.%26atitle%3DModeling%2520liver%2520fibrosis%2520in%2520rodents%26jtitle%3DMethods%2520Mol.%2520Med.%26date%3D2005%26volume%3D117%26spage%3D237%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Park, S.-A; Kim, M.-J.; Kim, S. W.; Lee, S.-J.; Park, S.-Y.; Kim, S.-J.; Jee, J. I.; Park, M.-K.; Kim, D.-K.; Nam, J.-S.; Sheen, Y. Y.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Park%2C+S.-A%3B+Kim%2C+M.-J.%3B+Kim%2C+S.+W.%3B+Lee%2C+S.-J.%3B+Park%2C+S.-Y.%3B+Kim%2C+S.-J.%3B+Jee%2C+J.+I.%3B+Park%2C+M.-K.%3B+Kim%2C+D.-K.%3B+Nam%2C+J.-S.%3B+Sheen%2C+Y.+Y.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="note"><p class="first last">The analysis was done by Bruker SMART APEX II X-ray crystallograph and Bruker SHELXTL structure analysis program.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Sawyer, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beight, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britt, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodson, T. G.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herron, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMillen, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mort, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yingling, J. M.</span><span> </span><span class="NLM_article-title">Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4<i>H</i>-pyrrolo[1,2-<i>b</i>]pyrazole inhibitors of the transforming growth factor-β type I receptor kinase domain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3581</span><span class="NLM_x">–</span> <span class="NLM_lpage">3584</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3581-3584&author=J.+S.+Sawyerauthor=D.+W.+Beightauthor=K.+S.+Brittauthor=B.+D.+Andersonauthor=R.+M.+Campbellauthor=T.+G.+Goodsonauthor=D.+K.+Herronauthor=H.-Y.+Liauthor=W.+T.+McMillenauthor=N.+Mortauthor=S.+Parsonsauthor=E.+C.+R.+Smithauthor=J.+R.+Wagnerauthor=L.+Yanauthor=F.+Zhangauthor=J.+M.+Yingling&title=Synthesis+and+activity+of+new+aryl-+and+heteroaryl-substituted+5%2C6-dihydro-4H-pyrrolo%5B1%2C2-b%5Dpyrazole+inhibitors+of+the+transforming+growth+factor-%CE%B2+type+I+receptor+kinase+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSawyer%26aufirst%3DJ.%2BS.%26aulast%3DBeight%26aufirst%3DD.%2BW.%26aulast%3DBritt%26aufirst%3DK.%2BS.%26aulast%3DAnderson%26aufirst%3DB.%2BD.%26aulast%3DCampbell%26aufirst%3DR.%2BM.%26aulast%3DGoodson%26aufirst%3DT.%2BG.%26aulast%3DHerron%26aufirst%3DD.%2BK.%26aulast%3DLi%26aufirst%3DH.-Y.%26aulast%3DMcMillen%26aufirst%3DW.%2BT.%26aulast%3DMort%26aufirst%3DN.%26aulast%3DParsons%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DE.%2BC.%2BR.%26aulast%3DWagner%26aufirst%3DJ.%2BR.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DYingling%26aufirst%3DJ.%2BM.%26atitle%3DSynthesis%2520and%2520activity%2520of%2520new%2520aryl-%2520and%2520heteroaryl-substituted%25205%252C6-dihydro-4H-pyrrolo%255B1%252C2-b%255Dpyrazole%2520inhibitors%2520of%2520the%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%2520I%2520receptor%2520kinase%2520domain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3581%26epage%3D3584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Tolonen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petsalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turpeinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uusitalo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelkonen, O.</span><span> </span><span class="NLM_article-title">In vitro interaction cocktail assay for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC/MSMS run: analytical validation and testing with monoclonal anti-CYP antibodies</span> <span class="citation_source-journal">J. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">960</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=960-966&author=A.+Tolonenauthor=A.+Petsaloauthor=M.+Turpeinenauthor=J.+Uusitaloauthor=O.+Pelkonen&title=In+vitro+interaction+cocktail+assay+for+nine+major+cytochrome+P450+enzymes+with+13+probe+reactions+and+a+single+LC%2FMSMS+run%3A+analytical+validation+and+testing+with+monoclonal+anti-CYP+antibodies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTolonen%26aufirst%3DA.%26aulast%3DPetsalo%26aufirst%3DA.%26aulast%3DTurpeinen%26aufirst%3DM.%26aulast%3DUusitalo%26aufirst%3DJ.%26aulast%3DPelkonen%26aufirst%3DO.%26atitle%3DIn%2520vitro%2520interaction%2520cocktail%2520assay%2520for%2520nine%2520major%2520cytochrome%2520P450%2520enzymes%2520with%252013%2520probe%2520reactions%2520and%2520a%2520single%2520LC%252FMSMS%2520run%253A%2520analytical%2520validation%2520and%2520testing%2520with%2520monoclonal%2520anti-CYP%2520antibodies%26jtitle%3DJ.%2520Mass%2520Spectrom.%26date%3D2007%26volume%3D42%26spage%3D960%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makielski, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">January, C. T.</span><span> </span><span class="NLM_article-title">Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature</span> <span class="citation_source-journal">Biophys. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1016%2FS0006-3495%2898%2977782-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=9449325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADyaK1cXhvFWjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1998&pages=230-241&author=Z.+Zhouauthor=Q.+Gongauthor=B.+Yeauthor=Z.+Fanauthor=J.+C.+Makielskiauthor=G.+A.+Robertsonauthor=C.+T.+January&title=Properties+of+HERG+channels+stably+expressed+in+HEK+293+cells+studied+at+physiological+temperature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature</span></div><div class="casAuthors">Zhou, Zhengfeng; Gong, Qiuming; Ye, Bin; Fan, Zheng; Makielski, Jonathan C.; Robertson, Gail A.; January, Craig T.</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">230-241</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Biophysical Society</span>)
        </div><div class="casAbstract">We have established stably transfected HEK 293 cell lines expressing high levels of functional human ether-a go-go-related gene (HERG) channels.  We used these cells to study biochem. characteristics of HERG protein, and to study electrophysiol. and pharmacol. properties of HERG channel current at 35°C.  HERG-transfected cells expressed an mRNA band at 4.0 kb.  Western blot anal. showed two protein bands (155 and 135 kDa) slightly larger than the predicted mol. mass (127 kDa).  Treatment with N-glycosidase F converted both bands to smaller mol. mass, suggesting that both are glycosylated, but at different levels.  HERG current activated at voltages pos. to -50 mV, max. current was reached with depolarizing steps to -10 mV, and the current amplitude declined at more pos. voltages, similar to HERG channel current expressed in other heterologous systems.  C.d. at 35°C, compared with 23°C, was increased by more than twofold to a max. of 53.4 ± 6.5 pA/pF.  Activation, inactivation, recovery from inactivation, and deactivation kinetics were rapid at 35°C, and more closely resemble values reported for the rapidly activating delayed rectifier K+ current (IKr) at physiol. temps.  HERG channels were highly selective for K+.  When we used an action potential clamp technique, HERG current activation began shortly after the upstroke of the action potential waveform.  HERG current increased during repolarization to reach a max. amplitude during phases 2 and 3 of the cardiac action potential.  HERG contributed current throughout the return of the membrane to the resting potential, and deactivation of HERG current could participate in phase 4 depolarization.  HERG current was blocked by low concns. of E-4031 (IC50 7.7 nM), a value close to that reported for IKr in native cardiac myocytes.  Our data support the postulate that HERG encodes a major constituent of IKr and suggest that at physiol. temps. HERG contributes current throughout most of the action potential and into the postrepolarization period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfeVZx9D4R2LVg90H21EOLACvtfcHk0lhGDzr98UcVnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhvFWjurg%253D&md5=4c7587215c9013a75b34d9fcbaaefc2c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0006-3495%2898%2977782-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3495%252898%252977782-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DYe%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DMakielski%26aufirst%3DJ.%2BC.%26aulast%3DRobertson%26aufirst%3DG.%2BA.%26aulast%3DJanuary%26aufirst%3DC.%2BT.%26atitle%3DProperties%2520of%2520HERG%2520channels%2520stably%2520expressed%2520in%2520HEK%2520293%2520cells%2520studied%2520at%2520physiological%2520temperature%26jtitle%3DBiophys.%2520J.%26date%3D1998%26volume%3D74%26spage%3D230%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Frazier, K.</span><span> </span><span class="NLM_article-title">Investigative toxicology: the state of the art</span>. In  <span class="citation_source-book">Emerging Safety Science: Workshop Summary</span>; <span class="NLM_contrib-group">Robinson, S.; Pool, R.; Giffin, R.</span>, Eds.; <span class="NLM_publisher-name">National Academies Press</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">, </span>: pp  <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=5-12&author=K.+Frazierauthor=S.+Robinson&author=R.+Pool&author=R.+Giffin&title=Emerging+Safety+Science%3A+Workshop+Summary"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFrazier%26aufirst%3DK.%26atitle%3DInvestigative%2520toxicology%253A%2520the%2520state%2520of%2520the%2520art%26btitle%3DEmerging%2520Safety%2520Science%253A%2520Workshop%2520Summary%26aulast%3DRobinson%26aufirst%3DS.%26pub%3DNational%2520Academies%2520Press%26date%3D2008%26spage%3D5%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Anderton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pass, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, R. R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heier, A.</span><span> </span><span class="NLM_article-title">Induction of heart valve lesions by small-molecule ALK5 inhibitors</span> <span class="citation_source-journal">Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">916</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1177%2F0192623311416259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=21859884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVGrsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=916-924&author=M.+J.+Andertonauthor=H.+R.+Mellorauthor=A.+Bellauthor=C.+Sadlerauthor=M.+Passauthor=S.+Powellauthor=S.+J.+Steeleauthor=R.+R.+A.+Robertsauthor=A.+Heier&title=Induction+of+heart+valve+lesions+by+small-molecule+ALK5+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of heart valve lesions by small-molecule ALK5 inhibitors</span></div><div class="casAuthors">Anderton, Mark J.; Mellor, Howard R.; Bell, Alex; Sadler, Claire; Pass, Martin; Powell, Steve; Steele, Samantha J.; Roberts, Ruth. R. A.; Heier, Annabelle</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">916-924</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Aberrant signaling by transforming growth factor-β (TGF-β) and its type I (ALK5) receptor has been implicated in a no. of human diseases and this pathway is considered a potential target for therapeutic intervention.  Transforming growth factor-β signaling via ALK5 plays a crit. role during heart development, but the role of ALK5 in the adult heart is poorly understood.  In the current study, the preclin. toxicol. of ALK5 inhibitors from two different chem. scaffolds was explored.  Ten-week-old female Han Wistar rats received test compds. by the oral route for three to seven days.  Both compds. induced histopathol. heart valve lesions characterized by hemorrhage, inflammation, degeneration, and proliferation of valvular interstitial cells.  The pathol. was obsd. in all animals, at all doses tested, and occurred in all four heart valves.  Immunohistochem. anal. of ALK5 in rat hearts revealed expression in the valves, but not in the myocardium.  Compared to control animals, protein levels of ALK5 were unchanged in the heart valves of treated animals.  We also obsd. a physeal dysplasia in the femoro-tibial joint of rats treated with ALK5 inhibitors, a finding consistent with a pharmacol. effect described previously with ALK5 inhibitors.  Overall, these findings suggest that TGF-β signaling via ALK5 plays a crit. role in maintaining heart valve integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_pEB0XdgFC7Vg90H21EOLACvtfcHk0lhGDzr98UcVnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGrsLfF&md5=b835e106847bcb743d59ec95f9a097cc</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1177%2F0192623311416259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0192623311416259%26sid%3Dliteratum%253Aachs%26aulast%3DAnderton%26aufirst%3DM.%2BJ.%26aulast%3DMellor%26aufirst%3DH.%2BR.%26aulast%3DBell%26aufirst%3DA.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DPass%26aufirst%3DM.%26aulast%3DPowell%26aufirst%3DS.%26aulast%3DSteele%26aufirst%3DS.%2BJ.%26aulast%3DRoberts%26aufirst%3DR.%2BR.%2BA.%26aulast%3DHeier%26aufirst%3DA.%26atitle%3DInduction%2520of%2520heart%2520valve%2520lesions%2520by%2520small-molecule%2520ALK5%2520inhibitors%26jtitle%3DToxicol.%2520Pathol.%26date%3D2011%26volume%3D39%26spage%3D916%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Frazier, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicchitano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirabile, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grygielko, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Gouville, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laping, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F.</span><span> </span><span class="NLM_article-title">Inhibition of ALK5 signaling induces physeal dysplasia in rats</span> <span class="citation_source-journal">Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1080%2F01926230701198469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=17366323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsVSnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=284-295&author=K.+Frazierauthor=R.+Thomasauthor=M.+Scicchitanoauthor=R.+Mirabileauthor=R.+Boyceauthor=D.+Zimmermanauthor=E.+Grygielkoauthor=J.+Noldauthor=A.+C.+de+Gouvilleauthor=S.+Huetauthor=N.+Lapingauthor=F.+Gellibert&title=Inhibition+of+ALK5+signaling+induces+physeal+dysplasia+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of ALK5 signaling induces physeal dysplasia in rats</span></div><div class="casAuthors">Frazier, Kendall; Thomas, Roberta; Scicchitano, Marshall; Mirabile, Rosanna; Boyce, Rogely; Zimmerman, Dawn; Grygielko, Eugene; Nold, James; DeGouville, Anne-Charlotte; Huet, Stephane; Laping, Nicholas; Gellibert, Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">284-295</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare USA, Inc.</span>)
        </div><div class="casAbstract">TGF-|β|, and its type 1 (ALK5) receptor, are crit. to the pathogenesis of fibrosis.  In toxicol. studies of 4 or more days in 10-wk-old Sprague-Dawley rats, using an ALK5 inhibitor (GW788388), expansion of hypertrophic and proliferation zones of femoral physes were noted.  Subphyseal hyperostosis, chondrocyte hypertrophy/hyperplasia, and increased matrix were present.  Physeal zones were laser microdissected from ALK5 inhibitor-treated and control rats sacrificed after 3 days of treatment.  Transcripts for TGF-|β|1, TGF-|β|2, ALK5, IHH, VEGF, BMP-7, IGF-1, bFGF, and PTHrP were amplified by real-time PCR.  IGF and IHH increased in all physis zones with treatment, but were most prominent in prehypertrophic zones.  TGF-|β|2, bFGF and BMP7 expression increased in proliferative, pre- and hypertrophic zones.  PTHrP expression was elevated in proliferative zones but decreased in hypertrophic zones.  VEGF expression was increased after treatment in pre- and hypertrophic zones.  ALK5 expression was elevated in prehypertrophic zones.  Zymog. demonstrated gelatinolytic activity was reduced after treatment.  Apoptotic markers (TUNEL and caspase-3) were decreased in hypertrophic zones.  Proliferation assessed by Topoisomerase II and Ki67 was increased in multiple zones.  Movat stains demonstrated that proteoglycan deposition was altered.  Physeal changes occurred at doses well above those resulting in fibrosis.  Interactions of factors is important in producing the physeal dysplasia phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX60thajdZ97Vg90H21EOLACvtfcHk0lgxDeVeuAlMKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsVSnsrw%253D&md5=a0827c42ea4272d0196df9e1f488e2b1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1080%2F01926230701198469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F01926230701198469%26sid%3Dliteratum%253Aachs%26aulast%3DFrazier%26aufirst%3DK.%26aulast%3DThomas%26aufirst%3DR.%26aulast%3DScicchitano%26aufirst%3DM.%26aulast%3DMirabile%26aufirst%3DR.%26aulast%3DBoyce%26aufirst%3DR.%26aulast%3DZimmerman%26aufirst%3DD.%26aulast%3DGrygielko%26aufirst%3DE.%26aulast%3DNold%26aufirst%3DJ.%26aulast%3Dde%2BGouville%26aufirst%3DA.%2BC.%26aulast%3DHuet%26aufirst%3DS.%26aulast%3DLaping%26aufirst%3DN.%26aulast%3DGellibert%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520ALK5%2520signaling%2520induces%2520physeal%2520dysplasia%2520in%2520rats%26jtitle%3DToxicol.%2520Pathol.%26date%3D2007%26volume%3D35%26spage%3D284%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Carabello, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, F. A.,  Jr.</span><span> </span><span class="NLM_article-title">Valvular heart disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">337</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1056%2FNEJM199707033370107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=9203430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A280%3ADyaK2szjtVOksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=1997&pages=32-41&author=B.+A.+Carabelloauthor=F.+A.+Crawford&title=Valvular+heart+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Valvular heart disease</span></div><div class="casAuthors">Carabello B A; Crawford F A Jr</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-41</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCuKjiwv3RHdXdcedVHT5tfW6udTcc2eYpOwNK4PULyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2szjtVOksg%253D%253D&md5=cbcb7f2bbb3827bfc3bd17daf1792544</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1056%2FNEJM199707033370107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199707033370107%26sid%3Dliteratum%253Aachs%26aulast%3DCarabello%26aufirst%3DB.%2BA.%26aulast%3DCrawford%26aufirst%3DF.%2BA.%26atitle%3DValvular%2520heart%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1997%26volume%3D337%26spage%3D32%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Ahnert, J. R.; Baselga, J.; Calvo, E.; Seoane, J.; Brana, I.; Sicart, E.; Gueorguieva, I.; Cleverly, A.; Lahn, M. M. F.; Pillay, S.; Holdhoff, M.; Blakeley, J. O.; Carducci, M. A.</span><span> </span><span class="NLM_article-title">First human dose (FHD) study of the oral transforming growth factor-β receptor I kinase inhibitor LY2157299 in patients with treatment-refractory malignant glioma</span>.  <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">Abstract 3011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=Abstract+3011&author=J.+R.+Ahnert&author=J.+Baselga&author=E.+Calvo&author=J.+Seoane&author=I.+Brana&author=E.+Sicart&author=I.+Gueorguieva&author=A.+Cleverly&author=M.+M.+F.+Lahn&author=S.+Pillay&author=M.+Holdhoff&author=J.+O.+Blakeley&author=M.+A.+Carducci&title=First+human+dose+%28FHD%29+study+of+the+oral+transforming+growth+factor-%CE%B2+receptor+I+kinase+inhibitor+LY2157299+in+patients+with+treatment-refractory+malignant+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhnert%26aufirst%3DJ.%2BR.%26atitle%3DFirst%2520human%2520dose%2520%2528FHD%2529%2520study%2520of%2520the%2520oral%2520transforming%2520growth%2520factor-%25CE%25B2%2520receptor%2520I%2520kinase%2520inhibitor%2520LY2157299%2520in%2520patients%2520with%2520treatment-refractory%2520malignant%2520glioma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3DAbstract%25203011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Hodi, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Day, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haanen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schadendorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerley, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Eertwegh, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutzky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorigan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaubel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linette, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoqq, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottensmeier, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebbé, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peschel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quirt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolchok, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yellin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichol, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urba, W. J.</span><span> </span><span class="NLM_article-title">Improved survival with ipilimumab in patients with metastatic melanoma</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1056%2FNEJMoa1003466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=20525992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCrtrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=711-723&author=F.+S.+Hodiauthor=S.+J.+O%E2%80%99Dayauthor=D.+F.+McDermottauthor=R.+W.+Weberauthor=J.+A.+Sosmanauthor=J.+B.+Haanenauthor=R.+Gonzalezauthor=C.+Robertauthor=D.+Schadendorfauthor=J.+C.+Hasselauthor=W.+Akerleyauthor=A.+J.+van+den+Eertweghauthor=J.+Lutzkyauthor=P.+Loriganauthor=J.+M.+Vaubelauthor=G.+P.+Linetteauthor=D.+Hoqqauthor=C.+H.+Ottensmeierauthor=C.+Lebb%C3%A9author=C.+Peschelauthor=I.+Quirtauthor=J.+I.+Clarkauthor=J.+D.+Wolchokauthor=J.+S.+Weberauthor=J.+Tianauthor=M.+J.+Yellinauthor=G.+M.+Nicholauthor=A.+Hoosauthor=W.+J.+Urba&title=Improved+survival+with+ipilimumab+in+patients+with+metastatic+melanoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Improved survival with ipilimumab in patients with metastatic melanoma</span></div><div class="casAuthors">Hodi, F. Stephen; O'day, Steven J.; McDermott, David F.; Weber, Robert W.; Sosman, Jeffrey A.; Haanen, John B.; Gonzalez, Rene; Robert, Caroline; Schadendorf, Dirk; Hassel, Jessica C.; Akerley, Wallace; van den Eertwegh, Alfons J. M.; Lutzky, Jose; Lorigan, Paul; Vaubel, Julia M.; Linette, Gerald P.; Hogg, David; Ottensmeier, Christian H.; Lebbe, Celeste; Peschel, Christian; Quirt, Ian; Clark, Joseph I.; Wolchok, Jedd D.; Weber, Jeffrey S.; Tian, Jason; Yellin, Michael J.; Nichol, Geoffrey M.; Hoos, Axel; Urba, Walter J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">711-723</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: An improvement in overall survival among patients with metastatic melanoma has been an elusive goal.  In this phase 3 study, ipilimumab - which blocks cytotoxic T-lymphocyte-assocd. antigen 4 to potentiate an antitumor T-cell response - administered with or without a glycoprotein 100 (gp100) peptide vaccine was compared with gp100 alone in patients with previously treated metastatic melanoma.  Methods: A total of 676 HLA-A*0201-pos. patients with unresectable stage III or IV melanoma, whose disease had progressed while they were receiving therapy for metastatic disease, were randomly assigned, in a 3:1:1 ratio, to receive ipilimumab plus gp100 (403 patients), ipilimumab alone (137), or gp100 alone (136).  Ipilimumab, at a dose of 3 mg per kg of body wt., was administered with or without gp100 every 3 wk for up to four treatments (induction).  Eligible patients could receive reinduction therapy.  The primary end point was overall survival.  Results: The median overall survival was 10.0 mo among patients receiving ipilimumab plus gp100, as compared with 6.4 mo among patients receiving gp100 alone (hazard ratio for death, 0.68; P < 0.001).  The median overall survival with ipilimumab alone was 10.1 mo (hazard ratio for death in the comparison with gp100 alone, 0.66; P = 0.003).  No difference in overall survival was detected between the ipilimumab groups (hazard ratio with ipilimumab plus gp100, 1.04; P = 0.76).  Grade 3 or 4 immune-related adverse events occurred in 10 to 15% of patients treated with ipilimumab and in 3% treated with gp100 alone.  There were 14 deaths related to the study drugs (2.1%), and 7 were assocd. with immune-related adverse events.  Conclusions: Ipilimumab, with or without a gp100 peptide vaccine, as compared with gp100 alone, improved overall survival in patients with previously treated metastatic melanoma.  Adverse events can be severe, long-lasting, or both, but most are reversible with appropriate treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmWp_goUg4SbVg90H21EOLACvtfcHk0lgxDeVeuAlMKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCrtrbN&md5=170a241290808ccccac26a5169e6c715</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1003466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1003466%26sid%3Dliteratum%253Aachs%26aulast%3DHodi%26aufirst%3DF.%2BS.%26aulast%3DO%25E2%2580%2599Day%26aufirst%3DS.%2BJ.%26aulast%3DMcDermott%26aufirst%3DD.%2BF.%26aulast%3DWeber%26aufirst%3DR.%2BW.%26aulast%3DSosman%26aufirst%3DJ.%2BA.%26aulast%3DHaanen%26aufirst%3DJ.%2BB.%26aulast%3DGonzalez%26aufirst%3DR.%26aulast%3DRobert%26aufirst%3DC.%26aulast%3DSchadendorf%26aufirst%3DD.%26aulast%3DHassel%26aufirst%3DJ.%2BC.%26aulast%3DAkerley%26aufirst%3DW.%26aulast%3Dvan%2Bden%2BEertwegh%26aufirst%3DA.%2BJ.%26aulast%3DLutzky%26aufirst%3DJ.%26aulast%3DLorigan%26aufirst%3DP.%26aulast%3DVaubel%26aufirst%3DJ.%2BM.%26aulast%3DLinette%26aufirst%3DG.%2BP.%26aulast%3DHoqq%26aufirst%3DD.%26aulast%3DOttensmeier%26aufirst%3DC.%2BH.%26aulast%3DLebb%25C3%25A9%26aufirst%3DC.%26aulast%3DPeschel%26aufirst%3DC.%26aulast%3DQuirt%26aufirst%3DI.%26aulast%3DClark%26aufirst%3DJ.%2BI.%26aulast%3DWolchok%26aufirst%3DJ.%2BD.%26aulast%3DWeber%26aufirst%3DJ.%2BS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DYellin%26aufirst%3DM.%2BJ.%26aulast%3DNichol%26aufirst%3DG.%2BM.%26aulast%3DHoos%26aufirst%3DA.%26aulast%3DUrba%26aufirst%3DW.%2BJ.%26atitle%3DImproved%2520survival%2520with%2520ipilimumab%2520in%2520patients%2520with%2520metastatic%2520melanoma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D711%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Katre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akhter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanucchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postlethwait, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.-M.</span><span> </span><span class="NLM_article-title">Increased transforming growth factor beta 1 expression mediates ozone-induced airway fibrosis in mice</span> <span class="citation_source-journal">Inhalation Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.3109%2F08958378.2011.584919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=21689010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns1OhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2011&pages=486-494&author=A.+Katreauthor=C.+Ballingerauthor=H.+Akhterauthor=M.+Fanucchiauthor=D.-K.+Kimauthor=E.+Postlethwaitauthor=R.-M.+Liu&title=Increased+transforming+growth+factor+beta+1+expression+mediates+ozone-induced+airway+fibrosis+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Increased transforming growth factor beta 1 expression mediates ozone-induced airway fibrosis in mice</span></div><div class="casAuthors">Katre, Ashwini; Ballinger, Carol; Akhter, Hasina; Fanucchi, Michelle; Kim, Dae-Kee; Postlethwait, Edward; Liu, Rui-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Inhalation Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">486-494</span>CODEN:
                <span class="NLM_cas:coden">INHTE5</span>;
        ISSN:<span class="NLM_cas:issn">0895-8378</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Ozone (O3), a commonly encountered environmental pollutant, has been shown to induce pulmonary fibrosis in different animal models; the underlying mechanism, however, remains elusive.  To investigate the mol. mechanism underlying O3-induced pulmonary fibrosis, 6- to 8-wk-old C57BL/6 male mice were exposed to a cyclic O3 exposure protocol consisting of 2 days of filtered air and 5 days of O3 exposure (0.5 ppm, 8 h/day) for 5 and 10 cycles with or without i.p. injection of IN-1233, a specific inhibitor of the type 1 receptor of transforming growth factor beta (TGF-β), the most potent profibrogenic cytokine.  The results showed that O3 exposure for 5 or 10 cycles increased the TGF-β protein level in the epithelial lining fluid (ELF), assocd. with an increase in the expression of plasminogen activator inhibitor 1 (PAI-1), a TGF-β-responsive gene that plays a crit. role in the development of fibrosis under various pathol. conditions.  Cyclic O3 exposure also increased the deposition of collagens and alpha smooth muscle actin (α-SMA) in airway walls.  However, these fibrotic changes were not overt until after 10 cycles of O3 exposure.  Importantly, blockage of the TGF-β signaling pathway with IN-1233 suppressed O3-induced Smad2/3 phosphorylation, PAI-1 expression, as well as collagens and α-SMA deposition in the lung.  Our data demonstrate for the first time that O3 exposure increases TGF-β expression and activates TGF-β signaling pathways, which mediates O3-induced lung fibrotic responses in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfXxTCcW6eeLVg90H21EOLACvtfcHk0ljcitF7yiFShg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns1OhsL0%253D&md5=d6083cf3c42e14349530b8eec6f97f51</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.3109%2F08958378.2011.584919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08958378.2011.584919%26sid%3Dliteratum%253Aachs%26aulast%3DKatre%26aufirst%3DA.%26aulast%3DBallinger%26aufirst%3DC.%26aulast%3DAkhter%26aufirst%3DH.%26aulast%3DFanucchi%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DPostlethwait%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DR.-M.%26atitle%3DIncreased%2520transforming%2520growth%2520factor%2520beta%25201%2520expression%2520mediates%2520ozone-induced%2520airway%2520fibrosis%2520in%2520mice%26jtitle%3DInhalation%2520Toxicol.%26date%3D2011%26volume%3D23%26spage%3D486%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span> </span><span class="NLM_article-title">IN-1233, an ALK-5 inhibitor: prevention of granulation tissue formation after bare metallic stent placement in a rat urethral model</span> <span class="citation_source-journal">Radiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=2010&pages=75-82&author=J.+H.+Kimauthor=H.-Y.+Songauthor=J.-H.+Parkauthor=H.-J.+Yoonauthor=H.+G.+Parkauthor=D.-K.+Kim&title=IN-1233%2C+an+ALK-5+inhibitor%3A+prevention+of+granulation+tissue+formation+after+bare+metallic+stent+placement+in+a+rat+urethral+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DSong%26aufirst%3DH.-Y.%26aulast%3DPark%26aufirst%3DJ.-H.%26aulast%3DYoon%26aufirst%3DH.-J.%26aulast%3DPark%26aufirst%3DH.%2BG.%26aulast%3DKim%26aufirst%3DD.-K.%26atitle%3DIN-1233%252C%2520an%2520ALK-5%2520inhibitor%253A%2520prevention%2520of%2520granulation%2520tissue%2520formation%2520after%2520bare%2520metallic%2520stent%2520placement%2520in%2520a%2520rat%2520urethral%2520model%26jtitle%3DRadiology%26date%3D2010%26volume%3D255%26spage%3D75%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Yoon, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span> </span><span class="NLM_article-title">Role of IN-1233 in the prevention of neointimal hyperplasia after stent placement in a rat artery model</span> <span class="citation_source-journal">J. Vasc.  Interv. Radiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1321</span><span class="NLM_x">–</span> <span class="NLM_lpage">1328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=1321-1328&author=H.-J.+Yoonauthor=H.-Y.+Songauthor=J.+H.+Kimauthor=K.-S.+Hongauthor=Y.+J.+Kimauthor=H.+G.+Parkauthor=D.-K.+Kim&title=Role+of+IN-1233+in+the+prevention+of+neointimal+hyperplasia+after+stent+placement+in+a+rat+artery+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DH.-J.%26aulast%3DSong%26aufirst%3DH.-Y.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DHong%26aufirst%3DK.-S.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DPark%26aufirst%3DH.%2BG.%26aulast%3DKim%26aufirst%3DD.-K.%26atitle%3DRole%2520of%2520IN-1233%2520in%2520the%2520prevention%2520of%2520neointimal%2520hyperplasia%2520after%2520stent%2520placement%2520in%2520a%2520rat%2520artery%2520model%26jtitle%3DJ.%2520Vasc.%2520%2520Interv.%2520Radiol.%26date%3D2011%26volume%3D22%26spage%3D1321%26epage%3D1328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Kim, E.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Na, H. K.</span><span> </span><span class="NLM_article-title">IN-1233-eluting covered metallic stent to prevent hyperplasia: experimental study in a rabbit esophageal model</span> <span class="citation_source-journal">Radiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2013&pages=396-404&author=E.-Y.+Kimauthor=H.-Y.+Songauthor=J.+H.+Kimauthor=Y.+Fanauthor=S.+Parkauthor=D.-K.+Kimauthor=E.+W.+Leeauthor=H.+K.+Na&title=IN-1233-eluting+covered+metallic+stent+to+prevent+hyperplasia%3A+experimental+study+in+a+rabbit+esophageal+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DE.-Y.%26aulast%3DSong%26aufirst%3DH.-Y.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DLee%26aufirst%3DE.%2BW.%26aulast%3DNa%26aufirst%3DH.%2BK.%26atitle%3DIN-1233-eluting%2520covered%2520metallic%2520stent%2520to%2520prevent%2520hyperplasia%253A%2520experimental%2520study%2520in%2520a%2520rabbit%2520esophageal%2520model%26jtitle%3DRadiology%26date%3D2013%26volume%3D267%26spage%3D396%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Long, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southwood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrell, N. W.</span><span> </span><span class="NLM_article-title">Altered BMP and TGF-β signalling in rat models of pulmonary hypertension: potential for ALK-5 inhibition in prevention and progression of disease</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">566</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=566-576&author=L.+Longauthor=A.+Crosbyauthor=X.+Yangauthor=M.+Southwoodauthor=P.+D.+Uptonauthor=D.-K.+Kimauthor=N.+W.+Morrell&title=Altered+BMP+and+TGF-%CE%B2+signalling+in+rat+models+of+pulmonary+hypertension%3A+potential+for+ALK-5+inhibition+in+prevention+and+progression+of+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DL.%26aulast%3DCrosby%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DSouthwood%26aufirst%3DM.%26aulast%3DUpton%26aufirst%3DP.%2BD.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DMorrell%26aufirst%3DN.%2BW.%26atitle%3DAltered%2520BMP%2520and%2520TGF-%25CE%25B2%2520signalling%2520in%2520rat%2520models%2520of%2520pulmonary%2520hypertension%253A%2520potential%2520for%2520ALK-5%2520inhibition%2520in%2520prevention%2520and%2520progression%2520of%2520disease%26jtitle%3DCirculation%26date%3D2009%26volume%3D119%26spage%3D566%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span>SYBYL molecular modeling software, <span class="NLM_edition">8.1</span> ed.; <span class="NLM_publisher-name">Tripos Inc.</span>: <span class="NLM_publisher-loc">St. Louis, MO</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SYBYL+molecular+modeling+software%2C+8.1+ed.%3B+Tripos+Inc.%3A+St.+Louis%2C+MO%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSYBYL%2520molecular%2520modeling%2520software%26pub%3DTripos%2520Inc%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Spitzer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A. N.</span><span> </span><span class="NLM_article-title">Surflex-dock: docking benchmarks and real-world application</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1007%2Fs10822-011-9533-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=22569590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVelu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=687-699&author=R.+Spitzerauthor=A.+N.+Jain&title=Surflex-dock%3A+docking+benchmarks+and+real-world+application"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Surflex-Dock: Docking benchmarks and real-world application</span></div><div class="casAuthors">Spitzer, Russell; Jain, Ajay N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">687-699</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Benchmarks for mol. docking have historically focused on re-docking the cognate ligand of a well-detd. protein-ligand complex to measure geometric pose prediction accuracy, and measurement of virtual screening performance has been focused on increasingly large and diverse sets of target protein structures, cognate ligands, and various types of decoy sets.  Here, pose prediction is reported on the Astex Diverse set of 85 protein ligand complexes, and virtual screening performance is reported on the DUD set of 40 protein targets.  In both cases, prepd. structures of targets and ligands were provided by symposium organizers.  The re-prepd. data sets yielded results not significantly different than previous reports of Surflex-Dock on the two benchmarks.  Minor changes to protein coordinates resulting from complex pre-optimization had large effects on obsd. performance, highlighting the limitations of cognate ligand re-docking for pose prediction assessment.  Docking protocols developed for cross-docking, which address protein flexibility and produce discrete families of predicted poses, produced substantially better performance for pose prediction.  Performance on virtual screening performance was shown to benefit by employing and combining multiple screening methods: docking, 2D mol. similarity, and 3D mol. similarity.  In addn., use of multiple protein conformations significantly improved screening enrichment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPgES-yaoU4rVg90H21EOLACvtfcHk0lgsI2iQ5Yn_2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVelu7nN&md5=78637e767d2ad764f4b89c24ef3c7a56</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1007%2Fs10822-011-9533-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-011-9533-y%26sid%3Dliteratum%253Aachs%26aulast%3DSpitzer%26aufirst%3DR.%26aulast%3DJain%26aufirst%3DA.%2BN.%26atitle%3DSurflex-dock%253A%2520docking%2520benchmarks%2520and%2520real-world%2520application%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2012%26volume%3D26%26spage%3D687%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':[],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 64 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Thomas Hanke, Jong Fu Wong, Benedict-Tilman Berger, Ismahan Abdi, Lena Marie Berger, Roberta Tesch, Claudia Tredup, Alex N. Bullock, Susanne Müller, <span class="NLM_string-name hlFld-ContribAuthor">Stefan Knapp</span>. </span><span class="cited-content_cbyCitation_article-title">A Highly Selective Chemical Probe for Activin Receptor-like Kinases ALK4 and ALK5. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2020,</strong> <em>15 </em>
                                    (4)
                                     , 862-870. <a href="https://doi.org/10.1021/acschembio.0c00076" title="DOI URL">https://doi.org/10.1021/acschembio.0c00076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.0c00076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.0c00076%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DA%252BHighly%252BSelective%252BChemical%252BProbe%252Bfor%252BActivin%252BReceptor-like%252BKinases%252BALK4%252Band%252BALK5%26aulast%3DHanke%26aufirst%3DThomas%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28012020%26date%3D16032020%26date%3D20032020%26date%3D16032020%26volume%3D15%26issue%3D4%26spage%3D862%26epage%3D870" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yong Zhang, Yufen Zhao, Andrew J. Tebben, Steven Sheriff, Max Ruzanov, Mark P. Fereshteh, Yi Fan, Jonathan Lippy, Jesse Swanson, Ching-Ping Ho, Barri S. Wautlet, Anne Rose, Karen Parrish, Zheng Yang, Andrew F. Donnell, Liping Zhang, Brian E. Fink, Gregory D. Vite, Karen Augustine-Rauch, Joseph Fargnoli, <span class="NLM_string-name hlFld-ContribAuthor">Robert M. Borzilleri</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-Azaindole Inhibitors of TGFβRI as Immuno-oncology Agents. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (11)
                                     , 1117-1122. <a href="https://doi.org/10.1021/acsmedchemlett.8b00357" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00357</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00357&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00357%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252B4-Azaindole%252BInhibitors%252Bof%252BTGF%2525CE%2525B2RI%252Bas%252BImmuno-oncology%252BAgents%26aulast%3DZhang%26aufirst%3DYong%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06082018%26date%3D17102018%26date%3D22102018%26date%3D17102018%26volume%3D9%26issue%3D11%26spage%3D1117%26epage%3D1122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fan Zhang, Doug R. Braun, Gene E. Ananiev, F. Michael Hoffmann, I-Wei Tsai, Scott R. Rajski, <span class="NLM_string-name hlFld-ContribAuthor">Tim S. Bugni</span>. </span><span class="cited-content_cbyCitation_article-title">Biemamides A–E, Inhibitors of the TGF-β Pathway That Block the Epithelial to Mesenchymal Transition. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2018,</strong> <em>20 </em>
                                    (18)
                                     , 5529-5532. <a href="https://doi.org/10.1021/acs.orglett.8b01871" title="DOI URL">https://doi.org/10.1021/acs.orglett.8b01871</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.8b01871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.8b01871%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DBiemamides%252BA%2525E2%252580%252593E%25252C%252BInhibitors%252Bof%252Bthe%252BTGF-%2525CE%2525B2%252BPathway%252BThat%252BBlock%252Bthe%252BEpithelial%252Bto%252BMesenchymal%252BTransition%26aulast%3DZhang%26aufirst%3DFan%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D15062018%26date%3D30082018%26volume%3D20%26issue%3D18%26spage%3D5529%26epage%3D5532" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuelu  Zhu</span>, <span class="hlFld-ContribAuthor ">Cheng  Li</span>, <span class="hlFld-ContribAuthor ">Jidong  Zhang</span>, <span class="hlFld-ContribAuthor ">Mengyao  She</span>, <span class="hlFld-ContribAuthor ">Wei  Sun</span>, <span class="hlFld-ContribAuthor ">Kerou  Wan</span>, <span class="hlFld-ContribAuthor ">Yaqi  Wang</span>, <span class="hlFld-ContribAuthor ">Bin  Yin</span>, <span class="hlFld-ContribAuthor ">Ping  Liu</span>, and <span class="hlFld-ContribAuthor ">Jianli  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">A Facile FeCl3/I2-Catalyzed Aerobic Oxidative Coupling Reaction: Synthesis of Tetrasubstituted Imidazoles from Amidines and Chalcones. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (15)
                                     , 3872-3875. <a href="https://doi.org/10.1021/acs.orglett.5b01854" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b01854</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b01854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b01854%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DA%252BFacile%252BFeCl3%25252FI2-Catalyzed%252BAerobic%252BOxidative%252BCoupling%252BReaction%25253A%252BSynthesis%252Bof%252BTetrasubstituted%252BImidazoles%252Bfrom%252BAmidines%252Band%252BChalcones%26aulast%3DZhu%26aufirst%3DYuelu%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D27062015%26date%3D21072015%26date%3D07082015%26volume%3D17%26issue%3D15%26spage%3D3872%26epage%3D3875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Aly</span>, <span class="hlFld-ContribAuthor ">Mikhail  Romashko</span>, and <span class="hlFld-ContribAuthor ">Bruce A.  Arndtsen</span>  . </span><span class="cited-content_cbyCitation_article-title">Multicomponent Synthesis of Substituted and Fused-Ring Imidazoles via Phospha-münchnone Cycloaddition. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (5)
                                     , 2709-2714. <a href="https://doi.org/10.1021/jo5028936" title="DOI URL">https://doi.org/10.1021/jo5028936</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo5028936&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo5028936%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DMulticomponent%252BSynthesis%252Bof%252BSubstituted%252Band%252BFused-Ring%252BImidazoles%252Bvia%252BPhospha-m%2525C3%2525BCnchnone%252BCycloaddition%26aulast%3DAly%26aufirst%3DSara%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D21122014%26date%3D23022015%26date%3D06032015%26date%3D17022015%26volume%3D80%26issue%3D5%26spage%3D2709%26epage%3D2714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Byung-Gyu  Kim</span>, <span class="hlFld-ContribAuthor ">Ehsan  Malek</span>, <span class="hlFld-ContribAuthor ">Sung Hee  Choi</span>, <span class="hlFld-ContribAuthor ">James J.  Ignatz-Hoover</span>, <span class="hlFld-ContribAuthor ">James J.  Driscoll</span>. </span><span class="cited-content_cbyCitation_article-title">Novel therapies emerging in oncology to target the TGF-β pathway. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hematology & Oncology</span><span> <strong>2021,</strong> <em>14 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13045-021-01053-x" title="DOI URL">https://doi.org/10.1186/s13045-021-01053-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13045-021-01053-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13045-021-01053-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hematology%2520%2526%2520Oncology%26atitle%3DNovel%252Btherapies%252Bemerging%252Bin%252Boncology%252Bto%252Btarget%252Bthe%252BTGF-%2525CE%2525B2%252Bpathway%26aulast%3DKim%26aufirst%3DByung-Gyu%26date%3D2021%26date%3D2021%26volume%3D14%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elmira  Kohan</span>, <span class="hlFld-ContribAuthor ">Mahdi  Gholamhosseini-Nazari</span>, <span class="hlFld-ContribAuthor ">Maryam  Allahvirdinesbat</span>, <span class="hlFld-ContribAuthor ">Abdol Ali  Alemi</span>. </span><span class="cited-content_cbyCitation_article-title">Green and efficiently synthesized tetrasubstituted imidazole: introduced bismuth oxide co-doped Lu
              3+
              , Er
              3+
              as a novel reusable heterogeneous nanocatalyst. </span><span class="cited-content_cbyCitation_journal-name">Inorganic and Nano-Metal Chemistry</span><span> <strong>2021,</strong> <em>51 </em>
                                    (8)
                                     , 1036-1046. <a href="https://doi.org/10.1080/24701556.2020.1814327" title="DOI URL">https://doi.org/10.1080/24701556.2020.1814327</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/24701556.2020.1814327&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F24701556.2020.1814327%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganic%2520and%2520Nano-Metal%2520Chemistry%26atitle%3DGreen%252Band%252Befficiently%252Bsynthesized%252Btetrasubstituted%252Bimidazole%25253A%252Bintroduced%252Bbismuth%252Boxide%252Bco-doped%252BLu%252B3%25252B%252B%25252C%252BEr%252B3%25252B%252Bas%252Ba%252Bnovel%252Breusable%252Bheterogeneous%252Bnanocatalyst%26aulast%3DKohan%26aufirst%3DElmira%26date%3D2021%26date%3D2020%26volume%3D51%26issue%3D8%26spage%3D1036%26epage%3D1046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fang  Yan Guo</span>, <span class="hlFld-ContribAuthor ">Chang  Ji Zheng</span>, <span class="hlFld-ContribAuthor ">Meiyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Jiangping  Ai</span>, <span class="hlFld-ContribAuthor ">Lan  Ying Han</span>, <span class="hlFld-ContribAuthor ">Liu  Yang</span>, <span class="hlFld-ContribAuthor ">Ye  Fang Lu</span>, <span class="hlFld-ContribAuthor ">Yu  Xuan Yang</span>, <span class="hlFld-ContribAuthor ">Ming  Guan Piao</span>, <span class="hlFld-ContribAuthor ">Hu‐Ri  Piao</span>, <span class="hlFld-ContribAuthor ">Chun‐Mei  Jin</span>, <span class="hlFld-ContribAuthor ">Cheng Hua  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antimicrobial Activity Evaluation of Imidazole‐Fused Imidazo[2,1‐
              b
              ][1,3,4]thiadiazole Analogues. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>45 </em><a href="https://doi.org/10.1002/cmdc.202100122" title="DOI URL">https://doi.org/10.1002/cmdc.202100122</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100122&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100122%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DSynthesis%252Band%252BAntimicrobial%252BActivity%252BEvaluation%252Bof%252BImidazole%2525E2%252580%252590Fused%252BImidazo%25255B2%25252C1%2525E2%252580%252590%252Bb%252B%25255D%25255B1%25252C3%25252C4%25255Dthiadiazole%252BAnalogues%26aulast%3DYan%2BGuo%26aufirst%3DFang%26date%3D2021%26date%3D2021%26volume%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yue Ying  Liu</span>, <span class="hlFld-ContribAuthor ">Zhen  Guo</span>, <span class="hlFld-ContribAuthor ">Jing Ying  Wang</span>, <span class="hlFld-ContribAuthor ">Hui Min  Wang</span>, <span class="hlFld-ContribAuthor ">Jun  Da Qi</span>, <span class="hlFld-ContribAuthor ">Juan  Ma</span>, <span class="hlFld-ContribAuthor ">Hu-Ri  Piao</span>, <span class="hlFld-ContribAuthor ">Cheng Hua  Jin</span>, <span class="hlFld-ContribAuthor ">Xuejun  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of the epithelial-to- mesenchymal inhibitory activity of indazole-derived imidazoles as dual ALK5/p38α MAP inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113311. <a href="https://doi.org/10.1016/j.ejmech.2021.113311" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113311</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113311%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bthe%252Bepithelial-to-%252Bmesenchymal%252Binhibitory%252Bactivity%252Bof%252Bindazole-derived%252Bimidazoles%252Bas%252Bdual%252BALK5%25252Fp38%2525CE%2525B1%252BMAP%252Binhibitors%26aulast%3DLiu%26aufirst%3DYue%2BYing%26date%3D2021%26volume%3D216%26spage%3D113311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shan  Li</span>, <span class="hlFld-ContribAuthor ">Jian  Liang</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Liu</span>, <span class="hlFld-ContribAuthor ">Liqing  Xian</span>, <span class="hlFld-ContribAuthor ">Mingxu  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Iodine-mediated aminohalogenation-oxidation to synthesize 2-fluoroalkyl imidazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemical Papers</span><span> <strong>2021,</strong> <em>75 </em>
                                    (3)
                                     , 1041-1053. <a href="https://doi.org/10.1007/s11696-020-01360-6" title="DOI URL">https://doi.org/10.1007/s11696-020-01360-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11696-020-01360-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11696-020-01360-6%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Papers%26atitle%3DIodine-mediated%252Baminohalogenation-oxidation%252Bto%252Bsynthesize%252B2-fluoroalkyl%252Bimidazole%252Bderivatives%26aulast%3DLi%26aufirst%3DShan%26date%3D2021%26date%3D2020%26volume%3D75%26issue%3D3%26spage%3D1041%26epage%3D1053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ho-Jae  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Development of TGF-β Signaling Inhibitors for Anticancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cancer Prevention</span><span> <strong>2020,</strong> <em>25 </em>
                                    (4)
                                     , 213-222. <a href="https://doi.org/10.15430/JCP.2020.25.4.213" title="DOI URL">https://doi.org/10.15430/JCP.2020.25.4.213</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15430/JCP.2020.25.4.213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15430%2FJCP.2020.25.4.213%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cancer%2520Prevention%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BDevelopment%252Bof%252BTGF-%2525CE%2525B2%252BSignaling%252BInhibitors%252Bfor%252BAnticancer%252BTherapy%26aulast%3DLee%26aufirst%3DHo-Jae%26date%3D2020%26volume%3D25%26issue%3D4%26spage%3D213%26epage%3D222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jipeng  Wang</span>, <span class="hlFld-ContribAuthor ">Carlos  Paz</span>, <span class="hlFld-ContribAuthor ">Gilda  Padalino</span>, <span class="hlFld-ContribAuthor ">Avril  Coghlan</span>, <span class="hlFld-ContribAuthor ">Zhigang  Lu</span>, <span class="hlFld-ContribAuthor ">Irina  Gradinaru</span>, <span class="hlFld-ContribAuthor ">Julie N. R.  Collins</span>, <span class="hlFld-ContribAuthor ">Matthew  Berriman</span>, <span class="hlFld-ContribAuthor ">Karl F.  Hoffmann</span>, <span class="hlFld-ContribAuthor ">James J.  Collins</span>. </span><span class="cited-content_cbyCitation_article-title">Large-scale RNAi screening uncovers
                                                  therapeutic targets in the parasite
              Schistosoma
                                                  mansoni. </span><span class="cited-content_cbyCitation_journal-name">Science</span><span> <strong>2020,</strong> <em>369 </em>
                                    (6511)
                                     , 1649-1653. <a href="https://doi.org/10.1126/science.abb7699" title="DOI URL">https://doi.org/10.1126/science.abb7699</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/science.abb7699&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscience.abb7699%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%26atitle%3DLarge-scale%252BRNAi%252Bscreening%252Buncovers%252Btherapeutic%252Btargets%252Bin%252Bthe%252Bparasite%252BSchistosoma%252Bmansoni%26aulast%3DWang%26aufirst%3DJipeng%26date%3D2020%26date%3D2020%26volume%3D369%26issue%3D6511%26spage%3D1649%26epage%3D1653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Tan</span>, <span class="hlFld-ContribAuthor ">Xiaomeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Xu  Quan</span>, <span class="hlFld-ContribAuthor ">Guochuang  Zheng</span>, <span class="hlFld-ContribAuthor ">Xue  Li</span>, <span class="hlFld-ContribAuthor ">Liwen  Zhao</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Bo  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological activity evaluation of novel 4-((1-cyclopropyl-3-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl) oxy) pyridine-2-yl) amino derivatives as potent transforming growth factor-β (TGF-β) type I receptor inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (16)
                                     , 127339. <a href="https://doi.org/10.1016/j.bmcl.2020.127339" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127339%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bactivity%252Bevaluation%252Bof%252Bnovel%252B4-%252528%2525281-cyclopropyl-3-%252528tetrahydro-2H-pyran-4-yl%252529-1H-pyrazol-4-yl%252529%252Boxy%252529%252Bpyridine-2-yl%252529%252Bamino%252Bderivatives%252Bas%252Bpotent%252Btransforming%252Bgrowth%252Bfactor-%2525CE%2525B2%252B%252528TGF-%2525CE%2525B2%252529%252Btype%252BI%252Breceptor%252Binhibitors%26aulast%3DTan%26aufirst%3DBin%26date%3D2020%26volume%3D30%26issue%3D16%26spage%3D127339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guofeng  Xu</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Hai  Wang</span>, <span class="hlFld-ContribAuthor ">Zhuang  Guo</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Wang</span>, <span class="hlFld-ContribAuthor ">Xue  Li</span>, <span class="hlFld-ContribAuthor ">Shaohua  Chang</span>, <span class="hlFld-ContribAuthor ">Tianwen  Sun</span>, <span class="hlFld-ContribAuthor ">Zhuangzhuang  Yu</span>, <span class="hlFld-ContribAuthor ">Tianwei  Xu</span>, <span class="hlFld-ContribAuthor ">Liwen  Zhao</span>, <span class="hlFld-ContribAuthor ">Yazhou  Wang</span>, <span class="hlFld-ContribAuthor ">Wenying  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 4-(pyridin-4-oxy)-3-(3,3-difluorocyclobutyl)-pyrazole derivatives as novel potent transforming growth factor-β type 1 receptor inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>198 </em>, 112354. <a href="https://doi.org/10.1016/j.ejmech.2020.112354" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112354%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B4-%252528pyridin-4-oxy%252529-3-%2525283%25252C3-difluorocyclobutyl%252529-pyrazole%252Bderivatives%252Bas%252Bnovel%252Bpotent%252Btransforming%252Bgrowth%252Bfactor-%2525CE%2525B2%252Btype%252B1%252Breceptor%252Binhibitors%26aulast%3DXu%26aufirst%3DGuofeng%26date%3D2020%26volume%3D198%26spage%3D112354" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Su Young  Jung</span>, <span class="hlFld-ContribAuthor ">Sunjin  Hwang</span>, <span class="hlFld-ContribAuthor ">Jeffery M.  Clarke</span>, <span class="hlFld-ContribAuthor ">Todd M.  Bauer</span>, <span class="hlFld-ContribAuthor ">Vicki L.  Keedy</span>, <span class="hlFld-ContribAuthor ">Hukeun  Lee</span>, <span class="hlFld-ContribAuthor ">Neunggyu  Park</span>, <span class="hlFld-ContribAuthor ">Seong-Jin  Kim</span>, <span class="hlFld-ContribAuthor ">Jangik I.  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic characteristics of vactosertib, a new activin receptor-like kinase 5 inhibitor, in patients with advanced solid tumors in a first-in-human phase 1 study. </span><span class="cited-content_cbyCitation_journal-name">Investigational New Drugs</span><span> <strong>2020,</strong> <em>38 </em>
                                    (3)
                                     , 812-820. <a href="https://doi.org/10.1007/s10637-019-00835-y" title="DOI URL">https://doi.org/10.1007/s10637-019-00835-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10637-019-00835-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10637-019-00835-y%26sid%3Dliteratum%253Aachs%26jtitle%3DInvestigational%2520New%2520Drugs%26atitle%3DPharmacokinetic%252Bcharacteristics%252Bof%252Bvactosertib%25252C%252Ba%252Bnew%252Bactivin%252Breceptor-like%252Bkinase%252B5%252Binhibitor%25252C%252Bin%252Bpatients%252Bwith%252Badvanced%252Bsolid%252Btumors%252Bin%252Ba%252Bfirst-in-human%252Bphase%252B1%252Bstudy%26aulast%3DJung%26aufirst%3DSu%2BYoung%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D3%26spage%3D812%26epage%3D820" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Wang</span>, <span class="hlFld-ContribAuthor ">Meiling  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Sang</span>, <span class="hlFld-ContribAuthor ">Xuefu  You</span>, <span class="hlFld-ContribAuthor ">Yucheng  Wang</span>, <span class="hlFld-ContribAuthor ">Ian C.  Paterson</span>, <span class="hlFld-ContribAuthor ">Wei  Hong</span>, <span class="hlFld-ContribAuthor ">Xinyi  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of small molecule inhibitors targeting TGF-β ligand and receptor: Structures, mechanism, preclinical studies and clinical usage. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>191 </em>, 112154. <a href="https://doi.org/10.1016/j.ejmech.2020.112154" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112154%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Bsmall%252Bmolecule%252Binhibitors%252Btargeting%252BTGF-%2525CE%2525B2%252Bligand%252Band%252Breceptor%25253A%252BStructures%25252C%252Bmechanism%25252C%252Bpreclinical%252Bstudies%252Band%252Bclinical%252Busage%26aulast%3DWang%26aufirst%3DHao%26date%3D2020%26volume%3D191%26spage%3D112154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenlong  Li</span>, <span class="hlFld-ContribAuthor ">Matthijs  Tibben</span>, <span class="hlFld-ContribAuthor ">Yaogeng  Wang</span>, <span class="hlFld-ContribAuthor ">Maria C.  Lebre</span>, <span class="hlFld-ContribAuthor ">Hilde  Rosing</span>, <span class="hlFld-ContribAuthor ">Jos H.  Beijnen</span>, <span class="hlFld-ContribAuthor ">Alfred H.  Schinkel</span>. </span><span class="cited-content_cbyCitation_article-title">P‐glycoprotein (MDR1/ABCB1) controls brain accumulation and intestinal disposition of the novel TGF‐β signaling pathway inhibitor galunisertib. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Cancer</span><span> <strong>2020,</strong> <em>146 </em>
                                    (6)
                                     , 1631-1642. <a href="https://doi.org/10.1002/ijc.32568" title="DOI URL">https://doi.org/10.1002/ijc.32568</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ijc.32568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fijc.32568%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Cancer%26atitle%3DP%2525E2%252580%252590glycoprotein%252B%252528MDR1%25252FABCB1%252529%252Bcontrols%252Bbrain%252Baccumulation%252Band%252Bintestinal%252Bdisposition%252Bof%252Bthe%252Bnovel%252BTGF%2525E2%252580%252590%2525CE%2525B2%252Bsignaling%252Bpathway%252Binhibitor%252Bgalunisertib%26aulast%3DLi%26aufirst%3DWenlong%26date%3D2020%26date%3D2019%26volume%3D146%26issue%3D6%26spage%3D1631%26epage%3D1642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Praveen Reddy  Adiyala</span>, <span class="hlFld-ContribAuthor ">Seungwook  Jang</span>, <span class="hlFld-ContribAuthor ">Niraj K.  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">Yoon-Ho  Hwang</span>, <span class="hlFld-ContribAuthor ">Dong-Pyo  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Continuous-flow photo-induced decarboxylative annulative access to fused imidazole derivatives
              via
              a microreactor containing immobilized ruthenium. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2020,</strong> <em>22 </em>
                                    (5)
                                     , 1565-1571. <a href="https://doi.org/10.1039/C9GC03496J" title="DOI URL">https://doi.org/10.1039/C9GC03496J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9GC03496J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9GC03496J%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DContinuous-flow%252Bphoto-induced%252Bdecarboxylative%252Bannulative%252Baccess%252Bto%252Bfused%252Bimidazole%252Bderivatives%252Bvia%252Ba%252Bmicroreactor%252Bcontaining%252Bimmobilized%252Bruthenium%26aulast%3DAdiyala%26aufirst%3DPraveen%2BReddy%26date%3D2020%26date%3D2020%26volume%3D22%26issue%3D5%26spage%3D1565%26epage%3D1571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Su Young  Jung</span>, <span class="hlFld-ContribAuthor ">Ju-Hwan  Park</span>, <span class="hlFld-ContribAuthor ">Min-Jun  Baek</span>, <span class="hlFld-ContribAuthor ">Gyu-Ho  Kim</span>, <span class="hlFld-ContribAuthor ">Jaehwan  Kim</span>, <span class="hlFld-ContribAuthor ">Hong-Mei  Zheng</span>, <span class="hlFld-ContribAuthor ">Jae-Min  Kim</span>, <span class="hlFld-ContribAuthor ">Il-Mo  Kang</span>, <span class="hlFld-ContribAuthor ">Dae-Duk  Kim</span>, <span class="hlFld-ContribAuthor ">Jangik I.  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Development of an oral bentonite-based modified-release freeze-dried powder of vactosertib: Pharmacokinetics and anti-colitis activity in rodent models of ulcerative colitis. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Pharmaceutics</span><span> <strong>2020,</strong> <em>578 </em>, 119103. <a href="https://doi.org/10.1016/j.ijpharm.2020.119103" title="DOI URL">https://doi.org/10.1016/j.ijpharm.2020.119103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpharm.2020.119103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpharm.2020.119103%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Pharmaceutics%26atitle%3DDevelopment%252Bof%252Ban%252Boral%252Bbentonite-based%252Bmodified-release%252Bfreeze-dried%252Bpowder%252Bof%252Bvactosertib%25253A%252BPharmacokinetics%252Band%252Banti-colitis%252Bactivity%252Bin%252Brodent%252Bmodels%252Bof%252Bulcerative%252Bcolitis%26aulast%3DJung%26aufirst%3DSu%2BYoung%26date%3D2020%26volume%3D578%26spage%3D119103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Atena  Soleimani</span>, <span class="hlFld-ContribAuthor ">Fereshteh  Asgharzadeh</span>, <span class="hlFld-ContribAuthor ">Farzad  Rahmani</span>, <span class="hlFld-ContribAuthor ">Amir  Avan</span>, <span class="hlFld-ContribAuthor ">Saeedeh  Mehraban</span>, <span class="hlFld-ContribAuthor ">Maryam  Fakhraei</span>, <span class="hlFld-ContribAuthor ">Mohammad Hassan  Arjmand</span>, <span class="hlFld-ContribAuthor ">Maryam Moradi  Binabaj</span>, <span class="hlFld-ContribAuthor ">Mohammad Reza  Parizadeh</span>, <span class="hlFld-ContribAuthor ">Gordon A.  Ferns</span>, <span class="hlFld-ContribAuthor ">Mikhail  Ryzhikov</span>, <span class="hlFld-ContribAuthor ">Amir Reza  Afshari</span>, <span class="hlFld-ContribAuthor ">Jalal  Naghinezhad</span>, <span class="hlFld-ContribAuthor ">Sayyed Hadi  Sayyed‐Hosseinian</span>, <span class="hlFld-ContribAuthor ">Majid  Khazaei</span>, <span class="hlFld-ContribAuthor ">Seyed Mahdi  Hassanian</span>. </span><span class="cited-content_cbyCitation_article-title">Novel oral transforming growth factor‐β signaling inhibitor potently inhibits postsurgical adhesion band formation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular Physiology</span><span> <strong>2020,</strong> <em>235 </em>
                                    (2)
                                     , 1349-1357. <a href="https://doi.org/10.1002/jcp.29053" title="DOI URL">https://doi.org/10.1002/jcp.29053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jcp.29053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjcp.29053%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520Physiology%26atitle%3DNovel%252Boral%252Btransforming%252Bgrowth%252Bfactor%2525E2%252580%252590%2525CE%2525B2%252Bsignaling%252Binhibitor%252Bpotently%252Binhibits%252Bpostsurgical%252Badhesion%252Bband%252Bformation%26aulast%3DSoleimani%26aufirst%3DAtena%26date%3D2020%26date%3D2019%26volume%3D235%26issue%3D2%26spage%3D1349%26epage%3D1357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongxin  Han</span>, <span class="hlFld-ContribAuthor ">Li  Zhu</span>, <span class="hlFld-ContribAuthor ">Wei  Wu</span>, <span class="hlFld-ContribAuthor ">Hui  Zhang</span>, <span class="hlFld-ContribAuthor ">Wei  Hu</span>, <span class="hlFld-ContribAuthor ">Liguang  Dai</span>, <span class="hlFld-ContribAuthor ">Yanqing  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Small Molecular Immune Modulators as Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 547-618. <a href="https://doi.org/10.1007/978-981-15-3266-5_22" title="DOI URL">https://doi.org/10.1007/978-981-15-3266-5_22</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-15-3266-5_22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-15-3266-5_22%26sid%3Dliteratum%253Aachs%26atitle%3DSmall%252BMolecular%252BImmune%252BModulators%252Bas%252BAnticancer%252BAgents%26aulast%3DHan%26aufirst%3DYongxin%26date%3D2020%26date%3D2020%26spage%3D547%26epage%3D618%26pub%3DSpringer%2520Singapore%26atitle%3DRegulation%252Bof%252BCancer%252BImmune%252BCheckpoints%26aulast%3DXu%26aufirst%3DJie%26date%3D2020%26volume%3D1248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Su Young  Jung</span>, <span class="hlFld-ContribAuthor ">Ji Seob  Yug</span>, <span class="hlFld-ContribAuthor ">Jeffery M.  Clarke</span>, <span class="hlFld-ContribAuthor ">Todd M.  Bauer</span>, <span class="hlFld-ContribAuthor ">Vicki L.  Keedy</span>, <span class="hlFld-ContribAuthor ">Sunjin  Hwang</span>, <span class="hlFld-ContribAuthor ">Seong-Jin  Kim</span>, <span class="hlFld-ContribAuthor ">Eun Kyoung  Chung</span>, <span class="hlFld-ContribAuthor ">Jangik I.  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Population pharmacokinetics of vactosertib, a new TGF-β receptor type Ι inhibitor, in patients with advanced solid tumors. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2020,</strong> <em>85 </em>
                                    (1)
                                     , 173-183. <a href="https://doi.org/10.1007/s00280-019-03979-z" title="DOI URL">https://doi.org/10.1007/s00280-019-03979-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-019-03979-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-019-03979-z%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DPopulation%252Bpharmacokinetics%252Bof%252Bvactosertib%25252C%252Ba%252Bnew%252BTGF-%2525CE%2525B2%252Breceptor%252Btype%252B%2525CE%252599%252Binhibitor%25252C%252Bin%252Bpatients%252Bwith%252Badvanced%252Bsolid%252Btumors%26aulast%3DJung%26aufirst%3DSu%2BYoung%26date%3D2020%26date%3D2019%26volume%3D85%26issue%3D1%26spage%3D173%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kang-Moon  Song</span>, <span class="hlFld-ContribAuthor ">Doo Yong  Chung</span>, <span class="hlFld-ContribAuthor ">Min Ji  Choi</span>, <span class="hlFld-ContribAuthor ">Kalyan  Ghatak</span>, <span class="hlFld-ContribAuthor ">Nguyen Nhat  Minh</span>, <span class="hlFld-ContribAuthor ">Anita  Limanjaya</span>, <span class="hlFld-ContribAuthor ">Mi-Hye  Kwon</span>, <span class="hlFld-ContribAuthor ">Jiyeon  Ock</span>, <span class="hlFld-ContribAuthor ">Guo Nan  Yin</span>, <span class="hlFld-ContribAuthor ">Dae-Kee  Kim</span>, <span class="hlFld-ContribAuthor ">Ji-Kan  Ryu</span>, <span class="hlFld-ContribAuthor ">Jun-Kyu  Suh</span>. </span><span class="cited-content_cbyCitation_article-title">Vactosertib, a Novel, Orally Bioavailable Activin Receptor-Like Kinase 5 Inhibitor, Promotes Regression of Fibrotic Plaques in a Rat Model of Peyronie's Disease. </span><span class="cited-content_cbyCitation_journal-name">The World Journal of Men's Health</span><span> <strong>2020,</strong> <em>38 </em>
                                    (4)
                                     , 552. <a href="https://doi.org/10.5534/wjmh.190071" title="DOI URL">https://doi.org/10.5534/wjmh.190071</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5534/wjmh.190071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5534%2Fwjmh.190071%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520World%2520Journal%2520of%2520Men%2527s%2520Health%26atitle%3DVactosertib%25252C%252Ba%252BNovel%25252C%252BOrally%252BBioavailable%252BActivin%252BReceptor-Like%252BKinase%252B5%252BInhibitor%25252C%252BPromotes%252BRegression%252Bof%252BFibrotic%252BPlaques%252Bin%252Ba%252BRat%252BModel%252Bof%252BPeyronie%252527s%252BDisease%26aulast%3DSong%26aufirst%3DKang-Moon%26date%3D2020%26volume%3D38%26issue%3D4%26spage%3D552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan-Wei  Li</span>, <span class="hlFld-ContribAuthor ">Xiang-Yu  Li</span>, <span class="hlFld-ContribAuthor ">Shanji  Li</span>, <span class="hlFld-ContribAuthor ">Li-Min  Zhao</span>, <span class="hlFld-ContribAuthor ">Juan  Ma</span>, <span class="hlFld-ContribAuthor ">Hu-Ri  Piao</span>, <span class="hlFld-ContribAuthor ">Zhe  Jiang</span>, <span class="hlFld-ContribAuthor ">Cheng Hua  Jin</span>, <span class="hlFld-ContribAuthor ">Xuejun  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of the HIF-1α inhibitory activity of 3(5)-substituted-4-(quinolin-4-yl)- and 4-(2-phenylpyridin-4-yl)pyrazoles as inhibitors of ALK5. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (2)
                                     , 126822. <a href="https://doi.org/10.1016/j.bmcl.2019.126822" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126822</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126822%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bthe%252BHIF-1%2525CE%2525B1%252Binhibitory%252Bactivity%252Bof%252B3%2525285%252529-substituted-4-%252528quinolin-4-yl%252529-%252Band%252B4-%2525282-phenylpyridin-4-yl%252529pyrazoles%252Bas%252Binhibitors%252Bof%252BALK5%26aulast%3DLi%26aufirst%3DYan-Wei%26date%3D2020%26volume%3D30%26issue%3D2%26spage%3D126822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Myoung-Soon  Park</span>, <span class="hlFld-ContribAuthor ">Hyun-Ju  Park</span>, <span class="hlFld-ContribAuthor ">Young Jae  An</span>, <span class="hlFld-ContribAuthor ">Joon Hun  Choi</span>, <span class="hlFld-ContribAuthor ">Geunyoung  Cha</span>, <span class="hlFld-ContribAuthor ">Hwa Jeong  Lee</span>, <span class="hlFld-ContribAuthor ">So-Jung  Park</span>, <span class="hlFld-ContribAuthor ">Purushottam M.  Dewang</span>, <span class="hlFld-ContribAuthor ">Dae-Kee  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation and molecular modelling of 2,4-disubstituted-5-(6-alkylpyridin-2-yl)-1
              H
              -imidazoles as ALK5 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2020,</strong> <em>35 </em>
                                    (1)
                                     , 702-712. <a href="https://doi.org/10.1080/14756366.2020.1734799" title="DOI URL">https://doi.org/10.1080/14756366.2020.1734799</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2020.1734799&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2020.1734799%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bmodelling%252Bof%252B2%25252C4-disubstituted-5-%2525286-alkylpyridin-2-yl%252529-1%252BH%252B-imidazoles%252Bas%252BALK5%252Binhibitors%26aulast%3DPark%26aufirst%3DMyoung-Soon%26date%3D2020%26date%3D2020%26volume%3D35%26issue%3D1%26spage%3D702%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renzo  Rossi</span>, <span class="hlFld-ContribAuthor ">Maurizio  Ciofalo</span>. </span><span class="cited-content_cbyCitation_article-title">Current Advances in the Synthesis and Biological Evaluation of Pharmacologically Relevant 1,2,4,5-Tetrasubstituted-1H-Imidazole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Current Organic Chemistry</span><span> <strong>2019,</strong> <em>23 </em>
                                    (19)
                                     , 2016-2101. <a href="https://doi.org/10.2174/1385272823666191014154129" title="DOI URL">https://doi.org/10.2174/1385272823666191014154129</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1385272823666191014154129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1385272823666191014154129%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Organic%2520Chemistry%26atitle%3DCurrent%252BAdvances%252Bin%252Bthe%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BPharmacologically%252BRelevant%252B1%25252C2%25252C4%25252C5-Tetrasubstituted-1H-Imidazole%252BDerivatives%26aulast%3DRossi%26aufirst%3DRenzo%26date%3D2019%26volume%3D23%26issue%3D19%26spage%3D2016%26epage%3D2101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lonneke  Rotteveel</span>, <span class="hlFld-ContribAuthor ">Alex J.  Poot</span>, <span class="hlFld-ContribAuthor ">Harm Jan  Bogaard</span>, <span class="hlFld-ContribAuthor ">Peter  ten Dijke</span>, <span class="hlFld-ContribAuthor ">Adriaan A.  Lammertsma</span>, <span class="hlFld-ContribAuthor ">Albert D.  Windhorst</span>. </span><span class="cited-content_cbyCitation_article-title">In vivo imaging of TGFβ signalling components using positron emission tomography. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2019,</strong> <em>24 </em>
                                    (12)
                                     , 2258-2272. <a href="https://doi.org/10.1016/j.drudis.2019.08.011" title="DOI URL">https://doi.org/10.1016/j.drudis.2019.08.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2019.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2019.08.011%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DIn%252Bvivo%252Bimaging%252Bof%252BTGF%2525CE%2525B2%252Bsignalling%252Bcomponents%252Busing%252Bpositron%252Bemission%252Btomography%26aulast%3DRotteveel%26aufirst%3DLonneke%26date%3D2019%26volume%3D24%26issue%3D12%26spage%3D2258%26epage%3D2272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wen-Jing  Zhu</span>, <span class="hlFld-ContribAuthor ">Ben-Wen  Cui</span>, <span class="hlFld-ContribAuthor ">Hui Min  Wang</span>, <span class="hlFld-ContribAuthor ">Ji-Xing  Nan</span>, <span class="hlFld-ContribAuthor ">Hu-Ri  Piao</span>, <span class="hlFld-ContribAuthor ">Li-Hua  Lian</span>, <span class="hlFld-ContribAuthor ">Cheng Hua  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and antifibrosis evaluation of 4-(benzo-[c][1,2,5]thiadiazol-5-yl)-3(5)-(6-methyl- pyridin-2-yl)pyrazole and 3(5)-(6-methylpyridin- 2-yl)-4-(thieno-[3,2,-c]pyridin-2-yl)pyrazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>180 </em>, 15-27. <a href="https://doi.org/10.1016/j.ejmech.2019.07.013" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.07.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.07.013%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bantifibrosis%252Bevaluation%252Bof%252B4-%252528benzo-%25255Bc%25255D%25255B1%25252C2%25252C5%25255Dthiadiazol-5-yl%252529-3%2525285%252529-%2525286-methyl-%252Bpyridin-2-yl%252529pyrazole%252Band%252B3%2525285%252529-%2525286-methylpyridin-%252B2-yl%252529-4-%252528thieno-%25255B3%25252C2%25252C-c%25255Dpyridin-2-yl%252529pyrazole%252Bderivatives%26aulast%3DZhu%26aufirst%3DWen-Jing%26date%3D2019%26volume%3D180%26spage%3D15%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhen  Guo</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Song</span>, <span class="hlFld-ContribAuthor ">Li-Min  Zhao</span>, <span class="hlFld-ContribAuthor ">Ming Guan  Piao</span>, <span class="hlFld-ContribAuthor ">Jishan  Quan</span>, <span class="hlFld-ContribAuthor ">Hu-Ri  Piao</span>, <span class="hlFld-ContribAuthor ">Cheng Hua  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel benzo[c][1,2,5]thiadiazol-5-yl and thieno[3,2-c]- pyridin-2-yl imidazole derivatives as ALK5 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (16)
                                     , 2070-2075. <a href="https://doi.org/10.1016/j.bmcl.2019.07.015" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.07.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.07.015%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bbenzo%25255Bc%25255D%25255B1%25252C2%25252C5%25255Dthiadiazol-5-yl%252Band%252Bthieno%25255B3%25252C2-c%25255D-%252Bpyridin-2-yl%252Bimidazole%252Bderivatives%252Bas%252BALK5%252Binhibitors%26aulast%3DGuo%26aufirst%3DZhen%26date%3D2019%26volume%3D29%26issue%3D16%26spage%3D2070%26epage%3D2075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pino  Bordignon</span>, <span class="hlFld-ContribAuthor ">Giulia  Bottoni</span>, <span class="hlFld-ContribAuthor ">Xiaoying  Xu</span>, <span class="hlFld-ContribAuthor ">Alma S.  Popescu</span>, <span class="hlFld-ContribAuthor ">Zinnia  Truan</span>, <span class="hlFld-ContribAuthor ">Emmanuella  Guenova</span>, <span class="hlFld-ContribAuthor ">Lukas  Kofler</span>, <span class="hlFld-ContribAuthor ">Paris  Jafari</span>, <span class="hlFld-ContribAuthor ">Paola  Ostano</span>, <span class="hlFld-ContribAuthor ">Martin  Röcken</span>, <span class="hlFld-ContribAuthor ">Victor  Neel</span>, <span class="hlFld-ContribAuthor ">G. Paolo  Dotto</span>. </span><span class="cited-content_cbyCitation_article-title">Dualism of FGF and TGF-β Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2019,</strong> <em>28 </em>
                                    (9)
                                     , 2358-2372.e6. <a href="https://doi.org/10.1016/j.celrep.2019.07.092" title="DOI URL">https://doi.org/10.1016/j.celrep.2019.07.092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2019.07.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2019.07.092%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DDualism%252Bof%252BFGF%252Band%252BTGF-%2525CE%2525B2%252BSignaling%252Bin%252BHeterogeneous%252BCancer-Associated%252BFibroblast%252BActivation%252Bwith%252BETV1%252Bas%252Ba%252BCritical%252BDeterminant%26aulast%3DBordignon%26aufirst%3DPino%26date%3D2019%26volume%3D28%26issue%3D9%26spage%3D2358%26epage%3D2372.e6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xinrui  Yuan</span>, <span class="hlFld-ContribAuthor ">Hanshu  Wu</span>, <span class="hlFld-ContribAuthor ">Hong  Bu</span>, <span class="hlFld-ContribAuthor ">Jinpei  Zhou</span>, <span class="hlFld-ContribAuthor ">Huibin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the immunity protein kinases for immuno-oncology. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>163 </em>, 413-427. <a href="https://doi.org/10.1016/j.ejmech.2018.11.072" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.11.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.11.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.11.072%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bthe%252Bimmunity%252Bprotein%252Bkinases%252Bfor%252Bimmuno-oncology%26aulast%3DYuan%26aufirst%3DXinrui%26date%3D2019%26volume%3D163%26spage%3D413%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Min  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhen  Guo</span>, <span class="hlFld-ContribAuthor ">Yi-Jie  Xue</span>, <span class="hlFld-ContribAuthor ">Jun  Min</span>, <span class="hlFld-ContribAuthor ">Wen-Jing  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiang-Yu  Li</span>, <span class="hlFld-ContribAuthor ">Hu-Ri  Piao</span>, <span class="hlFld-ContribAuthor ">Cheng  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of 3-Substituted-4-(quinoxalin-6-yl) Pyrazoles as TGF-β Type I Receptor Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (12)
                                     , 3369. <a href="https://doi.org/10.3390/molecules23123369" title="DOI URL">https://doi.org/10.3390/molecules23123369</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23123369&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23123369%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252B3-Substituted-4-%252528quinoxalin-6-yl%252529%252BPyrazoles%252Bas%252BTGF-%2525CE%2525B2%252BType%252BI%252BReceptor%252BKinase%252BInhibitors%26aulast%3DZhao%26aufirst%3DLi-Min%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D12%26spage%3D3369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiaywei  Tsauo</span>, <span class="hlFld-ContribAuthor ">Ho-Young  Song</span>, <span class="hlFld-ContribAuthor ">Eun Young  Choi</span>, <span class="hlFld-ContribAuthor ">Dae-Kee  Kim</span>, <span class="hlFld-ContribAuthor ">Kun Yung  Kim</span>, <span class="hlFld-ContribAuthor ">Jung-Hoon  Park</span>, <span class="hlFld-ContribAuthor ">Min Tae  Kim</span>, <span class="hlFld-ContribAuthor ">Sung Hwan  Yoon</span>, <span class="hlFld-ContribAuthor ">Young Je  Lim</span>. </span><span class="cited-content_cbyCitation_article-title">EW-7197, an oral transforming growth factor β type I receptor kinase inhibitor, for preventing peritoneal adhesion formation in a rat model. </span><span class="cited-content_cbyCitation_journal-name">Surgery</span><span> <strong>2018,</strong> <em>164 </em>
                                    (5)
                                     , 1100-1108. <a href="https://doi.org/10.1016/j.surg.2018.07.005" title="DOI URL">https://doi.org/10.1016/j.surg.2018.07.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.surg.2018.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.surg.2018.07.005%26sid%3Dliteratum%253Aachs%26jtitle%3DSurgery%26atitle%3DEW-7197%25252C%252Ban%252Boral%252Btransforming%252Bgrowth%252Bfactor%252B%2525CE%2525B2%252Btype%252BI%252Breceptor%252Bkinase%252Binhibitor%25252C%252Bfor%252Bpreventing%252Bperitoneal%252Badhesion%252Bformation%252Bin%252Ba%252Brat%252Bmodel%26aulast%3DTsauo%26aufirst%3DJiaywei%26date%3D2018%26volume%3D164%26issue%3D5%26spage%3D1100%26epage%3D1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jung-Hyun  Cho</span>, <span class="hlFld-ContribAuthor ">Ah-Young  Oh</span>, <span class="hlFld-ContribAuthor ">Soyoung  Park</span>, <span class="hlFld-ContribAuthor ">So-mi  Kang</span>, <span class="hlFld-ContribAuthor ">Min-Ho  Yoon</span>, <span class="hlFld-ContribAuthor ">Tae-Gyun  Woo</span>, <span class="hlFld-ContribAuthor ">Shin-Deok  Hong</span>, <span class="hlFld-ContribAuthor ">Jihwan  Hwang</span>, <span class="hlFld-ContribAuthor ">Nam-Chul  Ha</span>, <span class="hlFld-ContribAuthor ">Ho-Young  Lee</span>, <span class="hlFld-ContribAuthor ">Bum-Joon  Park</span>. </span><span class="cited-content_cbyCitation_article-title">Loss of NF2 Induces TGFβ Receptor 1–mediated Noncanonical and Oncogenic TGFβ Signaling: Implication of the Therapeutic Effect of TGFβ Receptor 1 Inhibitor on NF2 Syndrome. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2018,</strong> <em>17 </em>
                                    (11)
                                     , 2271-2284. <a href="https://doi.org/10.1158/1535-7163.MCT-17-1210" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-17-1210</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-17-1210&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-17-1210%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DLoss%252Bof%252BNF2%252BInduces%252BTGF%2525CE%2525B2%252BReceptor%252B1%2525E2%252580%252593mediated%252BNoncanonical%252Band%252BOncogenic%252BTGF%2525CE%2525B2%252BSignaling%25253A%252BImplication%252Bof%252Bthe%252BTherapeutic%252BEffect%252Bof%252BTGF%2525CE%2525B2%252BReceptor%252B1%252BInhibitor%252Bon%252BNF2%252BSyndrome%26aulast%3DCho%26aufirst%3DJung-Hyun%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D11%26spage%3D2271%26epage%3D2284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng-Nan  Jiang</span>, <span class="hlFld-ContribAuthor ">Xiao-Ping  Zhou</span>, <span class="hlFld-ContribAuthor ">Dong-Ru  Sun</span>, <span class="hlFld-ContribAuthor ">Huan  Gao</span>, <span class="hlFld-ContribAuthor ">Qing-Chuan  Zheng</span>, <span class="hlFld-ContribAuthor ">Hong-Xing  Zhang</span>, <span class="hlFld-ContribAuthor ">Di  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">2D-QSAR study, molecular docking, and molecular dynamics simulation studies of interaction mechanism between inhibitors and transforming growth factor-beta receptor I (ALK5). </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2018,</strong> <em>36 </em>
                                    (14)
                                     , 3705-3717. <a href="https://doi.org/10.1080/07391102.2017.1396256" title="DOI URL">https://doi.org/10.1080/07391102.2017.1396256</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2017.1396256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2017.1396256%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3D2D-QSAR%252Bstudy%25252C%252Bmolecular%252Bdocking%25252C%252Band%252Bmolecular%252Bdynamics%252Bsimulation%252Bstudies%252Bof%252Binteraction%252Bmechanism%252Bbetween%252Binhibitors%252Band%252Btransforming%252Bgrowth%252Bfactor-beta%252Breceptor%252BI%252B%252528ALK5%252529%26aulast%3DJiang%26aufirst%3DMeng-Nan%26date%3D2018%26date%3D2017%26volume%3D36%26issue%3D14%26spage%3D3705%26epage%3D3717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Binbin  Cheng</span>, <span class="hlFld-ContribAuthor ">Wei-En  Yuan</span>, <span class="hlFld-ContribAuthor ">Jing  Su</span>, <span class="hlFld-ContribAuthor ">Yao  Liu</span>, <span class="hlFld-ContribAuthor ">Jianjun  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in small molecule based cancer immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>157 </em>, 582-598. <a href="https://doi.org/10.1016/j.ejmech.2018.08.028" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.08.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.08.028%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252Bsmall%252Bmolecule%252Bbased%252Bcancer%252Bimmunotherapy%26aulast%3DCheng%26aufirst%3DBinbin%26date%3D2018%26volume%3D157%26spage%3D582%26epage%3D598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Iftikhar Ali  Khawar</span>, <span class="hlFld-ContribAuthor ">Jong Kook  Park</span>, <span class="hlFld-ContribAuthor ">Eun Sun  Jung</span>, <span class="hlFld-ContribAuthor ">Myung Ah  Lee</span>, <span class="hlFld-ContribAuthor ">Suhwan  Chang</span>, <span class="hlFld-ContribAuthor ">Hyo-Jeong  Kuh</span>. </span><span class="cited-content_cbyCitation_article-title">Three Dimensional Mixed-Cell Spheroids Mimic Stroma-Mediated Chemoresistance and Invasive Migration in hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Neoplasia</span><span> <strong>2018,</strong> <em>20 </em>
                                    (8)
                                     , 800-812. <a href="https://doi.org/10.1016/j.neo.2018.05.008" title="DOI URL">https://doi.org/10.1016/j.neo.2018.05.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neo.2018.05.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neo.2018.05.008%26sid%3Dliteratum%253Aachs%26jtitle%3DNeoplasia%26atitle%3DThree%252BDimensional%252BMixed-Cell%252BSpheroids%252BMimic%252BStroma-Mediated%252BChemoresistance%252Band%252BInvasive%252BMigration%252Bin%252Bhepatocellular%252Bcarcinoma%26aulast%3DKhawar%26aufirst%3DIftikhar%2BAli%26date%3D2018%26volume%3D20%26issue%3D8%26spage%3D800%26epage%3D812" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianguang  Lv</span>, <span class="hlFld-ContribAuthor ">Zhiqing  He</span>, <span class="hlFld-ContribAuthor ">Jianmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuwei  Guo</span>, <span class="hlFld-ContribAuthor ">Ziwei  Han</span>, <span class="hlFld-ContribAuthor ">Xinhua  Bao</span>. </span><span class="cited-content_cbyCitation_article-title">One-pot synthesis of [1,2,4]Triazolo[1,5-a]pyridines from azines and benzylidenemalononitriles via copper-catalyzed tandem cyclization. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (29)
                                     , 3996-4004. <a href="https://doi.org/10.1016/j.tet.2018.06.002" title="DOI URL">https://doi.org/10.1016/j.tet.2018.06.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.06.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.06.002%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DOne-pot%252Bsynthesis%252Bof%252B%25255B1%25252C2%25252C4%25255DTriazolo%25255B1%25252C5-a%25255Dpyridines%252Bfrom%252Bazines%252Band%252Bbenzylidenemalononitriles%252Bvia%252Bcopper-catalyzed%252Btandem%252Bcyclization%26aulast%3DLv%26aufirst%3DJianguang%26date%3D2018%26volume%3D74%26issue%3D29%26spage%3D3996%26epage%3D4004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mossaraf  Hossain</span>, <span class="hlFld-ContribAuthor ">Renjith  Thomas</span>, <span class="hlFld-ContribAuthor ">Y. Sheena  Mary</span>, <span class="hlFld-ContribAuthor ">K.S.Resmi</span>, <span class="hlFld-ContribAuthor ">Stevan  Armaković</span>, <span class="hlFld-ContribAuthor ">Sanja J.  Armaković</span>, <span class="hlFld-ContribAuthor ">Ashis Kumar  Nanda</span>, <span class="hlFld-ContribAuthor ">G.  Vijayakumar</span>, <span class="hlFld-ContribAuthor ">C. Van  Alsenoy</span>. </span><span class="cited-content_cbyCitation_article-title">Understanding reactivity of two newly synthetized imidazole derivatives by spectroscopic characterization and computational study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2018,</strong> <em>1158 </em>, 176-196. <a href="https://doi.org/10.1016/j.molstruc.2018.01.029" title="DOI URL">https://doi.org/10.1016/j.molstruc.2018.01.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2018.01.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2018.01.029%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DUnderstanding%252Breactivity%252Bof%252Btwo%252Bnewly%252Bsynthetized%252Bimidazole%252Bderivatives%252Bby%252Bspectroscopic%252Bcharacterization%252Band%252Bcomputational%252Bstudy%26aulast%3DHossain%26aufirst%3DMossaraf%26date%3D2018%26volume%3D1158%26spage%3D176%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kichang  Han</span>, <span class="hlFld-ContribAuthor ">Jung-Hoon  Park</span>, <span class="hlFld-ContribAuthor ">Su-Geun  Yang</span>, <span class="hlFld-ContribAuthor ">Deok Hee  Lee</span>, <span class="hlFld-ContribAuthor ">Jiaywei  Tsauo</span>, <span class="hlFld-ContribAuthor ">Kun Yung  Kim</span>, <span class="hlFld-ContribAuthor ">Min Tae  Kim</span>, <span class="hlFld-ContribAuthor ">Sung Gwon  Gang</span>, <span class="hlFld-ContribAuthor ">Dae-Kee  Kim</span>, <span class="hlFld-ContribAuthor ">Dong-Hyun  Kim</span>, <span class="hlFld-ContribAuthor ">Ho-Young  Song</span>, . </span><span class="cited-content_cbyCitation_article-title">EW-7197 eluting nano-fiber covered self-expandable metallic stent to prevent granulation tissue formation in a canine urethral model. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2018,</strong> <em>13 </em>
                                    (2)
                                     , e0192430. <a href="https://doi.org/10.1371/journal.pone.0192430" title="DOI URL">https://doi.org/10.1371/journal.pone.0192430</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0192430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0192430%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DEW-7197%252Beluting%252Bnano-fiber%252Bcovered%252Bself-expandable%252Bmetallic%252Bstent%252Bto%252Bprevent%252Bgranulation%252Btissue%252Bformation%252Bin%252Ba%252Bcanine%252Burethral%252Bmodel%26aulast%3DHan%26aufirst%3DKichang%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D2%26spage%3De0192430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter L.  Toogood</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule immuno-oncology therapeutic agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (3)
                                     , 319-329. <a href="https://doi.org/10.1016/j.bmcl.2017.12.044" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.12.044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.12.044%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSmall%252Bmolecule%252Bimmuno-oncology%252Btherapeutic%252Bagents%26aulast%3DToogood%26aufirst%3DPeter%2BL.%26date%3D2018%26volume%3D28%26issue%3D3%26spage%3D319%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan M.  Yingling</span>, <span class="hlFld-ContribAuthor ">William T.  McMillen</span>, <span class="hlFld-ContribAuthor ">Lei  Yan</span>, <span class="hlFld-ContribAuthor ">Huocong  Huang</span>, <span class="hlFld-ContribAuthor ">J. Scott  Sawyer</span>, <span class="hlFld-ContribAuthor ">Jeremy  Graff</span>, <span class="hlFld-ContribAuthor ">David K.  Clawson</span>, <span class="hlFld-ContribAuthor ">Karen S.  Britt</span>, <span class="hlFld-ContribAuthor ">Bryan D.  Anderson</span>, <span class="hlFld-ContribAuthor ">Douglas W.  Beight</span>, <span class="hlFld-ContribAuthor ">Durisala  Desaiah</span>, <span class="hlFld-ContribAuthor ">Michael M.  Lahn</span>, <span class="hlFld-ContribAuthor ">Karim A.  Benhadji</span>, <span class="hlFld-ContribAuthor ">Maria J.  Lallena</span>, <span class="hlFld-ContribAuthor ">Rikke B.  Holmgaard</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Xu</span>, <span class="hlFld-ContribAuthor ">Faming  Zhang</span>, <span class="hlFld-ContribAuthor ">Jason R.  Manro</span>, <span class="hlFld-ContribAuthor ">Philip W.  Iversen</span>, <span class="hlFld-ContribAuthor ">Chandrasekar V.  Iyer</span>, <span class="hlFld-ContribAuthor ">Rolf A.  Brekken</span>, <span class="hlFld-ContribAuthor ">Michael D.  Kalos</span>, <span class="hlFld-ContribAuthor ">Kyla E.  Driscoll</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2018,</strong> <em>9 </em>
                                    (6)
                                     , 6659-6677. <a href="https://doi.org/10.18632/oncotarget.23795" title="DOI URL">https://doi.org/10.18632/oncotarget.23795</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.23795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.23795%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DPreclinical%252Bassessment%252Bof%252Bgalunisertib%252B%252528LY2157299%252Bmonohydrate%252529%25252C%252Ba%252Bfirst-in-class%252Btransforming%252Bgrowth%252Bfactor-%2525CE%2525B2%252Breceptor%252Btype%252BI%252Binhibitor%26aulast%3DYingling%26aufirst%3DJonathan%2BM.%26date%3D2018%26date%3D2017%26volume%3D9%26issue%3D6%26spage%3D6659%26epage%3D6677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.  DeVito</span>, <span class="hlFld-ContribAuthor ">M. A.  Morse</span>, <span class="hlFld-ContribAuthor ">B.  Hanks</span>, <span class="hlFld-ContribAuthor ">J. M.  Clarke</span>. </span><span class="cited-content_cbyCitation_article-title">Immune Checkpoint Combinations with Inflammatory Pathway Modulators. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 219-241. <a href="https://doi.org/10.1007/978-3-319-63757-0_8" title="DOI URL">https://doi.org/10.1007/978-3-319-63757-0_8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-63757-0_8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-63757-0_8%26sid%3Dliteratum%253Aachs%26atitle%3DImmune%252BCheckpoint%252BCombinations%252Bwith%252BInflammatory%252BPathway%252BModulators%26aulast%3DDeVito%26aufirst%3DN.%26date%3D2018%26date%3D2017%26spage%3D219%26epage%3D241%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DEarly%252BPhase%252BCancer%252BImmunotherapy%26aulast%3DPatel%26aufirst%3DSandip%2BPravin%26date%3D2018%26volume%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Renzo  Rossi</span>, <span class="hlFld-ContribAuthor ">Marco  Lessi</span>, <span class="hlFld-ContribAuthor ">Chiara  Manzini</span>, <span class="hlFld-ContribAuthor ">Fabio  Bellina</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Profiles of 4,5-, 1,5-, and 1,2-Diaryl-1 H -imidazoles. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 83-160. <a href="https://doi.org/10.1016/B978-0-08-102237-5.00004-3" title="DOI URL">https://doi.org/10.1016/B978-0-08-102237-5.00004-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-102237-5.00004-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-102237-5.00004-3%26sid%3Dliteratum%253Aachs%26atitle%3DSynthesis%252Band%252BBiological%252BProfiles%252Bof%252B4%25252C5-%25252C%252B1%25252C5-%25252C%252Band%252B1%25252C2-Diaryl-1%252BH%252B-imidazoles%26aulast%3DRossi%26aufirst%3DRenzo%26date%3D2018%26spage%3D83%26epage%3D160%26pub%3DElsevier%26atitle%3DVicinal%252BDiaryl%252BSubstituted%252BHeterocycles%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sachin D.  Pardeshi</span>, <span class="hlFld-ContribAuthor ">Pratima A.  Sathe</span>, <span class="hlFld-ContribAuthor ">Kamlesh S.  Vadagaonkar</span>, <span class="hlFld-ContribAuthor ">Atul C.  Chaskar</span>. </span><span class="cited-content_cbyCitation_article-title">One-Pot Protocol for the Synthesis of Imidazoles and Quinoxalines using
              N
              -Bromosuccinimide. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2017,</strong> <em>359 </em>
                                    (23)
                                     , 4217-4226. <a href="https://doi.org/10.1002/adsc.201700900" title="DOI URL">https://doi.org/10.1002/adsc.201700900</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201700900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201700900%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DOne-Pot%252BProtocol%252Bfor%252Bthe%252BSynthesis%252Bof%252BImidazoles%252Band%252BQuinoxalines%252Busing%252BN%252B-Bromosuccinimide%26aulast%3DPardeshi%26aufirst%3DSachin%2BD.%26date%3D2017%26date%3D2017%26volume%3D359%26issue%3D23%26spage%3D4217%26epage%3D4226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shivananda  Kandagalla</span>, <span class="hlFld-ContribAuthor ">B. S.  Sharath</span>, <span class="hlFld-ContribAuthor ">Basavapattana Rudresh  Bharath</span>, <span class="hlFld-ContribAuthor ">Umme  hani</span>, <span class="hlFld-ContribAuthor ">Hanumanthappa  Manjunatha</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular docking analysis of curcumin analogues against kinase domain of ALK5. </span><span class="cited-content_cbyCitation_journal-name">In Silico Pharmacology</span><span> <strong>2017,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1007/s40203-017-0034-0" title="DOI URL">https://doi.org/10.1007/s40203-017-0034-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40203-017-0034-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40203-017-0034-0%26sid%3Dliteratum%253Aachs%26jtitle%3DIn%2520Silico%2520Pharmacology%26atitle%3DMolecular%252Bdocking%252Banalysis%252Bof%252Bcurcumin%252Banalogues%252Bagainst%252Bkinase%252Bdomain%252Bof%252BALK5%26aulast%3DKandagalla%26aufirst%3DShivananda%26date%3D2017%26date%3D2017%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rosemary J.  Akhurst</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting TGF-β Signaling for Therapeutic Gain. </span><span class="cited-content_cbyCitation_journal-name">Cold Spring Harbor Perspectives in Biology</span><span> <strong>2017,</strong> <em>9 </em>
                                    (10)
                                     , a022301. <a href="https://doi.org/10.1101/cshperspect.a022301" title="DOI URL">https://doi.org/10.1101/cshperspect.a022301</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1101/cshperspect.a022301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1101%2Fcshperspect.a022301%26sid%3Dliteratum%253Aachs%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspectives%2520in%2520Biology%26atitle%3DTargeting%252BTGF-%2525CE%2525B2%252BSignaling%252Bfor%252BTherapeutic%252BGain%26aulast%3DAkhurst%26aufirst%3DRosemary%2BJ.%26date%3D2017%26date%3D2017%26volume%3D9%26issue%3D10%26spage%3Da022301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sachin D.  Pardeshi</span>, <span class="hlFld-ContribAuthor ">Kamlesh S.  Vadagaonkar</span>, <span class="hlFld-ContribAuthor ">Jatin J.  Lade</span>, <span class="hlFld-ContribAuthor ">Lucio  Melone</span>, <span class="hlFld-ContribAuthor ">Atul C.  Chaskar</span>. </span><span class="cited-content_cbyCitation_article-title">An Efficient Synthesis of 1,2,4-Trisubstituted Imidazoles from Arylacetic Acids and
              N
              -Arylbenzamidines via Simultaneous C-H and N-H Bond Activation. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2017,</strong> <em>2 </em>
                                    (19)
                                     , 5409-5413. <a href="https://doi.org/10.1002/slct.201700522" title="DOI URL">https://doi.org/10.1002/slct.201700522</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201700522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201700522%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DAn%252BEfficient%252BSynthesis%252Bof%252B1%25252C2%25252C4-Trisubstituted%252BImidazoles%252Bfrom%252BArylacetic%252BAcids%252Band%252BN%252B-Arylbenzamidines%252Bvia%252BSimultaneous%252BC-H%252Band%252BN-H%252BBond%252BActivation%26aulast%3DPardeshi%26aufirst%3DSachin%2BD.%26date%3D2017%26date%3D2017%26volume%3D2%26issue%3D19%26spage%3D5409%26epage%3D5413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eun Jung  Jun</span>, <span class="hlFld-ContribAuthor ">Jung-Hoon  Park</span>, <span class="hlFld-ContribAuthor ">Jiaywei  Tsauo</span>, <span class="hlFld-ContribAuthor ">Su-Geun  Yang</span>, <span class="hlFld-ContribAuthor ">Dae-Kee  Kim</span>, <span class="hlFld-ContribAuthor ">Kun Yung  Kim</span>, <span class="hlFld-ContribAuthor ">Min Tae  Kim</span>, <span class="hlFld-ContribAuthor ">Sung-Hwan  Yoon</span>, <span class="hlFld-ContribAuthor ">Young Je  Lim</span>, <span class="hlFld-ContribAuthor ">Ho-Young  Song</span>. </span><span class="cited-content_cbyCitation_article-title">EW-7197, an activin-like kinase 5 inhibitor, suppresses granulation tissue after stent placement in rat esophagus. </span><span class="cited-content_cbyCitation_journal-name">Gastrointestinal Endoscopy</span><span> <strong>2017,</strong> <em>86 </em>
                                    (1)
                                     , 219-228. <a href="https://doi.org/10.1016/j.gie.2017.01.013" title="DOI URL">https://doi.org/10.1016/j.gie.2017.01.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.gie.2017.01.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.gie.2017.01.013%26sid%3Dliteratum%253Aachs%26jtitle%3DGastrointestinal%2520Endoscopy%26atitle%3DEW-7197%25252C%252Ban%252Bactivin-like%252Bkinase%252B5%252Binhibitor%25252C%252Bsuppresses%252Bgranulation%252Btissue%252Bafter%252Bstent%252Bplacement%252Bin%252Brat%252Besophagus%26aulast%3DJun%26aufirst%3DEun%2BJung%26date%3D2017%26volume%3D86%26issue%3D1%26spage%3D219%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Sabat</span>, <span class="hlFld-ContribAuthor ">Haixia  Wang</span>, <span class="hlFld-ContribAuthor ">Nick  Scorah</span>, <span class="hlFld-ContribAuthor ">J. David  Lawson</span>, <span class="hlFld-ContribAuthor ">Joy  Atienza</span>, <span class="hlFld-ContribAuthor ">Ruhi  Kamran</span>, <span class="hlFld-ContribAuthor ">Mark S.  Hixon</span>, <span class="hlFld-ContribAuthor ">Douglas R.  Dougan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and optimization of 7-substituted-pyrazolo[4,3-b]pyridine ALK5 (activin receptor-like kinase 5) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (9)
                                     , 1955-1961. <a href="https://doi.org/10.1016/j.bmcl.2017.03.026" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.03.026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.03.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.03.026%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Boptimization%252Bof%252B7-substituted-pyrazolo%25255B4%25252C3-b%25255Dpyridine%252BALK5%252B%252528activin%252Breceptor-like%252Bkinase%252B5%252529%252Binhibitors%26aulast%3DSabat%26aufirst%3DMark%26date%3D2017%26volume%3D27%26issue%3D9%26spage%3D1955%26epage%3D1961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seon Pyo  Hong</span>, <span class="hlFld-ContribAuthor ">Sukhyun  Song</span>, <span class="hlFld-ContribAuthor ">Sung Woo  Cho</span>, <span class="hlFld-ContribAuthor ">Seungjoo  Lee</span>, <span class="hlFld-ContribAuthor ">Bong Ihn  Koh</span>, <span class="hlFld-ContribAuthor ">Hosung  Bae</span>, <span class="hlFld-ContribAuthor ">Kyun Hoo  Kim</span>, <span class="hlFld-ContribAuthor ">Jin-Sung  Park</span>, <span class="hlFld-ContribAuthor ">Hyo-Sang  Do</span>, <span class="hlFld-ContribAuthor ">Ilkyun  Im</span>, <span class="hlFld-ContribAuthor ">Hye Jin  Heo</span>, <span class="hlFld-ContribAuthor ">Tae Hee  Ko</span>, <span class="hlFld-ContribAuthor ">Jae-Hyeong  Park</span>, <span class="hlFld-ContribAuthor ">Jae Boum  Youm</span>, <span class="hlFld-ContribAuthor ">Seong-Jin  Kim</span>, <span class="hlFld-ContribAuthor ">Injune  Kim</span>, <span class="hlFld-ContribAuthor ">Jin  Han</span>, <span class="hlFld-ContribAuthor ">Yong-Mahn  Han</span>, <span class="hlFld-ContribAuthor ">Gou Young  Koh</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of PDGFRα+ Cardioblasts from Pluripotent Stem Cells. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2017,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep41840" title="DOI URL">https://doi.org/10.1038/srep41840</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep41840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep41840%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DGeneration%252Bof%252BPDGFR%2525CE%2525B1%25252B%252BCardioblasts%252Bfrom%252BPluripotent%252BStem%252BCells%26aulast%3DHong%26aufirst%3DSeon%2BPyo%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sirichat  Kaowinn</span>, <span class="hlFld-ContribAuthor ">Jeonghyo  Kim</span>, <span class="hlFld-ContribAuthor ">Jaebeom  Lee</span>, <span class="hlFld-ContribAuthor ">Dong Hoon  Shin</span>, <span class="hlFld-ContribAuthor ">Chi-Dug  Kang</span>, <span class="hlFld-ContribAuthor ">Dae-Kee  Kim</span>, <span class="hlFld-ContribAuthor ">Soojin  Lee</span>, <span class="hlFld-ContribAuthor ">Min Kyung  Kang</span>, <span class="hlFld-ContribAuthor ">Sang Seok  Koh</span>, <span class="hlFld-ContribAuthor ">Seong-Jin  Kim</span>, <span class="hlFld-ContribAuthor ">Young-Hwa  Chung</span>. </span><span class="cited-content_cbyCitation_article-title">Cancer upregulated gene 2 induces epithelial-mesenchymal transition of human lung cancer cells via TGF-β signaling. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2017,</strong> <em>8 </em>
                                    (3)
                                     , 5092-5110. <a href="https://doi.org/10.18632/oncotarget.13867" title="DOI URL">https://doi.org/10.18632/oncotarget.13867</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.13867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.13867%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DCancer%252Bupregulated%252Bgene%252B2%252Binduces%252Bepithelial-mesenchymal%252Btransition%252Bof%252Bhuman%252Blung%252Bcancer%252Bcells%252Bvia%252BTGF-%2525CE%2525B2%252Bsignaling%26aulast%3DKaowinn%26aufirst%3DSirichat%26date%3D2017%26date%3D2016%26volume%3D8%26issue%3D3%26spage%3D5092%26epage%3D5110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masoumeh  Divar</span>, <span class="hlFld-ContribAuthor ">Farhad  Panahi</span>, <span class="hlFld-ContribAuthor ">Sayedeh Rojin  Shariatipour</span>, <span class="hlFld-ContribAuthor ">Ali  Khalafi-Nezhad</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Imidazole and Theophylline Derivatives Incorporating Pyrimidine-Fused Heterocycles Using Magnetic Nanoparticles-Supported Tungstic Acid (MNP-TA) Catalyst. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2017,</strong> <em>54 </em>
                                    (1)
                                     , 660-669. <a href="https://doi.org/10.1002/jhet.2639" title="DOI URL">https://doi.org/10.1002/jhet.2639</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2639%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BImidazole%252Band%252BTheophylline%252BDerivatives%252BIncorporating%252BPyrimidine-Fused%252BHeterocycles%252BUsing%252BMagnetic%252BNanoparticles-Supported%252BTungstic%252BAcid%252B%252528MNP-TA%252529%252BCatalyst%26aulast%3DDivar%26aufirst%3DMasoumeh%26date%3D2017%26date%3D2016%26volume%3D54%26issue%3D1%26spage%3D660%26epage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Juan  Du</span>, <span class="hlFld-ContribAuthor ">Yu  Yu</span>, <span class="hlFld-ContribAuthor ">Jun  Zhan</span>, <span class="hlFld-ContribAuthor ">Hongquan  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted Therapies Against Growth Factor Signaling in Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 125-146. <a href="https://doi.org/10.1007/978-981-10-6020-5_6" title="DOI URL">https://doi.org/10.1007/978-981-10-6020-5_6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-10-6020-5_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-10-6020-5_6%26sid%3Dliteratum%253Aachs%26atitle%3DTargeted%252BTherapies%252BAgainst%252BGrowth%252BFactor%252BSignaling%252Bin%252BBreast%252BCancer%26aulast%3DDu%26aufirst%3DJuan%26date%3D2017%26date%3D2017%26spage%3D125%26epage%3D146%26pub%3DSpringer%2520Singapore%26atitle%3DTranslational%252BResearch%252Bin%252BBreast%252BCancer%26aulast%3DSong%26aufirst%3DErwei%26date%3D2017%26volume%3D1026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.L.  Adams</span>, <span class="hlFld-ContribAuthor ">K.J.  Duffy</span>, <span class="hlFld-ContribAuthor ">M.L.  Moore</span>, <span class="hlFld-ContribAuthor ">J.  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Cancer Immunotherapy—An Emerging Field That Bridges Oncology and Immunology Research. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 357-394. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12400-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12400-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12400-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12400-X%26sid%3Dliteratum%253Aachs%26atitle%3DCancer%252BImmunotherapy%2525E2%252580%252594An%252BEmerging%252BField%252BThat%252BBridges%252BOncology%252Band%2525C2%2525A0Immunology%252BResearch%26aulast%3DAdams%26aufirst%3DJ.L.%26date%3D2017%26spage%3D357%26epage%3D394%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Uttam Kumar  Das</span>, <span class="hlFld-ContribAuthor ">Linda J. W.  Shimon</span>, <span class="hlFld-ContribAuthor ">David  Milstein</span>. </span><span class="cited-content_cbyCitation_article-title">Imidazole synthesis by transition metal free, base-mediated deaminative coupling of benzylamines and nitriles. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2017,</strong> <em>53 </em>
                                    (98)
                                     , 13133-13136. <a href="https://doi.org/10.1039/C7CC08322J" title="DOI URL">https://doi.org/10.1039/C7CC08322J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7CC08322J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7CC08322J%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DImidazole%252Bsynthesis%252Bby%252Btransition%252Bmetal%252Bfree%25252C%252Bbase-mediated%252Bdeaminative%252Bcoupling%252Bof%252Bbenzylamines%252Band%252Bnitriles%26aulast%3DDas%26aufirst%3DUttam%2BKumar%26date%3D2017%26date%3D2017%26volume%3D53%26issue%3D98%26spage%3D13133%26epage%3D13136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hilmar  Weinmann</span>. </span><span class="cited-content_cbyCitation_article-title">Cancer Immunotherapy: Selected Targets and Small-Molecule Modulators. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (5)
                                     , 450-466. <a href="https://doi.org/10.1002/cmdc.201500566" title="DOI URL">https://doi.org/10.1002/cmdc.201500566</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201500566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201500566%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DCancer%252BImmunotherapy%25253A%252BSelected%252BTargets%252Band%252BSmall-Molecule%252BModulators%26aulast%3DWeinmann%26aufirst%3DHilmar%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D5%26spage%3D450%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kazuhito  Naka</span>, <span class="hlFld-ContribAuthor ">Kaori  Ishihara</span>, <span class="hlFld-ContribAuthor ">Yoshie  Jomen</span>, <span class="hlFld-ContribAuthor ">Cheng Hua  Jin</span>, <span class="hlFld-ContribAuthor ">Dong‐Hyun  Kim</span>, <span class="hlFld-ContribAuthor ">Yoon‐Kang  Gu</span>, <span class="hlFld-ContribAuthor ">Eun‐Sook  Jeong</span>, <span class="hlFld-ContribAuthor ">Shaoguang  Li</span>, <span class="hlFld-ContribAuthor ">Daniela S.  Krause</span>, <span class="hlFld-ContribAuthor ">Dong‐Wook  Kim</span>, <span class="hlFld-ContribAuthor ">Eunjin  Bae</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Takihara</span>, <span class="hlFld-ContribAuthor ">Atsushi  Hirao</span>, <span class="hlFld-ContribAuthor ">Hiroko  Oshima</span>, <span class="hlFld-ContribAuthor ">Masanobu  Oshima</span>, <span class="hlFld-ContribAuthor ">Akira  Ooshima</span>, <span class="hlFld-ContribAuthor ">Yhun Yhong  Sheen</span>, <span class="hlFld-ContribAuthor ">Seong‐Jin  Kim</span>, <span class="hlFld-ContribAuthor ">Dae‐Kee  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Novel oral transforming growth factor‐β signaling inhibitor
              EW
              ‐7197 eradicates
              CML
              ‐initiating cells. </span><span class="cited-content_cbyCitation_journal-name">Cancer Science</span><span> <strong>2016,</strong> <em>107 </em>
                                    (2)
                                     , 140-148. <a href="https://doi.org/10.1111/cas.12849" title="DOI URL">https://doi.org/10.1111/cas.12849</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cas.12849&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcas.12849%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Science%26atitle%3DNovel%252Boral%252Btransforming%252Bgrowth%252Bfactor%2525E2%252580%252590%2525CE%2525B2%252Bsignaling%252Binhibitor%252BEW%252B%2525E2%252580%2525907197%252Beradicates%252BCML%252B%2525E2%252580%252590initiating%252Bcells%26aulast%3DNaka%26aufirst%3DKazuhito%26date%3D2016%26date%3D2016%26volume%3D107%26issue%3D2%26spage%3D140%26epage%3D148" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José M.  Muñoz-Félix</span>, <span class="hlFld-ContribAuthor ">María  González-Núñez</span>, <span class="hlFld-ContribAuthor ">Carlos  Martínez-Salgado</span>, <span class="hlFld-ContribAuthor ">José M.  López-Novoa</span>. </span><span class="cited-content_cbyCitation_article-title">TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25years of trials and tribulations?. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2015,</strong> <em>156 </em>, 44-58. <a href="https://doi.org/10.1016/j.pharmthera.2015.10.003" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2015.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2015.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2015.10.003%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DTGF-%2525CE%2525B2%25252FBMP%252Bproteins%252Bas%252Btherapeutic%252Btargets%252Bin%252Brenal%252Bfibrosis.%252BWhere%252Bhave%252Bwe%252Barrived%252Bafter%252B25years%252Bof%252Btrials%252Band%252Btribulations%25253F%26aulast%3DMu%25C3%25B1oz-F%25C3%25A9lix%26aufirst%3DJos%25C3%25A9%2BM.%26date%3D2015%26volume%3D156%26spage%3D44%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sang-A  Park</span>, <span class="hlFld-ContribAuthor ">Min-Jin  Kim</span>, <span class="hlFld-ContribAuthor ">So-Yeon  Park</span>, <span class="hlFld-ContribAuthor ">Jung-Shin  Kim</span>, <span class="hlFld-ContribAuthor ">Woosung  Lim</span>, <span class="hlFld-ContribAuthor ">Jeong-Seok  Nam</span>, <span class="hlFld-ContribAuthor ">Yhun  Yhong Sheen</span>. </span><span class="cited-content_cbyCitation_article-title">TIMP-1 mediates TGF-β-dependent crosstalk between hepatic stellate and cancer cells via FAK signaling. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2015,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep16492" title="DOI URL">https://doi.org/10.1038/srep16492</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep16492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep16492%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DTIMP-1%252Bmediates%252BTGF-%2525CE%2525B2-dependent%252Bcrosstalk%252Bbetween%252Bhepatic%252Bstellate%252Band%252Bcancer%252Bcells%252Bvia%252BFAK%252Bsignaling%26aulast%3DPark%26aufirst%3DSang-A%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maddeboina  Krishnaiah</span>, <span class="hlFld-ContribAuthor ">Cheng Hua  Jin</span>, <span class="hlFld-ContribAuthor ">Yhun Yhong  Sheen</span>, <span class="hlFld-ContribAuthor ">Dae-Kee  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 5-(fluoro-substituted-6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)imidazoles as inhibitors of transforming growth factor-β type I receptor kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (22)
                                     , 5228-5231. <a href="https://doi.org/10.1016/j.bmcl.2015.09.058" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.09.058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.09.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.09.058%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B5-%252528fluoro-substituted-6-methylpyridin-2-yl%252529-4-%252528%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-a%25255Dpyridin-6-yl%252529imidazoles%252Bas%252Binhibitors%252Bof%252Btransforming%252Bgrowth%252Bfactor-%2525CE%2525B2%252Btype%252BI%252Breceptor%252Bkinase%26aulast%3DKrishnaiah%26aufirst%3DMaddeboina%26date%3D2015%26volume%3D25%26issue%3D22%26spage%3D5228%26epage%3D5231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeong-Hwan  Yoon</span>, <span class="hlFld-ContribAuthor ">Katsuko  Sudo</span>, <span class="hlFld-ContribAuthor ">Masahiko  Kuroda</span>, <span class="hlFld-ContribAuthor ">Mitsuyasu  Kato</span>, <span class="hlFld-ContribAuthor ">In-Kyu  Lee</span>, <span class="hlFld-ContribAuthor ">Jin Soo  Han</span>, <span class="hlFld-ContribAuthor ">Susumu  Nakae</span>, <span class="hlFld-ContribAuthor ">Takeshi  Imamura</span>, <span class="hlFld-ContribAuthor ">Juryun  Kim</span>, <span class="hlFld-ContribAuthor ">Ji Hyeon  Ju</span>, <span class="hlFld-ContribAuthor ">Dae-Kee  Kim</span>, <span class="hlFld-ContribAuthor ">Koichi  Matsuzaki</span>, <span class="hlFld-ContribAuthor ">Michael  Weinstein</span>, <span class="hlFld-ContribAuthor ">Isao  Matsumoto</span>, <span class="hlFld-ContribAuthor ">Takayuki  Sumida</span>, <span class="hlFld-ContribAuthor ">Mizuko  Mamura</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphorylation status determines the opposing functions of Smad2/Smad3 as STAT3 cofactors in TH17 differentiation. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2015,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/ncomms8600" title="DOI URL">https://doi.org/10.1038/ncomms8600</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/ncomms8600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fncomms8600%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DPhosphorylation%252Bstatus%252Bdetermines%252Bthe%252Bopposing%252Bfunctions%252Bof%252BSmad2%25252FSmad3%252Bas%252BSTAT3%252Bcofactors%252Bin%252BTH17%252Bdifferentiation%26aulast%3DYoon%26aufirst%3DJeong-Hwan%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jerry L.  Adams</span>, <span class="hlFld-ContribAuthor ">James  Smothers</span>, <span class="hlFld-ContribAuthor ">Roopa  Srinivasan</span>, <span class="hlFld-ContribAuthor ">Axel  Hoos</span>. </span><span class="cited-content_cbyCitation_article-title">Big opportunities for small molecules in immuno-oncology. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2015,</strong> <em>14 </em>
                                    (9)
                                     , 603-622. <a href="https://doi.org/10.1038/nrd4596" title="DOI URL">https://doi.org/10.1038/nrd4596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd4596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd4596%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DBig%252Bopportunities%252Bfor%252Bsmall%252Bmolecules%252Bin%252Bimmuno-oncology%26aulast%3DAdams%26aufirst%3DJerry%2BL.%26date%3D2015%26date%3D2015%26volume%3D14%26issue%3D9%26spage%3D603%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sang-A  Park</span>, <span class="hlFld-ContribAuthor ">Min-Jin  Kim</span>, <span class="hlFld-ContribAuthor ">So-Yeon  Park</span>, <span class="hlFld-ContribAuthor ">Jung-Shin  Kim</span>, <span class="hlFld-ContribAuthor ">Seon-Joo  Lee</span>, <span class="hlFld-ContribAuthor ">Hyun Ae  Woo</span>, <span class="hlFld-ContribAuthor ">Dae-Kee  Kim</span>, <span class="hlFld-ContribAuthor ">Jeong-Seok  Nam</span>, <span class="hlFld-ContribAuthor ">Yhun Yhong  Sheen</span>. </span><span class="cited-content_cbyCitation_article-title">EW-7197 inhibits hepatic, renal, and pulmonary fibrosis by blocking TGF-β/Smad and ROS signaling. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Life Sciences</span><span> <strong>2015,</strong> <em>72 </em>
                                    (10)
                                     , 2023-2039. <a href="https://doi.org/10.1007/s00018-014-1798-6" title="DOI URL">https://doi.org/10.1007/s00018-014-1798-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00018-014-1798-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00018-014-1798-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Life%2520Sciences%26atitle%3DEW-7197%252Binhibits%252Bhepatic%25252C%252Brenal%25252C%252Band%252Bpulmonary%252Bfibrosis%252Bby%252Bblocking%252BTGF-%2525CE%2525B2%25252FSmad%252Band%252BROS%252Bsignaling%26aulast%3DPark%26aufirst%3DSang-A%26date%3D2015%26date%3D2014%26volume%3D72%26issue%3D10%26spage%3D2023%26epage%3D2039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. ALK5 inhibitors under development.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structure of a major metabolite of <b>6</b> in rat and mouse.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 2-phenoxyacetaldehyde (for <b>9a</b>) or 2-(phenylthio)acetaldehyde (for <b>9b</b>), NH<sub>4</sub>OAc, <i>t</i>-BuOMe/MeOH, rt, 70–180 min.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 60% 2,2-dimethoxyacetaldehyde in H<sub>2</sub>O, NH<sub>4</sub>OAc, <i>t</i>-BuOMe/MeOH, rt, 4 h; (b) 1 N HCl, 70 °C, 4 h; (c) AcOH, 1,2-dichloroethane, reflux (for <b>12a</b>–<b>h</b>, <b>12j</b>–<b>l</b>, <b>12n</b>–<b>an</b>, <b>12ap</b>, <b>12ar</b>–<b>az</b>, and <b>12bb</b>–<b>bh</b>), rt (for <b>12i</b>, <b>12ao</b>, and <b>12bi</b> (without AcOH)), or 120 °C (for <b>12ba</b>, in sealed tube), then (AcO)<sub>3</sub>BHNa (for <b>12c</b>, <b>12e</b>–<b>h</b>, <b>12j</b>, <b>12k</b>, <b>12q</b>, <b>12s</b>–<b>x</b>, <b>12ab</b>–<b>af</b>, <b>12ah</b>, <b>12aj</b>–<b>an</b>, <b>12ap</b>, <b>12ar</b>, <b>12as</b>, <b>12au</b>, <b>12ax</b>, <b>12az</b>, <b>12bd</b>, <b>12be</b>, and <b>12bg</b>–<b>bi</b>) or NaBH<sub>4</sub> (<b>12a</b>, <b>12b</b>, <b>12d</b>, <b>12i</b>, <b>12m</b>, <b>12n</b>–<b>p</b>, <b>12r</b>, <b>12y</b>, <b>12z</b>, <b>12aa</b>, <b>12ag</b>, <b>12ai</b>, <b>12ao</b>, <b>12at</b>, <b>12av</b>, <b>12aw</b>, <b>12ay</b>, <b>12ba</b>–<b>bc</b>, and <b>12bf</b>), THF, MeOH, rt; (d) 34.5% H<sub>2</sub>O<sub>2</sub>, 1 N NaOH, EtOH, rt, 2–3 h (for <b>12m</b> and <b>12aq</b>).</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) AcOH, 1,2-dichloroethane, reflux, then (AcO)<sub>3</sub>BHNa (for <b>14a</b>–<b>e</b> and <b>14j</b>–<b>l</b>) or NaBH<sub>4</sub> (for <b>14f</b>–<b>i</b> and <b>14m</b>–<b>p</b>), THF, MeOH, rt.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (A) Progress curves for ALK5. (B) Michaelis–Menten plot for ALK5/<b>12b</b>. (C) Lineweaver–Burk plot for ALK5/<b>12b</b>. (D) Global fit of Michaelis–Menten plot by GraFit software for ALK5/<b>12b</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystallographic structure of <b>12b</b>·MeOH.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/medium/jm-2014-00115w_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Docking pose of candidate compounds in the active site of ALK5 (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RW8">1RW8</a>). (A) Docking pose of <b>12b</b> (magenta capped sticks). (B) <b>12a</b> (cyan capped sticks). (C) <b>9a</b> (yellow capped sticks). (D) <b>9b</b> (green capped sticks). Gray capped sticks represent key amino acid residues within the binding site and ribbon is backbone of ALK5. Ball and stick is water molecule. Red dashed lines are hydrogen bonding interactions (<2.8 Å). (E) Docking pose of <b>12b</b> (magenta carbon). The active site is shown as MOLCAD lipophilic potential surface map. Lipophilicity increases from blue (hydrophilic) to brown (lipophilic).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-10/jm500115w/20160122/images/large/jm-2014-00115w_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm500115w&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i122">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75420" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75420" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 63 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Massague, J.</span><span> </span><span class="NLM_article-title">How cells read TGF-β signals</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1038%2F35043051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=11252892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivVGjsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2000&pages=169-178&author=J.+Massague&title=How+cells+read+TGF-%CE%B2+signals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">How cells read TGF-β signals</span></div><div class="casAuthors">Massague, Joan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-178</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with 109 refs.  Cell proliferation, differentiation and death are controlled by a multitude of cell-cell signals, and loss of this control has devastating consequences.  Prominent among these regulatory signals is the transforming growth factor-β (TGF-β) family of cytokines, which can trigger a bewildering diversity of responses, depending on the genetic makeup and environment of the target cell.  The networks of cell-specific mols. that mold the TGF-β response to each cell's needs are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhcrvp8y40VLVg90H21EOLACvtfcHk0lhRSEpRt_Y4ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivVGjsro%253D&md5=1959515f609d76d5c6de2fe95fb78d49</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2F35043051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35043051%26sid%3Dliteratum%253Aachs%26aulast%3DMassague%26aufirst%3DJ.%26atitle%3DHow%2520cells%2520read%2520TGF-%25CE%25B2%2520signals%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2000%26volume%3D1%26spage%3D169%26epage%3D178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Derynck, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y. E.</span><span> </span><span class="NLM_article-title">Smad-dependent and Smad-independent pathways in TGF-β family signalling</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">425</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">584</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=577-584&author=R.+Derynckauthor=Y.+E.+Zhang&title=Smad-dependent+and+Smad-independent+pathways+in+TGF-%CE%B2+family+signalling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDerynck%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%2BE.%26atitle%3DSmad-dependent%2520and%2520Smad-independent%2520pathways%2520in%2520TGF-%25CE%25B2%2520family%2520signalling%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D577%26epage%3D584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Akhurst, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hata, A.</span><span> </span><span class="NLM_article-title">Targeting the TGFβ signalling pathway in disease</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">790</span><span class="NLM_x">–</span> <span class="NLM_lpage">811</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=790-811&author=R.+J.+Akhurstauthor=A.+Hata&title=Targeting+the+TGF%CE%B2+signalling+pathway+in+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkhurst%26aufirst%3DR.%2BJ.%26aulast%3DHata%26aufirst%3DA.%26atitle%3DTargeting%2520the%2520TGF%25CE%25B2%2520signalling%2520pathway%2520in%2520disease%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D790%26epage%3D811" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Byfield, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Major, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laping, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. B.</span><span> </span><span class="NLM_article-title">SB-505124 is a selective inhibitor of transforming growth factor-β type I receptors ALK4, ALK5, and ALK7</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">744</span><span class="NLM_x">–</span> <span class="NLM_lpage">752</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=744-752&author=S.+D.+Byfieldauthor=C.+Majorauthor=N.+J.+Lapingauthor=A.+B.+Roberts&title=SB-505124+is+a+selective+inhibitor+of+transforming+growth+factor-%CE%B2+type+I+receptors+ALK4%2C+ALK5%2C+and+ALK7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DByfield%26aufirst%3DS.%2BD.%26aulast%3DMajor%26aufirst%3DC.%26aulast%3DLaping%26aufirst%3DN.%2BJ.%26aulast%3DRoberts%26aufirst%3DA.%2BB.%26atitle%3DSB-505124%2520is%2520a%2520selective%2520inhibitor%2520of%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%2520I%2520receptors%2520ALK4%252C%2520ALK5%252C%2520and%2520ALK7%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D65%26spage%3D744%26epage%3D752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Grygielko, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tweed, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laping, N. J.</span><span> </span><span class="NLM_article-title">Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-β type I receptor kinase in puromycin-induced nephritis</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">313</span><span class="NLM_x">, </span> <span class="NLM_fpage">943</span><span class="NLM_x">–</span> <span class="NLM_lpage">951</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1124%2Fjpet.104.082099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=15769863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslektrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=943-951&author=E.+T.+Grygielkoauthor=W.+M.+Martinauthor=C.+Tweedauthor=P.+Thorntonauthor=J.+Harlingauthor=D.+P.+Brooksauthor=N.+J.+Laping&title=Inhibition+of+gene+markers+of+fibrosis+with+a+novel+inhibitor+of+transforming+growth+factor-%CE%B2+type+I+receptor+kinase+in+puromycin-induced+nephritis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-β type I receptor kinase in puromycin-induced nephritis</span></div><div class="casAuthors">Grygielko, Eugene T.; Martin, William M.; Tweed, Christopher; Thornton, Peter; Harling, John; Brooks, David P.; Laping, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">943-951</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">SB-525334 (6-[2-tert-butyl-5-(6-methyl-pyridin-2-yl)-1H-imidazol-4-yl]-quinoxaline) has been characterized as a potent and selective inhibitor of the transforming growth factor-β1 (TGF-β1) receptor, activin receptor-like kinase (ALK5).  The compd. inhibited ALK5 kinase activity with an IC50 of 14.3 nM and was ∼4-fold less potent as an inhibitor of ALK4 (IC50 = 58.5 nM).  SB-525334 was inactive as an inhibitor of ALK2, ALK3, and ALK6 (IC50 > 10,000 nM).  In cell-based assays, SB-525334 (1 μM) blocked TGF-β1-induced phosphorylation and nuclear translocation of Smad2/3 in renal proximal tubule cells and inhibited TGF-β1-induced increases in plasminogen activator inhibitor-1 (PAI-1) and procollagen α1(I) mRNA expression in A498 renal epithelial carcinoma cells.  In view of this profile, SB-525334 was used to investigate the role of TGF-β1 in the acute puromycin aminonucleoside (PAN) rat model of renal disease, a model of nephritis-induced renal fibrosis.  Orally administered doses of 1, 3, or 10 mg/kg/day SB-525334 for 11 days produced statistically significant redns. in renal PAI-1 mRNA.  Also, the compd. produced dose-dependent decreases in renal procollagen α1(I) and procollagen α1(III) mRNA, which reached statistical significance at the 10-mg/kg/day dose when compared with vehicle-treated PAN controls.  Furthermore, PAN-induced proteinuria was significantly inhibited at the 10-mg/kg/day dose level.  These results provide further evidence for the involvement of TGF-β1 in the profibrotic changes that occur in the PAN model and for the first time, demonstrate the ability of a small mol. inhibitor of ALK5 to block several of the markers that are predictive of fibrosis and renal injury in this model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquItdIyglCEbVg90H21EOLACvtfcHk0ljHSwQJpXqdcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslektrw%253D&md5=405654b7353c72eb3f3ad8b51c8b4a62</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.082099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.082099%26sid%3Dliteratum%253Aachs%26aulast%3DGrygielko%26aufirst%3DE.%2BT.%26aulast%3DMartin%26aufirst%3DW.%2BM.%26aulast%3DTweed%26aufirst%3DC.%26aulast%3DThornton%26aufirst%3DP.%26aulast%3DHarling%26aufirst%3DJ.%26aulast%3DBrooks%26aufirst%3DD.%2BP.%26aulast%3DLaping%26aufirst%3DN.%2BJ.%26atitle%3DInhibition%2520of%2520gene%2520markers%2520of%2520fibrosis%2520with%2520a%2520novel%2520inhibitor%2520of%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%2520I%2520receptor%2520kinase%2520in%2520puromycin-induced%2520nephritis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D943%26epage%3D951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">De Gouville, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boullay, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krysa, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilot, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brusq, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriolle, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papworth, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laroze, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huet, S.</span><span> </span><span class="NLM_article-title">Inhibition of TGF-β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1038%2Fsj.bjp.0706172" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=15723089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkt1ShtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2005&pages=166-177&author=A.+C.+De+Gouvilleauthor=V.+Boullayauthor=G.+Krysaauthor=J.+Pilotauthor=J.+M.+Brusqauthor=F.+Loriolleauthor=J.+M.+Gauthierauthor=S.+A.+Papworthauthor=A.+Larozeauthor=F.+Gellibertauthor=S.+Huet&title=Inhibition+of+TGF-%CE%B2+signaling+by+an+ALK5+inhibitor+protects+rats+from+dimethylnitrosamine-induced+liver+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of TGF-β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis</span></div><div class="casAuthors">de Gouville, Anne-Charlotte; Boullay, Valerie; Krysa, Gael; Pilot, Julia; Brusq, Jean-Marie; Loriolle, Florence; Gauthier, Jean-Michel; Papworth, Stephen A.; Laroze, Alain; Gellibert, Francoise; Huet, Stephane</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">166-177</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chronic liver disease is characterized by an exacerbated accumulation of matrix, causing progressive fibrosis, which may lead to cirrhosis.  Transforming growth factor beta (TGF-β), a well-known profibrotic cytokine, transduces its signal through the ALK5 ser/thr kinase receptor, and increases transcription of different genes including PAI-1 and collagens.  The identification of GW6604 (2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine), an ALK5 inhibitor, allowed us to evaluate the therapeutic potential of inhibiting TGF-β pathway in different models of liver disease.  A cellular assay was used to identify GW6604 as a TGF-β signaling pathway inhibitor.  This ALK5 inhibitor was then tested in a model of liver hepatectomy in TGF-β-overexpressing transgenic mice, in an acute model of liver disease and in a chronic model of dimethylnitrosamine (DMN)-induced liver fibrosis.  In vitro, GW6604 inhibited autophosphorylation of ALK5 with an IC50 of 140 nM and in a cellular assay inhibited TGF-β-induced transcription of PAI-1 (IC50: 500 nM).  In vivo, GW6604 (40 mg kg-1 p.o.) increased liver regeneration in TGF-β-overexpressing mice, which had undergone partial hepatectomy.  In an acute model of liver disease, GW6604 reduced by 80% the expression of collagen IA1.  In a chronic model of DMN-induced fibrosis where DMN was administered for 6 wk and GW6604 dosed for the last 3 wk (80 mg kg-1 p.o., b.i.d.), mortality was prevented and DMN-induced elevations of mRNA encoding for collagen IA1, IA2, III, TIMP-1 and TGF-β were reduced by 50-75%.  Inhibition of matrix genes overexpression was accompanied by reduced matrix deposition and redn. in liver function deterioration, as assessed by bilirubin and liver enzyme levels.  Our results suggest that inhibition of ALK5 could be an attractive new approach to treatment of liver fibrotic diseases by both preventing matrix deposition and promoting hepatocyte regeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3D2GxxCUg5bVg90H21EOLACvtfcHk0ljHSwQJpXqdcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkt1ShtbY%253D&md5=f499fcf77d4b4d58bbf9b52ecf0131df</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0706172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0706172%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGouville%26aufirst%3DA.%2BC.%26aulast%3DBoullay%26aufirst%3DV.%26aulast%3DKrysa%26aufirst%3DG.%26aulast%3DPilot%26aufirst%3DJ.%26aulast%3DBrusq%26aufirst%3DJ.%2BM.%26aulast%3DLoriolle%26aufirst%3DF.%26aulast%3DGauthier%26aufirst%3DJ.%2BM.%26aulast%3DPapworth%26aufirst%3DS.%2BA.%26aulast%3DLaroze%26aufirst%3DA.%26aulast%3DGellibert%26aufirst%3DF.%26aulast%3DHuet%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520TGF-%25CE%25B2%2520signaling%2520by%2520an%2520ALK5%2520inhibitor%2520protects%2520rats%2520from%2520dimethylnitrosamine-induced%2520liver%2520fibrosis%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D145%26spage%3D166%26epage%3D177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Ge, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajeev, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ray, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lattime, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittling, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medicherla, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreiner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnard, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiss, M.</span><span> </span><span class="NLM_article-title">Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-β type I receptor kinase in vivo</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">4315</span><span class="NLM_x">–</span> <span class="NLM_lpage">4330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1158%2F1078-0432.CCR-06-0162" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=16857807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFSmsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=4315-4330&author=R.+Geauthor=V.+Rajeevauthor=P.+Rayauthor=E.+Lattimeauthor=S.+Rittlingauthor=S.+Medicherlaauthor=A.+Protterauthor=A.+Murphyauthor=J.+Chakravartyauthor=S.+Dugarauthor=G.+Schreinerauthor=N.+Barnardauthor=M.+Reiss&title=Inhibition+of+growth+and+metastasis+of+mouse+mammary+carcinoma+by+selective+inhibitor+of+transforming+growth+factor-%CE%B2+type+I+receptor+kinase+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-β type I receptor kinase in vivo</span></div><div class="casAuthors">Ge, Rongrong; Rajeev, Vaishali; Ray, Partha; Lattime, Edmund; Rittling, Susan; Medicherla, Satya; Protter, Andy; Murphy, Alison; Chakravarty, Jit; Dugar, Sundeep; Schreiner, George; Barnard, Nicola; Reiss, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">14, Pt. 1</span>),
    <span class="NLM_cas:pages">4315-4330</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Transforming growth factor-β (TGF-β) suppresses tumor development by inhibiting cellular proliferation, inducing differentiation and apoptosis, and maintaining genomic integrity.  However, once tumor cells escape from the tumor-suppressive effects of TGF-β, they often constitutively overexpress and activate TGF-β, which may promote tumor progression by enhancing invasion, metastasis, and angiogenesis and by suppressing antitumor immunity.  The purpose of this study was to test this hypothesis using TGF-β pathway antagonists.  We examd. the effects of selective TGF-β type I receptor kinase inhibitors, SD-093 and SD-208, on two murine mammary carcinoma cell lines (R3T and 4T1) in vitro and in vivo.  Both agents blocked TGF-β-induced phosphorylation of the receptor-assocd. Smads, Smad2 and Smad3, in a dose-dependent manner, with IC50 between 20 and 80 nmol/L.  TGF-β failed to inhibit growth of these cell lines but stimulated epithelial-to-mesenchymal trans-differentiation, migration, and invasiveness into Matrigel in vitro.  These effects were inhibited by SD-093, indicating that these processes are partly driven by TGF-β.  Treatment of syngeneic R3T or 4T1 tumor-bearing mice with orally given SD-208 inhibited primary tumor growth as well as the no. and size of metastases.  In contrast, SD-208 failed to inhibit R3T tumor growth or metastasis in athymic nude mice.  Moreover, in vitro anti-4T1 cell cytotoxic T-cell responses of splenocytes from drug-treated animals were enhanced compared with cells from control animals.  In addn., SD-208 treatment resulted in a decrease in tumor angiogenesis.  CONCLUSION: TGF-β type I receptor kinase inhibitors hold promise as novel therapeutic agents for metastatic breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqDEiIuRyLeLVg90H21EOLACvtfcHk0liIkoaYxKsGEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFSmsb8%253D&md5=610a8880817eae037d36b257fa066d64</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-0162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-0162%26sid%3Dliteratum%253Aachs%26aulast%3DGe%26aufirst%3DR.%26aulast%3DRajeev%26aufirst%3DV.%26aulast%3DRay%26aufirst%3DP.%26aulast%3DLattime%26aufirst%3DE.%26aulast%3DRittling%26aufirst%3DS.%26aulast%3DMedicherla%26aufirst%3DS.%26aulast%3DProtter%26aufirst%3DA.%26aulast%3DMurphy%26aufirst%3DA.%26aulast%3DChakravarty%26aufirst%3DJ.%26aulast%3DDugar%26aufirst%3DS.%26aulast%3DSchreiner%26aufirst%3DG.%26aulast%3DBarnard%26aufirst%3DN.%26aulast%3DReiss%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520growth%2520and%2520metastasis%2520of%2520mouse%2520mammary%2520carcinoma%2520by%2520selective%2520inhibitor%2520of%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%2520I%2520receptor%2520kinase%2520in%2520vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D4315%26epage%3D4330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Kapoun, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspar, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damm, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Young, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quon, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dugar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Protter, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, F.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennard, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, L. S.</span><span> </span><span class="NLM_article-title">Transforming growth factor-β receptor type 1 (TGFβRI) kinase activity but not p38 activation is required for TGFβRI-induced myofibroblast differentiation and profibrotic gene expression</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">518</span><span class="NLM_x">–</span> <span class="NLM_lpage">531</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=518-531&author=A.+M.+Kapounauthor=N.+J.+Gasparauthor=Y.+Wangauthor=D.+Dammauthor=Y.-W.+Liuauthor=G.+O%E2%80%99Youngauthor=D.+Quonauthor=A.+Lamauthor=K.+Munsonauthor=T.-T.+Tranauthor=J.+Y.+Maauthor=A.+Murphyauthor=S.+Dugarauthor=S.+Chakravartyauthor=A.+A.+Protterauthor=F.-Q.+Wenauthor=X.+Liuauthor=S.+I.+Rennardauthor=L.+S.+Higgins&title=Transforming+growth+factor-%CE%B2+receptor+type+1+%28TGF%CE%B2RI%29+kinase+activity+but+not+p38+activation+is+required+for+TGF%CE%B2RI-induced+myofibroblast+differentiation+and+profibrotic+gene+expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKapoun%26aufirst%3DA.%2BM.%26aulast%3DGaspar%26aufirst%3DN.%2BJ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DDamm%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DY.-W.%26aulast%3DO%25E2%2580%2599Young%26aufirst%3DG.%26aulast%3DQuon%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DA.%26aulast%3DMunson%26aufirst%3DK.%26aulast%3DTran%26aufirst%3DT.-T.%26aulast%3DMa%26aufirst%3DJ.%2BY.%26aulast%3DMurphy%26aufirst%3DA.%26aulast%3DDugar%26aufirst%3DS.%26aulast%3DChakravarty%26aufirst%3DS.%26aulast%3DProtter%26aufirst%3DA.%2BA.%26aulast%3DWen%26aufirst%3DF.-Q.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DRennard%26aufirst%3DS.%2BI.%26aulast%3DHiggins%26aufirst%3DL.%2BS.%26atitle%3DTransforming%2520growth%2520factor-%25CE%25B2%2520receptor%2520type%25201%2520%2528TGF%25CE%25B2RI%2529%2520kinase%2520activity%2520but%2520not%2520p38%2520activation%2520is%2520required%2520for%2520TGF%25CE%25B2RI-induced%2520myofibroblast%2520differentiation%2520and%2520profibrotic%2520gene%2520expression%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D518%26epage%3D531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Bueno, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Alwis, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pitou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yingling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glatt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trocóniz, I. F.</span><span> </span><span class="NLM_article-title">Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-β kinase antagonist, in mice</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">142</span><span class="NLM_x">–</span> <span class="NLM_lpage">150</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2008&pages=142-150&author=L.+Buenoauthor=D.+P.+de+Alwisauthor=C.+Pitouauthor=J.+Yinglingauthor=M.+Lahnauthor=S.+Glattauthor=I.+F.+Troc%C3%B3niz&title=Semi-mechanistic+modelling+of+the+tumour+growth+inhibitory+effects+of+LY2157299%2C+a+new+type+I+receptor+TGF-%CE%B2+kinase+antagonist%2C+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBueno%26aufirst%3DL.%26aulast%3Dde%2BAlwis%26aufirst%3DD.%2BP.%26aulast%3DPitou%26aufirst%3DC.%26aulast%3DYingling%26aufirst%3DJ.%26aulast%3DLahn%26aufirst%3DM.%26aulast%3DGlatt%26aufirst%3DS.%26aulast%3DTroc%25C3%25B3niz%26aufirst%3DI.%2BF.%26atitle%3DSemi-mechanistic%2520modelling%2520of%2520the%2520tumour%2520growth%2520inhibitory%2520effects%2520of%2520LY2157299%252C%2520a%2520new%2520type%2520I%2520receptor%2520TGF-%25CE%25B2%2520kinase%2520antagonist%252C%2520in%2520mice%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2008%26volume%3D44%26spage%3D142%26epage%3D150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Kim, D.-K.; Bang, Y.-J.; Kim, H.-T.; Cho, I.-S.; Park, M.-S.; An, Y. J.; Choi, J. H.</span><span> </span><span class="NLM_article-title">2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors</span>. US 7,407,958 B2,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=D.-K.+Kim&author=Y.-J.+Bang&author=H.-T.+Kim&author=I.-S.+Cho&author=M.-S.+Park&author=Y.+J.+An&author=J.+H.+Choi&title=2-Pyridyl+substituted+imidazoles+as+ALK5+and%2For+ALK4+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.-K.%26atitle%3D2-Pyridyl%2520substituted%2520imidazoles%2520as%2520ALK5%2520and%252For%2520ALK4%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Lee, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, I. Y.</span><span> </span><span class="NLM_article-title">Effect of IN-1130, a small molecule inhibitor of transforming growth factor-β type I receptor/activin receptor-like kinase-5, on prostate cancer cells</span> <span class="citation_source-journal">J. Urol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">180</span><span class="NLM_x">, </span> <span class="NLM_fpage">2660</span><span class="NLM_x">–</span> <span class="NLM_lpage">2667</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1016%2Fj.juro.2008.08.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=18951571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFant7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=180&publication_year=2008&pages=2660-2667&author=G.+T.+Leeauthor=J.+H.+Hongauthor=T.+J.+Muellerauthor=J.+A.+Watsonauthor=C.+Kwakauthor=Y.+Y.+Sheenauthor=D.-K.+Kimauthor=S.+J.+Kimauthor=I.+Y.+Kim&title=Effect+of+IN-1130%2C+a+small+molecule+inhibitor+of+transforming+growth+factor-%CE%B2+type+I+receptor%2Factivin+receptor-like+kinase-5%2C+on+prostate+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of IN-1130, a small molecule inhibitor of transforming growth factor-β type I receptor/activin receptor-like kinase-5, on prostate cancer cells</span></div><div class="casAuthors">Lee, Geun Taek; Hong, Jun Hyuk; Mueller, Thomas J.; Watson, John A.; Kwak, Cheol; Sheen, Youn Young; Kim, Dae-Kee; Kim, Seong Jin; Kim, Isaac Yi</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">180</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2660-2667</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Purpose: Transforming growth factor-β is a potent immune suppressor that is over expressed by most malignant cells to evade the host immune response.  Thus, a potential anticancer therapeutic strategy is the inhibition of transforming growth factor-β signaling.  Materials and Methods: We investigated the specificity and the antitumor effect of IN-1130, a novel small mol. inhibitor of the transforming growth factor-β type I receptor ALK-5.  Results: IN-1130 inhibited transforming growth factor-β induced cell death and gene transcriptional activity in a concn. dependent manner in the human hepatoma cell line HepG2.  Simultaneously immunoblot anal. demonstrated that IN-1130 inhibited the Smad2 phosphorylation induced by transforming growth factor-β.  To det. the specificity of IN-1130 for transforming growth factor-β signaling the effect on active and bone morphogenic protein signaling was subsequently investigated.  Results demonstrated that IN-1130 did not inhibit bone morphogenic protein signaling.  However, active signaling was blocked by IN-1130 in a concn. dependent manner.  Furthermore, immunoblot anal. for phospho-Smad2 following transfection with constitutively active ALK-1 to 7 demonstrated that IN-1130 inhibited ALK-4 (active receptor type IB), 5 (TβRI) and 7 (nodal type I receptor).  To investigate the antitumor effect of IN-1130 WT mice were injected s.c. with the murine prostate cancer cell line Tramp C2.  Seven days later IN-1130 was administered i.p. daily for 30 days.  Results demonstrated a dramatic decrease in tumor vol. in assocn. with an enhanced immune response in the treatment group.  Conclusions: Taken together these results demonstrate that IN-1130 is a relatively nontoxic inhibitor of ALK-4/5/7 that may potentially treat prostate cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiaK-TKcMdlLVg90H21EOLACvtfcHk0livF_uOiNV9nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFant7vL&md5=76ec24260fef96d45b275d5b22d8109f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2008.08.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2008.08.008%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DG.%2BT.%26aulast%3DHong%26aufirst%3DJ.%2BH.%26aulast%3DMueller%26aufirst%3DT.%2BJ.%26aulast%3DWatson%26aufirst%3DJ.%2BA.%26aulast%3DKwak%26aufirst%3DC.%26aulast%3DSheen%26aufirst%3DY.%2BY.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DKim%26aufirst%3DI.%2BY.%26atitle%3DEffect%2520of%2520IN-1130%252C%2520a%2520small%2520molecule%2520inhibitor%2520of%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%2520I%2520receptor%252Factivin%2520receptor-like%2520kinase-5%252C%2520on%2520prostate%2520cancer%2520cells%26jtitle%3DJ.%2520Urol.%26date%3D2008%26volume%3D180%26spage%3D2660%26epage%3D2667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Galarreta, C. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thornhill, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forbes, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpkins, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chevalier, R. L.</span><span> </span><span class="NLM_article-title">Transforming growth factor-β1 receptor inhibition preserves glomerulotubular integrity during ureteral obstruction in adults but worsens injury in neonatal mice</span> <span class="citation_source-journal">J. Physiol. Renal Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">304</span><span class="NLM_x">, </span> <span class="NLM_fpage">F481</span><span class="NLM_x">–</span> <span class="NLM_lpage">F490</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=304&publication_year=2013&pages=F481-F490&author=C.+I.+Galarretaauthor=B.+A.+Thornhillauthor=M.+S.+Forbesauthor=L.+N.+Simpkinsauthor=D.-K.+Kimauthor=R.+L.+Chevalier&title=Transforming+growth+factor-%CE%B21+receptor+inhibition+preserves+glomerulotubular+integrity+during+ureteral+obstruction+in+adults+but+worsens+injury+in+neonatal+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGalarreta%26aufirst%3DC.%2BI.%26aulast%3DThornhill%26aufirst%3DB.%2BA.%26aulast%3DForbes%26aufirst%3DM.%2BS.%26aulast%3DSimpkins%26aufirst%3DL.%2BN.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DChevalier%26aufirst%3DR.%2BL.%26atitle%3DTransforming%2520growth%2520factor-%25CE%25B21%2520receptor%2520inhibition%2520preserves%2520glomerulotubular%2520integrity%2520during%2520ureteral%2520obstruction%2520in%2520adults%2520but%2520worsens%2520injury%2520in%2520neonatal%2520mice%26jtitle%3DJ.%2520Physiol.%2520Renal%2520Physiol.%26date%3D2013%26volume%3D304%26spage%3DF481%26epage%3DF490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Moon, J.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, I.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span> </span><span class="NLM_article-title">IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy</span> <span class="citation_source-journal">Kidney Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">1234</span><span class="NLM_x">–</span> <span class="NLM_lpage">1243</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1038%2Fsj.ki.5001775" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=16929250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpsl2qtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1234-1243&author=J.-A.+Moonauthor=H.-T.+Kimauthor=I.-S.+Choauthor=Y.+Y.+Sheenauthor=D.-K.+Kim&title=IN-1130%2C+a+novel+transforming+growth+factor-%CE%B2+type+I+receptor+kinase+%28ALK5%29+inhibitor%2C+suppresses+renal+fibrosis+in+obstructive+nephropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy</span></div><div class="casAuthors">Moon, J.-A.; Kim, H.-T.; Cho, I.-S.; Sheen, Y. Y.; Kim, D.-K.</div><div class="citationInfo"><span class="NLM_cas:title">Kidney International</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1234-1243</span>CODEN:
                <span class="NLM_cas:coden">KDYIA5</span>;
        ISSN:<span class="NLM_cas:issn">0085-2538</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The transforming growth factor-β (TGF-β) plays a central role in the progression of renal fibrosis.  TGF-β transduces its signal through the activin receptor-like kinase (ALK)5.  IN-1130, a novel small mol. ALK5 inhibitor, inhibited the purified kinase domain of ALK5-mediated Smad3 phosphorylation with an IC50 value of 5.3 nM.  IN-1130 proved to be highly selective in a panel of 27 serine/threonine and tyrosine kinases including p38α mitogen-activated protein kinase.  We evaluated the efficacy of IN-1130 to block renal fibrogenesis induced by unilateral ureteral obstruction (UUO) in rats.  Either vehicle (saline) or IN-1130 (10 and 20 mg/kg/day) was i.p. administered to UUO rats for 7 and 14 days.  Phosphorylated Smad2 (pSmad2) and markers of fibrosis were analyzed in kidney tissues.  In UUO control kidneys, interstitial fibrosis including tubular atrophy, loss and dilation, inflammatory cell infiltration, and fibroblast cell proliferation was prominent.  These morphol. changes were notably reduced by IN-1130 treatment.  IN-1130 decreased levels of TGF-β1 mRNA (mRNA), type I collagen mRNA, and pSmad2, compared to UUO control rats.  As detd. by measuring the hydroxyproline content, total kidney collagen amt. was increased in UUO control kidneys, but significantly reduced by IN-1130 treatment, which was comparable to results of histochem. staining for collagen.  IN-1130 also suppressed the expression of α-smooth muscle actin (α-SMA) and fibronectin in UUO kidneys.  Our results show that IN-1130 suppressed the fibrogenic process of UUO, further underscoring the potential clin. benefits of IN-1130 in the treatment of renal fibrosis.Kidney International (2006) 70, 1234-1243.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraDwwUCC-olrVg90H21EOLACvtfcHk0livF_uOiNV9nQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpsl2qtr0%253D&md5=1f0a083a00e7d2fc967ada1cca7bcb6c</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fsj.ki.5001775&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ki.5001775%26sid%3Dliteratum%253Aachs%26aulast%3DMoon%26aufirst%3DJ.-A.%26aulast%3DKim%26aufirst%3DH.-T.%26aulast%3DCho%26aufirst%3DI.-S.%26aulast%3DSheen%26aufirst%3DY.%2BY.%26aulast%3DKim%26aufirst%3DD.-K.%26atitle%3DIN-1130%252C%2520a%2520novel%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%2520I%2520receptor%2520kinase%2520%2528ALK5%2529%2520inhibitor%252C%2520suppresses%2520renal%2520fibrosis%2520in%2520obstructive%2520nephropathy%26jtitle%3DKidney%2520Int.%26date%3D2006%26volume%3D70%26spage%3D1234%26epage%3D1243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckwalter, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marion, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambhir, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss-Coray, T.</span><span> </span><span class="NLM_article-title">Glia-dependent TGF-β signaling, acting independently of the TH 17 pathway, is critical for initiation of murine autoimmune encephalomyelitis</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">3306</span><span class="NLM_x">–</span> <span class="NLM_lpage">3315</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2007&pages=3306-3315&author=J.+Luoauthor=P.+P.+Hoauthor=M.+S.+Buckwalterauthor=S.+Marionauthor=T.+Hsuauthor=L.+Y.+Leeauthor=H.+Zhangauthor=D.-K.+Kimauthor=S.-J.+Kimauthor=S.+S.+Gambhirauthor=L.+Steinmanauthor=T.+Wyss-Coray&title=Glia-dependent+TGF-%CE%B2+signaling%2C+acting+independently+of+the+TH+17+pathway%2C+is+critical+for+initiation+of+murine+autoimmune+encephalomyelitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DHo%26aufirst%3DP.%2BP.%26aulast%3DBuckwalter%26aufirst%3DM.%2BS.%26aulast%3DMarion%26aufirst%3DS.%26aulast%3DHsu%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DL.%2BY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DKim%26aufirst%3DS.-J.%26aulast%3DGambhir%26aufirst%3DS.%2BS.%26aulast%3DSteinman%26aufirst%3DL.%26aulast%3DWyss-Coray%26aufirst%3DT.%26atitle%3DGlia-dependent%2520TGF-%25CE%25B2%2520signaling%252C%2520acting%2520independently%2520of%2520the%2520TH%252017%2520pathway%252C%2520is%2520critical%2520for%2520initiation%2520of%2520murine%2520autoimmune%2520encephalomyelitis%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2007%26volume%3D117%26spage%3D3306%26epage%3D3315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ryu, J.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shin, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, H.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, I.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suh, J.-K.</span><span> </span><span class="NLM_article-title">IN-1130, a novel transforming growth factor-β type 1 receptor kinase (activin receptor-like kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie’s disease</span> <span class="citation_source-journal">J. Sex. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1284</span><span class="NLM_x">–</span> <span class="NLM_lpage">1296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1111%2Fj.1743-6109.2009.01216.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=19473283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD1MXmtFaitLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2009&pages=1284-1296&author=J.-K.+Ryuauthor=S.+Piaoauthor=H.-Y.+Shinauthor=M.+J.+Choiauthor=L.+W.+Zhangauthor=H.-R.+Jinauthor=W.+J.+Kimauthor=J.-Y.+Hanauthor=S.+S.+Hongauthor=S.+H.+Parkauthor=S.-J.+Leeauthor=I.-H.+Kimauthor=C.+R.+Leeauthor=D.-K.+Kimauthor=M.+Mamuraauthor=S.-J.+Kimauthor=J.-K.+Suh&title=IN-1130%2C+a+novel+transforming+growth+factor-%CE%B2+type+1+receptor+kinase+%28activin+receptor-like+kinase+5%29+inhibitor%2C+promotes+regression+of+fibrotic+plaque+and+corrects+penile+curvature+in+a+rat+model+of+Peyronie%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">IN-1130, a novel transforming growth factor-β type I receptor kinase (activin receptor-like kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie's disease</span></div><div class="casAuthors">Ryu, Ji-Kan; Piao, Shuguang; Shin, Hwa-Yean; Choi, Min Ji; Zhang, Lu Wei; Jin, Hai-Rong; Kim, Woo Jean; Han, Jee-Young; Hong, Soon Sun; Park, Seok Hee; Lee, Sang-Jin; Kim, In-Hoo; Lee, Chung Ryul; Kim, Dae-Kee; Mamura, Mizuko; Kim, Seong-Jin; Suh, Jun-Kyu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Sexual Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1284-1296</span>CODEN:
                <span class="NLM_cas:coden">JSMOAN</span>;
        ISSN:<span class="NLM_cas:issn">1743-6095</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Introduction: Transforming growth factor-β1 (TGF-β1) has been known to play a crucial role in the pathogenesis of Peyronie's disease (PD).  Aim: The aim of this paper was to investigate the therapeutic effect of IN-1130, a novel small mol. inhibitor of activin receptor-like kinase (ALK)5, a type I receptor of TGF-β, in an animal model of PD.  Methods: PD was induced in rats through repeated injections of adenovirus expressing TGF-β1 (days 0, 3, and 6; 1 × 1010 particles/0.1 mL, resp.) into the tunica albuginea.  The rats were divided into five groups (N = 10 per group): group 1, age-matched controls without treatment; group 2, age-matched controls receiving repeated injections of IN-1130 (days 30 and 37; 5 mg/kg in 0.1 mL saline, resp.); group 3, PD rats without treatment; group 4, PD rats receiving repeated injections of saline (days 30 and 37; 0.1 mL, resp.); group 5, PD rats receiving repeated injections of IN-1130 (days 30 and 37; 5 mg/kg in 0.1 mL saline, resp.) into the lesion.  Main Outcome Measures: Penile curvature was evaluated by use of an artificial erection test at day 45, and the penis was then harvested for histol. examn.  Collagen in the plaque was quant. assessed by hydroxyproline detn.  Results: IN-1130 induced significant regression of fibrotic plaque through reduced infiltration of inflammatory cells, reduced transnuclear expression of phospho-Smad2/phospho-Smad3, reduced hydroxyproline content, and reduced cartilage content and restoration of elastin fibers in the fibrotic plaque of PD rats, which was accompanied by the correction of penile curvature.  Conclusion: Antagonizing TGF-β signaling through the use of ALK5 inhibitors may represent an exciting new therapeutic strategy for the future treatment of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6d3E4YdiRcbVg90H21EOLACvtfcHk0lg5DjxhgP7p4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXmtFaitLw%253D&md5=069c9c8ec5f81feacf2d21d5bc9e81c7</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fj.1743-6109.2009.01216.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1743-6109.2009.01216.x%26sid%3Dliteratum%253Aachs%26aulast%3DRyu%26aufirst%3DJ.-K.%26aulast%3DPiao%26aufirst%3DS.%26aulast%3DShin%26aufirst%3DH.-Y.%26aulast%3DChoi%26aufirst%3DM.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%2BW.%26aulast%3DJin%26aufirst%3DH.-R.%26aulast%3DKim%26aufirst%3DW.%2BJ.%26aulast%3DHan%26aufirst%3DJ.-Y.%26aulast%3DHong%26aufirst%3DS.%2BS.%26aulast%3DPark%26aufirst%3DS.%2BH.%26aulast%3DLee%26aufirst%3DS.-J.%26aulast%3DKim%26aufirst%3DI.-H.%26aulast%3DLee%26aufirst%3DC.%2BR.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DMamura%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DS.-J.%26aulast%3DSuh%26aufirst%3DJ.-K.%26atitle%3DIN-1130%252C%2520a%2520novel%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%25201%2520receptor%2520kinase%2520%2528activin%2520receptor-like%2520kinase%25205%2529%2520inhibitor%252C%2520promotes%2520regression%2520of%2520fibrotic%2520plaque%2520and%2520corrects%2520penile%2520curvature%2520in%2520a%2520rat%2520model%2520of%2520Peyronie%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Sex.%2520Med.%26date%3D2009%26volume%3D6%26spage%3D1284%26epage%3D1296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Jin, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaiah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreenu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subrahmanyam, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span> </span><span class="NLM_article-title">4-([1,2,4]Triazolo[1,5-<i>a</i>]pyridin-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazole and -pyrazole derivatives as potent and selective inhibitors of transforming growth factor-β type 1 receptor kinase</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2724</span><span class="NLM_x">–</span> <span class="NLM_lpage">2732</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=2724-2732&author=C.+H.+Jinauthor=M.+Krishnaiahauthor=D.+Sreenuauthor=V.+B.+Subrahmanyamauthor=H.-J.+Parkauthor=S.-J.+Parkauthor=Y.+Y.+Sheenauthor=D.-K.+Kim&title=4-%28%5B1%2C2%2C4%5DTriazolo%5B1%2C5-a%5Dpyridin-6-yl%29-5%283%29-%286-methylpyridin-2-yl%29imidazole+and+-pyrazole+derivatives+as+potent+and+selective+inhibitors+of+transforming+growth+factor-%CE%B2+type+1+receptor+kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DC.%2BH.%26aulast%3DKrishnaiah%26aufirst%3DM.%26aulast%3DSreenu%26aufirst%3DD.%26aulast%3DSubrahmanyam%26aufirst%3DV.%2BB.%26aulast%3DPark%26aufirst%3DH.-J.%26aulast%3DPark%26aufirst%3DS.-J.%26aulast%3DSheen%26aufirst%3DY.%2BY.%26aulast%3DKim%26aufirst%3DD.-K.%26atitle%3D4-%2528%255B1%252C2%252C4%255DTriazolo%255B1%252C5-a%255Dpyridin-6-yl%2529-5%25283%2529-%25286-methylpyridin-2-yl%2529imidazole%2520and%2520-pyrazole%2520derivatives%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%25201%2520receptor%2520kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D2724%26epage%3D2732" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Kim, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, Y. Y.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and tissue distribution of 3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1<i>H</i>-imidazol-2-yl)methyl)benzamide; a novel ALK5 inhibitor and a potential anti-fibrosis drug</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=325-339&author=Y.+W.+Kimauthor=Y.+K.+Kimauthor=J.+Y.+Leeauthor=K.+T.+Changauthor=H.+J.+Leeauthor=D.-K.+Kimauthor=Y.+Y.+Sheen&title=Pharmacokinetics+and+tissue+distribution+of+3-%28%285-%286-methylpyridin-2-yl%29-4-%28quinoxalin-6-yl%29-1H-imidazol-2-yl%29methyl%29benzamide%3B+a+novel+ALK5+inhibitor+and+a+potential+anti-fibrosis+drug"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BW.%26aulast%3DKim%26aufirst%3DY.%2BK.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DChang%26aufirst%3DK.%2BT.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DSheen%26aufirst%3DY.%2BY.%26atitle%3DPharmacokinetics%2520and%2520tissue%2520distribution%2520of%25203-%2528%25285-%25286-methylpyridin-2-yl%2529-4-%2528quinoxalin-6-yl%2529-1H-imidazol-2-yl%2529methyl%2529benzamide%253B%2520a%2520novel%2520ALK5%2520inhibitor%2520and%2520a%2520potential%2520anti-fibrosis%2520drug%26jtitle%3DXenobiotica%26date%3D2008%26volume%3D38%26spage%3D325%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Kim, Y. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, Y. Y.</span><span> </span><span class="NLM_article-title">Identification of human cytochrome P450 enzymes involved in the metabolism of IN-1130, a novel activin receptor-like kinase-5 (ALK5) inhibitor</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">451</span><span class="NLM_x">–</span> <span class="NLM_lpage">464</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2008&pages=451-464&author=Y.+W.+Kimauthor=Y.+K.+Kimauthor=D.-K.+Kimauthor=Y.+Y.+Sheen&title=Identification+of+human+cytochrome+P450+enzymes+involved+in+the+metabolism+of+IN-1130%2C+a+novel+activin+receptor-like+kinase-5+%28ALK5%29+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DY.%2BW.%26aulast%3DKim%26aufirst%3DY.%2BK.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DSheen%26aufirst%3DY.%2BY.%26atitle%3DIdentification%2520of%2520human%2520cytochrome%2520P450%2520enzymes%2520involved%2520in%2520the%2520metabolism%2520of%2520IN-1130%252C%2520a%2520novel%2520activin%2520receptor-like%2520kinase-5%2520%2528ALK5%2529%2520inhibitor%26jtitle%3DXenobiotica%26date%3D2008%26volume%3D38%26spage%3D451%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, H. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoo, J.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 4(5)-(6-alkylpyridin-2-yl)imidazoles as transforming growth factor-β type 1 receptor kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3143</span><span class="NLM_x">–</span> <span class="NLM_lpage">3147</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070129k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3143-3147&author=D.-K.+Kimauthor=Y.+Jangauthor=H.+S.+Leeauthor=H.-J.+Parkauthor=J.+Yoo&title=Synthesis+and+biological+evaluation+of+4%285%29-%286-alkylpyridin-2-yl%29imidazoles+as+transforming+growth+factor-%CE%B2+type+1+receptor+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm070129k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070129k%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DJang%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DH.%2BS.%26aulast%3DPark%26aufirst%3DH.-J.%26aulast%3DYoo%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25204%25285%2529-%25286-alkylpyridin-2-yl%2529imidazoles%2520as%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%25201%2520receptor%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3143%26epage%3D3147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Dewang, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 2-pyridyl-substituted pyrazoles and imidazoles as transforming growth factor-β type 1 receptor kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4228</span><span class="NLM_x">–</span> <span class="NLM_lpage">4232</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4228-4232&author=P.+M.+Dewangauthor=D.-K.+Kim&title=Synthesis+and+biological+evaluation+of+2-pyridyl-substituted+pyrazoles+and+imidazoles+as+transforming+growth+factor-%CE%B2+type+1+receptor+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDewang%26aufirst%3DP.%2BM.%26aulast%3DKim%26aufirst%3DD.-K.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25202-pyridyl-substituted%2520pyrazoles%2520and%2520imidazoles%2520as%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%25201%2520receptor%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4228%26epage%3D4232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Jin, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krishnaiah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sreenu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subrahmanyam, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, Y. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin-2-yl)-4-(quinolin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2633</span><span class="NLM_x">–</span> <span class="NLM_lpage">2640</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=2633-2640&author=C.+H.+Jinauthor=M.+Krishnaiahauthor=D.+Sreenuauthor=K.+S.+Raoauthor=V.+B.+Subrahmanyamauthor=C.-Y.+Parkauthor=J.-Y.+Sonauthor=Y.+Y.+Sheenauthor=D.-K.+Kim&title=Synthesis+and+biological+evaluation+of+1-substituted-3%285%29-%286-methylpyridin-2-yl%29-4-%28quinolin-6-yl%29pyrazoles+as+transforming+growth+factor-%CE%B2+type+1+receptor+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DC.%2BH.%26aulast%3DKrishnaiah%26aufirst%3DM.%26aulast%3DSreenu%26aufirst%3DD.%26aulast%3DRao%26aufirst%3DK.%2BS.%26aulast%3DSubrahmanyam%26aufirst%3DV.%2BB.%26aulast%3DPark%26aufirst%3DC.-Y.%26aulast%3DSon%26aufirst%3DJ.-Y.%26aulast%3DSheen%26aufirst%3DY.%2BY.%26aulast%3DKim%26aufirst%3DD.-K.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25201-substituted-3%25285%2529-%25286-methylpyridin-2-yl%2529-4-%2528quinolin-6-yl%2529pyrazoles%2520as%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%25201%2520receptor%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D2633%26epage%3D2640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Gaster, L. M.; Hadley, M. S.; Harling, J. D.; Harrington, F. P.; Heer, J. P.; Heightman, T. D.</span><span> </span><span class="NLM_article-title">Pyridinylimidazoles</span>. WO 01/62756 A1,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=L.+M.+Gaster&author=M.+S.+Hadley&author=J.+D.+Harling&author=F.+P.+Harrington&author=J.+P.+Heer&author=T.+D.+Heightman&title=Pyridinylimidazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGaster%26aufirst%3DL.%2BM.%26atitle%3DPyridinylimidazoles%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Brussee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loos, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Der Gen, A.</span><span> </span><span class="NLM_article-title">Synthesis of optically active silyl protected cyanohydrins</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">979</span><span class="NLM_x">–</span> <span class="NLM_lpage">986</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1990&pages=979-986&author=J.+Brusseeauthor=W.+T.+Loosauthor=C.+G.+Kruseauthor=A.+Van+Der+Gen&title=Synthesis+of+optically+active+silyl+protected+cyanohydrins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrussee%26aufirst%3DJ.%26aulast%3DLoos%26aufirst%3DW.%2BT.%26aulast%3DKruse%26aufirst%3DC.%2BG.%26aulast%3DVan%2BDer%2BGen%26aufirst%3DA.%26atitle%3DSynthesis%2520of%2520optically%2520active%2520silyl%2520protected%2520cyanohydrins%26jtitle%3DTetrahedron%26date%3D1990%26volume%3D46%26spage%3D979%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Ishibashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kameoka, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iriyama, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kodama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, M.</span><span> </span><span class="NLM_article-title">Sulfur-directed regioselective radical cyclization leading to β-lactams: formal synthesis of (±)-PS-5 and (+)-thienamycin</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">1276</span><span class="NLM_x">–</span> <span class="NLM_lpage">1284</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00110a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=1276-1284&author=H.+Ishibashiauthor=C.+Kameokaauthor=H.+Iriyamaauthor=K.+Kodamaauthor=T.+Satoauthor=M.+Ikeda&title=Sulfur-directed+regioselective+radical+cyclization+leading+to+%CE%B2-lactams%3A+formal+synthesis+of+%28%C2%B1%29-PS-5+and+%28%2B%29-thienamycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjo00110a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00110a035%26sid%3Dliteratum%253Aachs%26aulast%3DIshibashi%26aufirst%3DH.%26aulast%3DKameoka%26aufirst%3DC.%26aulast%3DIriyama%26aufirst%3DH.%26aulast%3DKodama%26aufirst%3DK.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DIkeda%26aufirst%3DM.%26atitle%3DSulfur-directed%2520regioselective%2520radical%2520cyclization%2520leading%2520to%2520%25CE%25B2-lactams%253A%2520formal%2520synthesis%2520of%2520%2528%25C2%25B1%2529-PS-5%2520and%2520%2528%252B%2529-thienamycin%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D1276%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Wrana, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attisano, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carcamo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zentella, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doody, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laiho, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massague, J.</span><span> </span><span class="NLM_article-title">TGFβ signals through a heteromeric protein kinase receptor complex</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1003</span><span class="NLM_x">–</span> <span class="NLM_lpage">1014</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1992&pages=1003-1014&author=J.+L.+Wranaauthor=L.+Attisanoauthor=J.+Carcamoauthor=A.+Zentellaauthor=J.+Doodyauthor=M.+Laihoauthor=X.+F.+Wangauthor=J.+Massague&title=TGF%CE%B2+signals+through+a+heteromeric+protein+kinase+receptor+complex"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWrana%26aufirst%3DJ.%2BL.%26aulast%3DAttisano%26aufirst%3DL.%26aulast%3DCarcamo%26aufirst%3DJ.%26aulast%3DZentella%26aufirst%3DA.%26aulast%3DDoody%26aufirst%3DJ.%26aulast%3DLaiho%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%2BF.%26aulast%3DMassague%26aufirst%3DJ.%26atitle%3DTGF%25CE%25B2%2520signals%2520through%2520a%2520heteromeric%2520protein%2520kinase%2520receptor%2520complex%26jtitle%3DCell%26date%3D1992%26volume%3D71%26spage%3D1003%26epage%3D1014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Gerlach, K.; Priepke, H.; Wienen, W.; Schuler-Metz, A.; Nar, H.</span><span> </span><span class="NLM_article-title">Preparation of <i>N</i>-heteroaryl azetidinedicarboxamides as factor Xa inhibitors</span>. WO 2008/135525 A2,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=K.+Gerlach&author=H.+Priepke&author=W.+Wienen&author=A.+Schuler-Metz&author=H.+Nar&title=Preparation+of+N-heteroaryl+azetidinedicarboxamides+as+factor+Xa+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGerlach%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520N-heteroaryl%2520azetidinedicarboxamides%2520as%2520factor%2520Xa%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Taveras, A.; Zheng, J.; Biju, P. J.; Yu, Y.; Chao, J.; Fine, J.; Lundell, D.; Priestley, T.; Reggiani, A.; Merritt, J. R.; Baldwin, J. J.; Lai, G.; Wu, M.</span><span> </span><span class="NLM_article-title">Preparation of isothiazole dioxides as CXC- and CC-chemokine receptor ligands</span>. WO 2005/068460 A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=A.+Taveras&author=J.+Zheng&author=P.+J.+Biju&author=Y.+Yu&author=J.+Chao&author=J.+Fine&author=D.+Lundell&author=T.+Priestley&author=A.+Reggiani&author=J.+R.+Merritt&author=J.+J.+Baldwin&author=G.+Lai&author=M.+Wu&title=Preparation+of+isothiazole+dioxides+as+CXC-+and+CC-chemokine+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTaveras%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520isothiazole%2520dioxides%2520as%2520CXC-%2520and%2520CC-chemokine%2520receptor%2520ligands%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Dragovich, P.; Zhou, Y.; Webber, S. E.</span><span> </span><span class="NLM_article-title">Pyridazinone derivatives as NS5B polymerase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of hepatitis C infection</span>. US 2008/0188466 A1,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=P.+Dragovich&author=Y.+Zhou&author=S.+E.+Webber&title=Pyridazinone+derivatives+as+NS5B+polymerase+inhibitors+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+hepatitis+C+infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDragovich%26aufirst%3DP.%26atitle%3DPyridazinone%2520derivatives%2520as%2520NS5B%2520polymerase%2520inhibitors%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520hepatitis%2520C%2520infection%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Leznoff, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terekhov, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Multisubstituted phthalonitriles, naphthalenedicarbonitriles, and phenanthrenetetracarbonitriles as precursors for phthalocyanine syntheses</span> <span class="citation_source-journal">Can. J. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1995&pages=435-443&author=C.+C.+Leznoffauthor=D.+S.+Terekhovauthor=C.+R.+McArthurauthor=S.+Vighauthor=J.+Li&title=Multisubstituted+phthalonitriles%2C+naphthalenedicarbonitriles%2C+and+phenanthrenetetracarbonitriles+as+precursors+for+phthalocyanine+syntheses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeznoff%26aufirst%3DC.%2BC.%26aulast%3DTerekhov%26aufirst%3DD.%2BS.%26aulast%3DMcArthur%26aufirst%3DC.%2BR.%26aulast%3DVigh%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DMultisubstituted%2520phthalonitriles%252C%2520naphthalenedicarbonitriles%252C%2520and%2520phenanthrenetetracarbonitriles%2520as%2520precursors%2520for%2520phthalocyanine%2520syntheses%26jtitle%3DCan.%2520J.%2520Chem.%26date%3D1995%26volume%3D73%26spage%3D435%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Park, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, Y. Y.</span><span> </span><span class="NLM_article-title">EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type 1 receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells</span> <span class="citation_source-journal">Cancer Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1889</span><span class="NLM_x">–</span> <span class="NLM_lpage">1896</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1111%2Fj.1349-7006.2011.02014.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=21707864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVSis7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2011&pages=1889-1896&author=C.-Y.+Parkauthor=D.-K.+Kimauthor=Y.+Y.+Sheen&title=EW-7203%2C+a+novel+small+molecule+inhibitor+of+transforming+growth+factor-%CE%B2+%28TGF-%CE%B2%29+type+1+receptor%2Factivin+receptor-like+kinase-5%2C+blocks+TGF-%CE%B21-mediated+epithelial-to-mesenchymal+transition+in+mammary+epithelial+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">EW-7203, a novel small molecule inhibitor of transforming growth factor-β (TGF-β) type I receptor/activin receptor-like kinase-5, blocks TGF-β1-mediated epithelial-to-mesenchymal transition in mammary epithelial cells</span></div><div class="casAuthors">Park, Chul-Yong; Kim, Dae-Kee; Sheen, Yhun Yhong</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Science</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1889-1896</span>CODEN:
                <span class="NLM_cas:coden">CSACCM</span>;
        ISSN:<span class="NLM_cas:issn">1347-9032</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Recently, small mol. inhibitors of transforming growth factor-β (TGF-β) type I receptor kinase/activin receptor-like kinase-5 (ALK5) were developed to target TGF-β signaling as a therapeutic strategy for combating cancer.  In the present study, the authors examd. a novel small mol. inhibitor of ALK5, 3-((5-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(6-methylpyridin-2-yl)thiazol-2-ylamino)methyl)benzonitrile (EW-7203) in breast cancer cells to det. if it has potential for cancer treatment.  The inhibitory effects of EW-7203 on TGF-β-induced Smad signaling and epithelial-to-mesenchymal transition (EMT) were investigated in mammary epithelial cells using luciferase reporter assays, immunoblotting, confocal microscopy, and wound healing assays.  In addn., the suppressive effects of EW-7203 on mammary cancer metastasis to the lung were examd. using a Balb/c xenograft model system.  The novel ALK5 inhibitor, EW-7203, inhibited the TGF-β1-stimulated transcriptional activation of p3TP-Lux and pCAGA12-Luc.  In addn., EW-7203 decreased phosphorylated Smad2 levels and the nuclear translocation of Smad2 was increased by TGF-β1.  In addn., EW-7203 inhibited TGF-β1-induced EMT and wound healing of NMuMG cells.  Furthermore, in xenografted Balb/c mice, EW-7203 inhibited metastasis to the lung from breast tumors.  The novel ALK5 inhibitor, EW-7203, efficiently inhibited TGF-β1-induced Smad signaling, EMT, and breast tumor metastasis to the lung in vivo, demonstrating that EW-7203 has therapeutic potential for breast cancer metastasis to the lung.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBvoWNUurGorVg90H21EOLACvtfcHk0lgoXTX_5lQs0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVSis7%252FP&md5=99bb811045f057424651b0e127ff9d16</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1111%2Fj.1349-7006.2011.02014.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1349-7006.2011.02014.x%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.-Y.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DSheen%26aufirst%3DY.%2BY.%26atitle%3DEW-7203%252C%2520a%2520novel%2520small%2520molecule%2520inhibitor%2520of%2520transforming%2520growth%2520factor-%25CE%25B2%2520%2528TGF-%25CE%25B2%2529%2520type%25201%2520receptor%252Factivin%2520receptor-like%2520kinase-5%252C%2520blocks%2520TGF-%25CE%25B21-mediated%2520epithelial-to-mesenchymal%2520transition%2520in%2520mammary%2520epithelial%2520cells%26jtitle%3DCancer%2520Sci.%26date%3D2011%26volume%3D102%26spage%3D1889%26epage%3D1896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Son, J. Y.; Kim, S.-J.; Lee, S. J.; Park, S.-Y.; Park, S.-A.; Kim, M.-J.; Kim, S. W.; Kim, D.-K.; Nam, J.-S.; Sheen, Y. Y.</span><span> </span><span class="NLM_article-title">EW-7197, a novel ALK-5 kinase inhibitor, potently inhibits breast to lung metastasis</span>.  <span class="citation_source-journal">Mol. Cancer Ther.</span> In press. DOI:<span class="refDoi"> DOI: 10.1158/1535-7163.MCT-13-0903</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1158%2F1535-7163.MCT-13-0903" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Son%2C+J.+Y.%3B+Kim%2C+S.-J.%3B+Lee%2C+S.+J.%3B+Park%2C+S.-Y.%3B+Park%2C+S.-A.%3B+Kim%2C+M.-J.%3B+Kim%2C+S.+W.%3B+Kim%2C+D.-K.%3B+Nam%2C+J.-S.%3B+Sheen%2C+Y.+Y.+EW-7197%2C+a+novel+ALK-5+kinase+inhibitor%2C+potently+inhibits+breast+to+lung+metastasis.+Mol.+Cancer+Ther.+In+press.+DOI%3A+10.1158%2F1535-7163.MCT-13-0903."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-13-0903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-13-0903%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DJ.%2BY.%26atitle%3DEW-7197%252C%2520a%2520novel%2520ALK-5%2520kinase%2520inhibitor%252C%2520potently%2520inhibits%2520breast%2520to%2520lung%2520metastasis%26jtitle%3DMol.%2520Cancer%2520Ther.%26doi%3D10.1158%2F1535-7163.MCT-13-0903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Park, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Son, J.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nam, J.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheen, Y. Y.</span><span> </span><span class="NLM_article-title">EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2642</span><span class="NLM_x">–</span> <span class="NLM_lpage">2653</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=2642-2653&author=C.-Y.+Parkauthor=J.-Y.+Sonauthor=C.+H.+Jinauthor=J.-S.+Namauthor=D.-K.+Kimauthor=Y.+Y.+Sheen&title=EW-7195%2C+a+novel+inhibitor+of+ALK5+kinase+inhibits+EMT+and+breast+cancer+metastasis+to+lung"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.-Y.%26aulast%3DSon%26aufirst%3DJ.-Y.%26aulast%3DJin%26aufirst%3DC.%2BH.%26aulast%3DNam%26aufirst%3DJ.-S.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DSheen%26aufirst%3DY.%2BY.%26atitle%3DEW-7195%252C%2520a%2520novel%2520inhibitor%2520of%2520ALK5%2520kinase%2520inhibits%2520EMT%2520and%2520breast%2520cancer%2520metastasis%2520to%2520lung%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2011%26volume%3D47%26spage%3D2642%26epage%3D2653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Aissaoui, H.; Boss, C.; Gude, M.; Koberstein, R.; Sifferlen, T.; Zumbrunn, A. C.</span><span> </span><span class="NLM_article-title">Benzenesulfonamide compounds as orexin receptor antagonists, their preparation, pharmaceutical compositions, and use in therapy</span>. WO 2007/116374 A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=H.+Aissaoui&author=C.+Boss&author=M.+Gude&author=R.+Koberstein&author=T.+Sifferlen&author=A.+C.+Zumbrunn&title=Benzenesulfonamide+compounds+as+orexin+receptor+antagonists%2C+their+preparation%2C+pharmaceutical+compositions%2C+and+use+in+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAissaoui%26aufirst%3DH.%26atitle%3DBenzenesulfonamide%2520compounds%2520as%2520orexin%2520receptor%2520antagonists%252C%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%252C%2520and%2520use%2520in%2520therapy%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Sugiyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asakura, H.</span><span> </span><span class="NLM_article-title">Expression of activin A is increased in cirrhotic and fibrotic rat livers</span> <span class="citation_source-journal">Gastroentenology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">550</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1016%2FS0016-5085%2898%2970539-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=9496947" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1998&pages=550-558&author=M.+Sugiyamaauthor=T.+Ichidaauthor=T.+Satoauthor=T.+Ishikawaauthor=Y.+Matsudaauthor=H.+Asakura&title=Expression+of+activin+A+is+increased+in+cirrhotic+and+fibrotic+rat+livers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2FS0016-5085%2898%2970539-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0016-5085%252898%252970539-6%26sid%3Dliteratum%253Aachs%26aulast%3DSugiyama%26aufirst%3DM.%26aulast%3DIchida%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DT.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DMatsuda%26aufirst%3DY.%26aulast%3DAsakura%26aufirst%3DH.%26atitle%3DExpression%2520of%2520activin%2520A%2520is%2520increased%2520in%2520cirrhotic%2520and%2520fibrotic%2520rat%2520livers%26jtitle%3DGastroentenology%26date%3D1998%26volume%3D114%26spage%3D550%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Matsuse, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matusi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosoi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohga, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagase, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orimo, H.</span><span> </span><span class="NLM_article-title">Expression of immunoreactive and bioactive activin A protein in adult murine lung after bleomycin treatment</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">17</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1165%2Fajrcmb.13.1.7541220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=7541220" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADyaK2MXmvFWntro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1995&pages=17-24&author=T.+Matsuseauthor=Y.+Fukuchiauthor=Y.+Etoauthor=H.+Matusiauthor=T.+Hosoiauthor=T.+Okaauthor=E.+Ohgaauthor=T.+Nagaseauthor=H.+Orimo&title=Expression+of+immunoreactive+and+bioactive+activin+A+protein+in+adult+murine+lung+after+bleomycin+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of immunoreactive and bioactive activin A protein in adult murine lung after bleomycin treatment</span></div><div class="casAuthors">Matsuse, Takeshi; Fukuchi, Yoshinosuke; Eto, Yuzuru; Matsui, Hirotoshi; Hosoi, Takayuki; Oka, Teruaki; Ohga, Eijiro; Nagase, Takahide; Orimo, Hajime</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-24</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Lung Association</span>)
        </div><div class="casAbstract">Activin A is a homodimeric protein structurally and functionally related to transforming growth factor β (TGF-β), and the expression of activin A is modulated by TGF-β.  Here, we demonstrate the expression of activin A in normal and bleomycin (BLM)-treated murine lungs.  ICR mice were treated with BLM i.p. for 10 days, where saline vehicle was injected into control mice.  Intra-alveolar fibrotic changes were obsd. in the lung tissue obtained from the mice at day 14 after the final BLM administration.  Immunohistochem. studies using a polyclonal antibody to activin A revealed the presence of activin A in the bronchiolar epithelium and smooth muscle cells of veins in both control and BLM-treated mice.  In the BLM-treated mice at days 7 and 14, the marked infiltration of immunoreactive alveolar macrophages was obsd. in the area of fibrotic changes.  Bioactivity of activin A measured by erythroid differentiation factor assay in the conditioned medium of alveolar macrophages obtained from BLM-treated mice at day 14 was significantly increased.  These findings indicate that alveolar macrophages are a potent source of activin A after BLM treatment.  The present study demonstrates for the first time the abundant expression of activin A in murine lung tissues after BlM administration, suggesting that activin A may play a role in the pathogenesis of BLM-induced pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Fj3s3opZ4rVg90H21EOLACvtfcHk0lgoXTX_5lQs0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvFWntro%253D&md5=d6248478e7288ab0665e40f705507a4a</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1165%2Fajrcmb.13.1.7541220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Fajrcmb.13.1.7541220%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuse%26aufirst%3DT.%26aulast%3DFukuchi%26aufirst%3DY.%26aulast%3DEto%26aufirst%3DY.%26aulast%3DMatusi%26aufirst%3DH.%26aulast%3DHosoi%26aufirst%3DT.%26aulast%3DOka%26aufirst%3DT.%26aulast%3DOhga%26aufirst%3DE.%26aulast%3DNagase%26aufirst%3DT.%26aulast%3DOrimo%26aufirst%3DH.%26atitle%3DExpression%2520of%2520immunoreactive%2520and%2520bioactive%2520activin%2520A%2520protein%2520in%2520adult%2520murine%2520lung%2520after%2520bleomycin%2520treatment%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D1995%26volume%3D13%26spage%3D17%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Pawlowski, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentine, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hail, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrer, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowala, M. C.</span><span> </span><span class="NLM_article-title">Stimulation of activin A expression in rat aortic smooth muscle cells by thrombin and angiotensin II correlates with neointimal formation in vivo</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">639</span><span class="NLM_x">–</span> <span class="NLM_lpage">648</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=1997&pages=639-648&author=J.+E.+Pawlowskiauthor=D.+S.+Taylorauthor=M.+Valentineauthor=M.+E.+Hailauthor=P.+Ferrerauthor=M.+C.+Kowala&title=Stimulation+of+activin+A+expression+in+rat+aortic+smooth+muscle+cells+by+thrombin+and+angiotensin+II+correlates+with+neointimal+formation+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPawlowski%26aufirst%3DJ.%2BE.%26aulast%3DTaylor%26aufirst%3DD.%2BS.%26aulast%3DValentine%26aufirst%3DM.%26aulast%3DHail%26aufirst%3DM.%2BE.%26aulast%3DFerrer%26aufirst%3DP.%26aulast%3DKowala%26aufirst%3DM.%2BC.%26atitle%3DStimulation%2520of%2520activin%2520A%2520expression%2520in%2520rat%2520aortic%2520smooth%2520muscle%2520cells%2520by%2520thrombin%2520and%2520angiotensin%2520II%2520correlates%2520with%2520neointimal%2520formation%2520in%2520vivo%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1997%26volume%3D100%26spage%3D639%26epage%3D648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Hübner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smola, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, S.</span><span> </span><span class="NLM_article-title">Strong induction of activin expression after injury suggests an important role of activin in wound repair</span> <span class="citation_source-journal">Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=1996&pages=490-498&author=G.+H%C3%BCbnerauthor=Q.+Huauthor=H.+Smolaauthor=S.+Werner&title=Strong+induction+of+activin+expression+after+injury+suggests+an+important+role+of+activin+in+wound+repair"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DH%25C3%25BCbner%26aufirst%3DG.%26aulast%3DHu%26aufirst%3DQ.%26aulast%3DSmola%26aufirst%3DH.%26aulast%3DWerner%26aufirst%3DS.%26atitle%3DStrong%2520induction%2520of%2520activin%2520expression%2520after%2520injury%2520suggests%2520an%2520important%2520role%2520of%2520activin%2520in%2520wound%2520repair%26jtitle%3DDev.%2520Biol.%26date%3D1996%26volume%3D173%26spage%3D490%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Munz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smola, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engelhardt, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleuel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauchle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letin, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huylebroeck, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, S.</span><span> </span><span class="NLM_article-title">Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">5205</span><span class="NLM_x">–</span> <span class="NLM_lpage">5215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=5205-5215&author=B.+Munzauthor=H.+Smolaauthor=F.+Engelhardtauthor=K.+Bleuelauthor=M.+Brauchleauthor=I.+Letinauthor=L.+W.+Evansauthor=D.+Huylebroeckauthor=R.+Ballingauthor=S.+Werner&title=Overexpression+of+activin+A+in+the+skin+of+transgenic+mice+reveals+new+activities+of+activin+in+epidermal+morphogenesis%2C+dermal+fibrosis+and+wound+repair"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMunz%26aufirst%3DB.%26aulast%3DSmola%26aufirst%3DH.%26aulast%3DEngelhardt%26aufirst%3DF.%26aulast%3DBleuel%26aufirst%3DK.%26aulast%3DBrauchle%26aufirst%3DM.%26aulast%3DLetin%26aufirst%3DI.%26aulast%3DEvans%26aufirst%3DL.%2BW.%26aulast%3DHuylebroeck%26aufirst%3DD.%26aulast%3DBalling%26aufirst%3DR.%26aulast%3DWerner%26aufirst%3DS.%26atitle%3DOverexpression%2520of%2520activin%2520A%2520in%2520the%2520skin%2520of%2520transgenic%2520mice%2520reveals%2520new%2520activities%2520of%2520activin%2520in%2520epidermal%2520morphogenesis%252C%2520dermal%2520fibrosis%2520and%2520wound%2520repair%26jtitle%3DEMBO%2520J.%26date%3D1999%26volume%3D18%26spage%3D5205%26epage%3D5215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Wankell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hübner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hans, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goppelt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Werner, S.</span><span> </span><span class="NLM_article-title">Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5361</span><span class="NLM_x">–</span> <span class="NLM_lpage">5372</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2001&pages=5361-5372&author=M.+Wankellauthor=B.+Munzauthor=G.+H%C3%BCbnerauthor=W.+Hansauthor=E.+Wolfauthor=A.+Goppeltauthor=S.+Werner&title=Impaired+wound+healing+in+transgenic+mice+overexpressing+the+activin+antagonist+follistatin+in+the+epidermis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWankell%26aufirst%3DM.%26aulast%3DMunz%26aufirst%3DB.%26aulast%3DH%25C3%25BCbner%26aufirst%3DG.%26aulast%3DHans%26aufirst%3DW.%26aulast%3DWolf%26aufirst%3DE.%26aulast%3DGoppelt%26aufirst%3DA.%26aulast%3DWerner%26aufirst%3DS.%26atitle%3DImpaired%2520wound%2520healing%2520in%2520transgenic%2520mice%2520overexpressing%2520the%2520activin%2520antagonist%2520follistatin%2520in%2520the%2520epidermis%26jtitle%3DEMBO%2520J.%26date%3D2001%26volume%3D20%26spage%3D5361%26epage%3D5372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Thomson, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Real, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordon-Cardo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, A. N.</span><span> </span><span class="NLM_article-title">Differentiation antigens of melanocytes and melanoma: analysis of melanosome and cell surface markers of human pigmented cells with monoclonal antibodies</span> <span class="citation_source-journal">J. Invest. Dermatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">466</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=1988&pages=459-466&author=T.+M.+Thomsonauthor=F.+X.+Realauthor=S.+Murakamiauthor=C.+Cordon-Cardoauthor=L.+J.+Oldauthor=A.+N.+Houghton&title=Differentiation+antigens+of+melanocytes+and+melanoma%3A+analysis+of+melanosome+and+cell+surface+markers+of+human+pigmented+cells+with+monoclonal+antibodies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomson%26aufirst%3DT.%2BM.%26aulast%3DReal%26aufirst%3DF.%2BX.%26aulast%3DMurakami%26aufirst%3DS.%26aulast%3DCordon-Cardo%26aufirst%3DC.%26aulast%3DOld%26aufirst%3DL.%2BJ.%26aulast%3DHoughton%26aufirst%3DA.%2BN.%26atitle%3DDifferentiation%2520antigens%2520of%2520melanocytes%2520and%2520melanoma%253A%2520analysis%2520of%2520melanosome%2520and%2520cell%2520surface%2520markers%2520of%2520human%2520pigmented%2520cells%2520with%2520monoclonal%2520antibodies%26jtitle%3DJ.%2520Invest.%2520Dermatol.%26date%3D1988%26volume%3D90%26spage%3D459%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Russell, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ley, T. J.</span><span> </span><span class="NLM_article-title">Lymphocyte-mediated cytotoxicity</span> <span class="citation_source-journal">Annu. Rev. Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1146%2Fannurev.immunol.20.100201.131730" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=11861606" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD38XjtlWgtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2002&pages=323-370&author=J.+H.+Russellauthor=T.+J.+Ley&title=Lymphocyte-mediated+cytotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Lymphocyte-mediated cytotoxicity</span></div><div class="casAuthors">Russell, John H.; Ley, Timothy J.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Immunology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">323-370</span>CODEN:
                <span class="NLM_cas:coden">ARIMDU</span>;
        ISSN:<span class="NLM_cas:issn">0732-0582</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Virtually all of the measurable cell-mediated cytotoxicity delivered by cytotoxic T lymphocytes and natural killer cells comes from either the granule exocytosis pathway or the Fas pathway.  The granule exocytosis pathway utilizes perforin to traffic the granzymes to appropriate locations in target cells, where they cleave crit. substrates that initiate DNA fragmentation and apoptosis; granzymes A and B induce death via alternate, non-overlapping pathways.  The Fas/FasL system is responsible for activation-induced cell death but also plays an important role in lymphocyte-mediated killing under certain circumstances.  The interplay between these two cytotoxic systems provides opportunities for therapeutic interventions to control autoimmune diseases and graft vs. host disease, but over-suppression of these pathways may also lead to increased viral susceptibility and/or decreased tumor cell killing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokipSkNOcfwrVg90H21EOLACvtfcHk0liWZcDF5OTuZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjtlWgtLw%253D&md5=21fcde7e7b936ff95c7dbdfd2f77b643</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1146%2Fannurev.immunol.20.100201.131730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.immunol.20.100201.131730%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DJ.%2BH.%26aulast%3DLey%26aufirst%3DT.%2BJ.%26atitle%3DLymphocyte-mediated%2520cytotoxicity%26jtitle%3DAnnu.%2520Rev.%2520Immunol.%26date%3D2002%26volume%3D20%26spage%3D323%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Kirkwood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarhini, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Panelli, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moschos, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarour, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butterfield, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gogas, H. J.</span><span> </span><span class="NLM_article-title">Next generation of immunotherapy for melanoma</span> <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">3445</span><span class="NLM_x">–</span> <span class="NLM_lpage">3455</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1200%2FJCO.2007.14.6423" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=18612161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpvVWitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=3445-3455&author=J.+M.+Kirkwoodauthor=A.+A.+Tarhiniauthor=M.+C.+Panelliauthor=S.+J.+Moschosauthor=H.+M.+Zarourauthor=L.+H.+Butterfieldauthor=H.+J.+Gogas&title=Next+generation+of+immunotherapy+for+melanoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Next generation of immunotherapy for melanoma</span></div><div class="casAuthors">Kirkwood, John M.; Tarhini, Ahmad A.; Panelli, Monica C.; Moschos, Stergios J.; Zarour, Hassane M.; Butterfield, Lisa H.; Gogas, Helen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Oncology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3445-3455</span>CODEN:
                <span class="NLM_cas:coden">JCONDN</span>;
        ISSN:<span class="NLM_cas:issn">0732-183X</span>.
    
            (<span class="NLM_cas:orgname">American Society of Clinical Oncology</span>)
        </div><div class="casAbstract">A review.  Purpose Immunotherapy has a long history with striking but limited success in patients with melanoma.  To date, interleukin-2 and interferon-alfa2b are the only approved immunotherapeutic agents for melanoma in the United States.  Design Tumor evasion of host immune responses, and strategies for overcoming tumor-induced immunosuppression are reviewed.  Several novel immunotherapies currently in worldwide phase III clin. testing for melanoma are discussed.  Results The limitations of immunotherapy for melanoma stem from tumor-induced mechanisms of immune evasion that render the host tolerant of tumor antigens.  For example, melanoma inhibits the maturation of antigen-presenting cells, preventing full T-cell activation and downregulating the effector antitumor immune response.  New immunotherapies targeting crit. regulatory elements of the immune system may overcome tolerance and promote a more effective antitumor immune response.  These include monoclonal antibodies that block the cytotoxic T lymphocyte-assocd. antigen 4 (CTLA4) and toll-like receptor 9 (TLR9) agonists.  Blockade of CTLA4 prevents inhibitory signals that downregulate T-cell activation.  TLR9 agonists stimulate dendritic cell maturation and ultimately induce a more effective immune response.  These approaches have been shown to stimulate acute immune activation with concomitant appearance of transient adverse events mediated by the immune system.  The pattern and duration of immune responses assocd. with these new modalities differ from those assocd. with cytokines and cytotoxic agents.  In addn., vaccines are being developed that may ultimately target melanoma either alone or in combination with these immunomodulatory therapies.  Conclusion The successes of cytokine and interferon therapy of melanoma, coupled with an array of new approaches, are generating new enthusiasm for the immunotherapy of melanoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyeng-cXpDZLVg90H21EOLACvtfcHk0liWZcDF5OTuZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpvVWitrY%253D&md5=bc7e4b7b8d72758e8ca3762b3079880c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1200%2FJCO.2007.14.6423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252FJCO.2007.14.6423%26sid%3Dliteratum%253Aachs%26aulast%3DKirkwood%26aufirst%3DJ.%2BM.%26aulast%3DTarhini%26aufirst%3DA.%2BA.%26aulast%3DPanelli%26aufirst%3DM.%2BC.%26aulast%3DMoschos%26aufirst%3DS.%2BJ.%26aulast%3DZarour%26aufirst%3DH.%2BM.%26aulast%3DButterfield%26aufirst%3DL.%2BH.%26aulast%3DGogas%26aufirst%3DH.%2BJ.%26atitle%3DNext%2520generation%2520of%2520immunotherapy%2520for%2520melanoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2008%26volume%3D26%26spage%3D3445%26epage%3D3455" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Javelaud, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexaki, V.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauviel, A.</span><span> </span><span class="NLM_article-title">Transforming growth factor-β in cutaneous melanoma</span> <span class="citation_source-journal">Pigm. Cell Melanoma Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">123</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1111%2Fj.1755-148X.2008.00450.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=18426405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvVSnsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=123-132&author=D.+Javelaudauthor=V.-I.+Alexakiauthor=A.+Mauviel&title=Transforming+growth+factor-%CE%B2+in+cutaneous+melanoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Transforming growth factor-β in cutaneous melanoma</span></div><div class="casAuthors">Javelaud, Delphine; Alexaki, Vasileia-Ismini; Mauviel, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Pigment Cell & Melanoma Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">123-132</span>CODEN:
                <span class="NLM_cas:coden">PCMRCM</span>;
        ISSN:<span class="NLM_cas:issn">1755-1471</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Transforming growth factor-β (TGF-β) plays a complex role during carcinogenesis.  It may either act as a tumor suppressor through its broad antiproliferative potential or as a tumor promoter either via direct effects on tumor cell aggressiveness or indirectly by modulating stromal responses, angiogenesis and immune surveillance.  Increased prodn. of TGF-β by cancer cells is often assocd. with tumor grade.  Melanoma cells largely escape cell cycle arrest normally induced by TGF-β in normal melanocytes, yet produce active TGF-β and are capable of efficient transcriptional responses to the growth factor.  In this review, we summarize the current knowledge about the role played by TGF-β in melanoma progression and hypothesize about the appropriateness of targeting TGF-β signaling for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3uy1imhjr0LVg90H21EOLACvtfcHk0liWZcDF5OTuZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvVSnsLg%253D&md5=89e8ceac1c0ce86a1a26da497fa70413</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-148X.2008.00450.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-148X.2008.00450.x%26sid%3Dliteratum%253Aachs%26aulast%3DJavelaud%26aufirst%3DD.%26aulast%3DAlexaki%26aufirst%3DV.-I.%26aulast%3DMauviel%26aufirst%3DA.%26atitle%3DTransforming%2520growth%2520factor-%25CE%25B2%2520in%2520cutaneous%2520melanoma%26jtitle%3DPigm.%2520Cell%2520Melanoma%2520Res.%26date%3D2008%26volume%3D21%26spage%3D123%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Yoon, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamashita, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, I.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakae, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, O.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, B.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sumida, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ju, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamura, M.</span><span> </span><span class="NLM_article-title">Activin receptor-like kinase 5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes</span> <span class="citation_source-journal">EMBO Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1720</span><span class="NLM_x">–</span> <span class="NLM_lpage">1739</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1002%2Femmm.201302524" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=24127404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslWms73I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=1720-1739&author=J.-H.+Yoonauthor=S.+M.+Jungauthor=S.+H.+Parkauthor=M.+Katoauthor=T.+Yamashitaauthor=I.-K.+Leeauthor=K.+Sudoauthor=S.+Nakaeauthor=J.+S.+Hanauthor=O.-H.+Kimauthor=B.-C.+Ohauthor=T.+Sumidaauthor=M.+Kurodaauthor=J.-H.+Juauthor=K.+C.+Jungauthor=S.+H.+Parkauthor=D.-K.+Kimauthor=M.+Mamura&title=Activin+receptor-like+kinase+5+inhibition+suppresses+mouse+melanoma+by+ubiquitin+degradation+of+Smad4%2C+thereby+derepressing+eomesodermin+in+cytotoxic+T+lymphocytes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes</span></div><div class="casAuthors">Yoon, Jeong-Hwan; Jung, Su Myung; Park, Seok Hee; Kato, Mitsuyasu; Yamashita, Tadashi; Lee, In-Kyu; Sudo, Katsuko; Nakae, Susumu; Han, Jin Soo; Kim, Ok-Hee; Oh, Byung-Chul; Sumida, Takayuki; Kuroda, Masahiko; Ju, Ji-Hyeon; Jung, Kyeong Cheon; Park, Seong Hoe; Kim, Dae-Kee; Mamura, Mizuko</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1720-1739</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Varieties of transforming growth factor-β (TGF-β) antagonists have been developed to intervene with excessive TGF-β signalling activity in cancer.  Activin receptor-like kinase5 (ALK5) inhibitors antagonize TGF-β signalling by blocking TGF-β receptor-activated Smad (R-Smad) phosphorylation.  Here we report the novel mechanisms how ALK5 inhibitors exert a therapeutic effect on a mouse B16 melanoma model.  Oral treatment with a novel ALK5 inhibitor, EW-7197 (2.5 mg/kg daily) or a representative ALK5 inhibitor, LY-2157299 (75 mg/kg bid) suppressed the progression of melanoma with enhanced cytotoxic T-lymphocyte (CTL) responses.  Notably, ALK5 inhibitors not only blocked R-Smad phosphorylation, but also induced ubiquitin-mediated degrdn. of the common Smad, Smad4 mainly in CD8+ T cells in melanoma-bearing mice.  Accordingly, T-cell-specific deletion of Smad4 was sufficient to suppress the progression of melanoma.  We further identified eomesodermin (Eomes), the T-box transcription factor regulating CTL functions, as a specific target repressed by TGF-β via Smad4 and Smad3 in CD8+ T cells.  Thus, ALK5 inhibition enhances anti-melanoma CTL responses through ubiquitin-mediated degrdn. of Smad4 in addn. to the direct inhibitory effect on R-Smad phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBWYUCVgPm97Vg90H21EOLACvtfcHk0lgLcaUjTEQatw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslWms73I&md5=f647384d8ad977a4ee446fb2de7623e6</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1002%2Femmm.201302524&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201302524%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DJ.-H.%26aulast%3DJung%26aufirst%3DS.%2BM.%26aulast%3DPark%26aufirst%3DS.%2BH.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DI.-K.%26aulast%3DSudo%26aufirst%3DK.%26aulast%3DNakae%26aufirst%3DS.%26aulast%3DHan%26aufirst%3DJ.%2BS.%26aulast%3DKim%26aufirst%3DO.-H.%26aulast%3DOh%26aufirst%3DB.-C.%26aulast%3DSumida%26aufirst%3DT.%26aulast%3DKuroda%26aufirst%3DM.%26aulast%3DJu%26aufirst%3DJ.-H.%26aulast%3DJung%26aufirst%3DK.%2BC.%26aulast%3DPark%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DMamura%26aufirst%3DM.%26atitle%3DActivin%2520receptor-like%2520kinase%25205%2520inhibition%2520suppresses%2520mouse%2520melanoma%2520by%2520ubiquitin%2520degradation%2520of%2520Smad4%252C%2520thereby%2520derepressing%2520eomesodermin%2520in%2520cytotoxic%2520T%2520lymphocytes%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2013%26volume%3D5%26spage%3D1720%26epage%3D1739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Constandinou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iredale, J. P.</span><span> </span><span class="NLM_article-title">Modeling liver fibrosis in rodents</span> <span class="citation_source-journal">Methods Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">237</span><span class="NLM_x">–</span> <span class="NLM_lpage">250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=16118456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A280%3ADC%252BD2MvltFCqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2005&pages=237-250&author=C.+Constandinouauthor=N.+Hendersonauthor=J.+P.+Iredale&title=Modeling+liver+fibrosis+in+rodents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Modeling liver fibrosis in rodents</span></div><div class="casAuthors">Constandinou Christothea; Henderson Neil; Iredale John P</div><div class="citationInfo"><span class="NLM_cas:title">Methods in molecular medicine</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">237-50</span>
        ISSN:<span class="NLM_cas:issn">1543-1894</span>.
    </div><div class="casAbstract">Animal models of hepatic fibrosis provide a means to study the cell and molecular mediators of fibrosis in a serial manner during both progression and recovery.  Several approaches to induction of fibrosis have been described.  Of these, CCl(4) intoxication in rats and mice is probably the most widely studied.  In addition, the CCl(4) model is the best characterized with respect to histological, biochemical, cell, and molecular changes associated with the development of fibrosis.  CCl(4) can be given intraperitoneally or by oral gavage; it induces zone III necrosis and hepatocyte apoptosis with associated hepatic stellate cell activation and tissue fibrosis.  With repetitive dosing CCl(4) can be used to induce bridging hepatic fibrosis (4 wk of twice-weekly dosing), cirrhosis (8 wk of twice-weekly dosing) and advanced micronodular cirrhosis (12 wk of twice-weekly dosing).  In addition, for each of these models spontaneous recovery from fibrosis can be studied after cessation of dosing.  Mechanistic studies using gene knockout and transgenic animals can also be established using CCl(4).  Together these models have provided unparalleled insights into the mechanisms underlying hepatic fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSzYI3kOuuGXZPq5LRczm8ffW6udTcc2eYv8yviIY3znrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MvltFCqsw%253D%253D&md5=1076cb561bd7ec945c2e3364dc778d39</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DConstandinou%26aufirst%3DC.%26aulast%3DHenderson%26aufirst%3DN.%26aulast%3DIredale%26aufirst%3DJ.%2BP.%26atitle%3DModeling%2520liver%2520fibrosis%2520in%2520rodents%26jtitle%3DMethods%2520Mol.%2520Med.%26date%3D2005%26volume%3D117%26spage%3D237%26epage%3D250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Park, S.-A; Kim, M.-J.; Kim, S. W.; Lee, S.-J.; Park, S.-Y.; Kim, S.-J.; Jee, J. I.; Park, M.-K.; Kim, D.-K.; Nam, J.-S.; Sheen, Y. Y.</span> Unpublished results.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Park%2C+S.-A%3B+Kim%2C+M.-J.%3B+Kim%2C+S.+W.%3B+Lee%2C+S.-J.%3B+Park%2C+S.-Y.%3B+Kim%2C+S.-J.%3B+Jee%2C+J.+I.%3B+Park%2C+M.-K.%3B+Kim%2C+D.-K.%3B+Nam%2C+J.-S.%3B+Sheen%2C+Y.+Y.+Unpublished+results."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.-A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="note"><p class="first last">The analysis was done by Bruker SMART APEX II X-ray crystallograph and Bruker SHELXTL structure analysis program.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Sawyer, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beight, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britt, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodson, T. G.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herron, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMillen, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mort, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yingling, J. M.</span><span> </span><span class="NLM_article-title">Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4<i>H</i>-pyrrolo[1,2-<i>b</i>]pyrazole inhibitors of the transforming growth factor-β type I receptor kinase domain</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3581</span><span class="NLM_x">–</span> <span class="NLM_lpage">3584</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3581-3584&author=J.+S.+Sawyerauthor=D.+W.+Beightauthor=K.+S.+Brittauthor=B.+D.+Andersonauthor=R.+M.+Campbellauthor=T.+G.+Goodsonauthor=D.+K.+Herronauthor=H.-Y.+Liauthor=W.+T.+McMillenauthor=N.+Mortauthor=S.+Parsonsauthor=E.+C.+R.+Smithauthor=J.+R.+Wagnerauthor=L.+Yanauthor=F.+Zhangauthor=J.+M.+Yingling&title=Synthesis+and+activity+of+new+aryl-+and+heteroaryl-substituted+5%2C6-dihydro-4H-pyrrolo%5B1%2C2-b%5Dpyrazole+inhibitors+of+the+transforming+growth+factor-%CE%B2+type+I+receptor+kinase+domain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSawyer%26aufirst%3DJ.%2BS.%26aulast%3DBeight%26aufirst%3DD.%2BW.%26aulast%3DBritt%26aufirst%3DK.%2BS.%26aulast%3DAnderson%26aufirst%3DB.%2BD.%26aulast%3DCampbell%26aufirst%3DR.%2BM.%26aulast%3DGoodson%26aufirst%3DT.%2BG.%26aulast%3DHerron%26aufirst%3DD.%2BK.%26aulast%3DLi%26aufirst%3DH.-Y.%26aulast%3DMcMillen%26aufirst%3DW.%2BT.%26aulast%3DMort%26aufirst%3DN.%26aulast%3DParsons%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DE.%2BC.%2BR.%26aulast%3DWagner%26aufirst%3DJ.%2BR.%26aulast%3DYan%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DYingling%26aufirst%3DJ.%2BM.%26atitle%3DSynthesis%2520and%2520activity%2520of%2520new%2520aryl-%2520and%2520heteroaryl-substituted%25205%252C6-dihydro-4H-pyrrolo%255B1%252C2-b%255Dpyrazole%2520inhibitors%2520of%2520the%2520transforming%2520growth%2520factor-%25CE%25B2%2520type%2520I%2520receptor%2520kinase%2520domain%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3581%26epage%3D3584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Tolonen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petsalo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turpeinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uusitalo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pelkonen, O.</span><span> </span><span class="NLM_article-title">In vitro interaction cocktail assay for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC/MSMS run: analytical validation and testing with monoclonal anti-CYP antibodies</span> <span class="citation_source-journal">J. Mass Spectrom.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">960</span><span class="NLM_x">–</span> <span class="NLM_lpage">966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2007&pages=960-966&author=A.+Tolonenauthor=A.+Petsaloauthor=M.+Turpeinenauthor=J.+Uusitaloauthor=O.+Pelkonen&title=In+vitro+interaction+cocktail+assay+for+nine+major+cytochrome+P450+enzymes+with+13+probe+reactions+and+a+single+LC%2FMSMS+run%3A+analytical+validation+and+testing+with+monoclonal+anti-CYP+antibodies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTolonen%26aufirst%3DA.%26aulast%3DPetsalo%26aufirst%3DA.%26aulast%3DTurpeinen%26aufirst%3DM.%26aulast%3DUusitalo%26aufirst%3DJ.%26aulast%3DPelkonen%26aufirst%3DO.%26atitle%3DIn%2520vitro%2520interaction%2520cocktail%2520assay%2520for%2520nine%2520major%2520cytochrome%2520P450%2520enzymes%2520with%252013%2520probe%2520reactions%2520and%2520a%2520single%2520LC%252FMSMS%2520run%253A%2520analytical%2520validation%2520and%2520testing%2520with%2520monoclonal%2520anti-CYP%2520antibodies%26jtitle%3DJ.%2520Mass%2520Spectrom.%26date%3D2007%26volume%3D42%26spage%3D960%26epage%3D966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Makielski, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">January, C. T.</span><span> </span><span class="NLM_article-title">Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature</span> <span class="citation_source-journal">Biophys. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">230</span><span class="NLM_x">–</span> <span class="NLM_lpage">241</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1016%2FS0006-3495%2898%2977782-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=9449325" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADyaK1cXhvFWjurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1998&pages=230-241&author=Z.+Zhouauthor=Q.+Gongauthor=B.+Yeauthor=Z.+Fanauthor=J.+C.+Makielskiauthor=G.+A.+Robertsonauthor=C.+T.+January&title=Properties+of+HERG+channels+stably+expressed+in+HEK+293+cells+studied+at+physiological+temperature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature</span></div><div class="casAuthors">Zhou, Zhengfeng; Gong, Qiuming; Ye, Bin; Fan, Zheng; Makielski, Jonathan C.; Robertson, Gail A.; January, Craig T.</div><div class="citationInfo"><span class="NLM_cas:title">Biophysical Journal</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">230-241</span>CODEN:
                <span class="NLM_cas:coden">BIOJAU</span>;
        ISSN:<span class="NLM_cas:issn">0006-3495</span>.
    
            (<span class="NLM_cas:orgname">Biophysical Society</span>)
        </div><div class="casAbstract">We have established stably transfected HEK 293 cell lines expressing high levels of functional human ether-a go-go-related gene (HERG) channels.  We used these cells to study biochem. characteristics of HERG protein, and to study electrophysiol. and pharmacol. properties of HERG channel current at 35°C.  HERG-transfected cells expressed an mRNA band at 4.0 kb.  Western blot anal. showed two protein bands (155 and 135 kDa) slightly larger than the predicted mol. mass (127 kDa).  Treatment with N-glycosidase F converted both bands to smaller mol. mass, suggesting that both are glycosylated, but at different levels.  HERG current activated at voltages pos. to -50 mV, max. current was reached with depolarizing steps to -10 mV, and the current amplitude declined at more pos. voltages, similar to HERG channel current expressed in other heterologous systems.  C.d. at 35°C, compared with 23°C, was increased by more than twofold to a max. of 53.4 ± 6.5 pA/pF.  Activation, inactivation, recovery from inactivation, and deactivation kinetics were rapid at 35°C, and more closely resemble values reported for the rapidly activating delayed rectifier K+ current (IKr) at physiol. temps.  HERG channels were highly selective for K+.  When we used an action potential clamp technique, HERG current activation began shortly after the upstroke of the action potential waveform.  HERG current increased during repolarization to reach a max. amplitude during phases 2 and 3 of the cardiac action potential.  HERG contributed current throughout the return of the membrane to the resting potential, and deactivation of HERG current could participate in phase 4 depolarization.  HERG current was blocked by low concns. of E-4031 (IC50 7.7 nM), a value close to that reported for IKr in native cardiac myocytes.  Our data support the postulate that HERG encodes a major constituent of IKr and suggest that at physiol. temps. HERG contributes current throughout most of the action potential and into the postrepolarization period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfeVZx9D4R2LVg90H21EOLACvtfcHk0lga94RedKCeBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhvFWjurg%253D&md5=4c7587215c9013a75b34d9fcbaaefc2c</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0006-3495%2898%2977782-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-3495%252898%252977782-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DYe%26aufirst%3DB.%26aulast%3DFan%26aufirst%3DZ.%26aulast%3DMakielski%26aufirst%3DJ.%2BC.%26aulast%3DRobertson%26aufirst%3DG.%2BA.%26aulast%3DJanuary%26aufirst%3DC.%2BT.%26atitle%3DProperties%2520of%2520HERG%2520channels%2520stably%2520expressed%2520in%2520HEK%2520293%2520cells%2520studied%2520at%2520physiological%2520temperature%26jtitle%3DBiophys.%2520J.%26date%3D1998%26volume%3D74%26spage%3D230%26epage%3D241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Frazier, K.</span><span> </span><span class="NLM_article-title">Investigative toxicology: the state of the art</span>. In  <span class="citation_source-book">Emerging Safety Science: Workshop Summary</span>; <span class="NLM_contrib-group">Robinson, S.; Pool, R.; Giffin, R.</span>, Eds.; <span class="NLM_publisher-name">National Academies Press</span>: <span class="NLM_publisher-loc">Washington, DC</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">, </span>: pp  <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=5-12&author=K.+Frazierauthor=S.+Robinson&author=R.+Pool&author=R.+Giffin&title=Emerging+Safety+Science%3A+Workshop+Summary"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DFrazier%26aufirst%3DK.%26atitle%3DInvestigative%2520toxicology%253A%2520the%2520state%2520of%2520the%2520art%26btitle%3DEmerging%2520Safety%2520Science%253A%2520Workshop%2520Summary%26aulast%3DRobinson%26aufirst%3DS.%26pub%3DNational%2520Academies%2520Press%26date%3D2008%26spage%3D5%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Anderton, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellor, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sadler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pass, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, R. R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heier, A.</span><span> </span><span class="NLM_article-title">Induction of heart valve lesions by small-molecule ALK5 inhibitors</span> <span class="citation_source-journal">Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">916</span><span class="NLM_x">–</span> <span class="NLM_lpage">924</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1177%2F0192623311416259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=21859884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVGrsLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2011&pages=916-924&author=M.+J.+Andertonauthor=H.+R.+Mellorauthor=A.+Bellauthor=C.+Sadlerauthor=M.+Passauthor=S.+Powellauthor=S.+J.+Steeleauthor=R.+R.+A.+Robertsauthor=A.+Heier&title=Induction+of+heart+valve+lesions+by+small-molecule+ALK5+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of heart valve lesions by small-molecule ALK5 inhibitors</span></div><div class="casAuthors">Anderton, Mark J.; Mellor, Howard R.; Bell, Alex; Sadler, Claire; Pass, Martin; Powell, Steve; Steele, Samantha J.; Roberts, Ruth. R. A.; Heier, Annabelle</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">916-924</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">Aberrant signaling by transforming growth factor-β (TGF-β) and its type I (ALK5) receptor has been implicated in a no. of human diseases and this pathway is considered a potential target for therapeutic intervention.  Transforming growth factor-β signaling via ALK5 plays a crit. role during heart development, but the role of ALK5 in the adult heart is poorly understood.  In the current study, the preclin. toxicol. of ALK5 inhibitors from two different chem. scaffolds was explored.  Ten-week-old female Han Wistar rats received test compds. by the oral route for three to seven days.  Both compds. induced histopathol. heart valve lesions characterized by hemorrhage, inflammation, degeneration, and proliferation of valvular interstitial cells.  The pathol. was obsd. in all animals, at all doses tested, and occurred in all four heart valves.  Immunohistochem. anal. of ALK5 in rat hearts revealed expression in the valves, but not in the myocardium.  Compared to control animals, protein levels of ALK5 were unchanged in the heart valves of treated animals.  We also obsd. a physeal dysplasia in the femoro-tibial joint of rats treated with ALK5 inhibitors, a finding consistent with a pharmacol. effect described previously with ALK5 inhibitors.  Overall, these findings suggest that TGF-β signaling via ALK5 plays a crit. role in maintaining heart valve integrity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_pEB0XdgFC7Vg90H21EOLACvtfcHk0lga94RedKCeBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVGrsLfF&md5=b835e106847bcb743d59ec95f9a097cc</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1177%2F0192623311416259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0192623311416259%26sid%3Dliteratum%253Aachs%26aulast%3DAnderton%26aufirst%3DM.%2BJ.%26aulast%3DMellor%26aufirst%3DH.%2BR.%26aulast%3DBell%26aufirst%3DA.%26aulast%3DSadler%26aufirst%3DC.%26aulast%3DPass%26aufirst%3DM.%26aulast%3DPowell%26aufirst%3DS.%26aulast%3DSteele%26aufirst%3DS.%2BJ.%26aulast%3DRoberts%26aufirst%3DR.%2BR.%2BA.%26aulast%3DHeier%26aufirst%3DA.%26atitle%3DInduction%2520of%2520heart%2520valve%2520lesions%2520by%2520small-molecule%2520ALK5%2520inhibitors%26jtitle%3DToxicol.%2520Pathol.%26date%3D2011%26volume%3D39%26spage%3D916%26epage%3D924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Frazier, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scicchitano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mirabile, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyce, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grygielko, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nold, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Gouville, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laping, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gellibert, F.</span><span> </span><span class="NLM_article-title">Inhibition of ALK5 signaling induces physeal dysplasia in rats</span> <span class="citation_source-journal">Toxicol. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">284</span><span class="NLM_x">–</span> <span class="NLM_lpage">295</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1080%2F01926230701198469" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=17366323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BD2sXlsVSnsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=284-295&author=K.+Frazierauthor=R.+Thomasauthor=M.+Scicchitanoauthor=R.+Mirabileauthor=R.+Boyceauthor=D.+Zimmermanauthor=E.+Grygielkoauthor=J.+Noldauthor=A.+C.+de+Gouvilleauthor=S.+Huetauthor=N.+Lapingauthor=F.+Gellibert&title=Inhibition+of+ALK5+signaling+induces+physeal+dysplasia+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of ALK5 signaling induces physeal dysplasia in rats</span></div><div class="casAuthors">Frazier, Kendall; Thomas, Roberta; Scicchitano, Marshall; Mirabile, Rosanna; Boyce, Rogely; Zimmerman, Dawn; Grygielko, Eugene; Nold, James; DeGouville, Anne-Charlotte; Huet, Stephane; Laping, Nicholas; Gellibert, Francoise</div><div class="citationInfo"><span class="NLM_cas:title">Toxicologic Pathology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">284-295</span>CODEN:
                <span class="NLM_cas:coden">TOPADD</span>;
        ISSN:<span class="NLM_cas:issn">0192-6233</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare USA, Inc.</span>)
        </div><div class="casAbstract">TGF-|β|, and its type 1 (ALK5) receptor, are crit. to the pathogenesis of fibrosis.  In toxicol. studies of 4 or more days in 10-wk-old Sprague-Dawley rats, using an ALK5 inhibitor (GW788388), expansion of hypertrophic and proliferation zones of femoral physes were noted.  Subphyseal hyperostosis, chondrocyte hypertrophy/hyperplasia, and increased matrix were present.  Physeal zones were laser microdissected from ALK5 inhibitor-treated and control rats sacrificed after 3 days of treatment.  Transcripts for TGF-|β|1, TGF-|β|2, ALK5, IHH, VEGF, BMP-7, IGF-1, bFGF, and PTHrP were amplified by real-time PCR.  IGF and IHH increased in all physis zones with treatment, but were most prominent in prehypertrophic zones.  TGF-|β|2, bFGF and BMP7 expression increased in proliferative, pre- and hypertrophic zones.  PTHrP expression was elevated in proliferative zones but decreased in hypertrophic zones.  VEGF expression was increased after treatment in pre- and hypertrophic zones.  ALK5 expression was elevated in prehypertrophic zones.  Zymog. demonstrated gelatinolytic activity was reduced after treatment.  Apoptotic markers (TUNEL and caspase-3) were decreased in hypertrophic zones.  Proliferation assessed by Topoisomerase II and Ki67 was increased in multiple zones.  Movat stains demonstrated that proteoglycan deposition was altered.  Physeal changes occurred at doses well above those resulting in fibrosis.  Interactions of factors is important in producing the physeal dysplasia phenotype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX60thajdZ97Vg90H21EOLACvtfcHk0lga94RedKCeBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXlsVSnsrw%253D&md5=a0827c42ea4272d0196df9e1f488e2b1</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1080%2F01926230701198469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F01926230701198469%26sid%3Dliteratum%253Aachs%26aulast%3DFrazier%26aufirst%3DK.%26aulast%3DThomas%26aufirst%3DR.%26aulast%3DScicchitano%26aufirst%3DM.%26aulast%3DMirabile%26aufirst%3DR.%26aulast%3DBoyce%26aufirst%3DR.%26aulast%3DZimmerman%26aufirst%3DD.%26aulast%3DGrygielko%26aufirst%3DE.%26aulast%3DNold%26aufirst%3DJ.%26aulast%3Dde%2BGouville%26aufirst%3DA.%2BC.%26aulast%3DHuet%26aufirst%3DS.%26aulast%3DLaping%26aufirst%3DN.%26aulast%3DGellibert%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520ALK5%2520signaling%2520induces%2520physeal%2520dysplasia%2520in%2520rats%26jtitle%3DToxicol.%2520Pathol.%26date%3D2007%26volume%3D35%26spage%3D284%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Carabello, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crawford, F. A.,  Jr.</span><span> </span><span class="NLM_article-title">Valvular heart disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">337</span><span class="NLM_x">, </span> <span class="NLM_fpage">32</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1056%2FNEJM199707033370107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=9203430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A280%3ADyaK2szjtVOksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=1997&pages=32-41&author=B.+A.+Carabelloauthor=F.+A.+Crawford&title=Valvular+heart+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Valvular heart disease</span></div><div class="casAuthors">Carabello B A; Crawford F A Jr</div><div class="citationInfo"><span class="NLM_cas:title">The New England journal of medicine</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">32-41</span>
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSCuKjiwv3RHdXdcedVHT5tfW6udTcc2eYAjfb83WFlLLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2szjtVOksg%253D%253D&md5=cbcb7f2bbb3827bfc3bd17daf1792544</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1056%2FNEJM199707033370107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199707033370107%26sid%3Dliteratum%253Aachs%26aulast%3DCarabello%26aufirst%3DB.%2BA.%26aulast%3DCrawford%26aufirst%3DF.%2BA.%26atitle%3DValvular%2520heart%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1997%26volume%3D337%26spage%3D32%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Ahnert, J. R.; Baselga, J.; Calvo, E.; Seoane, J.; Brana, I.; Sicart, E.; Gueorguieva, I.; Cleverly, A.; Lahn, M. M. F.; Pillay, S.; Holdhoff, M.; Blakeley, J. O.; Carducci, M. A.</span><span> </span><span class="NLM_article-title">First human dose (FHD) study of the oral transforming growth factor-β receptor I kinase inhibitor LY2157299 in patients with treatment-refractory malignant glioma</span>.  <span class="citation_source-journal">J. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">Abstract 3011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2011&pages=Abstract+3011&author=J.+R.+Ahnert&author=J.+Baselga&author=E.+Calvo&author=J.+Seoane&author=I.+Brana&author=E.+Sicart&author=I.+Gueorguieva&author=A.+Cleverly&author=M.+M.+F.+Lahn&author=S.+Pillay&author=M.+Holdhoff&author=J.+O.+Blakeley&author=M.+A.+Carducci&title=First+human+dose+%28FHD%29+study+of+the+oral+transforming+growth+factor-%CE%B2+receptor+I+kinase+inhibitor+LY2157299+in+patients+with+treatment-refractory+malignant+glioma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhnert%26aufirst%3DJ.%2BR.%26atitle%3DFirst%2520human%2520dose%2520%2528FHD%2529%2520study%2520of%2520the%2520oral%2520transforming%2520growth%2520factor-%25CE%25B2%2520receptor%2520I%2520kinase%2520inhibitor%2520LY2157299%2520in%2520patients%2520with%2520treatment-refractory%2520malignant%2520glioma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2011%26volume%3D29%26spage%3DAbstract%25203011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Hodi, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Day, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDermott, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sosman, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haanen, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schadendorf, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hassel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akerley, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van den Eertwegh, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lutzky, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorigan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaubel, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linette, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoqq, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottensmeier, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebbé, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peschel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quirt, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolchok, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yellin, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichol, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urba, W. J.</span><span> </span><span class="NLM_article-title">Improved survival with ipilimumab in patients with metastatic melanoma</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">711</span><span class="NLM_x">–</span> <span class="NLM_lpage">723</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1056%2FNEJMoa1003466" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=20525992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVCrtrbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=711-723&author=F.+S.+Hodiauthor=S.+J.+O%E2%80%99Dayauthor=D.+F.+McDermottauthor=R.+W.+Weberauthor=J.+A.+Sosmanauthor=J.+B.+Haanenauthor=R.+Gonzalezauthor=C.+Robertauthor=D.+Schadendorfauthor=J.+C.+Hasselauthor=W.+Akerleyauthor=A.+J.+van+den+Eertweghauthor=J.+Lutzkyauthor=P.+Loriganauthor=J.+M.+Vaubelauthor=G.+P.+Linetteauthor=D.+Hoqqauthor=C.+H.+Ottensmeierauthor=C.+Lebb%C3%A9author=C.+Peschelauthor=I.+Quirtauthor=J.+I.+Clarkauthor=J.+D.+Wolchokauthor=J.+S.+Weberauthor=J.+Tianauthor=M.+J.+Yellinauthor=G.+M.+Nicholauthor=A.+Hoosauthor=W.+J.+Urba&title=Improved+survival+with+ipilimumab+in+patients+with+metastatic+melanoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Improved survival with ipilimumab in patients with metastatic melanoma</span></div><div class="casAuthors">Hodi, F. Stephen; O'day, Steven J.; McDermott, David F.; Weber, Robert W.; Sosman, Jeffrey A.; Haanen, John B.; Gonzalez, Rene; Robert, Caroline; Schadendorf, Dirk; Hassel, Jessica C.; Akerley, Wallace; van den Eertwegh, Alfons J. M.; Lutzky, Jose; Lorigan, Paul; Vaubel, Julia M.; Linette, Gerald P.; Hogg, David; Ottensmeier, Christian H.; Lebbe, Celeste; Peschel, Christian; Quirt, Ian; Clark, Joseph I.; Wolchok, Jedd D.; Weber, Jeffrey S.; Tian, Jason; Yellin, Michael J.; Nichol, Geoffrey M.; Hoos, Axel; Urba, Walter J.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">711-723</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: An improvement in overall survival among patients with metastatic melanoma has been an elusive goal.  In this phase 3 study, ipilimumab - which blocks cytotoxic T-lymphocyte-assocd. antigen 4 to potentiate an antitumor T-cell response - administered with or without a glycoprotein 100 (gp100) peptide vaccine was compared with gp100 alone in patients with previously treated metastatic melanoma.  Methods: A total of 676 HLA-A*0201-pos. patients with unresectable stage III or IV melanoma, whose disease had progressed while they were receiving therapy for metastatic disease, were randomly assigned, in a 3:1:1 ratio, to receive ipilimumab plus gp100 (403 patients), ipilimumab alone (137), or gp100 alone (136).  Ipilimumab, at a dose of 3 mg per kg of body wt., was administered with or without gp100 every 3 wk for up to four treatments (induction).  Eligible patients could receive reinduction therapy.  The primary end point was overall survival.  Results: The median overall survival was 10.0 mo among patients receiving ipilimumab plus gp100, as compared with 6.4 mo among patients receiving gp100 alone (hazard ratio for death, 0.68; P < 0.001).  The median overall survival with ipilimumab alone was 10.1 mo (hazard ratio for death in the comparison with gp100 alone, 0.66; P = 0.003).  No difference in overall survival was detected between the ipilimumab groups (hazard ratio with ipilimumab plus gp100, 1.04; P = 0.76).  Grade 3 or 4 immune-related adverse events occurred in 10 to 15% of patients treated with ipilimumab and in 3% treated with gp100 alone.  There were 14 deaths related to the study drugs (2.1%), and 7 were assocd. with immune-related adverse events.  Conclusions: Ipilimumab, with or without a gp100 peptide vaccine, as compared with gp100 alone, improved overall survival in patients with previously treated metastatic melanoma.  Adverse events can be severe, long-lasting, or both, but most are reversible with appropriate treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmWp_goUg4SbVg90H21EOLACvtfcHk0ljNg32ou9zA5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVCrtrbN&md5=170a241290808ccccac26a5169e6c715</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1003466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1003466%26sid%3Dliteratum%253Aachs%26aulast%3DHodi%26aufirst%3DF.%2BS.%26aulast%3DO%25E2%2580%2599Day%26aufirst%3DS.%2BJ.%26aulast%3DMcDermott%26aufirst%3DD.%2BF.%26aulast%3DWeber%26aufirst%3DR.%2BW.%26aulast%3DSosman%26aufirst%3DJ.%2BA.%26aulast%3DHaanen%26aufirst%3DJ.%2BB.%26aulast%3DGonzalez%26aufirst%3DR.%26aulast%3DRobert%26aufirst%3DC.%26aulast%3DSchadendorf%26aufirst%3DD.%26aulast%3DHassel%26aufirst%3DJ.%2BC.%26aulast%3DAkerley%26aufirst%3DW.%26aulast%3Dvan%2Bden%2BEertwegh%26aufirst%3DA.%2BJ.%26aulast%3DLutzky%26aufirst%3DJ.%26aulast%3DLorigan%26aufirst%3DP.%26aulast%3DVaubel%26aufirst%3DJ.%2BM.%26aulast%3DLinette%26aufirst%3DG.%2BP.%26aulast%3DHoqq%26aufirst%3DD.%26aulast%3DOttensmeier%26aufirst%3DC.%2BH.%26aulast%3DLebb%25C3%25A9%26aufirst%3DC.%26aulast%3DPeschel%26aufirst%3DC.%26aulast%3DQuirt%26aufirst%3DI.%26aulast%3DClark%26aufirst%3DJ.%2BI.%26aulast%3DWolchok%26aufirst%3DJ.%2BD.%26aulast%3DWeber%26aufirst%3DJ.%2BS.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DYellin%26aufirst%3DM.%2BJ.%26aulast%3DNichol%26aufirst%3DG.%2BM.%26aulast%3DHoos%26aufirst%3DA.%26aulast%3DUrba%26aufirst%3DW.%2BJ.%26atitle%3DImproved%2520survival%2520with%2520ipilimumab%2520in%2520patients%2520with%2520metastatic%2520melanoma%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D711%26epage%3D723" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Katre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akhter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanucchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Postlethwait, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.-M.</span><span> </span><span class="NLM_article-title">Increased transforming growth factor beta 1 expression mediates ozone-induced airway fibrosis in mice</span> <span class="citation_source-journal">Inhalation Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">494</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.3109%2F08958378.2011.584919" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=21689010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns1OhsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2011&pages=486-494&author=A.+Katreauthor=C.+Ballingerauthor=H.+Akhterauthor=M.+Fanucchiauthor=D.-K.+Kimauthor=E.+Postlethwaitauthor=R.-M.+Liu&title=Increased+transforming+growth+factor+beta+1+expression+mediates+ozone-induced+airway+fibrosis+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Increased transforming growth factor beta 1 expression mediates ozone-induced airway fibrosis in mice</span></div><div class="casAuthors">Katre, Ashwini; Ballinger, Carol; Akhter, Hasina; Fanucchi, Michelle; Kim, Dae-Kee; Postlethwait, Edward; Liu, Rui-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Inhalation Toxicology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">486-494</span>CODEN:
                <span class="NLM_cas:coden">INHTE5</span>;
        ISSN:<span class="NLM_cas:issn">0895-8378</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Ozone (O3), a commonly encountered environmental pollutant, has been shown to induce pulmonary fibrosis in different animal models; the underlying mechanism, however, remains elusive.  To investigate the mol. mechanism underlying O3-induced pulmonary fibrosis, 6- to 8-wk-old C57BL/6 male mice were exposed to a cyclic O3 exposure protocol consisting of 2 days of filtered air and 5 days of O3 exposure (0.5 ppm, 8 h/day) for 5 and 10 cycles with or without i.p. injection of IN-1233, a specific inhibitor of the type 1 receptor of transforming growth factor beta (TGF-β), the most potent profibrogenic cytokine.  The results showed that O3 exposure for 5 or 10 cycles increased the TGF-β protein level in the epithelial lining fluid (ELF), assocd. with an increase in the expression of plasminogen activator inhibitor 1 (PAI-1), a TGF-β-responsive gene that plays a crit. role in the development of fibrosis under various pathol. conditions.  Cyclic O3 exposure also increased the deposition of collagens and alpha smooth muscle actin (α-SMA) in airway walls.  However, these fibrotic changes were not overt until after 10 cycles of O3 exposure.  Importantly, blockage of the TGF-β signaling pathway with IN-1233 suppressed O3-induced Smad2/3 phosphorylation, PAI-1 expression, as well as collagens and α-SMA deposition in the lung.  Our data demonstrate for the first time that O3 exposure increases TGF-β expression and activates TGF-β signaling pathways, which mediates O3-induced lung fibrotic responses in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfXxTCcW6eeLVg90H21EOLACvtfcHk0ljNg32ou9zA5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns1OhsL0%253D&md5=d6083cf3c42e14349530b8eec6f97f51</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.3109%2F08958378.2011.584919&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08958378.2011.584919%26sid%3Dliteratum%253Aachs%26aulast%3DKatre%26aufirst%3DA.%26aulast%3DBallinger%26aufirst%3DC.%26aulast%3DAkhter%26aufirst%3DH.%26aulast%3DFanucchi%26aufirst%3DM.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DPostlethwait%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DR.-M.%26atitle%3DIncreased%2520transforming%2520growth%2520factor%2520beta%25201%2520expression%2520mediates%2520ozone-induced%2520airway%2520fibrosis%2520in%2520mice%26jtitle%3DInhalation%2520Toxicol.%26date%3D2011%26volume%3D23%26spage%3D486%26epage%3D494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span> </span><span class="NLM_article-title">IN-1233, an ALK-5 inhibitor: prevention of granulation tissue formation after bare metallic stent placement in a rat urethral model</span> <span class="citation_source-journal">Radiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">75</span><span class="NLM_x">–</span> <span class="NLM_lpage">82</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=2010&pages=75-82&author=J.+H.+Kimauthor=H.-Y.+Songauthor=J.-H.+Parkauthor=H.-J.+Yoonauthor=H.+G.+Parkauthor=D.-K.+Kim&title=IN-1233%2C+an+ALK-5+inhibitor%3A+prevention+of+granulation+tissue+formation+after+bare+metallic+stent+placement+in+a+rat+urethral+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DSong%26aufirst%3DH.-Y.%26aulast%3DPark%26aufirst%3DJ.-H.%26aulast%3DYoon%26aufirst%3DH.-J.%26aulast%3DPark%26aufirst%3DH.%2BG.%26aulast%3DKim%26aufirst%3DD.-K.%26atitle%3DIN-1233%252C%2520an%2520ALK-5%2520inhibitor%253A%2520prevention%2520of%2520granulation%2520tissue%2520formation%2520after%2520bare%2520metallic%2520stent%2520placement%2520in%2520a%2520rat%2520urethral%2520model%26jtitle%3DRadiology%26date%3D2010%26volume%3D255%26spage%3D75%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Yoon, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, K.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span> </span><span class="NLM_article-title">Role of IN-1233 in the prevention of neointimal hyperplasia after stent placement in a rat artery model</span> <span class="citation_source-journal">J. Vasc.  Interv. Radiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1321</span><span class="NLM_x">–</span> <span class="NLM_lpage">1328</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=1321-1328&author=H.-J.+Yoonauthor=H.-Y.+Songauthor=J.+H.+Kimauthor=K.-S.+Hongauthor=Y.+J.+Kimauthor=H.+G.+Parkauthor=D.-K.+Kim&title=Role+of+IN-1233+in+the+prevention+of+neointimal+hyperplasia+after+stent+placement+in+a+rat+artery+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYoon%26aufirst%3DH.-J.%26aulast%3DSong%26aufirst%3DH.-Y.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DHong%26aufirst%3DK.-S.%26aulast%3DKim%26aufirst%3DY.%2BJ.%26aulast%3DPark%26aufirst%3DH.%2BG.%26aulast%3DKim%26aufirst%3DD.-K.%26atitle%3DRole%2520of%2520IN-1233%2520in%2520the%2520prevention%2520of%2520neointimal%2520hyperplasia%2520after%2520stent%2520placement%2520in%2520a%2520rat%2520artery%2520model%26jtitle%3DJ.%2520Vasc.%2520%2520Interv.%2520Radiol.%26date%3D2011%26volume%3D22%26spage%3D1321%26epage%3D1328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Kim, E.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, H.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Na, H. K.</span><span> </span><span class="NLM_article-title">IN-1233-eluting covered metallic stent to prevent hyperplasia: experimental study in a rabbit esophageal model</span> <span class="citation_source-journal">Radiology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">404</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2013&pages=396-404&author=E.-Y.+Kimauthor=H.-Y.+Songauthor=J.+H.+Kimauthor=Y.+Fanauthor=S.+Parkauthor=D.-K.+Kimauthor=E.+W.+Leeauthor=H.+K.+Na&title=IN-1233-eluting+covered+metallic+stent+to+prevent+hyperplasia%3A+experimental+study+in+a+rabbit+esophageal+model"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DE.-Y.%26aulast%3DSong%26aufirst%3DH.-Y.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DLee%26aufirst%3DE.%2BW.%26aulast%3DNa%26aufirst%3DH.%2BK.%26atitle%3DIN-1233-eluting%2520covered%2520metallic%2520stent%2520to%2520prevent%2520hyperplasia%253A%2520experimental%2520study%2520in%2520a%2520rabbit%2520esophageal%2520model%26jtitle%3DRadiology%26date%3D2013%26volume%3D267%26spage%3D396%26epage%3D404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Long, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Southwood, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, D.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrell, N. W.</span><span> </span><span class="NLM_article-title">Altered BMP and TGF-β signalling in rat models of pulmonary hypertension: potential for ALK-5 inhibition in prevention and progression of disease</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">566</span><span class="NLM_x">–</span> <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2009&pages=566-576&author=L.+Longauthor=A.+Crosbyauthor=X.+Yangauthor=M.+Southwoodauthor=P.+D.+Uptonauthor=D.-K.+Kimauthor=N.+W.+Morrell&title=Altered+BMP+and+TGF-%CE%B2+signalling+in+rat+models+of+pulmonary+hypertension%3A+potential+for+ALK-5+inhibition+in+prevention+and+progression+of+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DL.%26aulast%3DCrosby%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DSouthwood%26aufirst%3DM.%26aulast%3DUpton%26aufirst%3DP.%2BD.%26aulast%3DKim%26aufirst%3DD.-K.%26aulast%3DMorrell%26aufirst%3DN.%2BW.%26atitle%3DAltered%2520BMP%2520and%2520TGF-%25CE%25B2%2520signalling%2520in%2520rat%2520models%2520of%2520pulmonary%2520hypertension%253A%2520potential%2520for%2520ALK-5%2520inhibition%2520in%2520prevention%2520and%2520progression%2520of%2520disease%26jtitle%3DCirculation%26date%3D2009%26volume%3D119%26spage%3D566%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span>SYBYL molecular modeling software, <span class="NLM_edition">8.1</span> ed.; <span class="NLM_publisher-name">Tripos Inc.</span>: <span class="NLM_publisher-loc">St. Louis, MO</span>,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SYBYL+molecular+modeling+software%2C+8.1+ed.%3B+Tripos+Inc.%3A+St.+Louis%2C+MO%2C+2008."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSYBYL%2520molecular%2520modeling%2520software%26pub%3DTripos%2520Inc%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Spitzer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jain, A. N.</span><span> </span><span class="NLM_article-title">Surflex-dock: docking benchmarks and real-world application</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">699</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm500115w&amp;key=10.1007%2Fs10822-011-9533-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm500115w&amp;key=22569590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm500115w&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVelu7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2012&pages=687-699&author=R.+Spitzerauthor=A.+N.+Jain&title=Surflex-dock%3A+docking+benchmarks+and+real-world+application"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Surflex-Dock: Docking benchmarks and real-world application</span></div><div class="casAuthors">Spitzer, Russell; Jain, Ajay N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">687-699</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Benchmarks for mol. docking have historically focused on re-docking the cognate ligand of a well-detd. protein-ligand complex to measure geometric pose prediction accuracy, and measurement of virtual screening performance has been focused on increasingly large and diverse sets of target protein structures, cognate ligands, and various types of decoy sets.  Here, pose prediction is reported on the Astex Diverse set of 85 protein ligand complexes, and virtual screening performance is reported on the DUD set of 40 protein targets.  In both cases, prepd. structures of targets and ligands were provided by symposium organizers.  The re-prepd. data sets yielded results not significantly different than previous reports of Surflex-Dock on the two benchmarks.  Minor changes to protein coordinates resulting from complex pre-optimization had large effects on obsd. performance, highlighting the limitations of cognate ligand re-docking for pose prediction assessment.  Docking protocols developed for cross-docking, which address protein flexibility and produce discrete families of predicted poses, produced substantially better performance for pose prediction.  Performance on virtual screening performance was shown to benefit by employing and combining multiple screening methods: docking, 2D mol. similarity, and 3D mol. similarity.  In addn., use of multiple protein conformations significantly improved screening enrichment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPgES-yaoU4rVg90H21EOLACvtfcHk0lg-_QP5vOWgGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVelu7nN&md5=78637e767d2ad764f4b89c24ef3c7a56</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1007%2Fs10822-011-9533-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-011-9533-y%26sid%3Dliteratum%253Aachs%26aulast%3DSpitzer%26aufirst%3DR.%26aulast%3DJain%26aufirst%3DA.%2BN.%26atitle%3DSurflex-dock%253A%2520docking%2520benchmarks%2520and%2520real-world%2520application%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2012%26volume%3D26%26spage%3D687%26epage%3D699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RW8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1RW8','PDB','1RW8'); return false;">PDB: 1RW8</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i114"><a href="/doi/suppl/10.1021/jm500115w">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_73212"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures for compounds <b>13b</b>–<b>p</b> and detailed HPLC conditions for confirming purity of target compounds.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm500115w/suppl_file/jm500115w_si_001.pdf">jm500115w_si_001.pdf (288.13 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm500115w&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm500115w%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-10" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm500115w" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679906840d133c10","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
